0001038133-19-000050.txt : 20190807 0001038133-19-000050.hdr.sgml : 20190807 20190807122816 ACCESSION NUMBER: 0001038133-19-000050 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 84 CONFORMED PERIOD OF REPORT: 20190630 FILED AS OF DATE: 20190807 DATE AS OF CHANGE: 20190807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HESKA CORP CENTRAL INDEX KEY: 0001038133 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 770192527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-22427 FILM NUMBER: 191004629 BUSINESS ADDRESS: STREET 1: 3760 ROCKY MOUNTAIN AVENUE CITY: LOVELAND STATE: CO ZIP: 80538 BUSINESS PHONE: 9704937272 MAIL ADDRESS: STREET 1: 3760 ROCKY MOUNTAIN AVENUE CITY: LOVELAND STATE: CO ZIP: 80538 10-Q 1 heska-06302019x10q.htm 10-Q Document




UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2019
or
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from _________________ to _______________________
Commission file number: 0-22427
heskalogowhtbkgd08.jpg
HESKA CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
77-0192527
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)

3760 Rocky Mountain Avenue
Loveland, Colorado


80538
(Address of principal executive offices)
(Zip Code)

Registrant's telephone number, including area code: (970) 493-7272

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
Common stock, $0.01 par value
HSKA
The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x   No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes x  No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company.  See the definitions of "large accelerated filer," "accelerated filer", "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer o
Accelerated filer x
Non-accelerated filer o
Smaller Reporting Company ¨
 
Emerging growth company o






If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).  Yes o  No x
7,796,571 shares of the Registrant's Public Common Stock, $.01 par value, were outstanding at August 6, 2019.





TABLE OF CONTENTS
 
 
 
 
Page
PART I - FINANCIAL INFORMATION
 
 
Item 1.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       Note 2, Revenue
 
 
 
 
 
 
       Note 5, Income Taxes
 
 
       Note 6, Leases
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Item 2.
 
Item 3.
 
Item 4.
PART II - OTHER INFORMATION
 
 
Item 1.
 
Item 1A.
 
Item 2.
 
Item 6.
 
 

HESKA, ALLERCEPT, HemaTrue, Solo Step, Element DC, Element HT5, Element POC, Element i, Element COAG, Element DC5X and Element RC are registered trademarks of Heska Corporation. DRI-CHEM is a registered trademark of FUJIFILM Corporation. TRI-HEART is a registered trademark of Intervet Inc., d/b/a Merck Animal Health, formerly known as Schering-Plough Animal Health Corporation ("Merck Animal Health"), which is a unit of Merck & Co., Inc., in the United States and is a registered trademark of Heska Corporation in other countries. This quarterly report on Form 10-Q also refers to trademarks and trade names of other organizations.

- i-



PART I. FINANCIAL INFORMATION
Item 1. Financial Statements

HESKA CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share amounts)
 
 
June 30,
 
December 31,
 
 
2019
 
2018
 
 
(unaudited)
 
 
ASSETS
Current assets:
 
 

 
 

Cash and cash equivalents
 
$
9,992

 
$
13,389

Accounts receivable, net of allowance for doubtful accounts of $212 and $245, respectively
 
12,775

 
16,454

Inventories, net
 
28,977

 
25,104

Net investment in leases, current, net of allowance for doubtful accounts of $78 and $40, respectively
 
3,379

 
2,989

Prepaid expenses
 
2,322

 
1,533

Other current assets
 
3,044

 
2,938

Total current assets
 
60,489

 
62,407

 
 
 
 
 
Property and equipment, net
 
15,318

 
15,981

Operating lease right-of-use assets
 
6,092

 
—

Goodwill
 
27,190

 
26,679

Other intangible assets, net
 
9,526

 
9,764

Deferred tax asset, net
 
15,920

 
14,121

Net investment in leases, non-current
 
13,033

 
11,908

Investments in unconsolidated affiliates
 
7,711

 
8,018

Other non-current assets
 
7,565

 
7,574

Total assets
 
$
162,844

 
$
156,452

 
 
 
 
 
LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY
Current liabilities:
 
 

 
 

Accounts payable
 
$
7,330

 
$
7,469

Due to – related parties
 
—

 
226

Accrued liabilities
 
3,755

 
10,142

Current operating lease liabilities
 
1,685

 
—

Current portion of deferred revenue, and other
 
2,615

 
2,526

Total current liabilities
 
15,385

 
20,363

 
 
 
 
 
Deferred revenue, net of current portion
 
6,442

 
7,082

Line of credit
 
12,750

 
6,000

Non-current operating lease liabilities
 
4,819

 
—

Other liabilities
 
196

 
598

Total liabilities
 
39,592

 
34,043

 
 
 
 
 
Commitments and contingencies (Note 14)
 


 


 
 
 
 
 
Redeemable non-controlling interest and mezzanine equity
 
330

 
—

 
 
 
 
 
Stockholders' equity:
 
 

 
 

Preferred stock, $.01 par value, 2,500,000 and 2,500,000 shares authorized, respectively, none issued or outstanding
 
—

 
—

Common stock, $.01 par value, 10,250,000 and 10,250,000 shares authorized, respectively, none issued or outstanding
 
—

 
—

Public common stock, $.01 par value, 10,250,000 and 10,250,000 shares authorized, 7,794,271 and 7,675,692 shares issued and outstanding, respectively
 
78

 
77

Additional paid-in capital
 
256,952

 
257,034

Accumulated other comprehensive income
 
298

 
277

Accumulated deficit
 
(134,406
)
 
(134,979
)
Total stockholders' equity
 
122,922

 
122,409

Total liabilities, mezzanine equity and stockholders' equity
 
$
162,844

 
$
156,452


See accompanying notes to condensed consolidated financial statements.

-1-



HESKA CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(in thousands, except per share amounts)
(unaudited)
 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
 
2019
 
2018
 
2019
 
2018
Revenue:
 
 
 
 

 
 
 
 
Core companion animal
 
$
24,716

 
$
26,644

 
$
49,432

 
$
53,463

Other vaccines and pharmaceuticals
 
3,430

 
3,018

 
8,225

 
8,964

Total revenue, net
 
28,146

 
29,662

 
57,657

 
62,427

 
 
 
 
 
 
 
 
 
Cost of revenue
 
15,734

 
16,597

 
32,702

 
36,055

 
 
 
 
 
 
 
 
 
Gross profit
 
12,412

 
13,065

 
24,955

 
26,372

 
 
 
 
 
 
 
 
 
Operating expenses:
 
 
 
 

 
 
 
 
Selling and marketing
 
6,715

 
5,944

 
13,748

 
12,084

Research and development
 
2,239

 
559

 
3,605

 
1,229

General and administrative
 
4,024

 
4,358

 
8,243

 
8,984

Total operating expenses
 
12,978

 
10,861

 
25,596

 
22,297

Operating (loss) income
 
(566
)
 
2,204

 
(641
)
 
4,075

Interest and other expense, net
 
21

 
92

 
5

 
88

(Loss) income before income taxes and equity in losses of unconsolidated affiliates
 
(587
)
 
2,112

 
(646
)
 
3,987

Income tax (benefit) expense:
 
 
 
 

 
 
 
 
Current income tax expense
 
28

 
12

 
72

 
29

Deferred income tax (benefit) expense
 
(454
)
 
203

 
(1,508
)
 
(94
)
Total income tax (benefit) expense
 
(426
)
 
215

 
(1,436
)
 
(65
)
 
 
 
 
 
 
 
 
 
Net (loss) income before equity in losses of unconsolidated affiliates
 
(161
)
 
1,897

 
790

 
4,052

Equity in losses of unconsolidated affiliates
 
(127
)
 
—

 
(308
)
 
—

Net (loss) income after equity in losses of unconsolidated affiliates
 
(288
)
 
1,897

 
482

 
4,052

Net loss attributable to redeemable non-controlling interest
 
(47
)
 
—

 
(91
)
 
—

Net (loss) income attributable to Heska Corporation
 
$
(241
)
 
$
1,897

 
$
573

 
$
4,052

 
 
 
 
 
 
 
 
 
Basic (loss) earnings per share attributable to Heska Corporation
 
$
(0.03
)
 
$
0.26

 
$
0.08

 
$
0.57

Diluted (loss) earnings per share attributable to Heska Corporation
 
$
(0.03
)
 
$
0.24

 
$
0.07

 
$
0.52

 
 
 
 
 
 
 
 
 
Weighted average outstanding shares used to compute basic (loss) earnings per share attributable to Heska Corporation
 
7,486

 
7,226

 
7,463

 
7,146

Weighted average outstanding shares used to compute diluted (loss) earnings per share attributable to Heska Corporation
 
7,486

 
7,850

 
7,956

 
7,781

 
See accompanying notes to condensed consolidated financial statements.


-2-



HESKA CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in thousands) 
(unaudited)

 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
 
2019
 
2018
 
2019
 
2018
Net (loss) income after equity in losses of unconsolidated affiliates
 
$
(288
)
 
$
1,897

 
$
482

 
$
4,052

Other comprehensive (loss) income:
 
 
 
 

 
 
 
 
Foreign currency translation
 
83

 
(112
)
 
21

 
(31
)
Comprehensive (loss) income
 
(205
)
 
1,785

 
503

 
4,021

 
 
 
 
 
 
 
 
 
Comprehensive loss attributable to redeemable non-controlling interest
 
(47
)
 
—

 
(91
)
 
—

Comprehensive (loss) income attributable to Heska Corporation
 
$
(158
)
 
$
1,785

 
$
594

 
$
4,021

 
See accompanying notes to condensed consolidated financial statements.


-3-



HESKA CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(in thousands) 
(unaudited)

 
 
 
 
Common Stock
 
 
Additional
Paid-in
Capital
 
Accumulated
Other
Comprehensive
Income
 
 
 
Accumulated
Deficit
 
 
Total
Stockholders'
Equity
Three Months Ended June 30, 2018 and 2019
 
Shares
 
Amount
 
Balances, March 31, 2018
 
7,419

 
$
74

 
$
243,377

 
$
313

 
$
(138,673
)
 
$
105,091

Net income attributable to Heska Corporation
 
—

 
—

 
—

 
—

 
1,897

 
1,897

Issuance of common stock, net of shares withheld for employee taxes
 
79

 
1

 
1,741

 
—

 
—

 
1,742

Stock-based compensation
 
—

 
—

 
1,304

 
—

 
—

 
1,304

Other comprehensive loss
 
—

 
—

 
—

 
(112
)
 
—

 
(112
)
Balances, June 30, 2018
 
7,498

 
$
75

 
$
246,422

 
$
201

 
$
(136,776
)
 
$
109,922

 
 
 
 
 
 
 
 
 
 
 
 
 
Balances, March 31, 2019
 
7,747

 
$
77

 
$
255,150

 
$
215

 
$
(134,165
)
 
$
121,277

Net loss attributable to Heska Corporation
 
—

 
—

 
—

 
—

 
(241
)
 
(241
)
Issuance of common stock, net of shares withheld for employee taxes
 
47

 
1

 
607

 
—

 
—

 
608

Stock-based compensation
 
—

 
—

 
1,195

 
—

 
—

 
1,195

Other comprehensive income
 
—

 
—

 
—

 
83

 
—

 
83

Balances, June 30, 2019
 
7,794

 
$
78

 
$
256,952

 
$
298

 
$
(134,406
)
 
$
122,922

 
 
 
 
 
 
 
 
 
 
 
 
 
Note: Excludes amounts related to redeemable non-controlling interests recorded in mezzanine equity.
 
 
 
 
Common Stock
 
 
Additional
Paid-in
Capital
 
Accumulated
Other
Comprehensive
Income
 
 
 
Accumulated
Deficit
 
 
Total
Stockholders'
Equity
Six Months Ended June 30, 2018 and 2019
 
Shares
 
Amount
 
Balances, December 31, 2017
 
7,303

 
$
73

 
$
243,598

 
$
232

 
$
(143,463
)
 
$
100,440

Adoption of accounting standards
 
—

 
—

 
—

 
—

 
2,635

 
2,635

Balances, January 1, 2018, as adjusted
 
7,303

 
73

 
243,598

 
232

 
(140,828
)
 
103,075

Net income attributable to Heska Corporation
 
—

 
—

 
—

 
—

 
4,052

 
4,052

Issuance of common stock, net of shares withheld for employee taxes
 
195

 
2

 
456

 
—

 
—

 
458

Stock-based compensation
 
—

 
—

 
2,368

 
—

 
—

 
2,368

Other comprehensive loss
 
—

 
—

 
—

 
(31
)
 
—

 
(31
)
Balances, June 30, 2018
 
7,498

 
$
75

 
$
246,422

 
$
201

 
$
(136,776
)
 
$
109,922

 
 
 
 
 
 
 
 
 
 
 
 
 
Balances, December 31, 2018
 
7,676

 
$
77

 
$
257,034

 
$
277

 
$
(134,979
)
 
$
122,409

Net income attributable to Heska Corporation
 
—

 
—

 
—

 
—

 
573

 
573

Issuance of common stock, net of shares withheld for employee taxes
 
118

 
1

 
(2,462
)
 
—

 
—

 
(2,461
)
Stock-based compensation
 
—

 
—

 
2,380

 
—

 
—

 
2,380

Other comprehensive income
 
—

 
—

 
—

 
21

 
—

 
21

Balances, June 30, 2019
 
7,794

 
$
78

 
$
256,952

 
$
298

 
$
(134,406
)
 
$
122,922

 
 
 
 
 
 
 
 
 
 
 
 
 
Note: Excludes amounts related to redeemable non-controlling interests recorded in mezzanine equity.
See accompanying notes to condensed consolidated financial statements.

-4-



HESKA CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
 
 
Six Months Ended
June 30,
 
 
2019
 
2018
CASH FLOWS FROM OPERATING ACTIVITIES:
 
 
 
 
Net income after equity in losses from unconsolidated affiliates
 
$
482

 
$
4,052

Adjustments to reconcile net income to cash (used in) provided by operating activities:
 
 

 
 

Depreciation and amortization
 
2,522

 
2,333

Non-cash impact of operating leases
 
750

 
—

Deferred income tax benefit
 
(1,508
)
 
(94
)
Stock-based compensation
 
2,380

 
2,368

Equity in losses of unconsolidated affiliates

 
308

 
—

Other losses
 
245

 
8

Changes in operating assets and liabilities (net of the effect of acquisitions):
 
 

 
 

Accounts receivable
 
3,764

 
2,780

Inventories
 
(2,978
)
 
3,192

Due from related parties
 
—

 
1

Lease receivable, current
 
(392
)
 
(524
)
Other current assets
 
(531
)
 
250

Accounts payable
 
(707
)
 
(2,510
)
Due to related parties
 
(226
)
 
(1,336
)
Accrued liabilities and other
 
(7,680
)
 
(1,332
)
Lease receivable, non-current
 
(1,090
)
 
(1,526
)
Other non-current assets
 
28

 
(706
)
Deferred revenue and other
 
(723
)
 
(2,457
)
Net cash (used in) provided by operating activities
 
(5,356
)
 
4,499

CASH FLOWS FROM INVESTING ACTIVITIES:
 
 
 
 
Investment in subsidiary, net of cash acquired
 
(622
)
 
—

Purchases of property and equipment
 
(629
)
 
(811
)
Proceeds from disposition of property and equipment
 
—

 
4

Net cash used in investing activities
 
(1,251
)
 
(807
)
CASH FLOWS FROM FINANCING ACTIVITIES:
 
 
 
 
Borrowings on line of credit
 
6,750

 
—

Proceeds from issuance of common stock
 
1,018

 
1,613

Repurchase of common stock
 
(3,480
)
 
(1,155
)
Distributions to non-controlling interest members
 
—

 
(126
)
Repayments of other debt
 
(1,083
)
 
—

Net cash provided by financing activities
 
3,205

 
332

NET EFFECT OF EXCHANGE RATE CHANGES ON CASH
 
5

 
(8
)
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS
 
(3,397
)
 
4,016

CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD
 
13,389

 
9,659

CASH AND CASH EQUIVALENTS, END OF PERIOD
 
$
9,992

 
$
13,675

 
 
 
 
 
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
 
 
 
 
Non-cash transfers of equipment between inventory and property and equipment, net
 
$
878

 
$
528


See accompanying notes to condensed consolidated financial statements.

-5-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS



1.    OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Heska Corporation and its wholly-owned subsidiaries ("Heska", the "Company", "we" or "our") sell veterinary and animal health diagnostic and specialty products. Our offerings include Point of Care diagnostic laboratory instruments and supplies; digital imaging diagnostic products, software and services; vaccines; local and cloud-based data services; allergy testing and immunotherapy; and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. Our core focus is on supporting veterinarians in the canine and feline healthcare space.
Basis of Presentation and Consolidation
In the opinion of management, the accompanying unaudited Condensed Consolidated Financial Statements contain all adjustments, consisting of normal, recurring adjustments, necessary to present fairly the financial position of the Company as of June 30, 2019 and December 31, 2018, the results of our operations and statements of stockholders' equity for the three and six months ended June 30, 2019 and 2018, and cash flows for the six months ended June 30, 2019 and 2018.
The unaudited Condensed Consolidated Financial Statements included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") have been condensed or omitted pursuant to such rules and regulations. Our unaudited Condensed Consolidated Financial Statements include our accounts and the accounts of our wholly-owned subsidiaries since their respective dates of acquisitions. All intercompany accounts and transactions have been eliminated in consolidation. Where our ownership of a subsidiary is less than 100%, the non-controlling interest is reported on our Condensed Consolidated Balance Sheets. The non-controlling interest in our consolidated net income is reported as "Net loss attributable to redeemable non-controlling interest" on our Condensed Consolidated Statements of Income. These unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018 and other financial information filed with the SEC.
Reclassification
To maintain consistency and comparability, certain amounts in the financial statements have been reclassified to conform to current year presentation.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates are required when establishing the allowance for doubtful accounts and the net realizable value of inventory; determining future costs associated with warranties provided; determining the period over which our obligations are fulfilled under agreements to license product rights and/or technology rights; evaluating long-lived and intangible assets and investments for estimated useful lives and impairment; estimating the useful lives of instruments under leasing arrangements; determining the allocation of purchase price under purchase accounting; estimating the expense associated with the granting of stock; determining the need for, and the amount of a valuation allowance on deferred tax assets; and determining the value of the non-controlling interest in a business combination.

-6-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


Critical Accounting Policies
Our accounting policies are described in our audited Consolidated Financial Statements and Notes thereto contained in our Annual Report on Form 10-K for the year ended December 31, 2018 and other than the recently adopted accounting pronouncements described below, have not changed significantly since such filing.
Adoption of New Accounting Pronouncements

Effective January 1, 2019, we adopted ASU 2018-07, Compensation – Stock Compensation (Topic 718), Improvements to Non-employee Share-Based Payment Accounting. This ASU is intended to simplify aspects of share-based compensation issued to non-employees by making the guidance consistent with accounting for employee share-based compensation. Guidance related to the stock compensation granted to employees is followed for non-employees, including the measurement date, valuation approach and performance conditions. The expense is recognized in the same period as though cash were paid for the good or service, ratably over the service period. The adoption of this ASU did not have an impact on our consolidated financial statements but did have a minimal impact on our related disclosures.

Effective January 1, 2019, we adopted ASU 2018-02, Income Statement-Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. The ASU permits companies to elect a reclassification of the disproportionate tax effects in accumulated other comprehensive income ("AOCI") caused by the Tax Cuts and Jobs Act of 2017 to retained earnings. As of June 30, 2019, the Company does not have any disproportionate income tax effects in AOCI to reclassify. However, if the Company did have disproportionate income tax effects in AOCI in the future, it would reclassify them to retained earnings.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which supersedes ASC 840, Leases. This update requires lessees to recognize a right-of-use (“ROU”) asset and a lease liability for all leases, including operating leases, with terms greater than 12 months on its balance sheet. The update also expands the required quantitative and qualitative disclosures by lessees and lessors about the amount, timing and uncertainty of cash flows arising from leases. The accounting for lessors does not fundamentally change except for changes to conform and align guidance to the lessee guidance as well as to the new revenue recognition guidance in ASU 2014-09, Revenue from Contracts with Customers (Topic 606). Subsequent to the issuance of Topic 842, the FASB clarified the guidance through several ASUs; hereinafter the collection of lease guidance is referred to as “ASC 842”.

The Company adopted ASC 842 on January 1, 2019, using the modified retrospective approach for all lease arrangements at the beginning of the period of adoption. Results for reporting periods beginning January 1, 2019 are presented under ASC 842, while prior period amounts were not adjusted and continue to be reported in accordance with the Company’s historic accounting under ASC 840, Leases. For leases that commenced before the effective date of ASC 842, the Company elected the permitted practical expedients to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. The Company also elected to exclude leases with a term of 12 months or less from the recognized ROU assets and lease liabilities.

Adoption of the standard did not have a material net impact in our Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Income or Condensed Consolidated Statements of Cash Flows. The most significant impact was the recognition of ROU assets and lease liabilities for the operating leases, of which we are the lessee. As a result of the cumulative impact of adopting ASC 842, the Company recorded operating lease ROU assets of $6.5 million and operating lease liabilities of $6.9 million as of January 1,

-7-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


2019, primarily related to building, vehicle, and office equipment leases, based on the present value of the future lease payments on the date of adoption. As a lessor, accounting for our subscription agreements will remain substantially unchanged. Refer to Note 6 for additional disclosures required by ASC 842.
The Company determines if an arrangement is a lease at inception based on whether control of an identified asset is transferred. For leases where the Company is the lessee, ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as amortization expense and interest expense. The Company has lease agreements which require payments for lease and non-lease components and has elected to account for these as a single lease component for our building and office equipment leases, but as separate components for our vehicle leases.

Our revenue under subscription agreements relates to both operating-type lease (“OTL”) arrangements and sales-type lease (“STL”) arrangements. Determination of an OTL or STL is primarily determined as a result of the length of the contract as compared to the estimated useful life of the instrument, among other factors. A STL results in earlier recognition of instrument revenue. The cost of the customer-leased instruments is removed from inventory and recognized in the Consolidated Statements of Income. There is no residual value taken into consideration as it does not meet our capitalization requirements. Instrument lease revenue for OTL agreements is recognized on a straight-line basis over the life of the lease and included with the predominant non-lease components in consumable revenue. The costs of customer-leased instruments are recorded within property and equipment in the accompanying Consolidated Balance Sheets and depreciated over the instrument’s estimated useful life. The depreciation expense is reflected in cost of revenue in the accompanying Consolidated Statements of Income. The OTLs and STLs are not cancellable until after an initial term and include an option to renew.
For lease arrangements with lease and non-lease components where the Company is the lessor, the Company allocates the total contract consideration to the lease and non-lease components on a relative standalone selling price basis using the Company’s best estimate of the standalone selling price of each distinct product or service in the contract. The primary method used to estimate standalone selling price is the price observed in standalone sales to customers of a prior period. Changes in these values can impact the amount of consideration allocated to each component of the contract. When prices in standalone sales are not available, we may use a cost-plus margin approach. Allocation of the transaction price is determined at the inception of the lease arrangement. The Company’s leases consist of leases with fixed and variable lease payments. For those leases with variable lease payments, the variable lease payment is typically based upon purchase of consumables used with the leased instruments and included in consumable revenue.
Accounting Pronouncements Not Yet Adopted

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326), which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected. The income statement reflects the measurement of credit losses for newly recognized financial assets, as well as the increases or decreases of expected credit losses that have taken place during the period. The measurement of expected credit losses is based upon historical experience, current conditions and reasonable and supportable

-8-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


forecasts that affect the collectability of the reported amount. Subsequent to the issuance of ASU 2016-13, the FASB issued ASU 2018-19, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, in November 2018. This ASU clarifies that receivables from operating leases are accounted for using the lease guidance and not as financial instruments. In April 2019, the FASB issued ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments, which further clarifies and improves guidance related to accounting for credit losses. In May 2019, the FASB issued ASU 2019-05, Financial Instruments - Credit Losses (Topic 326). This ASU provides relief to certain entities adopting ASU 2016-13. The amendment provides entities with an option to irrevocably elect the fair value option for certain financial assets. These amendments are effective for fiscal years beginning after December 15, 2019 and interim periods within those annual periods. We are currently evaluating the amended guidance and the impact on our consolidated financial statements and will adopt the provisions in the first quarter of 2020.

2.     REVENUE

We separate our goods and services among:

•
Point of Care laboratory products including instruments, consumables and services;
•
Point of Care imaging products including instruments, software and services;
•
Single use pharmaceuticals, vaccines and diagnostic tests primarily related to companion animals; and
•
Other vaccines and pharmaceuticals ("OVP").
The following table summarizes our Core Companion Animal ("CCA") revenue (in thousands):
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Point of Care laboratory revenue:
$
16,120

 
$
15,053

 
$
32,081

 
$
28,693

    Consumables
13,208

 
11,524

 
25,524

 
22,344

    Sales-type leases
1,493

 
1,793

 
3,234

 
3,331

    Outright instrument sales
1,045

 
1,335

 
2,575

 
2,146

    Other
374

 
401

 
748

 
872

 
 
 
 
 
 
 
 
Point of Care imaging revenue:
5,229

 
4,462

 
10,639

 
10,434

    Outright instrument sales
4,405

 
3,566

 
8,951

 
8,705

    Service revenue
558

 
544

 
1,120

 
1,099

    Operating type leases and other
266

 
352

 
568

 
630

 
 
 
 
 
 
 
 
Other CCA revenue:
3,367

 
7,129

 
6,712

 
14,336

    Other pharmaceuticals, vaccines and diagnostic tests
3,281

 
6,991

 
6,527

 
14,102

    Research and development, license and royalty
    revenue
86

 
138

 
185

 
234

 
 
 
 
 
 
 
 
Total CCA revenue
$
24,716

 
$
26,644

 
$
49,432

 
$
53,463



-9-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


Revenue from our OVP segment consists of revenue generated from contract manufacturing agreements and from other license, research and development revenue. The following table summarizes our OVP revenue (in thousands):
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Contract manufacturing
$
3,327

 
$
2,887

 
$
7,994

 
$
8,678

License, research and development
103

 
131

 
231

 
286

Total OVP revenue
$
3,430

 
$
3,018

 
$
8,225

 
$
8,964


Remaining Performance Obligations

Remaining performance obligations represent the aggregate transaction price allocated to performance obligations with an original contract term greater than one year which are fully or partially unsatisfied at the end of the period. Remaining performance obligations include noncancelable purchase orders, the non-lease portion of minimum purchase commitments under long-term supply arrangements, extended warranty, service and other long-term contracts. Remaining performance obligations do not include revenue from contracts with customers with an original term of one year or less, revenue from long-term supply arrangements with no minimum purchase requirements, revenue expected from purchases made in excess of the minimum purchase requirements, or revenue from instruments leased to customers. While the remaining performance obligation disclosure is similar in concept to backlog, the definition of remaining performance obligations excludes leases and contracts that provide the customer with the right to cancel or terminate for convenience with no substantial penalty, even if historical experience indicates the likelihood of cancellation or termination is remote. Additionally, the Company has elected to exclude contracts with customers with an original term of one year or less from remaining performance obligations.

As of June 30, 2019, the aggregate amount of the transaction price allocated to remaining minimum performance obligations was approximately $89.5 million. As of June 30, 2019, the Company expects to recognize revenue as follows (in thousands):
Year Ending December 31,
Revenue
2019 (remaining)
$
12,289

2020
22,138

2021
18,315

2022
15,244

2023
11,848

Thereafter
9,641

 
$
89,475


Contract Balances

The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets) and deferred revenue, and customer deposits and billings in excess of revenue recognized (contract liabilities) on the Condensed Consolidated Balance Sheets. In addition, the Company defers certain costs incurred to obtain contracts (contract costs).


-10-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


Contract Receivables

Certain unbilled receivable balances related to long-term contracts for which we provide a free term to the customer where revenue has been recognized are recorded in other current and other non-current assets. We have no further performance obligations related to these receivable balances and the collection of these balances occurs over the term of the underlying contract. The balances as of June 30, 2019 were $1.0 million and $3.5 million for current and non-current assets, respectively, shown net of related unearned interest. The balances as of December 31, 2018 were $0.9 million and $3.3 million for current and non-current assets, respectively, shown net of related unearned interest.

Contract Liabilities

The Company receives cash payments from customers for licensing fees or other arrangements that extend for a specified term. These contract liabilities are classified as either current or long-term in the Condensed Consolidated Balance Sheets based on the timing of when the Company expects to recognize revenue. As of June 30, 2019 and December 31, 2018, contract liabilities were $8.9 million and $9.6 million, respectively, and are included within "Current portion of deferred revenue, and other" and "Deferred revenue, net of current portion" in the accompanying Condensed Consolidated Balance Sheets. The decrease in the contract liability balance during the six-month period ended June 30, 2019 is approximately $1.5 million of revenue recognized during the period, offset by approximately $0.7 million of additional deferred sales in 2019.

Contract Costs

The Company capitalizes certain direct incremental costs incurred to obtain customer contracts, typically sales-related commissions, where the recognition period for the related revenue is greater than one year. Contract costs are classified as current or non-current, and are included in "Other current assets" and "Other non-current assets" in the Condensed Consolidated Balance Sheets based on the timing of when the Company expects to recognize the expense. Contract costs are generally amortized into selling and marketing expense with a certain percentage recognized immediately based upon placement of the instrument with the remainder recognized on a straight-line basis (which is consistent with the transfer of control for the related goods or services) over the average term of the underlying contracts, approximately 6 years. Management assesses these costs for impairment at least quarterly on a portfolio basis and as “triggering” events occur that indicate it is more-likely-than-not that an impairment exists. The balance of contract costs as of June 30, 2019 and December 31, 2018 was $2.6 million and $2.5 million, respectively. Amortization expense for the six-month period ended June 30, 2019 was approximately $0.5 million, offset by approximately $0.6 million of additional contract costs capitalized.

Contract liabilities are reported on the accompanying Condensed Consolidated Balance Sheets on a contract-by-contract basis whereas contract costs are calculated and reported on a portfolio basis.

3.    ACQUISITIONS AND RELATED PARTY ITEMS
Optomed
On February 22, 2019, Heska acquired 70% of the equity of Optomed, a French-based endoscopy company, in exchange for approximately $0.2 million in cash and the assumption of approximately $0.4 million in debt. As part of the purchase, Heska entered into put options and call options on the remaining 30% minority interest. The written put options can be exercised based on the achievement of certain financial conditions over a specified period of time for a fixed amount. The options are not currently exercisable at the acquisition date or the reporting date. The estimated value of the non-controlling interest is inclusive of the probability

-11-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


weighted outcome of the options described herein. The Company is in process of finalizing its purchase price allocation. As part of the purchase agreement, Heska has committed to purchase from the minority interest holder, by the end of the fiscal year, real estate in the amount of approximately $1.0 million, which is currently under lease by Optomed.
Cuattro Veterinary Acquisitions
In February 2013, the Company acquired a majority interest in Cuattro Veterinary USA, LLC, which was owned by Kevin S. Wilson, among other members. The subsidiary was subsequently renamed Heska Imaging US, LLC ("US Imaging"). The remaining minority position in US Imaging was subject to purchase by Heska under a performance-based put option which was exercised in March 2017. In May 2017, we purchased the remaining minority interest position in US Imaging.

In May 2016, the Company closed a transaction to acquire Cuattro Veterinary, LLC ("International Imaging"), which was owned by Kevin S. Wilson, among other members. International Imaging is a provider to international markets of digital radiography technologies for veterinarians. As a leading provider of advanced veterinary diagnostic and specialty products, we made the acquisition in an effort to combine International Imaging's global reach with our domestic success in the imaging and laboratory markets in the United States.

In June 2017, the Company consolidated its assets and liabilities in the US Imaging and International Imaging companies into Heska Imaging, LLC ("Heska Imaging"). Cuattro, LLC ("Cuattro") is owned by Kevin S. Wilson, the CEO and President of the Company in addition to Mrs. Wilson and trusts for the benefit of Mr. and Mrs. Wilson's children and family. Steven M. Asakowicz and Rodney A. Lippincott, members of Cuattro Veterinary USA, LLC and Cuattro International prior to the acquisitions, each serve as Executive Vice President, Companion Animal Health Sales for the Company.
Purchase Agreement for Certain Assets
On December 21, 2018, the Company closed a transaction (the "Asset Acquisition") to acquire certain assets from Cuattro, all related to the CCA segment. Pursuant to the Asset Acquisition, dated November 26, 2018, the Company issued 54,763 shares of the Company's common stock, $0.01 par value per share (the "Common Stock"), to Cuattro on the closing date, at an aggregate value equal to approximately $5.4 million based on the adjusted closing price per share of the Common Stock as reported on the Nasdaq Stock Market on the Asset Acquisition agreement date. These shares were issued to Cuattro in a private placement in reliance upon an exemption from the registration requirements of the Securities Act pursuant to Section 4(a)(2) thereof and the safe harbor provided by Rule 506 of Regulation D promulgated thereunder. In addition to the Common Stock, the Company paid cash in the amount of $2.8 million to Cuattro as part of the transaction. The total purchase price was determined based on a valuation report from an independent third party. Part of the Asset Acquisition was an agreement to terminate the supply and license agreement that Heska had been operating under since the acquisition of Cuattro Veterinary USA, LLC.
The Company evaluated the acquisition of the purchased assets under ASC 805, Business Combinations and ASU 2017-01, Business Combinations (Topic 805) and concluded that as substantially all of the fair value of the gross assets acquired is concentrated in an identifiable group of similar assets, the transaction did not meet the requirements to be accounted for as a business combination and therefore was accounted for as an asset acquisition. Accordingly, the purchase price of the purchased assets was allocated entirely to an identifiable intangible asset. In addition to the software assets acquired, Cuattro is obligated, without further compensation, to assist the Company with the implementation of a third-party image hosting platform and necessary data migration.

-12-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


Other Related Party Activities
Cuattro charged Heska Imaging $6.0 thousand and $2.3 million during the six months ended June 30, 2019 and 2018, respectively. The charge in 2019 relates to minor inventory purchases as the Company transitions the digital imaging software assets away from Cuattro. The charge in 2018 was primarily for digital imaging products, pursuant to an underlying supply contract which was terminated in December 2018.

The Company had no receivables from or payables to Cuattro as of June 30, 2019. Heska Imaging owed Cuattro $0.2 million as of December 31, 2018, which is reported in "Due to – related parties" on the Company's Condensed Consolidated Balance Sheets.

4.    INVESTMENTS IN UNCONSOLIDATED AFFILIATES
The carrying values of investments in unconsolidated affiliates, categorized by type of investment, is as follows (in thousands):
 
June 30, 2019
 
December 31, 2018
Equity method investment
$
4,693

 
$
5,000

Non-marketable equity security investment
3,018

 
3,018

 
$
7,711

 
$
8,018

Equity Method Investment
On September 24, 2018, we invested $5.1 million, including costs, in exchange for a 28.7% interest of a business as part of our product development strategy. The Company accounts for this investment using the equity method of accounting. Under the equity method, the carrying value of the investment is adjusted for the Company's proportionate share of the investee's reported earnings or losses with the corresponding share of earnings or losses reported as Equity in losses of unconsolidated affiliates, listed below Net income before equity in losses of unconsolidated affiliates within the Condensed Consolidated Statements of Income. Additionally, the Company will enter into a 15-year Manufacturing Supply Agreement, which grants the Company global exclusivity to specified products.
Non-Marketable Equity Security Investment

On August 8, 2018, the Company invested $3.0 million, including costs, in MBio Diagnostics, Inc. ("MBio"), in exchange for preferred stock, representing a 6.9% interest in MBio. The Company’s investment in MBio is a non-marketable equity security, recorded using the measurement alternative of cost minus impairment, if any, plus or minus changes resulting from qualifying observable price changes.

As part of the agreement, the Company entered into a Supply and License Agreement with MBio, which provides that MBio produce and commercialize products that will enhance the Company's diagnostic portfolio. As part of this agreement, the Company made an upfront payment to MBio of $1.0 million related to a worldwide exclusive license agreement over a 20-year period, recorded in both short and long-term other assets. In addition, the agreement provides for an additional contingent payment from Heska to MBio of $10.0 million, relating to the successful achievement of sales milestones. This potential future milestone payment has not yet been accrued as it is not deemed by the Company to be probable at this time.

Both parties in this arrangement are active participants and are exposed to significant risks and rewards dependent on the commercial success of the activities of the collaboration. The parties are actively working on developing and testing the product as well as funding the research and development. Heska classifies the

-13-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


amounts paid for MBio's research and development work within the CCA segment research and development operating expenses. Expense is recognized ratably when incurred and in accordance with the development plan.
5.    INCOME TAXES

Our total income tax (benefit) expense for our (loss) income before income taxes were as follows (in thousands):
 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
 
2019
 
2018
 
2019
 
2018
(Loss) income before income taxes
 
$
(587
)
 
$
2,112

 
$
(646
)
 
$
3,987

Total income tax (benefit) expense
 
(426
)
 
215

 
(1,436
)
 
(65
)
    
There were cash payments of $28 thousand and cash refunds, net of payments, of $0.1 million, respectively, for income taxes for the three and six months ended June 30, 2019. There were $12 thousand and $30 thousand in cash payments for income taxes, net of refunds, for the three and six months ended June 30, 2018. The Company’s tax benefit increased to $0.4 million and $1.4 million for the three and six months ended June 30, 2019, respectively, compared to the tax expense of $0.2 million for the three months ended June 30, 2018 and tax benefit of $0.1 million for the six months ended June 30, 2018. The increase in tax benefits is due to lower financial income and stock-based compensation excess tax benefits recognized in our income statement. The Company recognized $0.3 million in excess tax benefits related to employee share-based compensation for the three months ended June 30, 2019 compared to $0.4 million recognized for the three months ended June 30, 2018. The Company recognized $1.4 million in excess tax benefits related to employee share-based compensation for the six months ended June 30, 2019 compared to $1.2 million recognized for the six months ended June 30, 2018.

6.    LEASES

Lessee Accounting

The Company leases buildings, office equipment, and vehicles. The Company’s finance leases were not material as of June 30, 2019 and for the three and six month period then ended. ROU assets arising from finance leases are included in Property and equipment, net in the accompanying Condensed Consolidated Balance Sheets. The current portion of the finance lease liabilities are included in Current portion of deferred revenue, and other and the non-current portion of the finance lease liabilities are included in Other liabilities in the accompanying Condensed Consolidated Balance Sheets.

For the three and six months ended June 30, 2019, operating lease expense was $0.6 million and $1.1 million, respectively, including immaterial variable lease costs.

Supplemental cash flow information related to the Company's operating leases for the six months ended June 30, 2019 was as follows (in thousands):

Cash paid for amounts included in the measurement of operating lease liabilities
$
889

ROU assets obtained in exchange for operating lease obligations
341



-14-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


The following table presents the weighted average remaining lease term and weighted average discount rate related to the Company's operating leases as of June 30, 2019:

Weighted average remaining lease term
4.2 years

Weighted average discount rate
4.45
%

The following table presents the maturity of the Company's operating lease liabilities as of June 30, 2019 (in thousands):
Remainder of 2019
$
1,052

2020
1,605

2021
1,429

2022
1,321

2023
1,766

Total operating lease payments
7,173

Less: imputed interest
669

Total operating lease liabilities
$
6,504


Lessor Accounting
 
In our CCA segment, primarily related to our Point of Care laboratory products, the Company enters into sales-type leases as part of our subscription agreements. The following table presents the maturity of the Company's undiscounted lease receivables as of June 30, 2019 (in thousands):

Year Ending December 31,
 
Remainder of 2019
$
1,614

2020
3,596

2021
3,574

2022
3,223

2023
2,431

Thereafter
1,974

 
$
16,412


7.    EARNINGS PER SHARE

Basic earnings per share ("EPS") is computed by dividing net income attributable to the Company by the weighted-average number of common shares outstanding during the period. The computation of diluted EPS is similar to the computation of basic EPS except that the numerator is increased to exclude charges that would not have been incurred, and the denominator is increased to include the number of additional common shares that would have been outstanding (using the if-converted and treasury stock methods), if securities containing potentially dilutive common shares such as stock options converting to common shares, and if such assumed conversion is dilutive.


-15-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


The following is a reconciliation of the weighted-average shares outstanding used in the calculation of basic and diluted EPS for the three and six months ended June 30, 2019 and 2018 (in thousands, except per share data):
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Net (loss) income attributable to Heska Corporation
$
(241
)
 
$
1,897

 
$
573

 
$
4,052

 
 
 
 
 
 
 
 
Basic weighted-average common shares outstanding
7,486

 
7,226

 
7,463

 
7,146

Assumed exercise of dilutive stock options and restricted shares
—

 
624

 
493

 
635

Diluted weighted-average common shares outstanding
$
7,486

 
$
7,850

 
$
7,956

 
$
7,781

 
 
 
 
 
 
 
 
Basic (loss) earnings per share attributable to Heska Corporation
$
(0.03
)
 
$
0.26

 
$
0.08

 
$
0.57

Diluted (loss) earnings per share attributable to Heska Corporation
$
(0.03
)
 
$
0.24

 
$
0.07

 
$
0.52


The following stock options and restricted shares were excluded from the computation of diluted EPS because they would have been anti-dilutive (in thousands):
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Stock options and restricted shares
714

 
169

 
225

 
238

8.    GOODWILL AND OTHER INTANGIBLES

The following summarizes the change in goodwill during the six months ended June 30, 2019 (in thousands):
Carrying amount, December 31, 2018
$
26,679

Goodwill attributable to acquisitions (subject to change)
503

Foreign currency adjustments
8

Carrying amount, June 30, 2019
$
27,190


Other intangibles consisted of the following (in thousands):
 
June 30, 2019
 
December 31, 2018
 
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
 
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
Developed technology
$
8,200

 
$
(410
)
 
$
7,790

 
$
8,200

 
$
—

 
$
8,200

Customer relationships and other
3,700

 
(1,964
)
 
1,736

 
3,303

 
(1,739
)
 
1,564

Total intangible assets
$
11,900

 
$
(2,374
)
 
$
9,526

 
$
11,503

 
$
(1,739
)
 
$
9,764



-16-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


Amortization expense relating to other intangibles was as follows (in thousands):
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Amortization expense
$
305

 
$
97

 
$
607

 
$
194


Estimated amortization expense related to intangibles for each of the five years from 2019 (remaining) through 2023 and thereafter is as follows (in thousands):
Year Ending December 31,
 
2019 (remaining)
$
666

2020
1,287

2021
1,283

2022
1,265

2023
918

Thereafter
4,107

 
$
9,526

9.    PROPERTY AND EQUIPMENT, NET
Property and equipment, net, consisted of the following (in thousands):
 
June 30, 2019
 
December 31, 2018
Land
$
377

 
$
377

Building
2,978

 
2,978

Machinery and equipment
31,013

 
33,087

Office furniture and equipment
1,700

 
1,687

Computer hardware and software
4,749

 
4,704

Leasehold and building improvements
9,981

 
9,953

Construction in progress
1,309

 
1,274

 
52,107

 
54,060

Less accumulated depreciation
(36,789
)
 
(38,079
)
Total property and equipment, net
$
15,318

 
$
15,981

Depreciation expense was $0.9 million and $1.0 million for the three months ended June 30, 2019 and 2018, respectively, and $1.9 million and $2.1 million for the six months ended June 30, 2019 and 2018, respectively.
The Company has subscription agreements whereby its instruments in inventory may be placed at a customer's location on a rental basis. The cost of these instruments is transferred to machinery and equipment and depreciated, typically over a 5 to 7 year period depending on the circumstance under which the instrument is placed with the customer. Our cost of instruments under operating leases as of June 30, 2019 and December 31, 2018, was $10.3 million and $10.8 million, respectively, before accumulated depreciation of $5.7 million and $6.1 million, respectively.

-17-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


10.    INVENTORIES, NET

Inventories, net, consisted of the following (in thousands):
 
June 30, 2019
 
December 31, 2018
Raw materials
$
16,832

 
$
15,000

Work in process
3,807

 
3,592

Finished goods
9,548

 
8,085

Allowance for excess or obsolete inventory
(1,210
)
 
(1,573
)
Total inventory, net
$
28,977

 
$
25,104


Inventories are measured on a first-in, first-out basis and stated at lower of cost or net realizable value.
11.    ACCRUED LIABILITIES
Accrued liabilities consisted of the following (in thousands):
 
June 30, 2019
 
December 31, 2018
Accrued settlement (see Note 14)
$
—

 
$
6,750

Accrued payroll and employee benefits
1,118

 
759

Accrued property taxes
402

 
632

Other
2,235

 
2,001

Total accrued liabilities
$
3,755

 
$
10,142

Other accrued liabilities consists of items that are individually less than 5% of total current liabilities.
12.    CAPITAL STOCK
Stock Option Plans
The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions for options granted in the three and six months ended June 30, 2019 and 2018.
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Risk-free interest rate
1.89%
 
2.76%
 
1.95%
 
2.64%
Expected lives
4.7 years
 
4.9 years
 
4.7 years
 
4.9 years
Expected volatility
40%
 
40%
 
40%
 
40%
Expected dividend yield
0%
 
0%
 
0%
 
0%

-18-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


A summary of our stock option plans is as follows:
 
Six Months Ended June 30,
 
Year Ended December 31,
 
2019
 
2018
 
 
 
 
Options
 
Weighted Average Exercise Price
 
 
 
 
Options
 
Weighted Average Exercise Price
Outstanding at beginning of period
620,553

 
$
40.741

 
630,847

 
$
29.312

Granted at market
11,200

 
$
73.193

 
153,700

 
$
75.244

Forfeited
(256
)
 
$
98.660

 
(18,978
)
 
$
53.010

Expired
—

 
$
—

 
(896
)
 
$
65.414

Exercised
(149,828
)
 
$
16.776

 
(144,120
)
 
$
25.740

Outstanding at end of period
481,669

 
$
48.920

 
620,553

 
$
40.741

Exercisable at end of period
305,452

 
$
33.655

 
386,176

 
$
21.214

The total estimated fair value of stock options granted during the six months ended June 30, 2019 and 2018 was computed to be approximately $0.3 million and $3.5 million, respectively. The amounts are amortized ratably over the vesting periods of the options. The weighted average estimated fair value of options granted during the six months ended June 30, 2019 and 2018 was computed to be approximately $26.67 and $26.74, respectively. The total intrinsic value of options exercised during the six months ended June 30, 2019 and 2018 was $11.6 million and $3.1 million, respectively. The cash proceeds from options exercised during the six months ended June 30, 2019 and 2018 was $0.5 million and $1.3 million, respectively.
The following table summarizes information about stock options outstanding and exercisable at June 30, 2019:
 
 
Options Outstanding
 
Options Exercisable
Exercise Prices
 
Number of
Options
Outstanding
at
June 30, 2019
 
Weighted
Average
Remaining
Contractual
Life in Years
 
Weighted
Average
Exercise
Price
 
Number of
Options
Exercisable
at
June 30, 2019
 
Weighted
Average
Exercise
Price
$ 4.96 - $ 7.36
 
93,352

 
3.65
 
$
6.998

 
93,352

 
$
6.998

$ 7.37 - $ 32.21
 
79,273

 
4.79
 
$
15.897

 
78,941

 
$
15.828

$ 32.22 - $ 62.50
 
57,533

 
6.57
 
$
39.797

 
46,524

 
$
39.724

$ 62.51 - $ 69.77
 
130,000

 
8.68
 
$
69.770

 
43,337

 
$
69.770

$ 69.78 - $ 108.25
 
121,511

 
8.10
 
$
84.684

 
43,298

 
$
80.960

$ 4.96 - $ 108.25
 
481,669

 
6.67
 
$
48.920

 
305,452

 
$
33.655

As of June 30, 2019, there was approximately $4.3 million in total unrecognized compensation cost related to outstanding stock options. That cost is expected to be recognized over a weighted average period of 1.36 years, with all cost to be recognized by the end of February 2023, assuming all options vest according to the vesting schedules in place at June 30, 2019. As of June 30, 2019, the aggregate intrinsic value of outstanding options was approximately $18.3 million and the aggregate intrinsic value of exercisable options was approximately $15.9 million.
The Company issues new shares upon share option exercise, which may be netted or withheld to meet strike price or related tax obligations.

-19-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


Employee Stock Purchase Plan (the "ESPP")

For the three months ended June 30, 2019 and 2018, we issued 2,786 and 2,327 shares under the ESPP, respectively. For the six months ended June 30, 2019 and 2018, we issued 5,369 and 5,454 shares under the ESPP, respectively.
For the three and six months ended June 30, 2019 and 2018, we estimated the fair values of stock purchase rights granted under the ESPP using the Black-Scholes pricing model. The weighted average assumptions used for the periods presented were as follows:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Risk-free interest rate
2.21%
 
1.09%
 
2.27%
 
1.06%
Expected lives
1.1 years
 
1.2 years
 
1.1 years
 
1.2 years
Expected volatility
39%
 
44%
 
39%
 
44%
Expected dividend yield
0%
 
0%
 
0%
 
0%
For the three months ended June 30, 2019 and 2018, the weighted-average fair value of the purchase rights granted was $18.69 and $17.98 per share, respectively. For the six months ended June 30, 2019 and 2018, the weighted-average fair value of the purchase rights granted was $18.82 and $15.86 per share, respectively.
Restricted Stock Issuances
We have granted non-vested restricted stock awards (“restricted stock” or "RSAs") to management and non-employee directors pursuant to the Company's amended and restated Stock Incentive Plan. The restricted stock awards have varying vesting periods, but generally become fully vested between one and four years after the grant date, depending on the specific award, performance targets met for performance-based awards granted to management, and vesting periods for time based awards. Management performance-based awards are granted at the target amount of shares that may be earned. We valued the restricted stock awards related to service and/or company performance targets based on grant date fair value and expense over the period when achievement of those conditions is deemed probable. For restricted stock awards related to market conditions, we utilize a Monte Carlo simulation model to estimate grant date fair value and expense over the requisite period. We recognize forfeitures as they occur. There were no modifications that affected our accounting for restricted stock awards in the six months ended June 30, 2019 or 2018.
The following table summarizes restricted stock transactions for the six months ended June 30, 2019:
 
RSAs
 
Weighted-Average Grant Date Fair Value Per Award
Non-vested as of December 31, 2018
259,430

 
$
74.26

     Granted
18,567

 
71.38

     Vested
(4,230
)
 
85.09

     Forfeited
(500
)
 
80.90

Non-vested as of June 30, 2019
273,267

 
$
73.90


The weighted average grant date fair value of awards granted was $71.35 and $85.09 for the three months ended June 30, 2019 and 2018, respectively. The weighted average grant date fair value of awards granted was $71.38 and $67.76 for the six months ended June 30, 2019 and 2018, respectively. Fair value of restricted

-20-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


stock vested was $0.3 million and $0.3 million for the three months ended June 30, 2019 and 2018, respectively. Fair value of restricted stock vested was $0.3 million and $4.4 million for the six months ended June 30, 2019 and 2018, respectively.

As of June 30, 2019, there was approximately $2.6 million of total unrecognized compensation cost related to restricted stock with market and time vesting conditions. The Company expects to recognize this expense over a weighted average period of 1.3 years. As of June 30, 2019, we reviewed each of the underlying corporate performance targets and determined that approximately 176,000 of shares of common stock were related to company performance targets in which we did not deem achievement probable. No compensation expense had been recorded at any period prior to June 30, 2019.
Restrictions on the transfer of Company stock

The Company's Restated Certificate of Incorporation, as amended (the "Certificate of Incorporation"), places restrictions (the "Transfer Restrictions") on the transfer of the Company's stock that could adversely affect the Company's ability to utilize its domestic Federal Net Operating Loss Position. In particular, the Transfer Restrictions prevent the transfer of shares without the approval of the Company's Board of Directors if, as a consequence of such transfer, an individual, entity or groups of individuals or entities would become a 5-percent holder under Section 382 of the Internal Revenue Code of 1986, as amended, and the related Treasury regulations, and also prevents any existing 5-percent holder from increasing his or her ownership position in the Company without the approval of the Company's Board of Directors. Any transfer of shares in violation of the Transfer Restrictions (a "Transfer Violation") shall be void ab initio under the Certificate of Incorporation, and the Company's Board of Directors has procedures under the Certificate of Incorporation to remedy a Transfer Violation including requiring the shares causing such Transfer Violation to be sold and any profit resulting from such sale to be transferred to a charitable entity chosen by the Company's Board of Directors in specified circumstances.
13.    ACCUMULATED OTHER COMPREHENSIVE INCOME
Accumulated other comprehensive income (loss) consisted of the following (in thousands):
 
Minimum Pension Liability
 
Foreign Currency Translation
 
Total Accumulated Other Comprehensive Income
Balances at December 31, 2018
$
(419
)
 
$
696

 
$
277

Current period other comprehensive income
—

 
21

 
21

Balances at June 30, 2019
$
(419
)
 
$
717

 
$
298

14.    COMMITMENTS AND CONTINGENCIES
Royalty Agreements
The Company holds certain rights to market and manufacture products developed or created under certain research, development, and licensing agreements with various entities. In connection with such agreements, the Company has agreed to pay the entities royalties on net product sales. In each of the three months ended June 30, 2019 and 2018, royalties of $0.1 million became payable under these agreements. In each of the six months ended June 30, 2019 and 2018, royalties of $0.2 million became payable under these agreements.

-21-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


Warranties

The Company's current terms and conditions of sale include a limited warranty that its products and services will conform to published specifications at the time of shipment and a more extensive warranty related to certain products. The Company also sells a renewal warranty for certain of its products. The typical remedy for breach of warranty is to correct or replace any defective product, and if not possible or practical, the Company will accept the return of the defective product and refund the amount paid. Historically, the Company has incurred minimal warranty costs. The Company's warranty reserve was $0.2 million at both June 30, 2019 and December 31, 2018.

Litigation
From time to time, the Company may be involved in litigation relating to claims arising out of its operations. The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred, and the amount can be reasonably estimated.

On October 10, 2018, we reached an agreement in principle to settle the complaint that was filed against the Company by Shaun Fauley on March 12, 2015 in the U.S. District Court Northern District of Illinois (the "Court") alleging our transmittal of unauthorized faxes in violation of the federal Telephone Consumer Protection Act of 1991, as amended by the Junk Fax Prevention Act of 2005, as a class action (the "Fauley Complaint"). The settlement, which received the Court's approval on February 28, 2019 and was not subsequently appealed by a class member, required us to make available a total of $6.8 million to pay class members, as well as to pay attorneys' fees and expenses to legal counsel to the class. The Company recorded the loss provision in the third quarter of 2018 in connection with the settlement agreement and does not have insurance coverage for the Fauley Complaint. The payment in respect of the settlement was made in full on April 3, 2019, and all activity related to the Fauley Complaint has ceased.
As of June 30, 2019, the Company was not a party to any other legal proceedings that were expected, individually or in the aggregate, to have a material adverse effect on its business, financial condition, or operating results.

Off-Balance Sheet Commitments

Unconditional Purchase Obligations
The Company has contractual obligations with suppliers for unconditional annual minimum inventory purchases in the amounts of $16.7 million as of June 30, 2019.
15.    INTEREST AND OTHER EXPENSE, NET
Interest and other expense, net, consisted of the following (in thousands):
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Interest income
$
(133
)
 
$
(63
)
 
$
(225
)
 
$
(119
)
Interest expense
147

 
77

 
224

 
142

Other expense, net
7

 
78

 
6

 
65

Total interest and other expense, net
$
21

 
$
92

 
$
5

 
$
88


-22-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


Cash paid for interest for the three months ended June 30, 2019 and 2018 was $71 thousand and $58 thousand, respectively. Cash paid for interest for the six months ended June 30, 2019 and 2018 was $127 thousand and $85 thousand, respectively.

16.    CREDIT FACILITY

On July 27, 2017, and subsequently amended in May 2018, December 2018 and July 2019, we entered into a Credit Agreement (the "Credit Agreement") with JPMorgan Chase Bank, N.A. ("Chase") which provides for a revolving credit facility up to $30.0 million (the "Credit Facility"). The Credit Facility provides us with the ability to borrow up to $30.0 million although the amount of the Credit Facility may be increased by an additional $20.0 million up to a total of $50.0 million subject to receipt of additional lender commitments and other conditions. Any interest on borrowings due is to be charged at either the (i) rate of interest per annum publicly announced from time to time by Chase as its prime rate in effect at its principal offices in New York City, subject to a floor, minus 1.65%, or (ii) the interest rate per annum equal to (a) LIBOR for the interest period in effect multiplied by (b) Chase's Statutory Reserve Rate (as defined in the Credit Agreement), plus 1.10% and payable monthly. There is an annual minimum interest charge of $60 thousand under the Credit Agreement. Chase holds first right of priority over all other liens, if any were to exist. Borrowings under the Credit Facility are subject to certain financial and non-financial covenants and are available for various corporate purposes, including general working capital, capital investments, and certain permitted acquisitions. Failure to comply with any of the covenants, representations or warranties could result in our being in default on the loan and could cause all outstanding amounts payable to Chase to become immediately due and payable or impact our ability to borrow under the agreement. The Credit Agreement also permits us to issue letters of credit, although there are currently none outstanding. The maturity date of the Credit Facility is July 27, 2020. The foregoing discussion of the Credit Facility is a summary only and is qualified in its entirety by reference to the full text of the Credit Agreement, a copy of which has been filed as an exhibit to the Company's Current Report on Form 8-K filed with the SEC on August 2, 2017, incorporated herein by reference. Additionally, the following amendments are included in summary only and are qualified in their entirety by reference to the full text of the First Facility Amendment, a copy of which has been filed as an exhibit to the Company's Quarterly Report on Form 10-Q filed with the SEC on August 8, 2018, the Second Facility Amendment, a copy of which has been filed as an exhibit to the Company's Annual Report on Form 10-K filed with the SEC on March 7, 2019 and the Third Facility Amendment, a copy of which has been filed as an exhibit to this Quarterly Report on Form 10-Q filed with the SEC on August 7, 2019, each of which are incorporated herein by reference.

At June 30, 2019, we had a $12.8 million line of credit outstanding under the Credit Facility and we were in compliance with all financial covenants.


17.    SEGMENT REPORTING
The Company is composed of two reportable segments: CCA and OVP. The CCA segment includes Point of Care diagnostic laboratory instruments and consumables, and Point of Care digital imaging diagnostic instruments and software services as well as single use diagnostic and other tests, pharmaceuticals and vaccines, primarily for canine and feline use. These products are sold directly by the Company as well as through independent third-party distributors and through other distribution relationships. CCA segment products manufactured at the Des Moines, Iowa production facility included in the OVP segment's assets are transferred at cost and are not recorded as revenue for the OVP segment. The OVP segment includes private label vaccine and pharmaceutical production, primarily for cattle, but also for other animals including small mammals. All OVP products are sold by third parties under third-party labels.


-23-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


Summarized financial information concerning the Company's reportable segments is shown in the following tables (in thousands):
Three Months Ended June 30, 2019
 
Core Companion Animal
 
Other Vaccines and Pharmaceuticals
 
 
 
Total
Total revenue
 
$
24,716

 
$
3,430

 
$
28,146

Operating loss
 
(254
)
 
(312
)
 
(566
)
Loss before income taxes
 
(275
)
 
(312
)
 
(587
)
Capital expenditures
 
32

 
363

 
395

Depreciation and amortization
 
934

 
323

 
1,257

Three Months Ended June 30, 2018
 
Core Companion Animal
 
Other Vaccines and Pharmaceuticals
 
 
 
Total
Total revenue
 
$
26,644

 
$
3,018

 
$
29,662

Operating (loss) income
 
2,864

 
(660
)
 
2,204

(Loss) income before income taxes
 
2,772

 
(660
)
 
2,112

Capital expenditures
 
39

 
397

 
436

Depreciation and amortization
 
838

 
300

 
1,138


Six Months Ended June 30, 2019
 
Core Companion Animal
 
Other Vaccines and Pharmaceuticals
 
 
 
Total
Total revenue
 
$
49,432

 
$
8,225

 
$
57,657

Operating loss
 
(305
)
 
(336
)
 
(641
)
Loss before income taxes
 
(310
)
 
(336
)
 
(646
)
Capital expenditures
 
76

 
553

 
629

Depreciation and amortization
 
1,881

 
641

 
2,522


Six Months Ended June 30, 2018
 
Core Companion Animal
 
Other Vaccines and Pharmaceuticals
 
 
 
Total
Total revenue
 
$
53,463

 
$
8,964

 
$
62,427

Operating (loss) income
 
4,787

 
(712
)
 
4,075

(Loss) income before income taxes
 
4,699

 
(712
)
 
3,987

Capital expenditures
 
96

 
715

 
811

Depreciation and amortization
 
1,746

 
587

 
2,333


Asset information by reportable segment as of June 30, 2019 is as follows (in thousands):
As of June 30, 2019
 
Core Companion Animal
 
Other Vaccines and Pharmaceuticals
 
Total
Investments in unconsolidated affiliates
 
$
7,711

 
$
—

 
$
7,711

Total assets
 
139,036

 
23,808

 
162,844

Net assets
 
103,455

 
19,797

 
123,252



-24-

HESKA CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


Asset information by reportable segment as of December 31, 2018 is as follows (in thousands):
As of December 31, 2018
 
Core Companion Animal
 
Other Vaccines and Pharmaceuticals
 
Total
Investments in unconsolidated affiliates
 
$
8,018

 
$
—

 
$
8,018

Total assets
 
133,586

 
22,866

 
156,452

Net assets
 
96,129

 
26,280

 
122,409



-25-



Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the unaudited Condensed Consolidated Financial Statements and related Notes included in Part I Item 1 of this Form 10-Q.
This discussion contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Rule 175 promulgated thereunder, that involve risks and uncertainties. Such statements, which include statements concerning future revenue sources and concentration, international market expansion, gross profit margins, selling and marketing expenses, remaining minimum performance obligations, research and development expenses, general and administrative expenses, capital resources, additional financings or borrowings and additional losses, are subject to risks and uncertainties, including, but not limited to, those discussed in "Risk Factors" in Item 1A in Part I of our Annual Report on Form 10-K for the year ended December 31, 2018 that could cause actual results to differ materially from those projected. The Risk Factors and others described in the Company’s periodic and current reports filed with the SEC from time to time are not necessarily all of the important factors that could cause the Company’s actual results to differ materially from those projected. Other unknown or unpredictable factors could also harm the Company’s results. The forward-looking statements set forth in this Form 10-Q are as of the close of business on August 6, 2019 and we undertake no duty and do not intend to update this information, except as required by applicable laws. If we updated one or more forward looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements set forth above.
Overview
We sell advanced veterinary diagnostic and specialty products. Our offerings include Point of Care laboratory instruments and consumables, Point of Care digital imaging diagnostic products; vaccines; local and cloud-based data services; allergy testing and immunotherapy; and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. Our core focus is on supporting veterinarians in the canine and feline healthcare space.
Our business is composed of two reportable segments, Core companion animal ("CCA") and Other vaccines and pharmaceuticals ("OVP"). The CCA segment includes, primarily for canine and feline use, Point of Care laboratory instruments and consumables; digital imaging diagnostic instruments, software and services; local and cloud-based data services; allergy testing and immunotherapy; and single use offerings such as in-clinic diagnostic tests and heartworm preventive products. The OVP segment includes private label vaccine and pharmaceutical production, primarily for cattle but also for other species including equine, porcine, avian, feline and canine. OVP products are sold by third parties under third party labels.
The CCA segment represented approximately 87.8% and 85.7% of our revenue for the three and six months ended June 30, 2019, respectively, and the OVP segment represented approximately 12.2% and 14.3% of our revenue for the three and six months ended June 30, 2019, respectively.
CCA Segment
Revenue from Point of Care laboratory represented 65.2% and 64.9% of CCA revenue for the three and six months ended June 30, 2019, respectively. Revenue from this area primarily involves placing an instrument under contract in the field and generating future revenue from testing consumables, such as cartridges and reagents, as that instrument is used. The majority of revenue from Point of Care laboratory results from the revenue of such testing consumables to an installed base of instruments, which are generally under minimum

-26-



take or pay contracts, followed by instrument sales and other revenue sources such as service and repairs. Instruments placed under subscription agreements are considered operating or sales-type leases, depending on the duration and other factors of the underlying agreement. A loss of, or disruption in, the procurement of consumables we are selling to an installed base of instruments could substantially harm our business. All of our Point of Care laboratory and other non-imaging instruments and consumables are supplied by third parties, who typically own the product rights and supply the product to us under marketing and/or distribution agreements. In many cases, we have collaborated with a third party to adapt a human instrument for veterinary use. Major products in this area include our instruments for chemistry, hematology, blood gas, coagulation and immunodiagnostic testing and their affiliated operating consumables.
Point of Care imaging hardware, software and services represented 21.2% and 21.5% of CCA revenue for the three and six months ended June 30, 2019, respectively. Digital radiography is the largest product offering in this area, which also includes ultrasound and endoscopy instruments. Digital radiography solutions typically consist of a combination of hardware and software placed with a customer, often combined with an ongoing service and support contract. We sell our imaging solutions both in the U.S. and internationally. Our experience has been that most of the revenue is generated at the time of sale in this area, in contrast to the Point of Care diagnostic laboratory placements discussed above where ongoing consumable revenue is often a larger component of economic value as a given instrument is used.
Other CCA revenue, including single use diagnostic and other tests, pharmaceuticals and biologicals as well as research and development, licensing and royalty revenue, represented 13.6% and 13.6% of CCA revenue for the three and six months ended June 30, 2019, respectively. Since items in this area are often single use by their nature, our typical aim is to build customer satisfaction and loyalty for each product, generate repeat annual sales from existing customers and expand our customer base in the future. Products in this area are both supplied by third parties and provided by us. Major products and services in this area include heartworm diagnostic tests and preventives, and allergy test kits, allergy immunotherapy and testing.
We consider the CCA segment to be our core business and devote most of our management time and other resources to improving the prospects for this segment. Maintaining a continuing, reliable and economic supply of products we currently obtain from third parties is critical to our success in this area. Virtually all of our sales and marketing expenses occur in the CCA segment. The majority of our research and development spending is dedicated to this segment as well.
All of our CCA products are ultimately sold primarily to or through veterinarians. In many cases, veterinarians will mark up their costs to their customer. The acceptance of our products by veterinarians is critical to our success. CCA products are sold directly to end users by us as well as through distribution relationships, such as the sale of kits to conduct blood testing to third-party veterinary diagnostic laboratories and sales to independent third-party distributors. Revenue from direct sales and distribution relationships represented approximately 73.6% and 26.4%, respectively, of CCA revenue for the three months ended June 30, 2019, and approximately 72.5% and 27.5%, respectively, of CCA revenue for the six months ended June 30, 2019.
OVP Segment
The OVP segment includes our approximately 160,000 square foot USDA and FDA licensed production facility in Des Moines, Iowa. We view this facility as an asset which could allow us to control our cost of goods on any pharmaceuticals and vaccines that we may commercialize in the future. We have increased integration of this facility with our operations elsewhere. For example, virtually all of our U.S. inventory, excluding our imaging products, is now stored at this facility and related fulfillment logistics are managed there. CCA segment products manufactured at this facility are transferred at cost and are not recorded as

-27-



revenue for our OVP segment. We view OVP reported revenue as revenue primarily to cover the overhead costs of the facility and to generate incremental cash flow to fund our CCA segment.
Historically, a significant portion of our OVP segment's revenue has been generated from the sale of certain bovine vaccines, which have been sold primarily under the Titanium® and MasterGuard® brands. We have an agreement with Eli Lilly and Company and its affiliates operating through Elanco for the production of these vaccines (the "Elanco Agreement"). Our OVP segment also produces vaccines and pharmaceuticals for other third parties.
Results of Operations
Our analysis presented below is organized to provide the information we believe will facilitate an understanding of our historical performance and relevant trends going forward.
The following tables set forth, for the periods indicated, certain data derived from our unaudited Condensed Consolidated Statements of Income (in thousands):
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Revenue
$
28,146

 
$
29,662

 
$
57,657

 
$
62,427

Gross profit
12,412

 
13,065

 
24,955

 
26,372

Operating expenses
12,978

 
10,861

 
25,596

 
22,297

Operating (loss) income
(566
)
 
2,204

 
(641
)
 
4,075

Interest and other expense, net
21

 
92

 
5

 
88

(Loss) income before income taxes and equity in losses of unconsolidated affiliates
(587
)
 
2,112

 
(646
)
 
3,987

Income tax (benefit) expense
(426
)
 
215

 
(1,436
)
 
(65
)
Net (loss) income before equity in losses of unconsolidated affiliates
(161
)
 
1,897

 
790

 
4,052

Equity in losses of unconsolidated affiliates
(127
)
 
—

 
(308
)
 
—

Net (loss) income after equity in losses of unconsolidated affiliates
(288
)
 
1,897

 
482

 
4,052

Net loss attributable to redeemable non-controlling interest
(47
)
 
—

 
(91
)
 
—

Net (loss) income attributable to Heska Corporation
$
(241
)
 
$
1,897

 
$
573

 
$
4,052


-28-




CCA Segment
 
Three Months Ended June 30,
 
Change
 
Six Months Ended June 30,
 
Change
 
2019
 
2018
 
Dollar Change
 
% Change
 
2019
 
2018
 
Dollar Change
 
% Change
Point of Care laboratory:
$
16,120

 
$
15,053

 
$
1,067

 
7.1
 %
 
$
32,081

 
$
28,693

 
$
3,388

 
11.8
 %
      Consumables
13,208

 
11,524

 
1,684

 
14.6
 %
 
25,524

 
22,344

 
3,180

 
14.2
 %
      Instruments
2,538

 
3,128

 
(590
)
 
(18.9
)%
 
5,809

 
5,477

 
332

 
6.1
 %
      Other
374

 
401

 
(27
)
 
(6.7
)%
 
748

 
872

 
(124
)
 
(14.2
)%
Point of Care imaging
5,229

 
4,462

 
767

 
17.2
 %
 
10,639

 
10,434

 
205

 
2.0
 %
Other CCA revenue
3,367

 
7,129

 
(3,762
)
 
(52.8
)%
 
6,712

 
14,336

 
(7,624
)
 
(53.2
)%
Total CCA revenue
$
24,716

 
$
26,644

 
$
(1,928
)
 
(7.2
)%
 
$
49,432

 
$
53,463

 
$
(4,031
)
 
(7.5
)%
Percent of total revenue
87.8
%
 
89.8
%
 
 
 
 
 
85.7
%
 
85.6
%
 
 
 
 
Cost of revenue
12,461

 
13,467

 
(1,006
)
 
(7.5
)%
 
25,083

 
27,537

 
(2,454
)
 
(8.9
)%
Gross profit
12,255

 
13,177

 
(922
)
 
(7.0
)%
 
24,349

 
25,926

 
(1,577
)
 
(6.1
)%
Operating (loss) income
$
(254
)
 
$
2,864

 
$
(3,118
)
 
(108.9
)%
 
$
(305
)
 
$
4,787

 
$
(5,092
)
 
(106.4
)%

OVP Segment
 
Three Months Ended June 30,
 
Change
 
Six Months Ended June 30,
 
Change
 
2019
 
2018
 
Dollar
 Change
 
%
 Change
 
2019
 
2018
 
Dollar
 Change
 
%
 Change
Revenue
$
3,430

 
$
3,018

 
$
412

 
13.7
 %
 
$
8,225

 
$
8,964

 
$
(739
)
 
(8.2
)%
Percent of total revenue
12.2
%
 
10.2
%
 
 
 
 
 
14.3
%
 
14.4
%
 
 
 
 
Cost of revenue
3,273

 
3,130

 
143

 
4.6
 %
 
7,619

 
8,518

 
(899
)
 
(10.6
)%
Gross profit
157

 
(112
)
 
269

 
(240.2
)%
 
606

 
446

 
160

 
35.9
 %
Operating loss
$
(312
)
 
$
(660
)
 
$
348

 
(52.7
)%
 
$
(336
)
 
$
(712
)
 
$
376

 
(52.8
)%
Revenue
Total revenue decreased 5.1% to $28.1 million in the three months ended June 30, 2019, compared to $29.7 million in the three months ended June 30, 2018. Total revenue decreased 7.6% to $57.7 million in the six months ended June 30, 2019, compared to $62.4 million in the six months ended June 30, 2018.
CCA segment revenue decreased 7.2% to $24.7 million in the three months ended June 30, 2019, compared to $26.6 million in the three months ended June 30, 2018. The $1.9 million decrease was primarily driven by a $3.5 million decrease in revenue from contract manufactured heartworm preventative, Tri-Heart, as a result of reduced customer demand. This was partially offset by a $1.7 million increase in Point of Care laboratory consumables revenue, which is largely driven by contractual take or pay minimums. CCA segment revenue decreased 7.5% to $49.4 million in the six months ended June 30, 2019, compared to $53.5 million in the six months ended June 30, 2018. The $4.1 million decrease was primarily driven by a $7.3 million decrease in Tri-Heart revenue, partially offset by a $3.2 million increase in Point of Care laboratory consumables revenue.
OVP segment revenue increased 13.7% to $3.4 million in the three months ended June 30, 2019, compared to $3.0 million in the three months ended June 30, 2018, due to timing of shipments related to customer demands. OVP segment revenue decreased 8.2% to $8.2 million in the six months ended June 30, 2019,

-29-



compared to $9.0 million in the six months ended June 30, 2018. The decrease is due to decreased volume of sales under our Elanco Agreement as well as other customer contracts.
Gross Profit
Gross profit decreased 5.0% to $12.4 million in the three months ended June 30, 2019, compared to $13.1 million in the three months ended June 30, 2018. Gross margin increased to 44.1% in the three months ended June 30, 2019 compared to 44.0% in the three months ended June 30, 2018. The decrease in gross profit was mainly driven by lower Tri-Heart revenue, partially offset by favorable pricing and subscription in Point of Care laboratory and sales of global imaging products. Gross profit decreased 5.4% to $25.0 million in the six months ended June 30, 2019, compared to $26.4 million in the six months ended June 30, 2018. Gross margin increased to 43.3% in the six months ended June 30, 2019 compared to 42.2% in the six months ended June 30, 2018.The decrease in gross profit was mainly driven by lower Tri-Heart revenue, while the increase in gross margin was related to favorable margins in Point of Care laboratory and imaging products.
Operating Expenses
Selling and marketing expenses increased 13.0% to $6.7 million in the three months ended June 30, 2019, compared to $5.9 million in the three months ended June 30, 2018. Selling and marketing expenses increased 13.8% to $13.7 million in the six months ended June 30, 2019, compared to $12.1 million in the six months ended June 30, 2018. The increase in both periods was primarily driven by an increase in compensation, including stock-based compensation, benefits, and commissions expense, which is mostly related to our commercial team expansion both domestically and internationally. The increase is in line with management expectations as we continue to invest in future growth and expanding the footprint of the Company.
Research and development expenses increased 300.5% to $2.2 million in the three months ended June 30, 2019, compared to $0.6 million in the three months ended June 30, 2018. Research and development expenses increased 193.3% to $3.6 million in the six months ended June 30, 2019, compared to $1.2 million in the six months ended June 30, 2018. The increase in both periods was primarily driven by spending on product development for urine and fecal diagnostics and enhanced immunodiagnostic offerings. As we invest in future growth of the Company, the increased research and development expenses are consistent with the spending initiatives of management.
General and administrative expenses decreased 7.7% to $4.0 million in the three months ended June 30, 2019, compared to $4.4 million in the three months ended June 30, 2018. The decrease was driven primarily by a decrease in severance expenses and consulting fees. General and administrative expenses decreased 8.2% to $8.2 million in the six months ended June 30, 2019, compared to $9.0 million in the six months ended June 30, 2018. The decrease was mainly driven by a decrease in severance expenses and consulting fees.
Interest and Other Expense (Income), net
Interest and other expense (income), net, was $21 thousand in the three months ended June 30, 2019, compared to $92 thousand in the three months ended June 30, 2018. Interest and other expense (income), net, was $5 thousand in the six months ended June 30, 2019, compared to $88 thousand in the six months ended June 30, 2018. The decrease in other expense for both periods was driven primarily by an increase in interest income and other gains, partially offset by an increase in interest expense.

-30-



Income Tax (Benefit) Expense
In the three months ended June 30, 2019, we had a total income tax benefit of $0.4 million, including $0.5 million of domestic deferred income tax benefit and $28 thousand current income tax expense. In the three months ended June 30, 2018, we had a total income tax expense of $0.2 million, including $0.2 million of domestic deferred income tax expense and $12 thousand of current income tax expense. In the six months ended June 30, 2019, we had a total income tax benefit of $1.4 million, including $1.5 million of domestic deferred income tax benefit and $72 thousand current income tax expense. In the six months ended June 30, 2018, we had a total income tax benefit of $0.1 million, including $0.1 million of domestic deferred income tax benefit and $29 thousand of current income tax expense. The increase in tax benefits is due to lower financial income and stock-based compensation excess tax benefits recognized in our income statement. The Company recognized $0.3 million in excess tax benefits related to employee share-based compensation for the three months ended June 30, 2019 compared to $0.4 million recognized for the three months ended June 30, 2018. The Company recognized $1.4 million in excess tax benefits related to employee share-based compensation for the six months ended June 30, 2019 compared to $1.2 million recognized for the six months ended June 30, 2018.
Net (Loss) Income Attributable to Heska Corporation
Net loss attributable to Heska was $0.2 million for the three months ended June 30, 2019, compared to net income attributable to Heska of $1.9 million in the prior year period. Net income attributable to Heska was $0.6 million for the six months ended June 30, 2019, compared to net income attributable to Heska of $4.1 million in the prior year period. The difference between this line item and "Net income after equity in losses of unconsolidated affiliates" is the net income or loss attributable to our minority interest in our French subsidiary, which we purchased in February 2019. Net income is lower in the three and six months ended June 30, 2019 as compared to the three and six months ended June 30, 2018 due to lower revenues and increased operating expenses as a result of our future growth initiatives.
Impact of Inflation
In recent years, inflation has not had a significant impact on our operations.

Liquidity, Capital Resources and Financial Condition
We believe that adequate liquidity and cash generation is important to the execution of our strategic initiatives. Our ability to fund our operations, acquisitions, capital expenditures, and product development efforts may depend on our ability to generate cash from operating activities, which is subject to future operating performance, as well as general economic, financial, competitive, legislative, regulatory, and other conditions, some of which may be beyond our control. Our primary sources of liquidity are our available cash, cash generated from current operations and availability under our credit facility noted below.

For the six months ended June 30, 2019, we had net income attributable to Heska Corporation of $0.6 million and net cash used by operations of $5.4 million. At June 30, 2019, we had $10.0 million of cash and cash equivalents and working capital of $45.1 million.

-31-



On July 27, 2017, and subsequently amended in May 2018, December 2018 and July 2019, we entered into a Credit Agreement (the "Credit Agreement") with JPMorgan Chase Bank, N.A. ("Chase") which provides for a revolving credit facility up to $30.0 million (the "Credit Facility"). The Credit Facility provides us with the ability to borrow up to $30.0 million, although the amount of the Credit Facility may be increased by an additional $20.0 million up to a total of $50.0 million subject to receipt of additional lender commitments and other conditions. Any interest on borrowings due is to be charged at either the (i) rate of interest per annum publicly announced from time to time by Chase as its prime rate in effect at its principal offices in New York City, subject to a floor, minus 1.65%, or (ii) the interest rate per annum equal to (a) LIBOR for the interest period in effect multiplied by (b) Chase's Statutory Reserve Rate (as defined in the Credit Agreement), plus 1.10% and payable monthly. There is an annual minimum interest charge of $60 thousand under the Credit Agreement. Chase holds first right of priority over all other liens, if any were to exist. Borrowings under the Credit Facility are subject to certain financial and non-financial covenants and are available for various corporate purposes, including general working capital, capital investments, and certain permitted acquisitions. Failure to comply with any of the covenants, representations or warranties could result in our being in default on the loan and could cause all outstanding amounts payable to Chase to become immediately due and payable or impact our ability to borrow under the agreement. The Credit Agreement also permits us to issue letters of credit, although there are currently none outstanding. The maturity date of the Credit Facility is July 27, 2020. The foregoing discussion of the Credit Facility is a summary only and is qualified in its entirety by reference to the full text of the Credit Agreement, a copy of which has been filed as an exhibit to the Company's Current Report on Form 8-K filed with the SEC on August 2, 2017, incorporated herein by reference. Additionally, the following amendments are included in summary only and are qualified in their entirety by reference to the full text of the First Facility Amendment, a copy of which has been filed as an exhibit to the Company's Quarterly Report on Form 10-Q filed with the SEC on August 8, 2018, the Second Facility Amendment, a copy of which has been filed as an exhibit to the Company's Annual Report on Form 10-K filed with the SEC on March 7, 2019 and the Third Facility Amendment, a copy of which has been filed as an exhibit to this Quarterly Report on Form 10-Q filed with the SEC on August 7, 2019, each of which are incorporated herein by reference.
At June 30, 2019, we had a $12.8 million line of credit outstanding under the Credit Facility and were in compliance with all financial covenants. We used a portion of the funds then available under this Credit Facility to pay in full in April 2019 the amount required to be paid by the Company in respect of the settlement of the Fauley Complaint discussed in further detail under Note 14 - Commitments and Contingencies in our Condensed Consolidated Financial Statements included in Item 1 of this Form 10-Q.
A summary of our cash from operating, investing and financing activities is as follows (in thousands):
 
Six Months Ended June 30,
 
Change
 
2019
 
2018
 
Dollar
Change
 
%
Change
Net cash (used in) provided by operating activities
$
(5,356
)
 
$
4,499

 
$
(9,855
)
 
(219.0
)%
Net cash used in investing activities
(1,251
)
 
(807
)
 
(444
)
 
55.0
 %
Net cash provided by financing activities
3,205

 
332

 
2,873

 
865.4
 %
Effect of currency translation on cash
5

 
(8
)
 
13

 
(162.5
)%
(Decrease) increase in cash and cash equivalents
(3,397
)
 
4,016

 
(7,413
)
 
(184.6
)%
Cash and cash equivalents, beginning of the period
13,389

 
9,659

 
3,730

 
38.6
 %
Cash and cash equivalents, end of the period
$
9,992

 
$
13,675

 
$
(3,683
)
 
(26.9
)%

-32-



Net cash used in operating activities was $5.4 million in the six months ended June 30, 2019, compared to net cash provided by operating activities of $4.5 million in the six months ended June 30, 2018, a decrease of approximately $9.9 million. Net cash from operating activities decreased due to significant working capital fluctuations such as a $6.3 million increase in cash used by accrued liabilities, driven by a $6.8 million settlement payment (See Note 14 of this Form 10-Q), and a $6.2 million decrease in cash provided by inventories due to timing of purchases and lower sales in the current year. Additionally, net cash from operating activities was $3.6 million less in the six months ended June 30, 2019 due to the decrease in net income compared to the six months ended June 30, 2018. These factors were partially offset by a $6.4 million increase in the cash provided by the aggregate of accounts payable, accounts receivable, related party balances, deferred revenue and other non-current assets, due to the timing of collections and payments in the ordinary course of business, as well as a $0.6 million increase in lease receivables. Non-cash transactions impacting cash used by operating activities included a $1.4 million increase in our deferred tax benefit, offset by the $0.8 million impact of adopting ASC 842, Leases.
Net cash used in investing activities was $1.3 million in the six months ended June 30, 2019, compared to net cash used in investing activities of $0.8 million in the six months ended June 30, 2018, an increase of approximately $0.4 million. The increase in cash used for investing activities was mainly driven by the $0.6 million acquisition in France, offset by a $0.2 million decrease in purchases of property and equipment.
Net cash provided by financing activities was $3.2 million in the six months ended June 30, 2019, compared to net cash provided by financing activities of $0.3 million in the six months ended June 30, 2018, an increase of approximately $2.9 million. The increase in cash provided by financing activities was driven primarily by a $6.8 million increase in borrowings on the line of credit. This was partially offset by a $2.3 million increase in cash used for the repurchase of common stock, a $1.1 million use of cash relating to debt repayments related to our subsidiary in France, and a $0.6 million decrease in proceeds from issuance of common stock.
Our financial plan for 2019, including selling and marketing team expansion and product development initiatives, indicates that our available cash and cash equivalents, together with cash from operations and borrowings expected to be available under our Credit Facility, will be sufficient to fund our operations for the foreseeable future. Additionally, we are actively seeking acquisitions that are consistent with our strategic direction, which may require additional capital. Our actual results may differ from this plan and we may be required to consider alternative strategies. We may be required to raise additional capital in the future, even in the absence of any acquisitions. If necessary, we expect to raise these additional funds through the sale of equity securities or the issuance of debt. There is no guarantee that additional capital will be available from these sources on acceptable terms, if at all, and certain of these sources may require approval by existing lenders. See "Risk Factors" in Item 1A in Part I of our Annual Report on Form 10-K for the year ended December 31, 2018 for a discussion of some of the factors that affect our capital raising alternatives.

Effect of currency translation on cash
Net effect of foreign currency translations on cash changed $13 thousand to a $5 thousand positive impact in the six months ended June 30, 2019, compared to a $8 thousand negative impact in the six months ended June 30, 2018. These effects are related to changes in exchange rates of our foreign subsidiaries functional currencies and the U.S. dollar, the functional and reporting currency of Heska Corporation. Our foreign subsidiaries primary currencies are the Swiss Franc, Euro, Canadian dollar and Australian dollar.
Off-Balance Sheet Arrangements and Contractual Obligations
The Company has not entered into any transactions with unconsolidated entities whereby the Company has financial guarantees, subordinated retained interests, derivative instruments, or other contingent arrangements that expose the Company to material continuing risks, contingent liabilities, or any other obligation under a

-33-



variable interest in an unconsolidated entity that provided financing, liquidity, market risk or credit risk support to the Company, or engages in leasing, hedging or research and development services with the Company.
Purchase Obligations
Purchase obligations represent contractual agreements to purchase goods or services that are legally binding; specify a fixed, minimum or range of quantities; specify a fixed, minimum, variable, or indexed price provision; and specify approximate timing of the transaction. As of June 30, 2019, the Company had purchase obligations for inventory of $16.7 million and an approximate commitment of $1.0 million to purchase real estate from Optomed's minority interest holder within a reasonable amount of time from acquisition date of the French company.
Critical Accounting Policies and Estimates
Our accounting policies are described in our audited Consolidated Financial Statements and Notes thereto contained in our Annual Report on Form 10-K for the year ended December 31, 2018 and other than the recently adopted accounting pronouncements described in Note 1 - Operations and Summary of Significant Accounting Policies in our Condensed Consolidated Financial Statements included in Item 1 of this Form 10-Q, have not changed significantly since such filing.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

For quantitative and qualitative disclosures about market risk affecting us, see the section under the heading “Part II, Item 7A. Quantitative and Qualitative Disclosures About Market Risk” of our Annual Report on Form 10-K for the year ended December 31, 2018, which is incorporated by reference herein. As of the date of this Quarterly Report on Form 10-Q, there have been no material changes to the market risks described in our Annual Report on Form 10-K for the year ended December 31, 2018.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our principal executive officer and our principal financial officer, evaluated the effectiveness of our disclosure controls and procedures, as defined by Rule 13a-15(e) of the Exchange Act, as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures were effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting
There was no change in our internal control over financial reporting that occurred since our last fiscal year-end that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.


PART II. OTHER INFORMATION

-34-



Item 1.    Legal Proceedings
The information required by this item is incorporated by reference to Note 14 (Commitments and Contingencies) to the unaudited Condensed Consolidated Financial Statements included in Part 1, Item 1 of this Form 10-Q.
Item 1A.Risk Factors

For a discussion of our risk factors, see Item 1A. Risk Factors in Part I of our Annual Report on Form 10-K for the year ended December 31, 2018, which is incorporated herein by reference.
Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds
None.

Item 6.        Exhibits

 
Exhibit Number
 
 
Notes
 
 
Description of Document
 
3.1
 
 
 
 
3.2
 
 
 
 
10.1
 
**
 
 
10.2
 
**
 
 
10.3
 
**
 
 
10.4
 
 
 
 
10.5
 
(1)
 
 
10.6
 
 
 
 
31.1
 
 
 
 
31.2
 
 
 
 
32.1
 
*
 
 
101.INS
 
 
 
XBRL Instance Document.
 
101.SCH
 
 
 
XBRL Taxonomy Extension Schema Document.
 
101.CAL
 
 
 
XBRL Taxonomy Extension Calculation Linkbase Document.
 
101.DEF
 
 
 
XBRL Taxonomy Extension Definition Linkbase Document.
 
101.PRE
 
 
 
XBRL Taxonomy Extension Presentation Linkbase Document.
 
101.LAB
 
 
 
XBRL Taxonomy Extension Label Linkbase Document.

-35-



Notes
 
*
Furnished and not filed herewith.
**
Certain confidential information contained in this exhibit has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.
(1)
Filed with the Registrant's Form 8-K on June 4, 2019.

-36-



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on August 7, 2019.
 
 
HESKA CORPORATION
 
 
 
By:  /s/ KEVIN S. WILSON  
Kevin S. Wilson
Chief Executive Officer and President
(Principal Executive Officer)
 
By:  /s/ CATHERINE GRASSMAN                              
Catherine Grassman
Executive Vice President, Chief Financial Officer
(Principal Financial and Accounting Officer)
 

 


-37-
 EX-3.1 2 heska-06302019xexx3x1.htm EXHIBIT 3.1 Exhibit

Exhibit 3.1

CERTIFICATE OF AMENDMENT
TO THE
RESTATED CERTIFICATE OF INCORPORATION, AS AMENDED,
OF
HESKA CORPORATION


Heska Corporation (the "Corporation"), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the "DGCL"), does hereby certify:
 
1.
This Certificate of Amendment to the Corporation’s Restated Certificate of Incorporation, as amended (the "Certificate"), has been duly adopted in accordance with the provisions of Section 242 of the DGCL.

2.
This Certificate of Amendment to the Certificate amends Article VI of the Certificate by deleting the existing Article VI in its entirety and substituting therefore a new Article VI, to read in its entirety as follows:

A. Board of Directors Structure.

1. Board of Directors Matters. Immediately prior to the election of directors at the 2019 annual meeting of stockholders, the Board of Directors was divided into three classes, designated Class I, Class II and Class III, as nearly equal in number as possible, with the term of office of directors of one class expiring at each annual meeting of stockholders, and in all cases as to each director when such director’s successor shall have been elected and qualified or upon such director’s earlier resignation, removal from office, death or incapacity. Additional directorships resulting from an increase in number of directors were to be apportioned among the classes as equally as possible. The term of office of directors: of Class I was set to expire at the 2019 annual meeting of stockholders; of Class II was set to expire at the 2020 annual meeting of stockholders; and of Class III was set to expire at the annual meeting in 2021, and in all cases as to each director when such director’s successor shall have been elected and qualified or upon such director’s earlier resignation, removal from office, death or incapacity. At each annual meeting of stockholders, the number of directors equal to the number of directors of the class whose term expires at the time of such meeting (or, if less, the number of directors properly nominated and qualified for election) were to be elected to hold office until the third succeeding annual meeting of stockholders after their election.

2. Two Class Board of Directors Transition. Commencing with the election of directors at the 2019 annual meeting of stockholders, pursuant to Section 141(d) of the DGCL, the Board of Directors shall be divided into two classes, designated Class I and Class II, as nearly equal in number as possible, with the term of office of directors of one class expiring at each annual meeting of stockholders, and in all cases as to each director when such director’s successor shall have been elected and qualified or upon such director’s earlier resignation, removal from office, death or incapacity. Additional directorships resulting from an increase in number of directors shall be apportioned among the classes as equally as possible. The initial term of office of directors: of Class I shall expire at the annual meeting of stockholders in 2020; and of Class II shall expire at the annual meeting of stockholders in 2021, and in all cases as to each director when such director’s successor shall be elected and shall qualify or upon such director’s earlier resignation, removal from office, death or incapacity. The successors of the directors who, immediately prior to the 2019 annual meeting of stockholders, were members of Class I (whose terms were to expire at the 2019 annual meeting of stockholders) shall be elected to Class I; the directors who, immediately prior to the 2019 annual meeting of stockholders, were members of Class II (whose terms were scheduled to expire at the 2020 annual meeting of stockholders) shall become members of Class I; and the directors who, immediately prior to the 2019 annual meeting of stockholders, were members of Class III (whose terms were scheduled to expire at the 2021 annual meeting of stockholders) shall become members of Class II, with a term expiring at the 2021 annual meeting of stockholders.

3. Elimination of Staggered Board of Directors. Commencing at and from and after the election of directors at the 2020 annual meeting of stockholders, the Board of Directors will cease to be classified as provided in Section 141(d) of the DGCL, the directors elected at the 2020 annual meeting of stockholders and each annual meeting thereafter shall be elected for a term of office expiring at the next annual meeting of stockholders, and in all cases as to each director when such director’s successor shall have been elected and qualified or upon such director’s earlier resignation, removal from office, death or incapacity, and directors so elected may thereafter be removed by the stockholders of the corporation with or without cause pursuant to Section 141(k) of the DGCL.

B. Changes. During any period when the Board of Directors of this corporation is classified, the Board of Directors, by amendment to the corporation’s bylaws, is expressly authorized to change the number of directors in any or all of the classes of directors without the consent of the stockholders.

C. Elections. Elections of directors need not be by written ballot unless the Bylaws of the Corporation shall so provide.

D. Vote Required to Amend or Repeal this Article VI. Until the election of directors at the 2020 annual meeting of stockholders, the affirmative vote of the holders of at least sixty-six and two-thirds percent (66-2/3%) of the voting power of all of the then outstanding shares of the stock of the corporation entitled to vote generally in the election of directors, voting together as a single class, shall be required to amend in any respect or repeal this Article VI. Effective automatically and contemporaneously with the election of directors at the 2020 annual meeting of stockholders, and without any further action by the Board of Directors, the stockholders of the corporation or any other person, this Section D of Article VI shall expire and be of no further force or effect and be deemed deleted in its entirety herefrom.

3.
This Certificate of Amendment to the Certificate amends Article VIII of the Certificate by deleting the last sentence of existing Article VIII in its entirety and substituting therefore a new last sentence of Article VIII, to read in its entirety as follows:

Notwithstanding the foregoing sentence, until the election of directors at the 2020 annual meeting of stockholders, at which time this sentence shall automatically expire and be of no further force or effect and be deemed deleted in its entirety from this Article VIII (without any further action by the Board of Directors, the stockholders of the corporation or any other person), the affirmative vote of the holders of at least sixty-six and two-thirds percent (66 2/3%) of the voting power of all of the then outstanding shares of the stock of the corporation entitled to vote generally in the election of directors, voting together as a single class, shall be required for the amendment or repeal of Article 3.1 of the Bylaws of the corporation.

4.
This Certificate of Amendment to the Certificate shall become effective at the time this Certificate of Amendment to the Certificate is filed with the Secretary of State of the State of Delaware.

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to the Certificate to be executed by a duly authorized officer on this 2nd day of May, 2019.
 
 
 
 
Heska Corporation
 
 
 
 
By:
/s/Jason A. Napolitano
 
Name:
Jason A. Napolitano
 
Title:
Chief Operating Officer and Chief Strategist



1
 EX-3.2 3 heska-06302019xexx3x2.htm EXHIBIT 3.2 Exhibit



Exhibit 3.2


Amended and Restated Bylaws as approved on May 2, 2019.
B Y L A W S
OF
HESKA CORPORATION
(a Delaware corporation)



-i-


ARTICLE 1

Offices
1.1    Principal Office.  The registered office of the corporation shall be 1209 Orange Street, Wilmington, Delaware.
1.2    Additional Offices.  The corporation may also have offices at such other places, either within or without the State of Delaware, as the Board of Directors (the "Board") may from time to time designate or the business of the corporation may require.
ARTICLE 2    

Meeting of Stockholders
2.1    Place of Meeting.  Meetings of stockholders may be held at such place, either within or without the State of Delaware, as may be designated by or in the manner provided in these Bylaws, or, if not so designated, as determined by the Board.
2.2    Annual Meeting.  Annual meetings of stockholders shall be held each year at such date and time as shall be designated from time to time by the Board and stated in the notice of the meeting. At such annual meetings, the stockholders shall elect by a plurality vote the number of directors equal to the number of directors (of the class, if applicable) whose term expires at such meetings (or, if fewer, the number of directors properly nominated and qualified for election) to hold office until the next succeeding annual meeting of stockholders after their election (or, if the Board is then classified, such later succeeding annual meeting of stockholders after their election if elected to a longer term). The stockholders shall also transact such other business as may properly be brought before the meetings.
To be properly brought before the annual meeting, business must be either (a) specified in the notice of meeting (or any supplement thereto) given by or at the direction of the Board or the Chief Executive Officer, (b) otherwise properly brought before the meeting by or at the direction of the Board or the Chief Executive Officer, or (c) otherwise properly brought before the meeting by a stockholder of record. In addition to any other applicable requirements, for business to be properly brought before the annual meeting by a stockholder, the stockholder must have given timely notice thereof in writing to the Secretary of the corporation. To be timely, a stockholder's notice must be delivered personally or deposited in the United States mail, or delivered to a common carrier for transmission to the recipient or actually transmitted by the person giving the notice by electronic means to the recipient or sent by other means of written communication, postage or delivery charges prepaid in all such cases, and received at the principal executive offices of the corporation, addressed to the attention of the Secretary of the corporation, not less than 60 days nor more than 90 days prior to the first anniversary of the date on which notice of the prior year's annual meeting was mailed to stockholders. A stockholder's notice to the Secretary shall set forth as to each matter the stockholder proposes to bring before the annual meeting (i) a brief description of the business desired to be brought before the annual meeting and the reasons for conducting such business at the annual meeting, (ii) the name and record address of the stockholder proposing such business, (iii) the class,




series and number of shares of the corporation that are owned beneficially by the stockholder, and (iv) any material interest of the stockholder in such business. Notwithstanding anything in these Bylaws to the contrary, no business shall be conducted at the annual meeting except in accordance with the procedures set forth in this Section; provided, however, that nothing in this Section shall be deemed to preclude discussion by any stockholder of any business properly brought before the annual meeting.
The Chair of the Board of the corporation (or such other person presiding at the meeting in accordance with these Bylaws) shall, if the facts warrant, determine and declare to the meeting that business was not properly brought before the meeting in accordance with the provisions of this Section, and if he or she should so determine, he or she shall so declare to the meeting and any such business not properly brought before the meeting shall not be transacted.
2.3    Special Meetings.  Special meetings of the stockholders may be called for any purpose or purposes, unless otherwise prescribed by statute or by the Restated Certificate of Incorporation, only at the request of the Chair of the Board, by the Chief Executive Officer of the corporation or by a resolution duly adopted by the affirmative vote of a majority of the Board. Such request shall state the purpose or purposes of the proposed meeting. Business transacted at any special meeting shall be limited to matters relating to the purpose or purposes stated in the notice of meeting.
2.4    Action Without a Meeting.  Any action which may be taken at any annual or special meeting of the stockholders of this corporation may be taken without a meeting, without prior notice, and without a vote, if a consent or consents in writing or electronic transmission, setting forth the action or actions so taken, shall be signed by the holders of outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted. Written consent or consents and, unless the Board otherwise provides, reproduction in paper form of electronic consent or consents, shall be delivered to the corporation by hand or certified mail, return receipt requested, to its principal executive office, or to an officer or agent of the corporation having custody of the book in which proceedings of meetings of stockholders are recorded.
2.5    Notice of Meetings.  Except as otherwise required by law, written notice of stockholders' meetings, stating the place, if any, date and time of the meeting, the means of remote communications, if any, by which stockholders and proxy holders may be deemed to be present and vote at such meeting, and, in the case of a special meeting, the purpose or purposes for which such special meeting is called, shall be given to each stockholder entitled to vote at such meeting not less than ten (10) nor more than sixty (60) days prior to the meeting.
When a meeting is adjourned to another place, date or time, written notice need not be given of the adjourned meeting if the place, if any, date and time thereof and the means of remote communications, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such adjourned meeting, are announced at the meeting at which the adjournment is taken; provided, however, that if the date of any adjourned meeting is more than thirty (30) days after the date for which the meeting was originally noticed, or if a new record date is fixed for the adjourned meeting, written notice of the place, if any, date and time of the adjourned meeting shall

-2-


be given in conformity herewith. At any adjourned meeting, any business may be transacted which might have been transacted at the original meeting.
Whenever, under the provisions of Delaware law or of the Restated Certificate of Incorporation or of these Bylaws, notice is required to be given to any stockholder it shall not be construed to mean personal notice, but such notice (a) may be given in writing, by mail, addressed to such stockholder, at his or her address as it appears on the records of the corporation, with postage thereon prepaid, and such notice shall be deemed to be given at the time when the same shall be deposited in the United States mail or (b) may be given by a form of electronic transmission consented to by the stockholder to whom the notice is given.
Whenever any notice is required to be given under the provisions of Delaware law or of the Restated Certificate of Incorporation or of these Bylaws, a waiver thereof in writing, signed by the person or persons entitled to said notice, or a waiver by electronic transmission by the person entitled to notice, whether before or after the time stated therein, shall be deemed equivalent thereto.
2.6    Business Matter of a Special Meeting.  Business transacted at any special meeting of stockholders shall be limited to the purposes stated in the notice, except to the extent such notice is waived or is not required.
2.7    List of Stockholders.  The officer in charge of the stock ledger of the corporation or the transfer agent shall prepare and make, at least ten (10) days before every meeting of stockholders, a complete list of the stockholders entitled to vote at the meeting arranged in alphabetical order, and showing the address of each stockholder and the number of shares registered in the name of each stockholder. Such list shall be open to the examination of any stockholder, for any purpose germane to the meeting for a period of at least ten (10) days prior to the meeting: (a) on a reasonably accessible electronic network, provided that the information required to gain access to such list is provided with the notice of the meeting, or (b) during ordinary business hours, at the principal place of business of the corporation. If the meeting is to be held at a place, then the list shall be produced and kept at the place of the meeting during the whole time thereof, and may be inspected by any stockholder who is present in person thereat. If the meeting is to be held solely by means of remote communication, then the list shall also be open to the examination of any stockholder during the whole time of the meeting on a reasonably accessible electronic network, and the information required to access such list shall be provided with the notice of the meeting.
2.8    Organization and Conduct of Business.  The Chair of the Board or, in his or her absence, the Lead Director, or in their absence, the Chief Executive Officer of the corporation or, in their absence, such person as the Board may have designated or, in the absence of such a person, such person as may be chosen by the holders of a majority of the shares entitled to vote who are present, in person or by proxy, shall call to order any meeting of the stockholders and act as Chair of the meeting. In the absence of the Secretary of the corporation, the Secretary of the meeting shall be such person as the Chair appoints.

-3-


The Chairman of any meeting of stockholders shall determine the order of business and the procedure at the meeting, including such regulation of the manner of voting and the conduct of discussion as seems to him or her in order.
2.9    Quorum and Adjournments.  Except where otherwise provided by law, the Restated Certificate of Incorporation, or these Bylaws, the holders of a majority of the stock issued and outstanding and entitled to vote, present in person or represented in proxy, shall constitute a quorum at all meetings of the stockholders. The stockholders present at a duly called or held meeting at which a quorum is present may continue to do business until adjournment, notwithstanding the withdrawal of enough stockholders to have less than a quorum if any action taken (other than adjournment) is approved by at least a majority of the shares required to constitute a quorum. At any adjourned meeting at which a quorum is present or represented, any business may be transacted which might have been transacted at the meeting as originally notified. If, however, a quorum shall not be present or represented at any meeting of the stockholders, the stockholders entitled to vote thereat who are present in person or represented by proxy shall have the power to adjourn the meeting from time to time, without notice other than announcement at the meeting, until a quorum shall be present or represented.
2.10    Voting Rights.  Unless otherwise provided in the Restated Certificate of Incorporation, each stockholder shall at every meeting of the stockholders be entitled to one vote in person or by proxy for each share of the capital stock having voting power held by such stockholder.
2.11    Majority Vote.  When a quorum is present at any meeting, the vote of the holders of a majority of the stock present in person or represented by proxy and entitled to vote on the subject matters shall decide any matter brought before such meeting, unless the matter is one upon which by express provision of law or of the Restated Certificate of Incorporation or of these Bylaws, a different vote is required, in which case such express provision shall govern and control the decision of such matter. For purposes of determining whether shares are present and entitled to vote with respect to any particular subject matter, abstentions and non-votes with respect to such subject matter shall be treated as not present or entitled to vote on such subject matter, but shall be treated as present and entitled to vote for all other purposes.
2.12    Record Date for Stockholder Notice and Voting. 
(i)    For purposes of determining the stockholders entitled to notice of any meeting or to vote, or entitled to receive payment of any dividend or other distribution, or entitled to exercise any right in respect of any change, conversion or exchange of stock or for the purpose of any other lawful action, the Board may fix, in advance, a record date, which shall not be more than sixty (60) days nor less than ten (10) days before the date of any such meeting nor more than sixty (60) days before any other action. If the Board does not so fix a record date, the record date for determining stockholders entitled to notice of or to vote at a meeting of stockholders shall be at the close of business on the business day next preceding the day on which notice is given or, if notice is waived, at the close of business on the business day next preceding the day on which the meeting is held.
(ii)    For purposes of determining the stockholders entitled to consent to corporate action in writing without a meeting, the Board may fix a record date, which record date shall not precede the

-4-


date upon which the resolution fixing the record date is adopted by the Board, and which date shall not be more than ten (10) days after the date upon which the resolution fixing such record date is adopted by the Board. If no record date has been fixed by the Board, the record date for determining stockholders entitled to consent to corporate action in writing without a meeting, when no prior action by the Board is required under Delaware law, shall be the first date on which a signed written consent setting forth the action taken or proposed to be taken is delivered to the corporation by hand or certified mail, return receipt requested, to its principal executive office, or to an officer or agent of the corporation having custody of the book in which proceedings of meetings of stockholders are recorded. If no record date has been fixed by the Board and prior action by the Board is required under Delaware law, the record date for determining stockholders entitled to consent to corporate action in writing without a meeting shall be the close of business on the day on which the Board adopts the resolution taking such prior action.
2.13    Proxies.  To the extent permitted by law, any stockholder of record may appoint a person or persons to act as the stockholder's proxy or proxies at any stockholder meeting for the purpose of representing and voting the stockholders' shares. The stockholder may make this appointment by any means the General Corporation Law of the State of Delaware specifically authorizes, and by any other means the Secretary of the corporation may permit. A validly executed proxy which does not state that it is irrevocable shall continue in full force and effect unless (i) revoked by the person executing it, before the vote pursuant to that proxy, by a writing delivered to the corporation stating that the proxy is revoked or by a subsequent proxy executed by, or attendance at the meeting and voting in person by, the person executing the proxy; or (ii) written notice of the death or incapacity of the maker of that proxy is received by the corporation before the vote pursuant to that proxy is counted; provided, however, that no proxy shall be valid after the expiration of three years from the date of the proxy, unless otherwise provided in the proxy.
2.14    Inspectors of Election.  The corporation shall, in advance of any meeting of stockholders, appoint one or more inspectors of election to act at the meeting and make a written report thereof. The corporation may designate one or more persons to act as alternate inspectors to replace any inspector who fails to act. If no inspector or alternate is able to act at a meeting of stockholders, the person presiding at the meeting shall appoint one or more inspectors to act at the meeting. Each inspector, before entering upon the discharge of his or her duties, shall take and sign an oath faithfully to execute the duties of inspector with strict impartiality and according to the best of his or her ability.
ARTICLE 3    

Directors
3.1    Number, Election, Tenure and Qualifications.  The Board of the corporation shall consist of not less than five (5) members nor more than nine (9) members and may be divided into classes to the extent set forth in the Restated Certificate of Incorporation (as amended from time to time, the "Restated Certificate of Incorporation"), and the exact number of members of any future Board, and the exact number of directors in any class (if applicable), shall be determined from time to time by resolution of the Board.

-5-


Only persons who are nominated in accordance with the following procedures shall be eligible for election as directors. Nominations of persons for election to the Board at the annual meeting, by or at the direction of the Board, may be made by any nominating committee or person appointed by the Board; nominations may also be made by any stockholder of record of the corporation entitled to vote for the election of directors at the meeting who complies with the notice procedures set forth in this Section. Such nominations, other than those made by or at the direction of the Board, shall be made pursuant to timely notice in writing to the Secretary of the corporation. To be timely, a stockholder's notice shall be delivered personally or deposited in the United States mail, or delivered to a common carrier for transmission to the recipient or actually transmitted by the person giving the notice by electronic means to the recipient or sent by other means of written communication, postage or delivery charges prepaid in all such cases, and received at the principal executive offices of the corporation addressed to the attention of the Secretary of the corporation not less than 60 days nor more than 90 days prior to the first anniversary of the date on which notice of the prior year's annual meeting was mailed to stockholders. Such stockholder's notice to the Secretary shall set forth (a) as to each person whom the stockholder proposes to nominate for election or reelection as a director, (i) the name, age, business address and residence address of the person, (ii) the principal occupation or employment of the person, (iii) the class, series and number of shares of capital stock of the corporation that are owned beneficially by the person, (iv) a statement as to the person's citizenship, and (v) any other information relating to the person that is required to be disclosed in solicitations for proxies for election of directors pursuant to Section 14 of the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder; and (b) as to the stockholder giving the notice, (i) the name and record address of the stockholder and (ii) the class, series and number of shares of capital stock of the corporation that are owned beneficially by the stockholder. The corporation may require any proposed nominee to furnish such other information as may reasonably be required by the corporation to determine the eligibility of such proposed nominee to serve as director of the corporation. No person shall be eligible for election as a director of the corporation unless nominated in accordance with the procedures set forth herein.
In connection with any annual meeting, the Chair of the Board (or such other person presiding at such meeting in accordance with these Bylaws) shall, if the facts warrant, determine and declare to the meeting that a nomination was not made in accordance with the foregoing procedure, and if he or she should so determine, he or she shall so declare to the meeting and the defective nomination shall be disregarded.
Directors shall serve as provided in the Restated Certificate of Incorporation of the corporation. Directors need not be stockholders.
3.2    Vacancies.  Vacancies and newly created directorships resulting from any increase in the authorized number of directors may be filled by a majority of the directors then in office, though less than a quorum, or by a sole remaining director, and the directors so chosen shall hold office until the next annual meeting of stockholders (or the annual meeting of stockholders at which the term of the class to which they have been elected expires, if applicable) and until their successors are duly elected and shall qualify, unless sooner displaced. If there are no directors in office, then an election

-6-


of directors may be held in the manner provided by law. In the event of a vacancy in the Board, the remaining directors, except as otherwise provided by law or these bylaws, may exercise the powers of the full Board until the vacancy is filled.
3.3    Resignation and Removal.  Any director may resign at any time upon written notice or by electronic transmission to the corporation at its principal place of business or to the Chief Executive Officer or the Secretary. Such resignation shall be effective upon receipt of such notice unless the notice specifies such resignation to be effective at some other time or upon the happening of some other event. Any director or the entire Board may be removed, with or without cause, by the holders of a majority of the shares then entitled to vote at an election of directors, unless otherwise specified by law or the Restated Certificate of Incorporation, or unless the Board is then classified under its Restated Certificate of Incorporation, in which case any director or the entire Board may be removed only for cause.
3.4    Powers.  The business of the corporation shall be managed by or under the direction of the Board which may exercise all such powers of the corporation and do all such lawful acts and things which are not by statute or by the Restated Certificate of Incorporation or by these Bylaws directed or required to be exercised or done by the stockholders.
3.5    Place of Meetings.  The Board may hold meetings, both regular and special, either within or without the State of Delaware.
3.6    Annual Meetings.  The annual meetings of the Board shall be held in the four month period either immediately preceding or immediately following the annual meeting of stockholders, and no notice of such meeting shall be necessary to the Board, provided a quorum shall be present. The annual meetings shall be for the purposes of organization, and an election of officers and the transaction of other business.
3.7    Regular Meetings.  Regular meetings of the Board may be held without notice at such time and place as may be determined from time to time by the Board.
3.8    Special Meetings.  Special meetings of the Board may be called by the Chair of the Board, the Lead Director, the Chief Executive Officer or by a majority of the Board upon one (1) day's notice to each director and can be delivered either personally, or by telephone, express delivery service (so that the scheduled delivery date of the notice is at least one (1) day in advance of the meeting), telegram, facsimile transmission or electronic transmission, and on five (5) day's notice, by mail. The notice need not describe the purpose of the special meeting.
3.9    Quorum and Adjournments.  At all meetings of the Board, a majority of the directors then in office shall constitute a quorum for the transaction of business, and the act of a majority of the directors present at any meeting at which there is a quorum shall be the act of the Board, except as may otherwise be specifically provided by law or the Restated Certificate of Incorporation. If a quorum is not present at any meeting of the Board, the directors present may adjourn the meeting from time to time, without notice other than announcement at the meeting at which the adjournment is taken, until a quorum shall be present. A meeting at which a quorum is initially present may continue to transact

-7-


business notwithstanding the withdrawal of directors, if any action taken is approved of by at least a majority of the required quorum for that meeting.
3.10    Action Without Meeting.  Unless otherwise restricted by law, the Restated Certificate of Incorporation or these Bylaws, any action required or permitted to be taken at any meeting of the Board or of any committee thereof may be taken without a meeting, if all members of the Board or committee, as the case may be, consent thereto in writing or by electronic transmission, and the writing or writings or electronic transmission or transmissions are filed with the minutes of proceedings of the Board or committee. Such filing shall be in paper form if the minutes are maintained in paper form and shall be in electronic form if the minutes are maintained in electronic form.
3.11    Telephone Meetings.  Unless otherwise restricted by law, the Restated Certificate of Incorporation or these Bylaws, any member of the Board or any committee may participate in a meeting by means of conference telephone or other communications equipment by means of which all persons participating in the meeting can hear each other, and such participation in a meeting shall constitute presence in person at the meeting.
3.12    Waiver of Notice.  Notice of a meeting need not be given to any director who signs a waiver of notice or a consent to holding the meeting or an approval of the minutes thereof, whether before or after the meeting, or who attends the meeting without protesting, prior thereto or at its commencement, the lack of notice to such director. All such waivers, consents and approvals shall be filed with the corporate records or made a part of the minutes of the meeting.
3.13    Fees and Compensation of Directors.  Unless otherwise restricted by law, the Restated Certificate of Incorporation or these Bylaws, the Board shall have the authority to fix the compensation of directors. The directors may be paid their expenses, if any, of attendance at each meeting of the Board and may be paid a fixed sum for attendance at each meeting of the Board or a stated salary as director. No such payment shall preclude any director from serving the corporation in any other capacity and receiving compensation therefor. Members of special or standing committees may be allowed like compensation for attending committee meetings.
3.14    Rights of Inspection.  Any director shall have the right to examine the corporation's stock ledger, a list of its stockholders and its other books and records for a purpose reasonably related to his or her position as a director.
3.15    The Chair of the Board. The Board shall choose a Chair of the Board from among its members with the powers, duties and responsibilities outlined in these Bylaws, among other powers, duties and responsibilities as the Board may provide. The Chair of the Board is to meet as needed with the Chief Executive Officer, participate in the hiring and firing of the Chief Executive Officer and act as spokesperson for the Board. The Chair of the Board shall serve in this capacity at the pleasure of the Board.
3.16    The Lead Director. If the Chair of the Board is an officer or employee of the Corporation or is otherwise not independent (an "Inside Chair"), the Board may choose a Lead Director from among its other members. The Lead Director shall serve in this capacity at the

-8-


pleasure of the Board. The Lead Director must be independent and must not be an officer or employee of the Corporation. The Lead Director is expected to chair sessions involving only the independent Directors, among other responsibilities as the Board may provide.
ARTICLE 4    

Committees of Directors
4.1    Selection.  The Board may, by resolution passed by a majority of the entire Board, designate one or more committees, each committee to consist of one or more of the directors of the corporation. The Board may designate one or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of the committee.
In the absence or disqualification of a member of a committee, the member or members thereof present at any meeting and not disqualified from voting, whether or not he or she or they constitute a quorum, may unanimously appoint another member of the Board to act at the meeting in the place of any such absent or disqualified member.
4.2    Power.  Any such committee, to the extent provided by law and to the extent provided in the resolution of the Board, shall have and may exercise all the powers and authority of the Board in the management of the business and affairs of the corporation, and may authorize the seal of the corporation to be affixed to all papers which may require it.
4.3    Committee Minutes.  Each committee shall keep regular minutes of its meetings and report the same to the Board when required.
ARTICLE 5    

Officers
5.1    Officers Designated.  The officers of the corporation shall be chosen by the Board and shall be a Chief Executive Officer, a Secretary and a Chief Financial Officer (or a Chief Accounting Officer in the absence of a Chief Financial Officer). The Board may also choose a President, a Chief Operating Officer, one or more Executive Vice Presidents, one or more Vice Presidents, a Chief Accounting Officer, and one or more Assistant Secretaries. Any number of offices may be held by the same person, unless the Restated Certificate of Incorporation or these Bylaws otherwise provide.
5.2    Appointment of Officers.  The officers of the corporation, except such officers as may be appointed in accordance with the provisions of Section 5.3 or 5.5 of this Article 5, shall be chosen in such manner and shall hold their offices for such terms as are prescribed by these Bylaws or determined by the Board. Each officer shall hold his or her office until his or her successor is elected and qualified or until his or her earlier resignation or removal. This section does not create any rights of employment or continued employment. The corporation may secure the fidelity of any or all of its officers or agents by bond or otherwise.

-9-


5.3    Subordinate Officers.  The Board may appoint, and may empower the Chief Executive Officer to appoint, such other officers and agents as the business of the corporation may require, each of whom shall hold office for such period, have such authority and perform such duties as are provided in the Bylaws or as the Board may from time to time determine.
5.4    Removal and Resignation of Officers.  Subject to the rights, if any, of an officer under any contract of employment, any officer may be removed, either with or without cause, by an affirmative vote of the majority of the Board, at any regular or special meeting of the Board, or if such officer has not been chosen or approved by the Board, by the Chief Executive Officer.
Any officer may resign at any time by giving written notice to the corporation. Any resignation shall take effect at the date of the receipt of that notice or at any later time specified in that notice; and, unless otherwise specified in that notice, the acceptance of the resignation shall not be necessary to make it effective. Any resignation is without prejudice to the rights, if any, of the corporation under any contract to which the officer is a party.
5.5    Vacancies in Offices.  A vacancy in any office because of death, resignation, removal, disqualification or any other cause shall be filled in the manner prescribed in these Bylaws for regular appointment to that office.
5.6    Compensation.  The salaries of all officers of the corporation shall be fixed from time to time by the Board and no officer shall be prevented from receiving a salary because he or she is also a director of the corporation.
5.7    The Executive Chair of the Board.  The Board may designate the Chair of the Board as an officer known as the Executive Chair of the Board. The Executive Chair of the Board shall, if present, perform such other powers and duties as may be assigned to him or her from time to time by the Board. If there is no elected Chief Executive Officer, the Executive Chair of the Board shall also be the Chief Executive Officer of the Corporation and shall have the powers and duties prescribed in Section 5.8 of this Article 5.
5.8    The Chief Executive Officer.  Subject to such supervisory powers, if any, as may be given by the Board to the Executive Chair of the Board, if there be such an officer, the Chief Executive Officer of the Corporation, shall preside at all meetings of the stockholders in the absence of the Chair of the Board and the Lead Director, shall preside at all meetings of the Board, in the absence of the Chair of the Board and the Lead Director, shall have all lawful powers necessary to conduct the general and active management of the business of the Corporation and shall see that all orders and resolutions of the Board are carried into effect. He or she shall execute bonds, mortgages and other contracts requiring a seal, under the seal of the Corporation, except where required or permitted by law to be otherwise signed and executed and except where the signing and execution thereof shall be expressly delegated by the Board to some other officer or agent of the Corporation.
5.9    The President.  The President, shall in the absence of the Chief Executive Officer or in the event of his or her disability or refusal to act, perform the duties of the Chief Executive Officer, and when so acting, shall have the powers of and subject to all the restrictions upon the Chief Executive

-10-


Officer. The President shall perform such other duties and have such other powers as may from time to time be prescribed for them by the Board, the Chief Executive Officer, the Executive Chair of the Board or these Bylaws.
5.10    The Chief Operating Officer.  The Chief Operating Officer, shall, in the absence of the President or in the event of his or her disability or refusal to act, perform the duties of the President, and when so acting, shall have the powers of and subject to all the restrictions upon the President. The Chief Operating Officer shall perform such other duties and have such other powers as may from time to time be prescribed for them by the Board, the Chief Executive Officer, the Executive Chair of the Board or these Bylaws.
5.11    The Executive Vice President.  The Executive Vice President (or in the event there be more than one, the Executive Vice Presidents in the order designated by the directors, or in the absence of any designation, in the order of their election), shall, in the absence of the President and the Chief Operating Officer or in the event of their disability or refusal to act, perform the duties of the President, and when so acting, shall have the powers of and subject to all the restrictions upon the President. The Executive Vice President(s) shall perform such other duties and have such other powers as may from time to time be prescribed for them by the Board, the Chief Executive Officer, the Executive Chair of the Board or these Bylaws.
5.12    The Vice President.  The Vice President (or in the event there be more than one, the Vice Presidents in the order designated by the directors, or in the absence of any designation, in the order of their election), shall, in the absence of the President, the Chief Operating Officer and any Executive Vice President or in the event of their disability or refusal to act, perform the duties of the President, and when so acting, shall have the powers of and subject to all the restrictions upon the President. The Vice President(s) shall perform such other duties and have such other powers as may from time to time be prescribed for them by the Board, the Chief Executive Officer, the Executive Chair of the Board or these Bylaws.
5.13    The Secretary.  The Secretary shall attend all meetings of the Board and the stockholders and record all votes and the proceedings of the meetings in a book to be kept for that purpose and shall perform like duties for the standing committees, when required. The Secretary shall give, or cause to be given, notice of all meetings of stockholders and special meetings of the Board, and shall perform such other duties as may from time to time be prescribed by the Board, the Executive Chair of the Board or the Chief Executive Officer, under whose supervision he or she shall act. The Secretary shall have custody of the seal of the corporation, and the Secretary, or an Assistant Secretary, shall have authority to affix the same to any instrument requiring it, and, when so affixed, the seal may be attested by his or her signature or by the signature of such Assistant Secretary. The Board may give general authority to any other officer to affix the seal of the corporation and to attest the affixing thereof by his or her signature. The Secretary shall keep, or cause to be kept, at the principal executive office or at the office of the corporation's transfer agent or registrar, as determined by resolution of the Board, a share register, or a duplicate share register, showing the names of all stockholders and their addresses, the number and classes of shares held by each, the number and date of certificates issued for the same and the number and date of cancellation of every certificate surrendered for cancellation.

-11-


5.14    The Assistant Secretary.  The Assistant Secretary, or if there be more than one, the Assistant Secretaries in the order designated by the Board (or in the absence of any designation, in the order of their election) shall, in the absence of the Secretary or in the event of his or her inability or refusal to act, perform the duties and exercise the powers of the Secretary and shall perform such other duties and have such other powers as may from time to time be prescribed by the Board.
5.15    The Chief Financial Officer.  The Chief Financial Officer shall have the custody of the Corporate funds and securities and shall keep full and accurate accounts of receipts and disbursements in books belonging to the corporation. The Chief Financial Officer shall have all lawful powers necessary to open and close accounts with banks and other financial institutions for the deposit of moneys and other valuable effects in the name and to the credit of the corporation. In conjunction with the Chief Executive Officer, the Chief Financial Officer shall have all lawful powers necessary to borrow money and obtain other credit accommodations including, but not limited to, the authority to mortgage or pledge as collateral the corporation's assets. The Chief Financial Officer shall disburse the funds of the corporation as may be ordered by the Board, taking proper vouchers for such disbursements, and shall render to the Chief Executive Officer and the Board, at its regular meetings, or when the Board so requires, an account of all his or her transactions as Chief Financial Officer and of the financial condition of the corporation.
5.16    The Chief Accounting Officer. The Chief Accounting Officer shall be responsible for overseeing all accounting functions, including accounting controls, and shall in the absence of the Chief Financial Officer or in the event of his or her disability or refusal to act, perform the duties of the Chief Financial Officer, and when so acting, shall have the powers of and subject to all the restrictions upon the Chief Financial Officer. The Chief Accounting Officer shall perform such other duties and have such other powers as may from time to time be prescribed for them by the Board, the Chief Executive Officer, the Executive Chair of the Board, the Chief Financial Officer or these Bylaws.

ARTICLE 6    

Stock Certificates
6.1    Certificates for Shares.  The shares of the corporation shall be represented by certificates or shall be uncertificated. Certificates shall be signed by, or in the name of the corporation by, the Executive Chair of the Board, the Chief Executive Officer, the President, the Chief Operating Officer, an Executive Vice President or a Vice President and by the Chief Financial Officer, the Secretary or an Assistant Secretary of the corporation.
Within a reasonable time after the issuance or transfer of uncertificated stock, the corporation shall send to the registered owner thereof a written notice containing the information required by the General Corporation Law of the State of Delaware or a statement that the corporation will furnish without charge to each stockholder who so requests the powers, designations, preferences and relative participating, optional or other special rights of each class of stock or series thereof and the qualifications, limitations or restrictions of such preferences and/or rights.

-12-


6.2    Signatures on Certificates.  Any or all of the signatures on a certificate may be a facsimile. In case any officer, transfer agent or registrar who has signed or whose facsimile signature has been placed upon a certificate shall have ceased to be such officer, transfer agent or registrar before such certificate is issued, it may be issued by the corporation with the same effect as if he or she were such officer, transfer agent or registrar at the date of issue.
6.3    Transfer of Stock.  Upon surrender to the corporation or the transfer agent of the corporation of a certificate of shares duly endorsed or accompanied by proper evidence of succession, assignation or authority to transfer, it shall be the duty of the corporation to issue a new certificate to the person entitled thereto, cancel the old certificate and record the transaction upon its books. Upon receipt of proper transfer instructions from the registered owner of uncertificated share, such uncertificated shares shall be canceled and issuance of new equivalent uncertificated shares or certificated shares shall be made to the person entitled thereto and the transaction shall be recorded upon the books of the corporation.
6.4    Registered Stockholders.  The corporation shall be entitled to recognize the exclusive right of a person registered on its books as the owner of shares to receive dividends, and to vote as such owner, and to hold liable for calls and assessments a percent registered on its books as the owner of shares, and shall not be bound to recognize any equitable or other claim to or interest in such share or shares on the part of any other person, whether or not it shall have express or other notice thereof, except as otherwise provided by the laws of Delaware.
6.5    Lost, Stolen or Destroyed Certificates.  The Board may direct that a new certificate or certificates be issued to replace any certificate or certificates theretofore issued by the corporation alleged to have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the person claiming the certificate of stock to be lost, stolen or destroyed. When authorizing the issue of a new certificate or certificates, the Board may, in its discretion and as a condition precedent to the issuance thereof, require the owner of the lost, stolen or destroyed certificate or certificates, or his or her legal representative, to advertise the same in such manner as it shall require, and/or to give the corporation a bond in such sum as it may direct as indemnity against any claim that may be made against the corporation with respect to the certificate alleged to have been lost, stolen or destroyed.
ARTICLE 7    

General Provisions
7.1    Dividends.  Dividends upon the capital stock of the corporation, subject to any restrictions contained in the General Corporation Law of the State of Delaware or the provisions of the Restated Certificate of Incorporation, if any, may be declared by the Board at any regular or special meeting. Dividends may be paid in cash, in property or in shares of the capital stock, subject to the provisions of the Restated Certificate of Incorporation.
7.2    Dividend Reserve.  Before payment of any dividend, there may be set aside out of any funds of the corporation available for dividends such sum or sums as the directors from time to time, in their absolute discretion, think proper as a reserve or reserves to meet contingencies, or for equalizing

-13-


dividends, or for repairing or maintaining any property of the corporation, or for such other purpose as the directors shall think conducive to the interest of the corporation, and the directors may modify or abolish any such reserve in the manner in which it was created.
7.3    Checks.  All checks or demands for money and notes of the corporation shall be signed by such officer or officers or such other person or persons as the Board may from time to time designate.
7.4    Corporate Seal.  The Board may provide a suitable seal, containing the name of the corporation, which seal shall be in charge of the Secretary. If and when so directed by the Board or a committee thereof, duplicates of the seal may be kept and used by the Chief Financial Officer or by any Assistant Secretary.
7.5    Execution of Corporate Contracts and Instruments.  The Board, except as otherwise provided in these Bylaws, may authorize any officer or officers, or agent or agents, to enter into any contract or execute any instrument in the name of and on behalf of the corporation; such authority may be general or confined to specific instances. Unless so authorized or ratified by the Board or within the agency power of an officer, no officer, agent or employee shall have any power or authority to bind the corporation by any contract or engagement or to pledge its credit or to render it liable for any purpose or for any amount.
7.6    Representation of Shares of Other Corporations.  The Executive Chair of the Board, Chief Executive Officer, President, the Chief Operating Officer, any Executive Vice President or any Vice President or the Chief Financial Officer, the Secretary or any Assistant Secretary of this corporation is authorized to vote, represent and exercise on behalf of this corporation all rights incident to any and all shares of any corporation or corporations standing in the name of this corporation. The authority herein granted to said officers to vote or represent on behalf of this corporation any and all shares held by this corporation in any other corporation or corporations may be exercised either by such officers in person or by any other person authorized so to do by proxy or power of attorney duly executed by said officers. The Board, in its discretion, may appoint specific officers the authority to vote, represent or exercise shares in certain other corporations, although other officers may exercise such authority in the event of the incapacitation or death of such specific officers.
ARTICLE 8    

Miscellaneous
8.1    Stock Options and Toxic Securities.   Except in the case of shares of common stock that may be offered to employees of the corporation at a discount to fair market value pursuant to an employee stock purchase or similar plan intended to qualify under section 423 of the Internal Revenue Code of 1986, as amended, which shall not be covered by this Section 8.1, unless approved by the holders of a majority of the shares entitled to vote at a duly convened meeting of stockholders, the corporation shall not:
(i)    grant any stock option, including stock appreciation right, with an exercise price that is less than 100% of the fair market value of the underlying stock on the date of grant;

-14-


(ii)    reduce the exercise price of any stock option, including stock appreciation right, outstanding or to be granted in the future; cancel and re-grant options at a lower exercise price (including entering into any "6 month and 1 day" cancellation and re-grant scheme), whether or not the cancelled options are put back into the available pool for grant; replace underwater options with restricted stock in an exchange, buy-back or other scheme; or replace any options with new options having a lower exercise price or accelerated vesting schedule in an exchange, buy-back or other scheme;
(iii)    sell or issue any security of the corporation convertible, exercisable or exchangeable into shares of common stock, having a conversion, exercise or exchange price per share which is subject to downward adjustment based on the market price of the common stock at the time of conversion, exercise or exchange of such security into common stock (except for appropriate adjustments made to give effect to any stock splits or stock dividends); or
(iv)    enter into (a) any equity line or similar agreement or arrangement; or (b) any agreement to sell common stock (or any security convertible, exercisable or exchangeable into shares of common stock ("Common Stock Equivalent")) at a per share price (or, with respect to a Common Stock Equivalent, at a conversion, exercise or exchange price, as the case may be ("Equivalent Price")) that is fixed after the execution date of the agreement, whether or not based on any predetermined price-setting formula or calculation method. Notwithstanding the foregoing, however, a price protection clause shall be permitted in an agreement for sale of common stock or Common Stock Equivalent, if such clause provides for an adjustment to the price per share of common stock or, with respect to a Common Stock Equivalent, to the Equivalent Price (provided that such price or Equivalent Price is fixed on or before the execution date of the agreement) (the "Fixed Price") in the event that the corporation, during the period beginning on the date of the agreement and ending no later than ninety (90) days after the closing date of the transaction, sells shares of common stock or Common Stock Equivalent to another investor at a price or Equivalent Price, as the case may be, below the Fixed Price.
8.2    Amendments. The Board of Directors is expressly empowered to adopt, amend or repeal these Bylaws, provided, however, that any adoption, amendment or repeal of these Bylaws by the Board of Directors shall require the approval of at least sixty-six and two-thirds percent (66‑2/3%) of the total number of authorized directors (whether or not there exist any vacancies in previously authorized directorships at the time any resolution providing for adoption, amendment or repeal is presented to the board). The stockholders shall also have power to adopt, amend or repeal these Bylaws, provided, however, that in addition to any vote of the holders of any class or series of stock of this corporation required by law or by the Restated Certificate of Incorporation of this corporation, the affirmative vote of the holders of more than fifty percent (50%) of the voting power of all of the then outstanding shares of the stock of the corporation entitled to vote generally in the election of directors, voting together as a single class, shall be required for such adoption, amendment or repeal by the stockholders of any provisions of these Bylaws. Notwithstanding the foregoing sentence, until the election of directors at the annual meeting of stockholders to be held in 2020, at which time this sentence shall automatically expire and be of no further force and effect and be deemed deleted and eliminated in its entirety from these Bylaws (without any further action by any person), the affirmative vote of the holders of at least

-15-


sixty-six and two-thirds percent (66-2/3%) of the voting power of all of the then outstanding shares of the stock of the corporation entitled to vote generally in the election of directors, voting together as a single class, shall be required for the amendment or repeal of Article 3.1 of these Bylaws.
Notwithstanding the foregoing paragraph or any provision of the Restated Certificate of Incorporation, Section 8.1 of these Bylaws may only be amended or repealed by the affirmative vote of the holders of a majority of the shares of the stock of the corporation entitled to vote at a duly convened meeting of stockholders.

-16-
 EX-10.1 4 heska-06302019xexx10x1.htm EXHIBIT 10.1 Exhibit

Exhibit 10.1


Certain confidential information contained in this document, marked by brackets as [***], has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.



AMENDMENT NO. 1 TO THE SUPPLEMENTAL AGREEMENT
BETWEEN
ELANCO US INC.
AND
DIAMOND ANIMAL HEALTH, INC

Elanco US Inc. (“Elanco”) (formerly Eli Lilly and Company and its Affiliates operating through its Elanco Animal Health division) and Diamond Animal Health Inc. (“Diamond”), parties to the Master Supply Agreement effective dated October 1st 2014 (the “Master Supply Agreement”) and the Supplemental Agreement for the supply of vaccines and subject to the Master Supply Agreement (the “Supplemental Agreement”) desire to amend the Supplemental Agreement by this Amendment No. 1 (this "Amendment") effective upon the date of last signature (the "Amendment Effective Date"). Elanco and Diamond may each be referred to as a “Party” and, collectively, as the “Parties.”

RECITALS:

A.
WHEREAS, Diamond and Elanco entered into that certain Asset Purchase and License Agreement, dated June 17, 2013 in connection with the sale and license back of, among other things, certain biological assets used in the manufacture of vaccine products, as amended, (the "APA");
B.
WHEREAS, capitalized terms in this Amendment refer to defined terms in the APA;
C.
WHEREAS, Diamond and Elanco entered into that certain Master Supply Agreement, dated October 1st 2014, in order to facilitate Elanco’s engagement of Diamond to supply certain products to Elanco from time to time (the “Master Supply Agreement”);
D.
WHEREAS, Diamond and Elanco entered into that certain Supplemental Agreement subject to the Master Supply Agreement effective dated October 1st 2014, for the supply of vaccines (the “Supplemental Agreement”)
E.
WHEREAS, Diamond and Elanco desire to formally amend the necessary agreements, including but not limited to the license back of rights in the APA, and the minimum purchase obligations to the extent applicable in the APA, the Master Supply Agreement and the Supplemental Agreement, to define new minimum purchase obligations for calendar year 2019 and through the remaining term and to revise the relationship to allow Diamond to commercialize vaccine products which utilize or incorporate the Purchased Assets for third party customers outside the United States beyond the previous Defined Third Parties as further specified in this Amendment and Amendment No. 2 to the APA.

NOW THEREFORE, in consideration of the foregoing premises and the following mutual covenants and
other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the
Parties agree as follows:

1.
Elanco agrees to pay to Diamond a one-time payment of [***] within thirty (30) days of the Amendment Effective Date.

2.
Section A.3.5 of the Supplemental Agreement is hereby deleted in its entirety and replaced with the following:

A.3.5
The Parties acknowledge that during the term of this Agreement, Diamond will have the obligation to make Product for Elanco and/or Defined Third Parties, and that such obligation will entail consumption of a portion of certain Purchased Assets. To the extent that such obligation to make Defined Product(s) pertain to supply by Diamond to Defined Third Parties or to the extent Diamond manufacturers Diamond Products, such supply should be sourced from the assets contained in the Diamond Subset. Conversely, to the extent that such obligation to make Products pertains to the supply by Diamond to Elanco, such supply should be sourced from the assets contained in the Elanco Subset.

3.
Section A.5.1 of the Supplemental Agreement is hereby deleted in its entirety and replaced with the following:

A.5.1
The Parties acknowledge that investments in capital improvement, maintenance and repair in Diamond's manufacturing facility (the "Manufacturing Facility") will be required during the term of this Agreement to: 1) provide for compliance with regulatory requirements from Regulatory Agencies are met and maintained throughout the term of this Agreement; and 2) provide that facilities and equipment are maintained in good working order to assure reliability of supply. Diamond shall be responsible for any and all investments required to meet or maintain compliance with such regulatory requirements in the United States or any other country for which Diamond manufactures as of the Effective Date of the APA and to maintain, refurbish and/or replace equipment and facilities, as Diamond reasonably determines are necessary, to provide for reliability of supply after the Effective Date of the APA. Moreover, Diamond shall be responsible for: (i) any and all investments required to meet or maintain compliance with such regulatory requirements in any other country outside the United States for which Diamond commercializes a Diamond Product after the Amendment Effective Date; and (ii) any product-specific investment required for Diamond to commercialize a Diamond Product outside the United States after the Amendment Effective Date. Elanco shall be responsible for: (i) any and all investments required to meet or maintain compliance with regulatory requirements in countries that Elanco has commercialized an Elanco Product after the Effective Date of the APA and prior to the Amendment Effective Date other than those countries for which Diamond manufactured as of the Effective Date of the APA; and (ii) any product-specific investment required for Elanco to commercialize an Elanco Product after the Amendment Effective Date and iii) all investments specifically requested by Elanco that are not otherwise required by an applicable Regulatory Agency or reasonably determined by Diamond to be needed to provide for on-going, reliable supply of Elanco Product.

4.
Section A.7.1 of the Supplemental Agreement is hereby deleted in its entirety and replaced with the following:

A.7.1
The Parties agree that Elanco shall have the responsibility for, and shall pay all Product Registration Costs associated with securing all appropriate regulatory licenses and approvals required for marketing the Products as of the Amendment Effective Date. Each party shall pay all Product Registration Costs associated with securing all appropriate regulatory licenses and approvals required for marketing their own respective new products after the Amendment Effective Date. License submissions for Diamond Products outside the USA will be made by Diamond or its designee in these countries. Elanco may, with Diamond's consent, engage Diamond to perform any activities connected with obtaining such licenses and approvals and shall pay all Product Registration Costs for Elanco Products associated with Diamond's services, excluding costs related to the facility licenses owned by Diamond, facility inspection relating to facility licenses owned by Diamond including but not limited to USDA/ APHIS/CVB, international licenses and inspections and their maintenance, all to the extent such licenses are owned by Diamond. Diamond shall be responsible, at Elanco's cost, for all dossier submissions to all regulatory authorities necessary to obtain registration of Elanco Products in such jurisdictions. License submissions for Elanco Products outside of the USA and Canada will be made by Elanco in these countries. The Parties shall agree upon a written work plan prior to commencement of any such services. Such work plan shall specify how Product Registration Costs will be calculated (e.g., hourly) and when they will be paid. Any estimate of Product Registration Costs shall be a non-binding estimate only. For the purposes of this Agreement, "Product Registration Costs" shall mean all direct costs and expenses associated with achieving regulatory licensure of a Product, including clinical trial costs, assay development and validation, development of seed stocks, production processes scale-up, formulation development, production of prelicensing serials, conduct of field safety trials, preparation of reports, preparation of regulatory submissions, application fees and other costs and expenses reasonably incidental thereto. As between the parties, additional costs and expenses shall include labor and service charges at Diamond's standard hourly rates, direct cost of required materials provided by Diamond, and out-of-pocket and third-party expenditures.

5.
Section A.7.2 of the Supplemental Agreement is hereby deleted in its entirety and replaced with the following:

A.7.2
Diamond shall be responsible for securing all appropriate regulatory licenses and approvals required for manufacturing the Products for sale in the United States and Canada. Except as provided in Section A.7.1 above, Elanco shall pay all Manufacturer Registration Costs set forth in this Supplemental Agreement, as may be amended by the Parties for a New Vaccine Product after the Amendment Effective Date. The Parties shall agree upon a written work plan prior to commencement of any registration activities for a New Vaccine Product after the Amendment Effective Date. Such work plan shall specify how Manufacturer Registration Costs will be calculated (e.g., hourly) and when they will be paid. Any estimate of Manufacturer Registration Costs shall be non-binding estimate only. For the purposes of this Agreement, "Manufacturer Registration Costs" shall mean all direct costs and expenses associated with achieving regulatory licensure of Diamond to manufacture any Product, including costs of animal studies, production process, validation costs, stability studies, production of pre-licensing serials, application fees and other costs and expenses reasonably incidental thereto. As between the parties, additional costs and expenses shall include labor and service charges at Diamond's standard hourly rates, direct cost of required materials provided by Diamond, and out-of-pocket and third-party expenditures.
 
6.
Section A.9.1 of the Supplemental Agreement is hereby deleted in its entirety and replaced with the following:

A.9.1
Diamond shall affix labeling to the Products as required, such labeling for an Elanco Product to bear one or more Elanco trademarks, as specified by Elanco. Nothing contained herein shall give Diamond any right to use any Elanco trademark except on Products for Elanco and Diamond shall not obtain any right, title or interest in any Elanco trademark by virtue of this Agreement. Elanco shall not use, nor shall Elanco obtain any right, title or interest in any Diamond trademark. Elanco shall cause all Elanco Product labeling to contain only such claims as are permitted under applicable licenses for such Elanco Product and otherwise comply with Applicable Law. Elanco shall be responsible for the costs of developing and changing packaging for the Elanco Products. Diamond shall be responsible for the costs of developing and changing packaging for the Diamond Products. Elanco shall be responsible for the costs of obsolete labeling and packaging due to changes requested by Elanco or required by Governmental Authorities for an Elanco Product. Elanco agrees to provide label specifications compatible with Diamond's equipment, as specified by Diamond. Additional details to be set forth on Exhibit A. In the event that Diamond purchases labeling or packaging materials for use with the Products, Diamond shall purchase an amount reasonably required for the amount of Products manufactured; provided the Parties agree that a six (6) month supply of labeling and packaging materials is reasonable, and Elanco shall be required to bear the full cost of such reasonable supply even if this Agreement is terminated, unless otherwise agreed upon by the Parties.

7.
Exhibit A, the Minimum Annual Purchases section of Exhibit A of the Supplemental Agreement is deleted in its entirety and replaced with the following:

Minimum Annual Purchases

For all purposes of the Supplemental Agreement, the Minimum Annual Purchases shall mean:
(a) [***] for each of calendar years 2019, 2020, 2021 and 2022; and,
(b) [***] pro-rated to the number of days the Supplemental Agreement remains in effect for a partial calendar year which equals [***]for the period of January 1, 2023 through June 16, 2023.
(collectively, the "Minimum Annual Purchases"). Except as set forth herein, all purchases of Products, [***] and/or [***] from Diamond or any of its Affiliates by Elanco or any of its Affiliates shall count toward satisfying the Minimum Annual Purchases requirement. Purchases of (i) [***], (ii) [***] and (iii) [***]by Elanco or any of its Affiliates, will not count as purchases that count toward satisfying the Minimum Annual Purchases requirement under this Agreement.

8.
Except as set forth above, all other terms and conditions of the Supplemental Agreement will remain in full force and effect. On and after the Amendment Effective Date, any reference to the Supplemental Agreement shall mean the Supplement Agreement as amended by this Amendment. In the event of a conflict between the terms of this Amendment and the terms of the Supplemental Agreement, the terms of this Amendment shall govern.



IN WITNESS WHEREOF, duly authorized representatives of the parties have signed this Amendment as of the Amendment Effective Date.


Diamond Animal Health, Inc.                Elanco US Inc.

By:     /s/Jason Napolitano                 By:     [***]                    
Print Name:     Jason Napolitano            Print Name:     [***]                
Title:     Chief Executive Officer                Title:     [***]                    
Date:     June 27, 2019                    Date:     June 25, 2019                



-1-

 EX-10.2 5 heska-06302019xexx10x2.htm EXHIBIT 10.2 Exhibit

Exhibit 10.2

Certain confidential information contained in this document, marked by brackets as [***], has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.



AMENDMENT TO ASSET PURCHASE and LICENSE AGREEMENT
This AMENDMENT TO ASSET PURCHASE and LICENSE AGREEMENT (this "Amendment") is entered into effective upon the date of last signature (the "Amendment Effective Date"), by and between:
DIAMOND ANIMAL HEALTH, INC., an Iowa Corporation having its place of business at 2538 S.E. 43rd Street, Des Moines, Iowa, 50317 (hereafter collectively referred to as "Diamond"); and
ELI LILLY AND COMPANY, a company registered in Indiana having its registered office at 2500 Innovation Way, Greenfield, Indiana 46140-9163 USA on behalf of its operating subsidiary Elanco Animal Health division and, and its Affiliates (hereafter collectively referred to as "Elanco").
Each a "Party" and together the "Parties".
RECITALS
A.
WHEREAS, Diamond and Elanco entered into that certain Asset Purchase and License Agreement, dated June 17, 2013 in connection with the sale and license back of, among other things, certain biological assets used in the manufacture of vaccine products (the "Agreement").
B.
WHEREAS, capitalized terms in this Amendment refer to defined terms in the Agreement.
C.
WHEREAS, pursuant to its authority set forth in the Agreement, on December 15, 2014, the Steering committee approved an amendment to a Contract Manufacturing Agreement between Diamond and [***] whereby Diamond would manufacture certain Defined Products in Central America and South America.
D.
WHEREAS, South America (with respect to Cattle Vaccine Products) were not countries originally designated in a Segment in the existing the Agreement.
E.
WHEREAS, pursuant to Section 4.2 of the Agreement, the Steering committee does not have the right, power or authority to amend the Agreement.
F.
WHEREAS, Diamond and Elanco desire to formally amend the Agreement to define new Segments to accommodate the amendment to the [***] Agreement as approved by the Steering committee.
NOW THEREFORE, in consideration of the foregoing premises and the following mutual covenants and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties agree as follows:
1.
Section 2.2(b) of the Agreement is hereby amended by restating vi) and vii) as follows and by appending the following new subsections viii) and ix) to the end of Section 2.2(b):
"vi) Cattle vaccine products for sale in South Africa;
vii)    Feline vaccine products as listed in Exhibit 9;
viii)    Cattle vaccine products for sale in South America (excluding Brazil); and
ix)    Cattle vaccine products for sale in Central America."
 
2.
Section 2.4 of the Agreement is hereby amended by appending a new final sentence to the Section as follows:
"For clarity, Elanco shall receive full credit for the doses of vaccine sold as a result of this March 2015 Amendment to expand sales geographies licensed under Section 2.2, and credited toward Elanco's contribution to the vaccine plant throughput.
3.
Effective as of the Amendment Effective Date, Exhibit 5 to the Agreement is hereby deleted in its entirety and replaced with the new Exhibit 5 attached hereto.
4.
Effective as of the Amendment Effective Date, Exhibit 6 to the Agreement is hereby deleted in its entirety and replaced with the new Exhibit 6 attached hereto.
5.
Except as set forth above, all other terms and conditions of the Agreement will remain in full force and effect. On and after the Amendment Effective Date, any reference to the Agreement shall mean the Agreement as amended by this Amendment. In the event of a conflict between the terms of this Amendment and the terms of the Agreement, the terms of this Amendment will govern.

AMENDMENT TO ASSET PURCHASE and LICENSE AGREEMENT EXECUTED
Signed on behalf of    )
Eli Lilly and Company, operating through its )
Elanco Animal Health division    )
by an authorized officer:    )


[***]

Signature of Authorized Officer


[***]
 
Name of Authorized Officer (please print)


June 30, 2015
 
Date Signed

 

)
)
)
Signed on behalf of
Diamond Animal Health, Inc. by an authorized officer:
   


[***]

Signature of Authorized Officer


[***]
 
Name of Authorized Officer (please print)


July 6, 2015
 
Date Signed




EXHIBIT 5
LIST OF DEFINED THIRD PARTIES AND DEFINED PRODUCTS SOURCED BY EACH DEFINED THIRD PARTY


EXHIBIT 6
DISTRIBUTION AGREEMENTS BETWEEN DIAMOND AND DEFINED THIRD PARTIES
INVOLVING CATTLE VACCINE PRODUCTS IN EFFECT AS OF THE EFFECTIVE DATE



1

 EX-10.3 6 heska-06302019xexx10x3.htm EXHIBIT 10.3 Exhibit

Exhibit 10.3

Certain confidential information contained in this document, marked by brackets as [***], has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.



AMENDMENT NO. 2 TO THE ASSET PURCHASE AND LICENSE AGREEMENT
BETWEEN
ELANCO US INC.
AND
DIAMOND ANIMAL HEALTH, INC

Elanco US Inc. (“Elanco”) (formerly Elanco Animal Health a division of Eli Lilly and Company) and Diamond Animal Health Inc. (“Diamond”), parties to the Asset Purchase and License Agreement effective date June 17, 2013, as first amended July 6, 2015 (the “APA”) desire to further amend the APA by this Amendment No. 2 (this "Amendment") effective upon the date of last signature (the "Amendment Effective Date"). Elanco and Diamond may each be referred to as a “Party” and, collectively, as the “Parties.”

RECITALS:

A.
WHEREAS, Diamond and Elanco entered into the APA in connection with the sale and license back of, among other things, certain biological assets used in the manufacture of vaccine products;
B.
WHEREAS, Diamond and Elanco entered into that certain Master Supply Agreement, dated October 1st 2014, in order to facilitate Elanco’s engagement of Diamond to supply certain products to Elanco from time to time (the “Master Supply Agreement”);
D.
WHEREAS, Diamond and Elanco entered into that certain Supplemental Agreement subject to the Master Supply Agreement effective dated October 1st 2014, for the supply of vaccines (the “Supplemental Agreement”)
E.
WHEREAS, Diamond and Elanco desire to formally amend the necessary agreements, including but not limited to the license back of rights in the APA, and the minimum purchase obligations to the extent applicable in the APA, the Master Supply Agreement and the Supplemental Agreement to define new minimum purchase obligations for calendar year 2019 and through the remaining term and to revise the relationship to allow Diamond to commercialize vaccine products which utilize or incorporate the Purchased Assets for third party customers outside the United States beyond the previous Defined Third Parties as further specified in this Amendment and Amendment No. 1 to the Supplemental Amendment, effective the same date as this Amendment.

NOW THEREFORE, in consideration of the foregoing premises and the following mutual covenants and
other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the
Parties agree as follows:

1.
Article I of the APA is hereby amended by adding the following:

“Diamond Product(s)” means any Product (excluding New Vaccine Products and any other embodiment that incorporates, uses or implements any of the Elanco Derivative Assets) and any other embodiment that incorporates, uses or implements any of the Diamond Derivative Assets.

“Elanco Product(s)” means any Product and any New Vaccine Product, including but not limited to and any other embodiment that incorporates, uses or implements any of the Elanco Derivative Assets.

2.
Section 2.2(b) of the APA is hereby deleted in its entirety and replaced with the following:

2.2(b)
Elanco hereby grants to Diamond and its Affiliates a non‐exclusive, royalty‐free, fully paid-up, time-limited (to the extent set forth herein), non‐sublicensable license to make, have made, use, sell, have sold and export Products (excluding New Vaccine Products and any other embodiment that incorporates, uses or implements any of the Elanco Derivative Assets) and Diamond Products that use or incorporate the Purchased Assets solely for the purpose of supplying (i) Products and Diamond Products for third parties (including without limitation Defined Third Parties) for sale outside the United States and (ii) Products for Elanco or its Affiliates for sale in the United States.

3.
Sections 2.3(a) and (b) of the APA are hereby deleted in their entireties.

4.
Section 2.4 of the APA is amended to delete the entire last sentence of this section, beginning after bullets 1 through 6 and ending at the end of section 2.4. Section 2.4 of the APA is further amended to delete the first two sentences of this section and be replaced with the following:

During the term of this Agreement, the Parties intend to maintain vaccine plant throughput at Diamond at levels equal to or greater those set forth in the Minimum Annual Purchases section of Exhibit A of the Supplemental Agreement. For clarity, and notwithstanding anything to the contrary, nothing in this agreement shall be construed as a warranty by Elanco of minimum plant throughput or coverage of plant overhead costs.

5.
Section 3.3 of the APA is amended to delete the entire third and fourth sentences of this section and replaced with the following:

Upon Notice of termination of this Agreement and request via Notice from Elanco, Diamond shall provide all reasonable support to Elanco in the prompt licensure of the Cattle Vaccine Products, the Elanco Products and the Other Vaccine Products at an Elanco manufacturing facility or at another manufacturing facility designated by Elanco (as applicable) with the intent that such facility receives such license(s) prior to the expiration or termination of this Agreement. For the avoidance of doubt, Diamond shall retain its Registrations for Cattle Vaccine Products and Diamond Products during and after the term of this Agreement.

6.
Section 3.4 of the APA is hereby deleted in its entirety.

7.
Exhibit 7, Section 1, Minimum Purchases, is hereby deleted in its entirety and replaced with the following:
 
1.    Minimum Purchase:

For all purposes of the Supply Agreement, the Minimum Annual Purchases shall mean:
(a) [***] for each of calendar years 2019, 2020, 2021 and 2022; and,
(b) [***] pro-rated to the number of days the Supply Agreement remains in effect for a partial calendar year which equals [***] for the period of January 1, 2023 through June 16, 2023.
(collectively, the "Minimum Annual Purchases"). Except as set forth herein, all purchases of Products, [***] and/or [***] from Diamond or any of its Affiliates by Elanco or any of its Affiliates shall count toward satisfying the Minimum Annual Purchases requirement. Purchases of (i) [***], (ii) [***] and (iii) [***] by Elanco or any of its Affiliates, will not count as purchases that count toward satisfying the Minimum Annual Purchases requirement under this Agreement.

8.
Except as set forth above, all other terms and conditions of the APA will remain in full force and effect. On and after the Amendment Effective Date, any reference to the APA shall mean the APA as amended by this Amendment. In the event of a conflict between the terms of this Amendment and the terms of the APA, the terms of this Amendment shall govern.


IN WITNESS WHEREOF, duly authorized representatives of the parties have signed this Amendment No. 2 as of the Amendment Effective Date.


Diamond Animal Health, Inc.                Elanco US Inc.

By:     /s/Jason Napolitano                 By:     [***]                    
Print Name:     Jason Napolitano            Print Name:     [***]                
Title:     Chief Executive Officer                Title:     [***]                    
Date:     June 27, 2019                    Date:     June 25, 2019                



-1-

 EX-10.4 7 heska-06302019xexx10x4.htm EXHIBIT 10.4 Exhibit

Exhibit 10.4






    



HESKA CORPORATION
STOCK INCENTIVE PLAN

i



HESKA CORPORATION
STOCK INCENTIVE PLAN

MOST RECENTLY AMENDED AND RESTATED EFFECTIVE MAY 2, 2019
TABLE OF CONTENTS
2.1Committee Composition    1
2.2Committee Responsibilities    2
2.3Indemnification    2
2.4Beneficiary Designations    2
3.1Basic Limitation    2
3.2Additional Shares    3
3.3Minimum Vesting Requirements    3
3.4Limitation on Outside Director Compensation    3
3.5Per-Participant Annual Award Limits    3
4.1Awards other than ISOs    4
4.2Incentive Stock Options    4
5.1Stock Option Agreement    4
5.2Number of Shares    4

ii

5.3Exercise Price    4
5.4Incentive Stock Options    4
5.5Exercisability    5
5.6Option Term    5
5.7Effect of Change in Control    6
5.8Modification or Assumption of Options    6
5.9Payment for Option Shares    6
6.1Time, Amount and Form of Awards    7
6.2Payment for Awards    7
6.3Vesting Conditions    7
6.4Voting and Dividend Rights    7
7.1Time, Amount and Form of Awards    8
7.2Restrictions and Conditions    8
7.3Rights as a Stockholder    8
7.4 Settlement of Restricted Stock Units    9
8.1In General    9
8.2Rights as Stockholder    9
8.3Exercisability    9
8.4Payment Upon Exercise    10
8.5Termination of Employment or Service    10

iii

8.6Term    10
9.1In General    11
9.2Vesting    11
ARTICLE 10. PERFORMANCE MEASURES.    11
10.1In General    11
10.2Performance Goals    11
12.1Adjustments    14
12.2Dissolution or Liquidation    14
12.3Reorganizations    14
14.1Retention Rights    15
14.2Stockholders’ Rights    15
14.3Regulatory Requirements    15
15.1General    15
15.2Section 280G    16
16.1Term of the Plan    16

iv

16.2Performance Awards    16



v


HESKA CORPORATION
STOCK INCENTIVE PLAN
Most Recently Amended and Restated Effective May 2, 2019
ARTICLE 1.
INTRODUCTION
The Heska Corporation 1997 Stock Incentive Plan was originally adopted by the Board effective March 15, 1997 (the “Original Plan”). The Original Plan was subsequently amended and/or restated as of March 6, 2007, May 5, 2009, February 22, 2012, March 25, 2014, and May 6, 2014, March 28, 2016, March 7, 2018, May 3, 2018 and December 19, 2018 (the “Amended and Restated Plan”). The number of Common Shares available for issuance and subject to Awards under the Amended and Restated Plan was adjusted in connection with completion of the Company’s 1-for-10 Reverse Stock Split on December 30, 2010. The Board approved on March 14, 2019, and the Company’s stockholders approved on May 2, 2019, the further amendment and restatement of the Amended and Restated Plan to, among other things, provide the Company with the ability to make Awards in the form of Restricted Stock Units, Stock Appreciation Rights, Other Cash-Based Awards, and Other Stock-Based Awards, in addition to its existing ability to grant Awards of Restricted Shares and Options, and to add an annual limit on the cash and equity compensation that may be paid to each Outside Director of the Company.
The purpose of the Plan is to promote the long-term success of the Company and the creation of stockholder value by (a) encouraging Employees, Outside Directors and Consultants to focus on critical long-range objectives, (b) encouraging the attraction and retention of Employees, Outside Directors and Consultants with exceptional qualifications and (c) linking Employees, Outside Directors and Consultants directly to stockholder interests through increased stock ownership. The Plan seeks to achieve this purpose by providing for Awards in the form of Restricted Shares, Restricted Stock Units, Options (which may constitute ISOs or NQOs), Stock Appreciation Rights, Performance-Based Awards, Other Cash-Based Awards, or Other Stock-Based Awards.
The Plan shall be governed by, and construed in accordance with, the laws of the State of Colorado (except its choice-of-law provisions).
ARTICLE 2.    
ADMINISTRATION.
2.1
COMMITTEE COMPOSITION    . The Plan shall be administered by the Committee. The Committee shall consist exclusively of two or more directors of the Company, who shall be appointed by the Board. In addition, the composition of the Committee shall satisfy:
(a)
Such requirements as the Securities and Exchange Commission may establish for administrators acting under plans intended to qualify for exemption under Rule 16b-3 (or its successor) under the Exchange Act; and
(b)
Such requirements as the Internal Revenue Service may establish for outside directors acting under plans intended to qualify for exemption under section 162(m)(4)(C) of the Code.
The Board may also appoint one or more separate committees of the Board, each composed of one or more directors of the Company who need not satisfy the foregoing requirements, who may administer the Plan with respect to Employees and Consultants who are not considered officers or directors of the Company under section 16 of the Exchange Act, may grant Awards under the Plan to such Employees and Consultants and may determine all terms of such Awards.
2.2
COMMITTEE RESPONSIBILITIES    . The Committee shall (a) select the Employees, Outside Directors and Consultants who are to receive Awards under the Plan, (b) determine the type, number, vesting requirements and other features and conditions of such Awards, (c) interpret the Plan and (d) make all other decisions relating to the operation of the Plan. The Committee may adopt such rules or guidelines as it deems appropriate to implement the Plan. The Committee may amend or modify any outstanding Awards in any manner to the extent the Committee would have had the authority under the Plan initially to make such Awards as so amended or modified. The Committee’s determinations under the Plan shall be final and binding on all persons.
2.3
INDEMNIFICATION. No member of the Board or the Committee, or any officer or employee of the Company or any Subsidiary thereof acting on behalf of the Board or the Committee, shall be personally liable for any action, omission, determination, or interpretation taken or made in good faith with respect to the Plan, and all members of the Board or the Committee and each and any officer or employee of the Company and of any Subsidiary thereof acting on their behalf shall, to the maximum extent permitted by applicable law and the Company’s by-laws and governing documents, be fully indemnified and protected by the Company in respect of any such action, omission, determination or interpretation.
2.4
BENEFICIARY DESIGNATIONS. If permitted by the Committee, a Participant under the Plan may name a beneficiary or beneficiaries to whom any vested but unpaid Award shall be paid in the event of the Participant’s death.  Each such designation shall revoke all prior designations by the Participant and shall be effective only if given in a form and manner acceptable to the Committee.  In the absence of any such designation, any vested benefits remaining unpaid at the Participant’s death shall be paid to the beneficiary designated by the Participant in the Company’s qualified 401(k) savings plan, or if none, to the Participant’s surviving spouse, or if none, to the Participant’s estate.
ARTICLE 3.    
SHARES AVAILABLE FOR GRANTS.
3.1
BASIC LIMITATION    . Common Shares issued pursuant to the Plan may be authorized but unissued shares or treasury shares, or shares reacquired by the Company in any manner. The number of Common Shares stated in this Section 3.1 as available for the grant of Awards is subject to adjustment in accordance with Article 12. As of March 7, 2018, the aggregate number of Common Shares cumulatively authorized by the Company’s stockholders for issuance as Awards under the Plan was 2,635,130. Of that total, as of March 7, 2018, Previously Issued Awards have been issued covering 2,578,093 Common Shares, leaving 57,037 Common Shares for the issuance of Awards under the Plan. With the March 7, 2018 amendment and restatement of the Plan, the Company’s Board and stockholders approved an increase of 250,000 in the aggregate number of Common Shares available for Awards under the Plan, to a new total of 2,885,130. Notwithstanding the foregoing, the additional 250,000 Common Shares the Company’s Board and stockholders approved for Awards under the Plan as of March 7, 2018 will not be available for issuance with respect to any Award granted prior to November 2, 2017.
3.2
ADDITIONAL SHARES    . Any Common Shares subject to an Award that is canceled, forfeited or expires prior to exercise or realization, either in full or in part, shall again become available for issuance under the Plan as Awards. Notwithstanding anything to the contrary contained herein: Common Shares subject to an Award under the Plan shall not again be made available for issuance or delivery under the Plan if such Common Shares are (a) tendered in payment of an Option, or (b) delivered or withheld by the Company to satisfy any tax withholding obligation.
3.3
MINIMUM VESTING REQUIREMENTS. Subject to the following sentence, Awards granted under the Plan shall be subject to a minimum vesting period of one year. Notwithstanding the foregoing, (a) the Committee may permit acceleration of vesting of an Award in the event of a Participant’s death, Disability, or Retirement, or the occurrence of a Change in Control, and (ii) the Committee may grant Awards covering five percent (5%) or fewer of the total number of Common Shares authorized under the Plan without respect to the above-described minimum vesting requirements. Notwithstanding the foregoing, with respect to Awards made to Outside Directors, the vesting of such Awards will be deemed to satisfy the one-year minimum vesting requirement to the extent that the Awards vest on the earlier of the one-year anniversary of the date of grant and the next regular annual meeting of the Company’s stockholders that is at least fifty (50) weeks after the immediately preceding year’s annual meeting.
3.4
LIMITATION ON OUTSIDE DIRECTOR COMPENSATION. Notwithstanding anything herein to the contrary, compensation paid to an Outside Director, including cash fees and Awards under the Plan (based on the grant date Fair Market Value of such Awards for financial reporting purposes), shall not exceed $300,000 per fiscal year in respect of his or her service as an Outside Director. For the avoidance of doubt, compensation shall be counted toward this limit for the Board compensation year in which it is earned (and not when it is paid or settled in the event that it is deferred).
3.5
PER-PARTICIPANT ANNUAL AWARD LIMITS. The Awards granted under the Plan to one Participant in a single fiscal year of the Company may not exceed the following limits: (i) 50,000 Common Shares subject to Options and/or Stock Appreciation Rights in the aggregate, except that Options and/or Stock Appreciation Rights granted to a new Employee in the fiscal year of the Company in which his or her service as an Employee first commences shall not cover more than 100,000 Common Shares in the aggregate; (ii) 45,000 Common Shares granted in the form of Restricted Shares, Restricted Stock Units, and/or Other Stock-Based Awards in the aggregate, except a new Employee may receive grants of up to 75,000 Restricted Shares, Restricted Stock Units, and/or Other Cash-Based Awards in the aggregate in the fiscal year of the Company in which his or her service with the Company begins; and (iii) no more than $500,000 may be paid in the form of Other Cash-Based Awards to any single Participant per calendar year. The limitations set forth in the preceding sentence shall be subject to adjustment in accordance with Article 12.
ARTICLE 4.    
ELIGIBILITY.
4.1
AWARDS OTHER THAN ISOS. Employees, Outside Directors and Consultants shall be eligible for the grant of Awards other than ISOs.
4.2
INCENTIVE STOCK OPTIONS    . Only Employees who are common-law employees of the Company, a Parent or a Subsidiary shall be eligible for the grant of ISOs.
ARTICLE 5.    
OPTIONS.
5.1
STOCK OPTION AGREEMENT    . Each grant of an Option under the Plan shall be evidenced by an Award Agreement between the Participant and the Company. Such Option shall be subject to all applicable terms of the Plan and may be subject to any other terms that are not inconsistent with the Plan. The Award Agreement shall specify whether the Option is an ISO or an NQO. The provisions of the various Award Agreements entered into under the Plan need not be identical. Options may be granted in consideration of a cash payment or in consideration of a reduction in the Participant’s other compensation.
5.2
NUMBER OF SHARES    . Each Award Agreement shall specify the number of Common Shares subject to the Option and shall provide for the adjustment of such number in accordance with Article 12.
5.3
EXERCISE PRICE    . Each Award Agreement shall specify the Exercise Price; provided that the Exercise Price under an Option shall in no event be less than 100% of the Fair Market Value of a Common Share on the date of grant.
5.4
INCENTIVE STOCK OPTIONS. The grant of ISOs shall be subject to all of the requirements of Code Section 422, including the following limitations:
(a)
The Exercise Price of an ISO shall not be less than one-hundred percent (100%) of the Fair Market Value of a Common Share on the date of grant; provided, however, if on the date of grant, the Employee (together with persons whose stock ownership is attributed to the Employee pursuant to Code Section 424(d)) owns stock possessing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or any of its Subsidiaries (a “10% Stockholder”), the Exercise Price shall not be less than one-hundred and ten percent (110%) of the Fair Market Value of a Common Share on the date of grant.
(b)
ISOs may be granted only to persons who are, as of the date of grant, Employees of the Company or a Subsidiary, and may not be granted to Consultants or Outside Directors.
(c)
To the extent that the aggregate Fair Market Value of the Common Shares with respect to which ISOs are exercisable for the first time by any individual during any calendar year (under all plans of the Company) exceeds $100,000, such Options will be treated as NQOs to the extent required by Code Section 422. For purposes of this Section 5.4(c), ISOs shall be taken into account in the order in which they were granted. The Fair Market Value of the Common Shares shall be determined as of the time the Option with respect to such Common Shares is granted.
(d)
In the event of a Participant’s change of status from Employee to Consultant or Outside Director, an ISO held by the Participant shall cease to be treated as an ISO and shall be treated for tax purposes as an NQO three (3) months and one (1) day following such change of status.
5.5
EXERCISABILITY     . Each Award Agreement shall specify the date when all or any installment of the Option is to become exercisable. A Stock Option Agreement may provide for accelerated exercisability in the event of the Participant’s death, Disability or Retirement or other events and may provide for expiration prior to the end of its term in the event of the termination of the Participant’s service. NQOs may also be awarded in combination with Restricted Shares, and such an Award may provide that the NQOs will not be exercisable unless the related Restricted Shares are forfeited.
5.6
OPTION TERM . Unless otherwise specified in an Award Agreement, but in any event, no later than ten (10) years from the date of grant thereof, each Option shall terminate no later than the first to occur of the following events:
(a)
Date in Award Agreement. The date for termination of the Option set forth in the Award Agreement;
(b)
Termination of Service. The ninetieth (90th) day following the date on which the Participant’s service terminates (other than for a reason described in subsections (c) or (d) below);
(c)
Disability. In the event that a Participant’s service terminates due to the Participant’s Disability, the Participant may exercise his or her Option at any time within twelve (12) months following the date of such termination, but only to the extent that the Participant was entitled to exercise it at the date of such termination (but in no event later than the expiration of the term of the Option as set forth in the applicable Award Agreement). If, at the date of termination, the Participant is not entitled to exercise his or her entire Option, the Common Shares covered by the unexercisable portion of the Option shall revert to the Plan. If, after termination, the Participant does not exercise his or her Option within the time specified herein, the Option shall terminate, and the Common Shares covered by such Option shall revert to the Plan;
(d)
Death. In the event of the death of a Participant, the Participant’s Option may be exercised at any time within twelve (12) months following the date of death (but in no event later than the expiration of the term of such Option as set forth in the applicable Award Agreement), by the Participant’s estate or by a person who acquired the right to exercise the Option by bequest or inheritance, but only to the extent that the Participant was entitled to exercise the Option at the date of death. If, at the time of death, the Participant was not entitled to exercise his or her entire Option, the Common Shares covered by the unexercisable portion of the Option shall immediately revert to the Plan. If, after death, the Participant’s estate or a person who acquired the right to exercise the Option by bequest or inheritance does not exercise the Option within the time specified herein, the Option shall terminate, and the Common Shares covered by such Option shall revert to the Plan; or
(e)
Ten Years from Grant. An Option shall expire no more than ten (10) years after the date of grant; provided, however, that if an ISO is granted to a 10% Stockholder, such ISO may not be exercised after the expiration of five (5) years from the date of grant.
5.7
EFFECT OF CHANGE IN CONTROL    . The Committee may determine, at the time of granting an Option or thereafter, that such Option shall become exercisable as to all or part of the Common Shares subject to such Option in the event that a Change in Control occurs with respect to the Company.
5.8
MODIFICATION OR ASSUMPTION OF OPTIONS    . The Committee may modify, extend or assume outstanding Options or may accept the cancellation of outstanding Options (whether granted by the Company or by another issuer) in return for the grant of new Options for the same or a different number of Common Shares and at the same or a different exercise price; provided, that an extension of the term of an ISO shall be subject to limitations applicable to ISOs and provided further that any such extension may not exceed the maximum term of the Option. The foregoing notwithstanding, no modification of an Option shall, without the consent of the Participant, alter or impair his or her rights or obligations under such Option (except that the Committee has the authority to amend any outstanding Option without the Participant’s consent if the Committee deems it necessary or advisable to comply with Code Section 409A). In addition, to the extent the Committee’s modification of the purchase price or the exercise price of any outstanding Award effects a repricing, shareholder approval shall be required before the repricing is effective.
5.9
PAYMENT FOR OPTION SHARES.
(a)
General Rule. The entire Exercise Price of Common Shares issued upon exercise of Options shall be payable in cash or cash equivalents at the time when such Common Shares are purchased, except as follows:
(1)
In the case of an ISO granted under the Plan, payment shall be made only pursuant to the express provisions of the applicable Award Agreement. The Award Agreement may specify that payment may be made in any form(s) described in this Section 5.9.
(2)
In the case of an NQO, the Committee may at any time accept payment in any form(s) described in this Section 5.9.
(b)
Surrender of Stock. To the extent that this Section 5.9(b) is applicable, all or any part of the Exercise Price may be paid by surrendering Common Shares that are already owned by the Participant. Such Common Shares shall be valued at their Fair Market Value on the date when the new Common Shares are purchased under the Plan. The Participant shall not surrender Common Shares in payment of the Exercise Price if such action could cause the Company to recognize additional compensation expense with respect to the Option for financial reporting purposes under GAAP accounting at the time of such proposed surrender.
(c)
Exercise/Sale. To the extent that this Section 5.9(c) is applicable, all or any part of the Exercise Price may be paid by delivering (on a form prescribed by the Company) an irrevocable direction to a securities broker approved by the Company to sell all or part of the Common Shares being purchased under the Plan and to deliver all or part of the sales proceeds to the Company.
(d)
Other Forms of Payment. To the extent that this Section 5.9(d) is applicable, all or any part of the Exercise Price may be paid in any other form that is consistent with applicable laws, regulations and rules, including, without limitation, pursuant to a net exercise.
ARTICLE 6.    
RESTRICTED SHARES.
6.1
TIME, AMOUNT AND FORM OF AWARDS    . Awards under the Plan may be granted in the form of Restricted Shares. Restricted Shares may also be awarded in combination with NQOs, and such an Award may provide that the Restricted Shares will be forfeited in the event that the related NQOs are exercised.
6.2
PAYMENT FOR AWARDS    . To the extent that an Award is granted in the form of newly issued Restricted Shares, the Award recipient, as a condition to the grant of such Award, shall be required to pay the Company in cash, cash equivalents or any other form of legal consideration acceptable to the Company, including but not limited to future services, an amount equal to the par value of such Restricted Shares. To the extent that an Award is granted in the form of Restricted Shares from the Company’s treasury, no cash consideration shall be required of the Award recipients.
6.3
VESTING CONDITIONS    . Each Award of Restricted Shares shall be subject to vesting. Vesting shall occur, in full or in installments, upon satisfaction of the conditions specified in the Award Agreement. An Award Agreement may provide for accelerated vesting in the event of the Participant’s death, Disability or Retirement or other events. Notwithstanding any other provision of the Plan to the contrary, the Committee may determine, at the time of granting Restricted Shares or thereafter, that all or part of such Restricted Shares shall become vested in the event that a Change in Control occurs with respect to the Company.
6.4
VOTING AND DIVIDEND RIGHTS    . Unless otherwise provided in the Award Agreement, the holder of Restricted Shares awarded under the Plan shall have the same voting, dividend and other rights as the Company’s other stockholders; provided, that to the extent that a Restricted Share carries with it a right to receive dividends, any dividends declared shall be accumulated and paid at the time (and to the extent) that the Restricted Shares vest, but in no event later than two-and-a-half months following the end of the calendar year in which the vesting occurs. Without limitation, an Award Agreement may require that the holders of Restricted Shares invest any cash dividends received in additional Restricted Shares (in which case such additional Restricted Shares shall be subject to the same conditions and restrictions as the Award with respect to which the dividends were paid).
ARTICLE 7.    
RESTRICTED STOCK UNITS.
7.1
TIME, AMOUNT AND FORM OF AWARDS    . Awards under the Plan may be granted in the form of Restricted Stock Units. Restricted Stock Units may be issued either alone or in addition to other Awards granted under the Plan. The Committee shall determine the eligible individuals to whom, and the time or times at which, grants of Restricted Stock Units shall be made; the number of Restricted Stock Units to be awarded; the period of restrictions, if any, applicable to Restricted Stock Units; the performance goals (if any) applicable to Restricted Stock Units; and all other conditions of the Restricted Stock Units. If the restrictions, performance goals and/or conditions established by the Committee are not attained, a Participant shall forfeit his or her Restricted Stock Units in accordance with the terms of the grant. The provisions of Restricted Stock Units need not be the same with respect to each Participant.
7.2
RESTRICTIONS AND CONDITIONS    . Each Award of Restricted Stock Units shall be subject to the following restrictions and conditions and any additional restrictions or conditions as determined by the Committee at the time of grant or, subject to Code Section 409A, thereafter:
(a)
Vesting shall occur, in full or in installments, upon satisfaction of the conditions specified in the Award Agreement.
(b)
An Award Agreement may provide for accelerated vesting in the event of the Participant’s death, Disability or Retirement or other events. Notwithstanding any other provision of the Plan to the contrary, the Committee may determine, at the time of granting Restricted Stock Units or thereafter, that all or part of such Restricted Stock Units shall become vested in the event that a Change in Control occurs with respect to the Company.
(c)
Participants holding Restricted Stock Units shall have no voting rights. A Restricted Stock Unit may, at the Committee’s discretion, carry with it a right to dividend equivalents. Such right would entitle the holder to be credited with an amount equal to all cash dividends paid on one Common Share while the Restricted Stock Unit is outstanding. The Committee, in its discretion, may grant dividend equivalents from the date of grant or only after a Restricted Stock Unit is vested. Notwithstanding anything herein to the contrary, to the extent that a Restricted Stock Unit carries with it rights to dividend equivalents, any dividend equivalents with respect to dividends declared shall be accumulated and paid at the time (and to the extent) that the Restricted Stock Units vest, but in no event later than two-and-a-half months following the end of the calendar year in which the vesting occurs.
(d)
The rights of Participants granted Restricted Stock Units upon termination of employment or service as an Outside Director or Consultant of the Company or an Affiliate thereof terminates for any reason while the Restricted Stock Units remain outstanding shall be set forth in the Award Agreement.
7.3
RIGHTS AS A STOCKHOLDER. Except as may otherwise be provided in an Award Agreement with respect to dividend equivalents (in accordance with Section 7.2(c)), a Participant shall have no rights to dividends or any other rights of a stockholder with respect to the Common Shares subject to Restricted Stock Units until the Participant has satisfied all conditions of the Award Agreement and the requirements of Section 15.1 of the Plan, and the Common Shares have been issued to the Participant.
7.4
SETTLEMENT OF RESTRICTED STOCK UNITS. Settlement of vested Restricted Stock Units shall be made to Participants in the form of Common Shares, unless the Committee, in its sole discretion, provides for the payment of the Restricted Stock Units in cash (or partly in cash and partly in Common Shares) equal to the Fair Market Value of the Common Shares that would otherwise be distributed to the Participant.
ARTICLE 8.    
STOCK APPRECIATION RIGHTS.
8.1
IN GENERAL. Stock Appreciation Rights may be granted either alone (“Free Standing Rights”) or in conjunction with all or part of any Option granted under the Plan (“Related Rights”). Related Rights may be granted either at or after the time of the grant of such Option. The Committee shall determine the eligible individuals to whom, and the time or times at which, grants of Stock Appreciation Rights shall be made, the number of Common Shares to be awarded, the price per Common Share, and all other conditions of Stock Appreciation Rights. Notwithstanding the foregoing, no Related Right may be granted for more Common Shares than are subject to the Option to which it relates and any Stock Appreciation Right must be granted with an Exercise Price not less than the Fair Market Value of Common Stock on the date of grant. The provisions of Stock Appreciation Rights need not be the same with respect to each Participant. Stock Appreciation Rights granted under the Plan shall be subject to the following terms and conditions set forth in this Section 8.1 and shall contain such additional terms and conditions, not inconsistent with the terms of the Plan, as the Committee shall deem desirable, as set forth in the applicable Award Agreement.
8.2
RIGHTS AS STOCKHOLDER . A Participant shall have no rights to dividends or any other rights of a stockholder with respect to the Common Shares subject to a Stock Appreciation Right until the Participant has given written notice of the exercise thereof, has satisfied the requirements of Section 15.1 of the Plan and the Common Shares have been issued to the Participant.
8.3
EXERCISABILITY.
(a)
Stock Appreciation Rights that are Free Standing Rights shall be exercisable at such time or times and subject to such terms and conditions as shall be determined by the Committee in the applicable Award Agreement.
(b)
Stock Appreciation Rights that are Related Rights shall be exercisable only at such time or times and to the extent that the Options to which they relate shall be exercisable in accordance with the provisions of Article 5 and this Article 8 of the Plan.
(c)
An Award Agreement may provide for accelerated vesting in the event of the Participant’s death, Disability or Retirement or other events. Notwithstanding any other provision of the Plan to the contrary, the Committee may determine, at the time of granting Stock Appreciation Rights or thereafter, that all or part of such Stock Appreciation Rights shall become vested in the event that a Change in Control occurs with respect to the Company.
8.4
PAYMENT UPON EXERCISE.
(a)
Upon the exercise of a Free Standing Right, the Participant shall be entitled to receive up to, but not more than, that number of Common Shares, determined using the Fair Market Value, equal in value to the excess of the Fair Market Value as of the date of exercise over the price per Common Share specified in the Free Standing Right multiplied by the number of Common Shares in respect of which the Free Standing Right is being exercised.
(b)
A Related Right may be exercised by a Participant by surrendering the applicable portion of the related Option. Upon such exercise and surrender, the Participant shall be entitled to receive up to, but not more than, that number of Common Shares, determined using the Fair Market Value, equal in value to the excess of the Fair Market Value as of the date of exercise over the Exercise Price specified in the related Option multiplied by the number of Common Shares in respect of which the Related Right is being exercised. Options which have been so surrendered, in whole or in part, shall no longer be exercisable to the extent the Related Rights have been so exercised.
(c)
Notwithstanding the foregoing, the Committee may determine to settle the exercise of a Stock Appreciation Right in cash (or in any combination of Common Shares and cash).
8.5
TERMINATION OF EMPLOYMENT OR SERVICE.
(a)
In the event of the termination of employment or service with the Company and all Affiliates thereof of a Participant who has been granted one or more Free Standing Rights, such rights shall be exercisable at such time or times and subject to such terms and conditions as shall be determined by the Committee in the applicable Award Agreement.
(b)
In the event of the termination of employment or service with the Company and all Affiliates thereof of a Participant who has been granted one or more Related Rights, such rights shall be exercisable at such time or times and subject to such terms and conditions as set forth in the related Options.
8.6
TERM.
(a)
The term of each Free Standing Right shall be fixed by the Committee, but no Free Standing Right shall be exercisable more than ten (10) years after the date such right is granted.
(b)
The term of each Related Right shall be the term of the Option to which it relates, but no Related Right shall be exercisable more than ten (10) years after the date such right is granted.
ARTICLE 9.    
OTHER STOCK-BASED OR CASH-BASED AWARDS.
9.1
IN GENERAL. The Committee is authorized to grant Awards to Participants in the form of Other Stock‑Based Awards or Other Cash-Based Awards, as deemed by the Committee to be consistent with the purposes of the Plan and as evidenced by an Award Agreement. The Committee shall determine the terms and conditions of such Awards, consistent with the terms of the Plan, at the date of grant or thereafter, including any performance goals and performance periods. Common Shares or other securities or property delivered pursuant to an Award in the nature of a purchase right granted under this Section 9.1 shall be purchased for such consideration, paid for at such times, by such methods, and in such forms, including, without limitation, Common Shares, other Awards, notes or other property, as the Committee shall determine, subject to any required corporate action.
9.2
VESTING. An Award Agreement with respect to an Other Stock-Based Award or Other Cash-Based Award may provide for accelerated vesting in the event of the Participant’s death, Disability or Retirement or other events. Notwithstanding any other provision of the Plan to the contrary, the Committee may determine, at the time of granting an Other Stock-Based Award or Other Cash-Based Award or thereafter, that all or part of such Awards shall become vested in the event that a Change in Control occurs with respect to the Company.
ARTICLE 10.    
PERFORMANCE MEASURES.
10.1
IN GENERAL. For purposes of qualifying grants of Restricted Shares as “performance-based compensation” under Code Section 162(m), the Committee, in its discretion, may make Restricted Shares subject to vesting based on the achievement of performance goals, in which case the Committee will specify in writing, by resolution or otherwise, the Participants eligible to receive such an Award (which may be expressed in terms of a class of individuals) and the performance goals applicable to such Awards within 90 days after the commencement of the period to which the performance goals relate, or such earlier time as required to comply with Section 162(m) of the Code. No such Award shall be payable unless the Committee certifies in writing, by resolution or otherwise, that the performance goals applicable to the Award were satisfied. In no case may the Committee increase the value of an Award granted under this Section 10.1 above the maximum value determined under the performance formula by the attainment of the applicable performance goals, but the Committee retains the discretion to reduce the value below such maximum.
10.2
PERFORMANCE GOALS. Unless and until the Committee proposes for stockholder vote and the stockholders approve a change in the general performance measures applicable to Awards, the performance goals upon which the payment or vesting of an Award that is intended to qualify as performance based compensation are limited to the following Performance Measures:
(1)
operating income or operating profit (including but not limited to operating income and any affiliated growth measure);
(2)
net earnings or net income (before or after taxes, including but not limited to deferred taxes, and any affiliated growth measure);
(3)
basic or diluted earnings per share (before or after taxes, including but not limited to deferred taxes, and any affiliated growth measure);
(4)
revenues (including but not limited to revenue, gross revenue, net revenue, and any affiliated growth measure);
(5)
gross profit or gross profit growth;
(6)
return on assets, capital, invested capital, equity or sales;
(7)
cash flow (including, but not limited to, operating cash flow, free cash flow, and cash flow return on capital);
(8)
earnings before or after taxes, interest, depreciation and/or amortization (including but not limited to changes in this measure);
(9)
improvements or changes in capital structure (including but not limited to debt balances or debt issuance);
(10)
budget management;
(11)
productivity targets;
(12)
economic value added or other value added measurements;
(13)
share price (including, but not limited to, growth measures and total shareholder return);
(14)
expense targets;
(15)
margins (including but not limited to gross or operating margins);
(16)
efficiency measurements (including but not limited to availability measurements, call wait times, call, meeting, shipping or other volume measurements, turnaround times and error rates);
(17)
working capital targets (including but not limited to items reported on the Company’s balance sheet and time-based or similar measures such as days inventory, days receivable and days payable);
(18)
equity or market value measures;
(19)
enterprise or adjusted market value measures;
(20)
safety record;
(21)
completion of business acquisition, divestment or expansion;
(22)
book value or changes in book value (including but not limited to tangible book value and net asset measures);
(23)
assets or changes in assets;
(24)
cash position or changes in cash position;
(25)
employee retention or recruiting measures;
(26)
milestones related to filings with government entities or related approvals (including but not limited to filings with the Securities and Exchange Commission which may require stockholder approval);
(27)
changes in location or the opening or closing of facilities;
(28)
contract or other development of relationship with identified suppliers, distributors or other business partners; and
(29)
new product development (including but not limited to third-party collaborations or contracts, and with milestones that may include but are not limited to contract execution, proof of concept, regulatory approval, product launch and targets such as unit volume and revenue following product launch).
Any performance measures may be used to measure the performance of the Company as a whole and/or any one or more business segments, regional operations, products and/or Affiliates of the Company or any combination thereof, as the Committee may deem appropriate, and any performance measures may be used in comparison to the performance of a group of peer companies, or a published or special index that the Committee, in its sole discretion, deems appropriate. The Committee also has the authority to provide in an Award for accelerated vesting of an Award based on the achievement of performance goals.
The Committee may provide in any Award that any evaluation of attainment of a performance goal may include or exclude any of the following events that occurs during the relevant period: (a) asset write downs; (b) litigation judgments or settlements; (c) the effect of changes in tax laws, accounting principles, or other laws or regulations affecting reported results; (d) any reorganization and/or restructuring transactions or programs; (e) extraordinary nonrecurring items as described in Accounting Principles Board Opinion No. 30 and/or in management’s discussion and analysis of financial condition and results of operations appearing in the Company’s Annual Report on Form 10-K for the applicable year; and (f) acquisitions or divestitures and associated costs; (g) any other specific unusual or nonrecurring events, or objectively determinable category thereof; (h) foreign currency gains and losses; and (i) a change in the Company’s fiscal year.
In the event that applicable tax and/or securities laws change to permit discretion by the Committee to alter the governing performance measures without obtaining stockholder approval of such changes, the Committee shall have sole discretion to make such changes without obtaining stockholder approval. In addition, in the event that the Committee determines that it is advisable to grant Awards that do not qualify as performance based compensation, the Committee may make such grants without satisfying the requirements of Section 162(m) of the Code. Effective with respect to Awards granted in 2018 or later, the Committee may make Awards subject to the achievement of performance goals other than the performance goals listed in Section 10.2 without regard to whether stockholders have approved such performance goals.
ARTICLE 11.    
CLAWBACK
Notwithstanding any other provisions in this Plan to the contrary, any Award received by a Subject Participant, and/or any Common Share issued upon exercise of any Award received by a Subject Participant hereunder, and/or any amount received with respect to any sale of any such Award or Common Share, will be subject to potential cancellation, recoupment, rescission, payback or other action to the extent required pursuant to applicable law, government regulation or national securities exchange listing requirement (or any clawback policy adopted by the Company from time to time pursuant to any such law, government regulation or national securities exchange listing requirement or to comport with good corporate governance practices). Each Subject Participant agrees and consents to the Company’s application, implementation and enforcement of any clawback policy established by the Company that may apply to the Subject Participant and any provision of applicable law, government regulation or national securities exchange listing requirement relating to cancellation, rescission, payback or recoupment of compensation, and expressly agrees that the Company may take such actions as are necessary to effectuate any such policy (as applicable to the Subject Participant) or applicable law, government regulation or national securities exchange listing requirement without further consent or action being required by the Subject Participant.
ARTICLE 12.    
PROTECTION AGAINST DILUTION.
12.1
ADJUSTMENTS    . In the event of a subdivision of the outstanding Common Shares, a declaration of a dividend payable in Common Shares, a declaration of a dividend payable in a form other than Common Shares in an amount that has a material effect on the price of Common Shares, a combination or consolidation of the outstanding Common Shares (by reclassification or otherwise) into a lesser number of Common Shares, a recapitalization, a spin-off or a similar occurrence, the Committee shall make such adjustments as it, in its sole discretion, deems appropriate in one or more of (a) the number of Common Shares available for issuance pursuant to future Awards under Article 3, (b) the limitations set forth in Section 3.5, (c) the number of Common Shares covered by each outstanding Option and Stock Appreciation Right or (d) the Exercise Price under each outstanding Option and Stock Appreciation Right. Except as provided in this Article 12, a Participant shall have no rights by reason of any issue by the Company of stock of any class or securities convertible into stock of any class, any subdivision or consolidation of shares of stock of any class, the payment of any stock dividend or any other increase or decrease in the number of shares of stock of any class.
12.2
DISSOLUTION OR LIQUIDATION    . To the extent not previously exercised, Options shall terminate immediately prior to the dissolution or liquidation of the Company.
12.3
REORGANIZATIONS    . In the event that the Company is a party to a merger or other reorganization, outstanding Awards shall be subject to the agreement of merger or reorganization. Such agreement may provide, without limitation, for the continuation of outstanding Awards by the Company (if the Company is a surviving corporation), for their assumption by the surviving corporation or its parent or subsidiary, for the substitution by the surviving corporation or its parent or subsidiary of its own awards for such Awards, for accelerated vesting and accelerated expiration, or for settlement in cash or cash equivalents.
ARTICLE 13.    
AWARDS UNDER OTHER PLANS.
The Company may grant awards under other plans or programs. Such awards may be settled in the form of Common Shares issued under this Plan. Such Common Shares shall be treated for all purposes under the Plan like Restricted Shares and shall, when issued, reduce the number of Common Shares available under Article 3.
ARTICLE 14.    
LIMITATION ON RIGHTS.
14.1
RETENTION RIGHTS    . Neither the Plan nor any Award granted under the Plan shall be deemed to give any individual a right to remain an Employee, Outside Director or Consultant. The Company and its Parents, Subsidiaries and Affiliates reserve the right to terminate the service of any Employee, Outside Director or Consultant at any time, with or without cause, subject to applicable laws, the Company’s certificate of incorporation and bylaws and a written employment agreement (if any).
14.2
STOCKHOLDERS’ RIGHTS    . Subject to the other terms and conditions of the Plan, a Participant shall have no dividend rights, voting rights or other rights as a stockholder with respect to any Common Shares covered by his or her Award prior to the time when a stock certificate for such Common Shares is issued or, in the case of an Option or Stock Appreciation Right, the time when he or she becomes entitled to receive such Common Shares by filing a notice of exercise and paying the Exercise Price. No adjustment shall be made for cash dividends or other rights for which the record date is prior to such time, except as expressly provided in the Plan.
14.3
REGULATORY REQUIREMENTS    . Any other provision of the Plan notwithstanding, the obligation of the Company to issue Common Shares under the Plan shall be subject to all applicable laws, rules and regulations and such approval by any regulatory body as may be required. The Company reserves the right to restrict, in whole or in part, the delivery of Common Shares pursuant to any Award prior to the satisfaction of all legal requirements relating to the issuance of such Common Shares, to their registration, qualification or listing or to an exemption from registration, qualification or listing.
ARTICLE 15.    
WITHHOLDING TAXES; PARACHUTE PAYMENTS.
15.1
GENERAL    . To the extent provided by the terms of an Award Agreement and subject to the discretion of the Committee, the Participant may satisfy any federal, state or local tax withholding obligation relating to the exercise or acquisition of Common Stock under an Award by any of the following means (in addition to the Company’s right to withhold from any compensation paid to the Participant by the Company) or by a combination of such means: (a) tendering a cash payment; (b) authorizing the Company to withhold Common Shares from the Common Shares otherwise issuable to the Participant as a result of the exercise or acquisition of Common Shares under the Award, provided, however, that no Common Shares are withheld with a value exceeding the amount of tax required to be withheld by law or such other greater amount up to the maximum statutory rate under applicable law, as applicable to such Participant, if such other greater amount would not result in adverse financial accounting treatment, as determined by the Committee (including in connection with the effectiveness of FASB Accounting Standards Update 2016-09); or (c) delivering to the Company previously owned and unencumbered Common Shares. The Company shall not be required to issue any Common Shares or make any cash payment under the Plan until such obligations are satisfied.
15.2
SECTION 280G    . To the extent that any of the payments and benefits provided for under the Plan or any other agreement or arrangement between the Company or its Affiliates and a Participant (collectively, the “Payments”) (i) constitute a “parachute payment” within the meaning of Code Section 280G and (ii) but for this paragraph would be subject to the excise tax imposed by Section 4999 of the Code, then the Payments shall be payable either (i) in full or (ii) as to such lesser amount which would result in no portion of such Payments being subject to excise tax under Section 4999 of the Code (determined in accordance with the reduction of payments and benefits paragraph set forth below); whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the excise tax imposed by Section 4999, results in the participant’s receipt on an after-tax basis, of the greatest amount of benefits under this Plan, notwithstanding that all or some portion of such benefits may be taxable under Section 4999 of the Code. Any determination required under this provision will be made by accountants chosen by the Company, whose determination shall be conclusive and binding upon the participant and the Company for all purposes.
Except to the extent, if any, otherwise agreed in writing between a participant and the Company, reduction of payments and benefits hereunder, if applicable, will be made by reducing, first, payments or benefits to be paid in cash in the order in which such payment or benefit would be paid or provided (beginning with such payment or benefit that would be made last in time and continuing, to the extent necessary, through to such payment or benefit that would be made first in time) and, then, reducing any benefit to be provided in-kind hereunder in a similar order; provided, however, that any reduction or elimination of accelerated vesting of any equity award will first be accomplished by reducing or eliminating the vesting of such awards that are valued in full for purposes of Section 280G of the Code, then the reduction or elimination of vesting of other equity awards.
ARTICLE 16.    
FUTURE OF THE PLAN.
16.1
TERM OF THE PLAN    . The Plan was initially effective on March 14, 1997. The Board may, at any time and for any reason, amend, suspend or terminate the Plan (subject to the approval of the Company’s stockholders only to the extent required by applicable law, regulations or rules). The Committee may issue ISOs under the Plan until the tenth anniversary of the date of its most recent amendment or restatement. The Committee may issue any Award other than ISOs at any time prior to the date, if any, that the Board suspends or terminates the Plan. No Award may be granted pursuant to the Plan after such date, but Awards granted before such date may extend beyond that date.
16.2
PERFORMANCE AWARDS    . Unless the Company determines to submit the Plan to the Company’s stockholders at the first stockholder meeting that occurs in the fifth year following the year in which the Plan was last approved by stockholders (or any earlier meeting designated by the Board), in accordance with the requirements of Code Section 162(m), and unless such stockholder approval is obtained, then no further Awards made under Article 10 will qualify as performance-based compensation for purposes of Code Section 162(m).
ARTICLE 17.    
CODE SECTION 409A
The intent of the parties is that payments and benefits under the Plan comply with Code Section 409A to the extent subject thereto, and, accordingly, to the maximum extent permitted, the Plan shall be interpreted and be administered to be in compliance therewith. Any payments described in the Plan that are due within the “short-term deferral period” as defined in Code Section 409A shall not be treated as deferred compensation unless applicable law requires otherwise. Notwithstanding anything to the contrary in the Plan, to the extent required in order to avoid accelerated taxation and/or tax penalties under Code Section 409A, amounts that would otherwise be payable and benefits that would otherwise be provided upon a “separation from service” to a Participant who is a “specified employee” shall be paid on the first business day after the date that is six (6) months following the Participant’s separation from service (or upon the Participant’s death, if earlier). In addition, for purposes of the Plan, each amount to be paid or benefit to be provided to the Participant pursuant to the Plan, which constitute deferred compensation subject to Code Section 409A, shall be construed as a separate identified payment for purposes of Code Section 409A. Nothing contained in the Plan or an Award Agreement shall be construed as a guarantee of any particular tax effect with respect to an Award. The Company does not guarantee that any Awards provided under the Plan will satisfy the provisions of Code Section 409A, and in no event will the Company be liable for any or all portion of any taxes, penalties, interest or other expenses that may be incurred by a Participant on account of any non-compliance with Code Section 409A.
ARTICLE 18.    
DEFINITIONS.
18.1
Affiliate means any entity other than a Subsidiary, if the Company and/or one or more Subsidiaries own not less than fifty percent (50%) of such entity.
18.2
Award means any award of an Option, Restricted Share, Restricted Stock Unit, Stock Appreciation Right, Other Stock-Based Award or Other Cash-Based Award under the Plan.
18.3
Award Agreement means any agreement, contract or other instrument or document evidencing an Award. Evidence of an Award may be in written or electronic form, may be limited to notation on the books and records of the Company and, with the approval of the Committee, need not be signed by a representative of the Company or a Participant. Any Common Shares that become deliverable to a Participant pursuant to the Plan may be issued in certificate form in the name of the Participant or in book-entry form in the name of the Participant.
18.4
Board means the Company’s Board of Directors, as constituted from time to time.
18.5
Cause shall have the meaning assigned to such term in a Participant’s written employment, severance, or similar agreement or Award Agreement with the Company, or, if no such agreement exists or the agreement does not define “Cause,” Cause means a Participant’s termination of service by the Company due to the Participant’s (a) failure to perform his or her assigned duties or responsibilities as an Employee, Consultant or Outside Director of the Company or an Affiliate thereof (other than a failure resulting from the Participant’s Disability) after notice thereof from the Company describing his or her failure to perform such duties or responsibilities; (b) breach of any confidentiality agreement, invention assignment agreement or written restrictive covenant agreement between the Participant and the Company or an Affiliate thereof; (c) engagement in any act of dishonesty, fraud, misrepresentation, moral turpitude or misappropriation of material property that was or is materially injurious to the Company or its Affiliates; (d) violation of any written Company policy, including, without limitation, any policy with respect to sexual harassment in the workplace; (e) violation of any federal or state law or regulation applicable to the Company’s business; or (f) conviction of, or entrance of a plea of nolo contendere to, any crime. In addition, a Participant’s service shall be deemed to have terminated for “Cause” if, on the date the Participant’s service terminates, facts and circumstances exist that would have justified a termination for Cause, even if such facts and circumstances are discovered after such termination.
18.6
Change in Control shall mean:
(a)
The consummation of a merger or consolidation of the Company with or into another entity of any other corporate reorganization, if more than fifty percent (50%) of the combined voting power of the continuing or surviving entity’s securities outstanding immediately after such merger, consolidation or other reorganization is owned by persons who were not stockholders of the Company immediately prior to such merger, consolidation, or other reorganization;
(b)
The consummation of a sale, transfer or other disposition of all or substantially all of the Company’s assets;
(c)
A majority of the members of the Board are replaced during any eighteen (18) month period by directors whose appointment or election is not endorsed by a majority of the Board before the date of appointment or election; or
(d)
Solely with respect to Awards granted in 2018 or later, any “person” (as such term is used in Sections 13(d) and 14(d) of the Exchange Act), other than (i) the Company, (ii) a Subsidiary thereof, (iii) any trustee or other fiduciary holding securities under an employee benefit plan of the Company or any Subsidiary thereof, or (iv) any company owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of stock of the Company, becomes the “beneficial owner” (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing more than fifty percent (50%) of the total voting power represented by the Company’s then outstanding voting securities.
18.7
Code means the Internal Revenue Code of 1986, as amended.
18.8
Committee means a committee of the Board, as described in Article 2.
18.9
Common Share means one share of common stock, par value $0.01 per share, of the Company.
18.10
Company means Heska Corporation, a Delaware corporation.
18.11
Consultant means a consultant or adviser who provides bona fide services to the Company, a Parent, a Subsidiary or an Affiliate as an independent contractor. Service as a Consultant shall be considered employment for all purposes of the Plan, except as provided in Section 4.2.
18.12
Disability shall have the meaning assigned to such term in a Participant’s written employment, severance, or similar agreement or Award Agreement with the Company, or, if no such agreement exists or the agreement does not define “Disability,” Disability means a Participant’s inability to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted, or can be expected to last, for a continuous period of not less than one year.
18.13
Employee means a common-law employee of the Company, a Parent, a Subsidiary or an Affiliate.
18.14
Exchange Act means the Securities Exchange Act of 1934, as amended.
18.15
Exercise Price means, with respect to any Award under which the holder may purchase Common Shares, the price per Common Share at which a holder of such Award granted hereunder may purchase Common Shares issuable upon exercise of such Award, as specified in the applicable Award Agreement.
18.16
Fair Market Value means, for so long as the Common Shares are listed on any established stock exchange or a national market system, the value of a Common Share as determined by reference to the most recent reported sale price of a Common Share (or if no sales were reported, the most recent closing price) as quoted on such exchange or system at the time of determination. In the absence of an established market for the Common Shares, the Fair Market Value shall be determined in good faith by the Committee and such determination shall be conclusive and binding on all persons.
18.17
ISO means an incentive stock option described in section 422(b) of the Code.
18.18
NQO means a stock option not described in sections 422 or 423 of the Code.
18.19
Option means an ISO or NQO granted under the Plan and entitling the holder to purchase Common Shares.
18.20
Other Cash-Based Award means a cash Award granted to a Participant under Article 9 of the Plan, including cash awarded as a bonus or upon the attainment of performance goals or otherwise as permitted under the Plan.
18.21
Other Stock-Based Award means a right or other interest granted to a Participant under Article 9 of the Plan that may be denominated or payable and valued in whole or in part by reference to, or otherwise based on or related to, Common Shares, including, but not limited to, unrestricted Common Shares or dividend equivalents, each of which may be subject to the attainment of performance goals or a period of continued employment or other terms or conditions as permitted under the Plan.
18.22
Outside Director shall mean a member of the Board who is not an Employee.
18.23
Parent means any corporation (other than the Company) in an unbroken chain of corporations ending with the Company, if each of the corporations other than the Company owns stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain. A corporation that attains the status of a Parent on a date after the adoption of the Plan shall be considered a Parent commencing as of such date.
18.24
Participant means an individual or estate who holds an Award.
18.25
Plan means this Heska Corporation Stock Incentive Plan, as amended from time to time.
18.26
Previously Issued Awards means Restricted Shares which were not subject to further vesting conditions, Common Shares issued pursuant to the exercise of ISOs, Common Shares issued pursuant to the exercise of NQOs, Restricted Shares subject to further vesting conditions, outstanding ISOs and outstanding NQOs.
18.27
Restricted Share means a Common Share awarded under the Plan. An Award of Restricted Shares constitutes a transfer of ownership of Common Shares to a Participant from the Company subject to restrictions against transferability, assignment and hypothecation. Under the terms of the Award, the restrictions against transferability are removed when the Participant has met the specified vesting requirement.
18.28
Restricted Stock Unit means a notional account established pursuant to an Award granted to a Participant, as described in Article 7 of the Plan, that is (i) valued solely by reference to Common Shares, (ii) subject to restrictions specified in the Award Agreement, and (iii) payable in cash or in Common Shares (as specified in the Award Agreement). The Restricted Stock Units awarded to the Participant will vest according to the time-based criteria or performance goal criteria specified in the Award Agreement.
18.29
Retirement shall mean a Participant’s termination of service with the Company (for any reason other than for Cause) on or after the attainment of age 55 with at least ten (10) years of service with the Company and its Affiliates (including service with another company prior to it becoming an Affiliate).
18.30
Stock Appreciation Right means the right pursuant to an Award granted under Article 8 of the Plan to receive an amount equal to the excess, if any, of (i) the aggregate Fair Market Value, as of the date such Award or portion thereof is surrendered, of the Common Shares covered by such Award or such portion thereof, over (ii) the aggregate Exercise Price of such Award or such portion thereof.
18.31
Subsidiary means any corporation (other than the Company) in an unbroken chain of corporations beginning with the Company, if each of the corporations other than the last corporation in the unbroken chain owns stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain. A corporation that attains the status of a Subsidiary on a date after the adoption of the Plan shall be considered a Subsidiary commencing as of such date.
18.32
Subject Participant means a Participant who is designated by the Board as an “executive officer” under the Exchange Act.

1


ARTICLE 19.    
EXECUTION.
To record the adoption of the Plan by the Board, the Company has caused its duly authorized officer to execute this document in the name of the Company.

HESKA CORPORATION



By: _/s/Jason Napolitano___________
    Chief Operating Officer and Chief Strategist




2
 EX-10.6 8 heska-06302019xexx10x6.htm EXHIBIT 10.6 Exhibit

Exhibit 10.6

THIRD AMENDMENT TO CREDIT AGREEMENT

This Third Amendment to Credit Agreement, dated as of July 16, 2019 (this "Amendment"), is among HESKA CORPORATION, DIAMOND ANIMAL HEALTH, INC. and HESKA IMAGING, LLC (the “Borrowers”), the other Loan Parties party hereto, the Lenders party hereto, and JPMORGAN CHASE BANK, N.A., as Administrative Agent (in such capacity, the “Administrative Agent”).

RECITAL

The Borrower, any other Loan Parties party thereto, the Lenders party thereto and the Administrative Agent are parties to a Credit Agreement dated as of July 27, 2017 (as it may be amended or modified from time to time, the “Credit Agreement”). The Borrowers desire to amend the Credit Agreement as set forth herein and the Lenders are willing to do so in accordance with the terms hereof.

TERMS

In consideration of the premises and of the mutual agreements herein contained, the parties agree as follows:
1.    ARTICLE 1.
AMENDMENTS.

Upon the satisfaction of the conditions set forth in Article 3 hereof, the Credit Agreement shall be amended as follows:

1.1    Section 1.04 of the Credit Agreement is amended by adding the following to the end thereof: “Notwithstanding anything to the contrary contained in Section 1.04 or in the definition of “Capital Lease Obligations,” any change in accounting for leases pursuant to GAAP resulting from the adoption of Financial Accounting Standards Board Accounting Standards Update No. 2016-02, Leases (Topic 842) (“FAS 842”), to the extent such adoption would require treating any lease (or similar arrangement conveying the right to use) as a capital lease where such lease (or similar arrangement) would not have been required to be so treated under GAAP prior to such adoption of FAS 842, such lease shall not be considered a capital lease, and all calculations and deliverables under this Agreement or any other Loan Document shall be made or delivered, as applicable, in accordance therewith.”
    
ARTICLE 2.
REPRESENTATIONS.

In order to induce the Lenders and the Administrative Agent to enter into this Amendment, each Loan Party represents and warrants to each Lender and the Administrative Agent, that the following statements are true, correct and complete:

2.1    The execution, delivery and performance of this Amendment are within its powers and have been duly authorized by it.

2.2    This Amendment is the legal, valid and binding obligation of it, enforceable against it in accordance with the terms hereof, subject to applicable bankruptcy, insolvency, reorganization, moratorium or other laws affecting creditors' rights generally and subject to general principles of equity, regardless of whether considered in a proceeding in equity or at law.

1



2.3    After giving effect to the amendments herein contained, the representations and warranties contained in the Credit Agreement and the representations and warranties contained in the other Loan Documents are true in all material respects on and as of the date hereof with the same force and effect as if made on and as of the date hereof (or, if any such representation or warranty is expressly stated to have been made as of a specific date, as of such specific date), and no Default exists or has occurred and is continuing on the date hereof.

ARTICLE 3.
CONDITIONS PRECEDENT.

This Amendment shall be effective as of the date hereof when each of the following conditions is satisfied or waived by the Administrative Agent:

3.1    This Amendment shall be executed by each of the Loan Parties and the Lenders.

    
2.    ARTICLE 4.
MISCELLANEOUS.

4.1    References in the Loan Documents to the Credit Agreement shall be deemed to be references to the Credit Agreement as amended hereby and as further amended from time to time. This Agreement is a Loan Document. Terms used but not defined herein shall have the respective meanings ascribed thereto in the Credit Agreement. This Amendment is a Loan Document. This Agreement may be signed upon any number of counterparts with the same effect as if the signatures thereto and hereto were upon the same instrument and signatures sent by facsimile or other electronic imaging shall be enforceable as originals.

4.2    Except as expressly amended hereby, each Loan Party agrees that the Loan Documents are ratified and confirmed and shall remain in full force and effect and that it has no set off, counterclaim, defense or other claim or dispute with respect to any of the foregoing. The Loan Parties acknowledge and agree that all Secured Obligations are unconditionally owing by the Loan Parties and their applicable Subsidiaries without setoff, recoupment, defense, or counterclaim, in law or in equity, of any kind or character, and all Secured Obligations are and will continue to be secured by valid, perfected, indefeasible Liens in, among other things, the Collateral under the Loan Documents, and each of the Loan Parties reaffirms its obligations and duties under the Loan Documents and the Liens in the Collateral that it granted to Administrative Agent under the Loan Documents to secure the Secured Obligations.


2


IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed by their respective authorized officers as of the day and year first above written.


HESKA CORPORATION


By:_/s/ Catherine Grassman_________
Name: Catherine Grassman
Title: Chief Financial Officer


DIAMOND ANIMAL HEALTH, INC.


By: _/s/ Catherine Grassman_________
Name: Catherine Grassman
Title: Chief Financial Officer


HESKA IMAGING, LLC


By: _/s/ Catherine Grassman_________
Name: Catherine Grassman
Title: Chief Financial Officer



3




JPMORGAN CHASE BANK, N.A., as a Lender, and as Administrative Agent, Swingline Lender and Issuing Bank

By:__/s/ Michele Liby_______________________
Name: Michele Liby
Title: Authorized Signer

DETROIT 7-7705 1500119v5

4

 EX-31.1 9 heska-06302019xex31x1.htm EXHIBIT 31.1 Exhibit
Exhibit 31.1
 
 
CERTIFICATION
 
I, Kevin S. Wilson, certify that:
 
1.
I have reviewed this quarterly report on Form 10-Q of Heska Corporation;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; and
c.
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
 
Dated: August 7, 2019
/s/ Kevin S. Wilson
 
KEVIN S. WILSON
 
Chief Executive Officer and President
 
(Principal Executive Officer)


 EX-31.2 10 heska-06302019xexx31x2.htm EXHIBIT 31.2 Exhibit
Exhibit 31.2
 
CERTIFICATION
 
I, Catherine Grassman, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Heska Corporation;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; and
c.
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
 
 
Dated: August 7, 2019
/s/ Catherine Grassman
 
CATHERINE GRASSMAN
 
Executive Vice President, Chief Financial Officer
 
(Principal Financial Officer)




 EX-32.1 11 heska-06302019xex32x1.htm EXHIBIT 32.1 Exhibit
Exhibit 32.1
 
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
I, Kevin S. Wilson, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Heska Corporation on Form 10-Q for the quarter ended June 30, 2019 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents in all material respects the financial condition and results of operations of Heska Corporation, to the best of my knowledge.
 

Dated: August 7, 2019
By:
/s/ Kevin S. Wilson
 
Name:
KEVIN S. WILSON
 
Title:
Chief Executive Officer and President
 
 
I, Catherine Grassman, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Heska Corporation on Form 10-Q for the quarter ended June 30, 2019 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents in all material respects the financial condition and results of operations of Heska Corporation, to the best of my knowledge.
 
Dated: August 7, 2019
By:
/s/ Catherine Grassman
 
Name:
CATHERINE GRASSMAN
 
Title:
Executive Vice President, Chief Financial Officer
 
A signed original of this written statement required by Section 906 has been provided to Heska Corporation and will be retained by Heska Corporation and furnished to the Securities and Exchange Commission or its staff upon request.


 EX-101.INS 12 hska-20190630.xml XBRL INSTANCE DOCUMENT 0001038133 2019-01-01 2019-06-30 0001038133 2019-08-06 0001038133 2018-12-31 0001038133 2019-06-30 0001038133 hska:PublicCommonStockMember 2019-06-30 0001038133 us-gaap:CommonStockMember 2019-06-30 0001038133 us-gaap:CommonStockMember 2018-12-31 0001038133 hska:PublicCommonStockMember 2018-12-31 0001038133 2018-04-01 2018-06-30 0001038133 2018-01-01 2018-06-30 0001038133 2019-04-01 2019-06-30 0001038133 hska:OtherVaccinesPharmaceuticalsAndProductsMember 2019-04-01 2019-06-30 0001038133 hska:CoreCompanionAnimalHealthMember 2019-01-01 2019-06-30 0001038133 hska:CoreCompanionAnimalHealthMember 2018-01-01 2018-06-30 0001038133 hska:CoreCompanionAnimalHealthMember 2019-04-01 2019-06-30 0001038133 hska:OtherVaccinesPharmaceuticalsAndProductsMember 2018-01-01 2018-06-30 0001038133 hska:OtherVaccinesPharmaceuticalsAndProductsMember 2018-04-01 2018-06-30 0001038133 hska:OtherVaccinesPharmaceuticalsAndProductsMember 2019-01-01 2019-06-30 0001038133 hska:CoreCompanionAnimalHealthMember 2018-04-01 2018-06-30 0001038133 2017-12-31 0001038133 hska:CommonStockPreferredStockAndPublicStockMember 2018-01-02 2018-06-30 0001038133 us-gaap:RetainedEarningsMember 2018-01-01 0001038133 hska:CommonStockPreferredStockAndPublicStockMember 2017-12-31 0001038133 hska:CommonStockPreferredStockAndPublicStockMember 2018-06-30 0001038133 us-gaap:AdditionalPaidInCapitalMember 2018-01-02 2018-06-30 0001038133 hska:CommonStockPreferredStockAndPublicStockMember 2019-06-30 0001038133 2018-01-02 2018-06-30 0001038133 hska:CommonStockPreferredStockAndPublicStockMember 2018-01-01 0001038133 us-gaap:RetainedEarningsMember 2019-06-30 0001038133 2018-01-01 0001038133 us-gaap:ComprehensiveIncomeMember 2017-12-31 0001038133 us-gaap:RetainedEarningsMember 2017-12-31 0001038133 us-gaap:ComprehensiveIncomeMember 2018-06-30 0001038133 us-gaap:ComprehensiveIncomeMember 2018-01-01 0001038133 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-06-30 0001038133 us-gaap:ComprehensiveIncomeMember 2018-12-31 0001038133 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001038133 us-gaap:RetainedEarningsMember 2018-06-30 0001038133 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001038133 us-gaap:ComprehensiveIncomeMember 2019-01-01 2019-06-30 0001038133 hska:CommonStockPreferredStockAndPublicStockMember 2018-12-31 0001038133 hska:CommonStockPreferredStockAndPublicStockMember 2019-01-01 2019-06-30 0001038133 us-gaap:RetainedEarningsMember 2018-01-02 2018-06-30 0001038133 2018-06-30 0001038133 us-gaap:RetainedEarningsMember 2019-01-01 2019-06-30 0001038133 us-gaap:ComprehensiveIncomeMember 2018-01-02 2018-06-30 0001038133 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 0001038133 us-gaap:ComprehensiveIncomeMember 2019-06-30 0001038133 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001038133 us-gaap:RetainedEarningsMember 2018-12-31 0001038133 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001038133 us-gaap:RetainedEarningsMember 2018-03-31 0001038133 us-gaap:RetainedEarningsMember 2018-04-01 2018-06-30 0001038133 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001038133 hska:CommonStockPreferredStockAndPublicStockMember 2018-04-01 2018-06-30 0001038133 hska:CommonStockPreferredStockAndPublicStockMember 2019-03-31 0001038133 hska:CommonStockPreferredStockAndPublicStockMember 2019-04-01 2019-06-30 0001038133 us-gaap:ComprehensiveIncomeMember 2019-03-31 0001038133 us-gaap:ComprehensiveIncomeMember 2018-04-01 2018-06-30 0001038133 2018-03-31 0001038133 us-gaap:AdditionalPaidInCapitalMember 2018-04-01 2018-06-30 0001038133 us-gaap:ComprehensiveIncomeMember 2018-03-31 0001038133 hska:CommonStockPreferredStockAndPublicStockMember 2018-03-31 0001038133 2019-03-31 0001038133 us-gaap:RetainedEarningsMember 2019-03-31 0001038133 us-gaap:ComprehensiveIncomeMember 2019-04-01 2019-06-30 0001038133 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0001038133 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001038133 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001038133 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 0001038133 hska:LicenseResearchAndDevelopmentMember 2018-04-01 2018-06-30 0001038133 hska:ContractManufacturingContractsMember 2018-04-01 2018-06-30 0001038133 hska:ContractManufacturingContractsMember 2018-01-01 2018-06-30 0001038133 hska:LicenseResearchAndDevelopmentMember 2019-01-01 2019-06-30 0001038133 hska:ContractManufacturingContractsMember 2019-01-01 2019-06-30 0001038133 hska:LicenseResearchAndDevelopmentMember 2019-04-01 2019-06-30 0001038133 hska:LicenseResearchAndDevelopmentMember 2018-01-01 2018-06-30 0001038133 hska:ContractManufacturingContractsMember 2019-04-01 2019-06-30 0001038133 hska:PointOfCareLaboratoryRevenueOutrightInstrumentSalesMember 2019-01-01 2019-06-30 0001038133 hska:PointOfCareLaboratoryRevenueConsumablesMember 2018-01-01 2018-06-30 0001038133 hska:PointOfCareLaboratoryRevenueOtherMember 2018-04-01 2018-06-30 0001038133 hska:OtherRevenueResearchAndDevelopmentLicenseAndRoyaltyRevenueMember 2019-04-01 2019-06-30 0001038133 hska:PointOfCareImagingRevenueOperatingTypeLeasesMember 2018-04-01 2018-06-30 0001038133 hska:PointOfCareLaboratoryRevenueMember 2019-04-01 2019-06-30 0001038133 hska:PointOfCareImagingRevenueOutrightInstrumentSalesMember 2019-01-01 2019-06-30 0001038133 hska:OtherRevenueResearchAndDevelopmentLicenseAndRoyaltyRevenueMember 2019-01-01 2019-06-30 0001038133 hska:PointOfCareImagingRevenueServiceRevenueMember 2018-04-01 2018-06-30 0001038133 hska:PointOfCareImagingRevenueOperatingTypeLeasesMember 2019-01-01 2019-06-30 0001038133 hska:PointOfCareLaboratoryRevenueConsumablesMember 2019-04-01 2019-06-30 0001038133 hska:OtherRevenueMember 2019-01-01 2019-06-30 0001038133 hska:PointOfCareImagingRevenueOperatingTypeLeasesMember 2018-01-01 2018-06-30 0001038133 hska:PointOfCareLaboratoryRevenueSalesTypeLeasesMember 2018-04-01 2018-06-30 0001038133 hska:PointOfCareLaboratoryRevenueSalesTypeLeasesMember 2019-01-01 2019-06-30 0001038133 hska:OtherRevenueMember 2018-01-01 2018-06-30 0001038133 hska:PointOfCareImagingRevenueMember 2019-01-01 2019-06-30 0001038133 hska:PointOfCareLaboratoryRevenueOutrightInstrumentSalesMember 2018-01-01 2018-06-30 0001038133 hska:PointOfCareImagingRevenueMember 2019-04-01 2019-06-30 0001038133 hska:OtherRevenueOtherPharmaceuticalsVaccinesAndDiagnosticTestsMember 2018-01-01 2018-06-30 0001038133 hska:PointOfCareLaboratoryRevenueMember 2018-04-01 2018-06-30 0001038133 hska:OtherRevenueResearchAndDevelopmentLicenseAndRoyaltyRevenueMember 2018-01-01 2018-06-30 0001038133 hska:OtherRevenueOtherPharmaceuticalsVaccinesAndDiagnosticTestsMember 2019-04-01 2019-06-30 0001038133 hska:PointOfCareLaboratoryRevenueConsumablesMember 2018-04-01 2018-06-30 0001038133 hska:PointOfCareImagingRevenueMember 2018-04-01 2018-06-30 0001038133 hska:PointOfCareLaboratoryRevenueConsumablesMember 2019-01-01 2019-06-30 0001038133 hska:OtherRevenueOtherPharmaceuticalsVaccinesAndDiagnosticTestsMember 2018-04-01 2018-06-30 0001038133 hska:PointOfCareImagingRevenueOutrightInstrumentSalesMember 2018-01-01 2018-06-30 0001038133 hska:PointOfCareLaboratoryRevenueSalesTypeLeasesMember 2019-04-01 2019-06-30 0001038133 hska:OtherRevenueMember 2018-04-01 2018-06-30 0001038133 hska:PointOfCareImagingRevenueOutrightInstrumentSalesMember 2019-04-01 2019-06-30 0001038133 hska:OtherRevenueMember 2019-04-01 2019-06-30 0001038133 hska:PointOfCareLaboratoryRevenueOutrightInstrumentSalesMember 2018-04-01 2018-06-30 0001038133 hska:PointOfCareImagingRevenueOutrightInstrumentSalesMember 2018-04-01 2018-06-30 0001038133 hska:PointOfCareImagingRevenueServiceRevenueMember 2019-04-01 2019-06-30 0001038133 hska:PointOfCareImagingRevenueServiceRevenueMember 2019-01-01 2019-06-30 0001038133 hska:PointOfCareImagingRevenueOperatingTypeLeasesMember 2019-04-01 2019-06-30 0001038133 hska:PointOfCareLaboratoryRevenueOtherMember 2018-01-01 2018-06-30 0001038133 hska:OtherRevenueResearchAndDevelopmentLicenseAndRoyaltyRevenueMember 2018-04-01 2018-06-30 0001038133 hska:PointOfCareImagingRevenueMember 2018-01-01 2018-06-30 0001038133 hska:OtherRevenueOtherPharmaceuticalsVaccinesAndDiagnosticTestsMember 2019-01-01 2019-06-30 0001038133 hska:PointOfCareLaboratoryRevenueMember 2019-01-01 2019-06-30 0001038133 hska:PointOfCareImagingRevenueServiceRevenueMember 2018-01-01 2018-06-30 0001038133 hska:PointOfCareLaboratoryRevenueSalesTypeLeasesMember 2018-01-01 2018-06-30 0001038133 hska:PointOfCareLaboratoryRevenueOtherMember 2019-01-01 2019-06-30 0001038133 hska:PointOfCareLaboratoryRevenueOtherMember 2019-04-01 2019-06-30 0001038133 hska:PointOfCareLaboratoryRevenueMember 2018-01-01 2018-06-30 0001038133 hska:PointOfCareLaboratoryRevenueOutrightInstrumentSalesMember 2019-04-01 2019-06-30 0001038133 2023-01-01 2019-06-30 0001038133 2022-01-01 2019-06-30 0001038133 2024-01-01 2019-06-30 0001038133 2021-01-01 2019-06-30 0001038133 2019-07-01 2019-06-30 0001038133 2020-01-01 2019-06-30 0001038133 hska:OptomedMember 2019-02-22 0001038133 hska:CuattroLLCMember 2018-12-21 2018-12-21 0001038133 hska:HeskaImagingMember srt:AffiliatedEntityMember 2019-06-30 0001038133 2018-12-21 0001038133 hska:CuattroLLCMember hska:HeskaImagingMember srt:AffiliatedEntityMember 2018-01-01 2018-06-30 0001038133 hska:OptomedMember 2019-02-22 0001038133 hska:CuattroLLCMember hska:HeskaImagingMember srt:AffiliatedEntityMember 2019-01-01 2019-06-30 0001038133 hska:OptomedMember 2019-02-22 2019-02-22 0001038133 hska:HeskaImagingMember srt:AffiliatedEntityMember 2018-12-31 0001038133 hska:MBioDiagnosticsInc.Member 2018-08-08 2018-08-08 0001038133 hska:GeneralFluidicsCorporationMember 2018-09-24 2018-09-24 0001038133 hska:GeneralFluidicsCorporationMember 2018-09-24 2018-09-24 0001038133 hska:GeneralFluidicsCorporationMember 2018-09-24 0001038133 hska:StockOptionsAndRestrictedUnitsMember 2019-04-01 2019-06-30 0001038133 hska:StockOptionsAndRestrictedUnitsMember 2018-04-01 2018-06-30 0001038133 hska:StockOptionsAndRestrictedUnitsMember 2018-01-01 2018-06-30 0001038133 hska:StockOptionsAndRestrictedUnitsMember 2019-01-01 2019-06-30 0001038133 hska:CustomerRelationshipsAndOtherMember 2019-06-30 0001038133 hska:CustomerRelationshipsAndOtherMember 2018-12-31 0001038133 us-gaap:DevelopedTechnologyRightsMember 2019-06-30 0001038133 us-gaap:DevelopedTechnologyRightsMember 2018-12-31 0001038133 srt:MinimumMember hska:InventoryTransferredToMachineryAndEquipmentMember 2019-01-01 2019-06-30 0001038133 srt:MaximumMember hska:InventoryTransferredToMachineryAndEquipmentMember 2019-01-01 2019-06-30 0001038133 us-gaap:BuildingMember 2018-12-31 0001038133 us-gaap:MachineryAndEquipmentMember 2019-06-30 0001038133 us-gaap:LandMember 2018-12-31 0001038133 us-gaap:BuildingMember 2019-06-30 0001038133 hska:OfficeFurnitureAndEquipmentMember 2019-06-30 0001038133 us-gaap:MachineryAndEquipmentMember 2018-12-31 0001038133 us-gaap:LandMember 2019-06-30 0001038133 us-gaap:ConstructionInProgressMember 2018-12-31 0001038133 hska:ComputerHardwareAndSoftwareMember 2018-12-31 0001038133 hska:LeaseholdandBuildingImprovementsMember 2018-12-31 0001038133 hska:OfficeFurnitureAndEquipmentMember 2018-12-31 0001038133 hska:ComputerHardwareAndSoftwareMember 2019-06-30 0001038133 hska:LeaseholdandBuildingImprovementsMember 2019-06-30 0001038133 us-gaap:ConstructionInProgressMember 2019-06-30 0001038133 us-gaap:RestrictedStockMember 2019-06-30 0001038133 us-gaap:RestrictedStockMember 2018-01-01 2018-06-30 0001038133 us-gaap:EmployeeStockMember 2019-01-01 2019-06-30 0001038133 us-gaap:RestrictedStockMember 2019-01-01 2019-06-30 0001038133 us-gaap:EmployeeStockOptionMember 2019-06-30 0001038133 srt:MaximumMember us-gaap:RestrictedStockMember 2019-01-01 2019-06-30 0001038133 us-gaap:EmployeeStockMember 2018-04-01 2018-06-30 0001038133 us-gaap:EmployeeStockMember 2019-04-01 2019-06-30 0001038133 us-gaap:RestrictedStockMember 2019-04-01 2019-06-30 0001038133 us-gaap:RestrictedStockMember 2018-04-01 2018-06-30 0001038133 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-06-30 0001038133 us-gaap:EmployeeStockMember 2018-01-01 2018-06-30 0001038133 srt:MinimumMember us-gaap:RestrictedStockMember 2019-01-01 2019-06-30 0001038133 hska:ExercisePriceRangeSixMember 2019-06-30 0001038133 hska:ExercisePriceRangeTwoMember 2019-06-30 0001038133 hska:ExercisePriceRangeThreeMember 2019-06-30 0001038133 hska:ExercisePriceRangeOneMember 2019-01-01 2019-06-30 0001038133 hska:ExercisePriceRangeFiveMember 2019-06-30 0001038133 hska:ExercisePriceRangeFourMember 2019-06-30 0001038133 hska:ExercisePriceRangeFiveMember 2019-01-01 2019-06-30 0001038133 hska:ExercisePriceRangeSixMember 2019-01-01 2019-06-30 0001038133 hska:ExercisePriceRangeFourMember 2019-01-01 2019-06-30 0001038133 hska:ExercisePriceRangeThreeMember 2019-01-01 2019-06-30 0001038133 hska:ExercisePriceRangeTwoMember 2019-01-01 2019-06-30 0001038133 hska:ExercisePriceRangeOneMember 2019-06-30 0001038133 us-gaap:RestrictedStockMember 2018-12-31 0001038133 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-06-30 0001038133 us-gaap:EmployeeStockOptionMember 2019-04-01 2019-06-30 0001038133 us-gaap:EmployeeStockOptionMember 2018-04-01 2018-06-30 0001038133 us-gaap:EmployeeStockOptionMember 2018-12-31 0001038133 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-12-31 0001038133 us-gaap:EmployeeStockOptionMember 2017-12-31 0001038133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001038133 us-gaap:AccumulatedTranslationAdjustmentMember 2019-06-30 0001038133 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-06-30 0001038133 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-06-30 0001038133 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0001038133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-06-30 0001038133 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-06-30 0001038133 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0001038133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001038133 2019-02-28 2019-02-28 0001038133 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2017-07-27 2017-07-27 0001038133 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2017-07-27 0001038133 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2019-06-30 0001038133 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-07-27 2017-07-27 0001038133 us-gaap:OperatingSegmentsMember hska:OtherVaccinesPharmaceuticalsandProductsSegmentMember 2019-01-01 2019-06-30 0001038133 us-gaap:OperatingSegmentsMember hska:CoreCompanionAnimalHealthSegmentMember 2019-01-01 2019-06-30 0001038133 us-gaap:OperatingSegmentsMember hska:OtherVaccinesPharmaceuticalsandProductsSegmentMember 2019-06-30 0001038133 us-gaap:OperatingSegmentsMember hska:CoreCompanionAnimalHealthSegmentMember 2019-06-30 0001038133 us-gaap:OperatingSegmentsMember hska:OtherVaccinesPharmaceuticalsandProductsSegmentMember 2019-04-01 2019-06-30 0001038133 us-gaap:OperatingSegmentsMember hska:CoreCompanionAnimalHealthSegmentMember 2019-04-01 2019-06-30 0001038133 us-gaap:OperatingSegmentsMember hska:CoreCompanionAnimalHealthSegmentMember 2018-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:OtherVaccinesPharmaceuticalsandProductsSegmentMember 2018-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:CoreCompanionAnimalHealthSegmentMember 2018-01-01 2018-06-30 0001038133 us-gaap:OperatingSegmentsMember hska:OtherVaccinesPharmaceuticalsandProductsSegmentMember 2018-01-01 2018-06-30 0001038133 us-gaap:OperatingSegmentsMember hska:OtherVaccinesPharmaceuticalsandProductsSegmentMember 2018-04-01 2018-06-30 0001038133 us-gaap:OperatingSegmentsMember hska:CoreCompanionAnimalHealthSegmentMember 2018-04-01 2018-06-30 iso4217:USD xbrli:shares xbrli:pure iso4217:USD xbrli:shares hska:segment false --12-31 Q2 2019 2019-06-30 10-Q 0001038133 7796571 Yes false Accelerated Filer Heska Corp false false 54763 5400000 1000000 600000 700000 1526000 1090000 20000000.0 50000000.0 60000 11908000 13033000 1897000 4052000 -288000 482000 3018000 3018000 10000000 1000000 P20Y 0.069 2800000 3000000 0.05 77000 78000 176000 P15Y 8000 245000 7469000 7330000 16454000 12775000 632000 402000 10142000 3755000 38079000 36789000 1000000 2100000 900000 1900000 277000 298000 257034000 256952000 2368000 2368000 1304000 1304000 1195000 1195000 2380000 2380000 245000 212000 97000 194000 305000 607000 169000 238000 714000 225000 156452000 133586000 22866000 162844000 139036000 23808000 62407000 60489000 122409000 96129000 26280000 123252000 103455000 19797000 0.70 400000 500000 2500000 2600000 9659000 13675000 13389000 9992000 4016000 -3397000 0.01 0.01 0.01 0.01 0.01 10250000 10250000 10250000 10250000 7675692 0 7794271 0 7675692 0 7794271 0 0 0 1785000 4021000 -158000 594000 0 0 -47000 -91000 1785000 4021000 -205000 503000 900000 1000000 3300000 3500000 9600000 8900000 7082000 6442000 1500000 P6Y0M0D 16597000 36055000 15734000 32702000 2635000 2635000 12000 29000 28000 72000 0.011 0.0165 203000 -94000 -454000 -1508000 2526000 2615000 14121000 15920000 1138000 838000 300000 2333000 1746000 587000 1257000 934000 323000 2522000 1881000 641000 126000 0 226000 0 200000 0 0.26 0.57 -0.03 0.08 0.24 0.52 -0.03 0.07 -8000 5000 400000 1200000 300000 1400000 759000 1118000 P1Y4M9D P1Y4M0D 4300000 2600000 0.287 5000000 4693000 1739000 1739000 0 2374000 1964000 410000 4107000 666000 918000 1265000 1283000 1287000 11503000 3303000 8200000 11900000 3700000 8200000 9764000 1564000 8200000 9526000 1736000 7790000 4358000 8984000 4024000 8243000 26679000 27190000 503000 8000 13065000 26372000 12412000 24955000 2112000 2772000 -660000 3987000 4699000 -712000 -587000 -275000 -312000 -646000 -310000 -336000 0 -308000 215000 -65000 -426000 -1436000 12000 30000 28000 100000 -2510000 -707000 -2780000 -3764000 -1332000 -7680000 -2457000 -723000 -1000 0 -1336000 -226000 -3192000 2978000 524000 392000 706000 -28000 -250000 531000 100000 200000 100000 200000 26679000 27190000 77000 142000 147000 224000 63000 119000 133000 225000 58000 85000 71000 127000 8085000 9548000 25104000 28977000 15000000 16832000 1573000 1210000 3592000 3807000 8018000 8018000 0 7711000 7711000 0 600000 1100000 7173000 1766000 1321000 1429000 1605000 1052000 669000 16412000 2431000 3223000 1614000 1974000 3574000 3596000 34043000 39592000 156452000 162844000 20363000 15385000 12800000 30000000.0 6000000 12750000 6750000 0 6800000 40000 78000 2989000 3379000 0.30 332000 3205000 -807000 -1251000 4499000 -5356000 4052000 4052000 1897000 1897000 4052000 -241000 -241000 573000 573000 0 0 127000 308000 0 0 -47000 -91000 -92000 -88000 -21000 -5000 2 10861000 22297000 12978000 25596000 2204000 2864000 -660000 4075000 4787000 -712000 -566000 -254000 -312000 -641000 -305000 -336000 889000 6504000 6900000 1685000 4819000 0 -750000 6092000 6500000 0.0445 P4Y2M12D 2001000 2235000 2938000 3044000 7574000 7565000 -112000 -31000 83000 21000 0 21000 21000 -31000 -31000 -112000 -112000 83000 83000 21000 21000 9764000 9526000 598000 196000 -78000 -65000 -7000 -6000 1155000 3480000 200000 5100000 0 622000 436000 39000 397000 811000 96000 715000 395000 32000 363000 629000 76000 553000 0.01 0.01 2500000 2500000 0 0 0 0 0 0 1533000 2322000 1613000 1018000 0 6750000 0 -1083000 4000 0 1300000 500000 200000 200000 1897000 4052000 -161000 790000 54060000 4704000 9953000 1687000 2978000 1274000 377000 33087000 52107000 4749000 9981000 1700000 2978000 1309000 377000 31013000 15981000 15318000 528000 878000 P7Y P5Y 6100000 5700000 10800000 10300000 16700000 0 330000 2300000 6000 559000 1229000 2239000 3605000 -134979000 -134406000 29662000 2887000 26644000 131000 7129000 6991000 138000 3018000 4462000 352000 3566000 544000 11524000 15053000 401000 1335000 1793000 62427000 8678000 53463000 286000 14336000 14102000 234000 8964000 10434000 630000 8705000 1099000 22344000 28693000 872000 2146000 3331000 28146000 3327000 24716000 103000 3367000 3281000 86000 3430000 5229000 266000 4405000 558000 13208000 16120000 374000 1045000 1493000 57657000 7994000 49432000 231000 6712000 6527000 185000 8225000 10639000 568000 8951000 1120000 25524000 32081000 748000 2575000 3234000 89475000 12289000 22138000 18315000 15244000 11848000 9641000 P6M P1Y P1Y P1Y P1Y 29662000 26644000 3018000 62427000 53463000 8964000 28146000 24716000 3430000 57657000 49432000 8225000 341000 5944000 12084000 6715000 13748000 2368000 2380000 P4Y P1Y 500000 80.90 18567000 17.98 85.09 15.86 67.76 18.69 71.35 18.82 71.38 259430000 273267000 74.26 73.90 4230000 300000 4400000 300000 85.09 0 0 0 0 0 0 0 0 0.44 0.40 0.44 0.40 0.39 0.40 0.39 0.40 0.0109 0.0276 0.0106 0.0264 0.0221 0.0189 0.0227 0.0195 386176 305452 21.214 33.655 3100000 11600000 15900000 896 0 18978 256 153700 11200 26.74 26.67 18300000 630847 620553 481669 2327 5454 2786 5369 25.740 16.776 65.414 0.000 53.010 98.660 75.244 73.193 69.78 62.51 4.96 4.96 32.22 7.37 43298 43337 93352 305452 46524 78941 121511 130000 93352 481669 57533 79273 108.25 69.77 7.36 108.25 62.50 32.21 P1Y2M18D P4Y10M24D P1Y2M18D P4Y10M24D P1Y1M6D P4Y8M6D P1Y1M6D P4Y8M6D 80.960 69.770 6.998 33.655 39.724 15.828 29.312 40.741 48.920 84.684 69.770 6.998 48.920 39.797 15.897 P8Y1M6D P8Y8M4D P3Y7M25D P6Y8M1D P6Y6M25D P4Y9M14D 7303000 7419000 7498000 7676000 7747000 7794000 7303000 3500000 300000 195000 79000 47000 118000 144120 149828 458000 2000 456000 1742000 1000 1741000 608000 1000 607000 -2461000 1000 -2462000 122409000 122922000 100440000 73000 243598000 232000 -143463000 105091000 74000 243377000 313000 -138673000 109922000 75000 246422000 201000 -136776000 122409000 77000 -419000 277000 696000 257034000 277000 -134979000 121277000 77000 255150000 215000 -134165000 122922000 78000 -419000 298000 717000 256952000 298000 -134406000 103075000 73000 243598000 232000 -140828000 624000 635000 0 493000 7850000 7781000 7486000 7956000 7226000 7146000 7486000 7463000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Interest and other expense, net, consisted of the following (in thousands):</font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Interest income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(133</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(63</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(225</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(119</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">147</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">77</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">224</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">142</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Other expense, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">78</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">65</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total interest and other expense, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">21</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">92</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">88</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">ACCRUED LIABILITIES</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Accrued liabilities consisted of the following (in thousands):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">June&#160;30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">December&#160;31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Accrued settlement (see Note 14)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">6,750</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Accrued payroll and employee benefits</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,118</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">759</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Accrued property taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">402</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">632</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2,235</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2,001</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total accrued liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,755</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">10,142</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Other accrued liabilities consists of items that are individually less than </font><font style="font-family:inherit;font-size:11pt;">5%</font><font style="font-family:inherit;font-size:11pt;"> of total current liabilities.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In the opinion of management, the accompanying unaudited Condensed Consolidated Financial Statements contain all adjustments, consisting of normal, recurring adjustments, necessary to present fairly the financial position of the Company as of </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:11pt;">, the results of our operations and statements of stockholders' equity for the </font><font style="font-family:inherit;font-size:11pt;">three and six</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;">, and cash flows for the </font><font style="font-family:inherit;font-size:11pt;">six</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;">.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The unaudited Condensed Consolidated Financial Statements included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") have been condensed or omitted pursuant to such rules and regulations. Our unaudited Condensed Consolidated Financial Statements include our accounts and the accounts of our wholly-owned subsidiaries since their respective dates of acquisitions. All intercompany accounts and transactions have been eliminated in consolidation. Where our ownership of a subsidiary is less than 100%, the non-controlling interest is reported on our Condensed Consolidated Balance Sheets. The non-controlling interest in our consolidated net income is reported as "Net loss attributable to redeemable non-controlling interest" on our Condensed Consolidated Statements of Income. These unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in our Annual Report on Form&#160;10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:11pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:11pt;"> and other financial information filed with the SEC.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">ACQUISITIONS AND RELATED PARTY ITEMS</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Optomed</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">On February 22, 2019, Heska acquired </font><font style="font-family:inherit;font-size:11pt;">70%</font><font style="font-family:inherit;font-size:11pt;"> of the equity of Optomed, a French-based endoscopy company, in exchange for approximately </font><font style="font-family:inherit;font-size:11pt;">$0.2 million</font><font style="font-family:inherit;font-size:11pt;"> in cash and the assumption of approximately </font><font style="font-family:inherit;font-size:11pt;">$0.4 million</font><font style="font-family:inherit;font-size:11pt;"> in debt. As part of the purchase, Heska entered into put options and call options on the remaining </font><font style="font-family:inherit;font-size:11pt;">30%</font><font style="font-family:inherit;font-size:11pt;"> minority interest. The written put options can be exercised based on the achievement of certain financial conditions over a specified period of time for a fixed amount. The options are not currently exercisable at the acquisition date or the reporting date. The estimated value of the non-controlling interest is inclusive of the probability weighted outcome of the options described herein. The Company is in process of finalizing its purchase price allocation. As part of the purchase agreement, Heska has committed to purchase from the minority interest holder, by the end of the fiscal year, real estate in the amount of approximately </font><font style="font-family:inherit;font-size:11pt;">$1.0 million</font><font style="font-family:inherit;font-size:11pt;">, which is currently under lease by Optomed.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Cuattro Veterinary Acquisitions</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In February 2013, the Company acquired a majority interest in Cuattro Veterinary USA, LLC, which was owned by Kevin S. Wilson, among other members. The subsidiary was subsequently renamed Heska Imaging US, LLC ("US Imaging"). The remaining minority position in US Imaging was subject to purchase by Heska under a performance-based put option which was exercised in March 2017. In May 2017, we purchased the remaining minority interest position in US Imaging.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In May 2016, the Company closed a transaction to acquire Cuattro Veterinary, LLC ("International Imaging"), which was owned by Kevin S. Wilson, among other members. International Imaging is a provider to international markets of digital radiography technologies for veterinarians. As a leading provider of advanced veterinary diagnostic and specialty products, we made the acquisition in an effort to combine International Imaging's global reach with our domestic success in the imaging and laboratory markets in the United States.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In June 2017, the Company consolidated its assets and liabilities in the US Imaging and International Imaging companies into Heska Imaging, LLC ("Heska Imaging"). Cuattro, LLC ("Cuattro") is owned by Kevin S. Wilson, the CEO and President of the Company in addition to Mrs. Wilson and trusts for the benefit of Mr. and Mrs. Wilson's children and family. Steven M. Asakowicz and Rodney A. Lippincott, members of Cuattro Veterinary USA, LLC and Cuattro International prior to the acquisitions, each serve as Executive Vice President, Companion Animal Health Sales for the Company.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Purchase Agreement for Certain Assets</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">On December 21, 2018, the Company closed a transaction (the "Asset Acquisition") to acquire certain assets from Cuattro, all related to the CCA segment. Pursuant to the Asset Acquisition, dated November 26, 2018, the Company issued </font><font style="font-family:inherit;font-size:11pt;">54,763</font><font style="font-family:inherit;font-size:11pt;"> shares of the Company's common stock, </font><font style="font-family:inherit;font-size:11pt;">$0.01</font><font style="font-family:inherit;font-size:11pt;"> par value per share (the "Common Stock"), to Cuattro on the closing date, at an aggregate value equal to approximately </font><font style="font-family:inherit;font-size:11pt;">$5.4 million</font><font style="font-family:inherit;font-size:11pt;"> based on the adjusted closing price per share of the Common Stock as reported on the Nasdaq Stock Market on the Asset Acquisition agreement date. These shares were issued to Cuattro in a private placement in reliance upon an exemption from the registration requirements of the Securities Act pursuant to Section 4(a)(2) thereof and the safe harbor provided by Rule 506 of Regulation D promulgated thereunder. In addition to the Common Stock, the Company paid cash in the amount of </font><font style="font-family:inherit;font-size:11pt;">$2.8 million</font><font style="font-family:inherit;font-size:11pt;"> to Cuattro as part of the transaction. The total purchase price was determined based on a valuation report from an independent third party. Part of the Asset Acquisition was an agreement to terminate the supply and license agreement that Heska had been operating under since the acquisition of Cuattro Veterinary USA, LLC. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The Company evaluated the acquisition of the purchased assets under ASC 805, </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Business Combinations</font><font style="font-family:inherit;font-size:11pt;"> and ASU 2017-01, </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Business Combinations (Topic 805)</font><font style="font-family:inherit;font-size:11pt;"> and concluded that as substantially all of the fair value of the gross assets acquired is concentrated in an identifiable group of similar assets, the transaction did not meet the requirements to be accounted for as a business combination and therefore was accounted for as an asset acquisition. Accordingly, the purchase price of the purchased assets was allocated entirely to an identifiable intangible asset. In addition to the software assets acquired, Cuattro is obligated, without further compensation, to assist the Company with the implementation of a third-party image hosting platform and necessary data migration. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Other Related Party Activities</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Cuattro charged Heska Imaging </font><font style="font-family:inherit;font-size:11pt;">$6.0 thousand</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">$2.3 million</font><font style="font-family:inherit;font-size:11pt;"> during </font><font style="font-family:inherit;font-size:11pt;">the six months ended June 30, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;">, respectively. The charge in 2019 relates to minor inventory purchases as the Company transitions the digital imaging software assets away from Cuattro. The charge in 2018 was primarily for digital imaging products, pursuant to an underlying supply contract which was terminated in December 2018. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The Company had </font><font style="font-family:inherit;font-size:11pt;">no</font><font style="font-family:inherit;font-size:11pt;"> receivables from or payables to Cuattro as of </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;">. Heska Imaging owed Cuattro </font><font style="font-family:inherit;font-size:11pt;">$0.2 million</font><font style="font-family:inherit;font-size:11pt;"> as of </font><font style="font-family:inherit;font-size:11pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:11pt;">, which is reported in "Due to &#8211; related parties" on the Company's Condensed Consolidated Balance Sheets.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">COMMITMENTS AND CONTINGENCIES</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Royalty Agreements</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The Company holds certain rights to market and manufacture products developed or created under certain research, development, and licensing agreements with various entities. In connection with such agreements, the Company has agreed to pay the entities royalties on net product sales. In each of </font><font style="font-family:inherit;font-size:11pt;">the three months ended June 30, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;">, royalties of </font><font style="font-family:inherit;font-size:11pt;">$0.1 million</font><font style="font-family:inherit;font-size:11pt;"> became payable under these agreements. In each of </font><font style="font-family:inherit;font-size:11pt;">the six months ended June 30, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;">, royalties of </font><font style="font-family:inherit;font-size:11pt;">$0.2 million</font><font style="font-family:inherit;font-size:11pt;"> became payable under these agreements.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Warranties</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The Company's current terms and conditions of sale include a limited warranty that its products and services will conform to published specifications at the time of shipment and a more extensive warranty related to certain products. The Company also sells a renewal warranty for certain of its products. The typical remedy for breach of warranty is to correct or replace any defective product, and if not possible or practical, the Company will accept the return of the defective product and refund the amount paid. Historically, the Company has incurred minimal warranty costs. The Company's warranty reserve was </font><font style="font-family:inherit;font-size:11pt;">$0.2 million</font><font style="font-family:inherit;font-size:11pt;"> at both </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:11pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Litigation</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">From time to time, the Company may be involved in litigation relating to claims arising out of its operations. The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred, and the amount can be reasonably estimated.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">On October 10, 2018, we reached an agreement in principle to settle the complaint that was filed against the Company by Shaun Fauley on March 12, 2015 in the U.S. District Court Northern District of Illinois (the "Court") alleging our transmittal of unauthorized faxes in violation of the federal Telephone Consumer Protection Act of 1991, as amended by the Junk Fax Prevention Act of 2005, as a class action (the "Fauley Complaint"). The settlement, which received the Court's approval on February 28, 2019 and was not subsequently appealed by a class member, required us to make available a total of </font><font style="font-family:inherit;font-size:11pt;">$6.8 million</font><font style="font-family:inherit;font-size:11pt;"> to pay class members, as well as to pay attorneys' fees and expenses to legal counsel to the class. The Company recorded the loss provision in the third quarter of 2018 in connection with the settlement agreement and does not have insurance coverage for the Fauley Complaint. The payment in respect of the settlement was made in full on April 3, 2019, and all activity related to the Fauley Complaint has ceased. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">As of </font><font style="font-family:inherit;font-size:11pt;">June 30,</font><font style="font-family:inherit;font-size:11pt;"> </font><font style="font-family:inherit;font-size:11pt;">2019</font><font style="font-family:inherit;font-size:11pt;">, the Company was not a party to any other legal proceedings that were expected, individually or in the aggregate, to have a material adverse effect on its business, financial condition, or operating results.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Off-Balance Sheet Commitments</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Unconditional Purchase Obligations</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The Company has contractual obligations with suppliers for unconditional annual minimum inventory purchases in the amounts of </font><font style="font-family:inherit;font-size:11pt;">$16.7 million</font><font style="font-family:inherit;font-size:11pt;"> as of </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">ACCUMULATED OTHER COMPREHENSIVE INCOME </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Accumulated other comprehensive income (loss) consisted of the following (in thousands):</font></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Minimum Pension Liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Foreign Currency Translation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Accumulated Other Comprehensive Income</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balances at December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(419</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">696</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">277</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current period other comprehensive income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balances at June 30, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(419</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">717</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">298</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">CREDIT FACILITY</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">On July 27, 2017, and subsequently amended in May 2018, December 2018 and July 2019, we entered into a Credit Agreement (the "Credit Agreement") with JPMorgan Chase Bank, N.A. ("Chase") which provides for a revolving credit facility up to </font><font style="font-family:inherit;font-size:11pt;">$30.0 million</font><font style="font-family:inherit;font-size:11pt;"> (the "Credit Facility"). The Credit Facility provides us with the ability to borrow up to </font><font style="font-family:inherit;font-size:11pt;">$30.0 million</font><font style="font-family:inherit;font-size:11pt;"> although the amount of the Credit Facility may be increased by an additional </font><font style="font-family:inherit;font-size:11pt;">$20.0 million</font><font style="font-family:inherit;font-size:11pt;"> up to a total of </font><font style="font-family:inherit;font-size:11pt;">$50.0 million</font><font style="font-family:inherit;font-size:11pt;"> subject to receipt of additional lender commitments and other conditions. Any interest on borrowings due is to be charged at either the (i) rate of interest per annum publicly announced from time to time by Chase as its prime rate in effect at its principal offices in New York City, subject to a floor, minus </font><font style="font-family:inherit;font-size:11pt;">1.65%</font><font style="font-family:inherit;font-size:11pt;">, or (ii) the interest rate per annum equal to (a) LIBOR for the interest period in effect multiplied by (b) Chase's Statutory Reserve Rate (as defined in the Credit Agreement), plus </font><font style="font-family:inherit;font-size:11pt;">1.10%</font><font style="font-family:inherit;font-size:11pt;"> and payable monthly. There is an annual minimum interest charge of </font><font style="font-family:inherit;font-size:11pt;">$60 thousand</font><font style="font-family:inherit;font-size:11pt;"> under the Credit Agreement. Chase holds first right of priority over all other liens, if any were to exist. Borrowings under the Credit Facility are subject to certain financial and non-financial covenants and are available for various corporate purposes, including general working capital, capital investments, and certain permitted acquisitions. Failure to comply with any of the covenants, representations or warranties could result in our being in default on the loan and could cause all outstanding amounts payable to Chase to become immediately due and payable or impact our ability to borrow under the agreement. The Credit Agreement also permits us to issue letters of credit, although there are currently none outstanding. The maturity date of the Credit Facility is July 27, 2020. The foregoing discussion of the Credit Facility is a summary only and is qualified in its entirety by reference to the full text of the </font><a style="font-family:inherit;font-size:11pt;" href="http://www.sec.gov/Archives/edgar/data/1038133/000119312517245779/d428566dex101.htm"><font style="font-family:inherit;font-size:11pt;">Credit Agreement</font></a><font style="font-family:inherit;font-size:11pt;">, a copy of which has been filed as an exhibit to the Company's Current Report on Form 8-K filed with the SEC on August 2, 2017, incorporated herein by reference. Additionally, the following amendments are included in summary only and are qualified in their entirety by reference to the full text of the </font><a style="font-family:inherit;font-size:11pt;" href="http://www.sec.gov/Archives/edgar/data/1038133/000103813318000050/heska-6302018xex105.htm"><font style="font-family:inherit;font-size:11pt;">First Facility Amendment</font></a><font style="font-family:inherit;font-size:11pt;">, a copy of which has been filed as an exhibit to the Company's Quarterly Report on Form 10-Q filed with the SEC on August 8, 2018, the </font><a style="font-family:inherit;font-size:11pt;" href="http://www.sec.gov/Archives/edgar/data/1038133/000103813319000015/exhibit1066q42018.htm"><font style="font-family:inherit;font-size:11pt;">Second Facility Amendment</font></a><font style="font-family:inherit;font-size:11pt;">, a copy of which has been filed as an exhibit to the Company's Annual Report on Form 10-K filed with the SEC on March 7, 2019 and the </font><a style="font-family:inherit;font-size:11pt;" href="#sF720B04DA024C87EC275475945C15D8E"><font style="font-family:inherit;font-size:11pt;">Third Facility Amendment</font></a><font style="font-family:inherit;font-size:11pt;">, a copy of which has been filed as an exhibit to this Quarterly Report on Form 10-Q filed with the SEC on August 7, 2019, each of which are incorporated herein by reference. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">At </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;">, we had a </font><font style="font-family:inherit;font-size:11pt;">$12.8 million</font><font style="font-family:inherit;font-size:11pt;"> line of credit outstanding under the Credit Facility and we were in compliance with all financial covenants.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following table summarizes our Core Companion Animal ("CCA") revenue (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Point of Care laboratory revenue:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">16,120</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">15,053</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">32,081</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">28,693</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Consumables</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">13,208</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">11,524</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">25,524</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">22,344</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Sales-type leases</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">1,493</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">1,793</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">3,234</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">3,331</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Outright instrument sales</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">1,045</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">1,335</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">2,575</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">2,146</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">374</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">401</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">748</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">872</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Point of Care imaging revenue:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5,229</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4,462</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">10,639</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">10,434</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Outright instrument sales</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">4,405</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">3,566</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">8,951</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">8,705</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Service revenue</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">558</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">544</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">1,120</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">1,099</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Operating type leases and other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">266</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">352</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">568</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">630</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Other CCA revenue:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,367</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,129</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">6,712</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">14,336</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Other pharmaceuticals, vaccines and diagnostic tests</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">3,281</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">6,991</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">6,527</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">14,102</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Research and development, license and royalty</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;revenue</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">86</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">138</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">185</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">234</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total CCA revenue</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">24,716</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">26,644</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">49,432</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">53,463</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Revenue from our OVP segment consists of revenue generated from contract manufacturing agreements and from other license, research and development revenue. The following table summarizes our OVP revenue (in thousands): </font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.79423868312757%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Contract manufacturing</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,327</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2,887</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,994</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8,678</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">License, research and development</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">103</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">131</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">231</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">286</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total OVP revenue</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,430</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8,225</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8,964</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">CAPITAL STOCK</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Stock Option Plans</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions for options granted in the </font><font style="font-family:inherit;font-size:11pt;">three and six</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">June 30,</font><font style="font-family:inherit;font-size:11pt;"> </font><font style="font-family:inherit;font-size:11pt;">2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;">.</font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;padding-left:24px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;padding-left:24px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Risk-free interest rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1.89%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2.76%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1.95%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2.64%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Expected lives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.7 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.9 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.7 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.9 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Expected volatility</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">40%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">40%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">40%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">40%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Expected dividend yield</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">A summary of our stock option plans is as follows:</font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Six Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="padding-bottom:28px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#160;<br clear="none"/>&#160;<br clear="none"/>&#160;<br clear="none"/>Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Weighted Average Exercise Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="padding-bottom:28px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#160;<br clear="none"/>&#160;<br clear="none"/>&#160;<br clear="none"/>Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Weighted Average Exercise Price</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at beginning of period</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">620,553</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40.741</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">630,847</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.312</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted at market</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,200</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.193</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">153,700</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75.244</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(256</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">98.660</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18,978</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53.010</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expired</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(896</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65.414</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(149,828</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.776</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(144,120</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.740</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">481,669</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.920</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">620,553</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40.741</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercisable at end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">305,452</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33.655</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">386,176</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.214</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The total estimated fair value of stock options granted during </font><font style="font-family:inherit;font-size:11pt;">the six months ended June 30, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;"> was computed to be approximately </font><font style="font-family:inherit;font-size:11pt;">$0.3 million</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">$3.5 million</font><font style="font-family:inherit;font-size:11pt;">, respectively. The amounts are amortized ratably over the vesting periods of the options. The weighted average estimated fair value of options granted during </font><font style="font-family:inherit;font-size:11pt;">the six months ended June 30, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;"> was computed to be approximately </font><font style="font-family:inherit;font-size:11pt;">$26.67</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">$26.74</font><font style="font-family:inherit;font-size:11pt;">, respectively. The total intrinsic value of options exercised during </font><font style="font-family:inherit;font-size:11pt;">the six months ended June 30, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;"> was </font><font style="font-family:inherit;font-size:11pt;">$11.6 million</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">$3.1 million</font><font style="font-family:inherit;font-size:11pt;">, respectively. The cash proceeds from options exercised during </font><font style="font-family:inherit;font-size:11pt;">the six months ended June 30, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;"> was </font><font style="font-family:inherit;font-size:11pt;">$0.5 million</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">$1.3 million</font><font style="font-family:inherit;font-size:11pt;">, respectively.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following table summarizes information about stock options outstanding and exercisable at </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;">:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:25%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Options Outstanding</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Options Exercisable</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exercise Prices</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of<br clear="none"/>Options<br clear="none"/>Outstanding<br clear="none"/>at<br clear="none"/>June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Remaining</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contractual</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Life in Years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exercise</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of<br clear="none"/>Options<br clear="none"/>Exercisable<br clear="none"/>at<br clear="none"/>June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exercise</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Price</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$ 4.96 - $ 7.36</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93,352</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.65</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.998</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93,352</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.998</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$ 7.37 - $ 32.21</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79,273</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.79</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.897</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,941</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.828</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$ 32.22 - $ 62.50</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57,533</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.57</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39.797</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46,524</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39.724</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$ 62.51 - $ 69.77</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">130,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.68</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69.770</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,337</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69.770</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$ 69.78 - $ 108.25</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121,511</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">84.684</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,298</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80.960</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$ 4.96 - $ 108.25</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">481,669</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.67</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.920</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">305,452</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33.655</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">As of </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;">, there was approximately </font><font style="font-family:inherit;font-size:11pt;">$4.3 million</font><font style="font-family:inherit;font-size:11pt;"> in total unrecognized compensation cost related to outstanding stock options. That cost is expected to be recognized over a weighted average period of </font><font style="font-family:inherit;font-size:11pt;">1.36</font><font style="font-family:inherit;font-size:11pt;"> years, with all cost to be recognized by the end of February 2023, assuming all options vest according to the vesting schedules in place at </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;">. As of </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;">, the aggregate intrinsic value of outstanding options was approximately </font><font style="font-family:inherit;font-size:11pt;">$18.3 million</font><font style="font-family:inherit;font-size:11pt;"> and the aggregate intrinsic value of exercisable options was approximately </font><font style="font-family:inherit;font-size:11pt;">$15.9 million</font><font style="font-family:inherit;font-size:11pt;">.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The Company issues new shares upon share option exercise, which may be netted or withheld to meet strike price or related tax obligations.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Employee Stock Purchase Plan (the "ESPP")</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">For </font><font style="font-family:inherit;font-size:11pt;">the three months ended June 30, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;">, we issued </font><font style="font-family:inherit;font-size:11pt;">2,786</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2,327</font><font style="font-family:inherit;font-size:11pt;"> shares under the ESPP, respectively. For </font><font style="font-family:inherit;font-size:11pt;">the six months ended June 30, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;">, we issued </font><font style="font-family:inherit;font-size:11pt;">5,369</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">5,454</font><font style="font-family:inherit;font-size:11pt;"> shares under the ESPP, respectively.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">For the </font><font style="font-family:inherit;font-size:11pt;">three and six</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;">, we estimated the fair values of stock purchase rights granted under the ESPP using the Black-Scholes pricing model. The weighted average assumptions used for the periods presented were as follows:</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.79423868312757%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Risk-free interest rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2.21%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1.09%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2.27%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1.06%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Expected lives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1.1 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1.2 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1.1 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1.2 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Expected volatility</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">39%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">44%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">39%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">44%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Expected dividend yield</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">For </font><font style="font-family:inherit;font-size:11pt;">the three months ended June 30, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;">, the weighted-average fair value of the purchase rights granted was </font><font style="font-family:inherit;font-size:11pt;">$18.69</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">$17.98</font><font style="font-family:inherit;font-size:11pt;"> per share, respectively. For </font><font style="font-family:inherit;font-size:11pt;">the six months ended June 30, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;">, the weighted-average fair value of the purchase rights granted was </font><font style="font-family:inherit;font-size:11pt;">$18.82</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">$15.86</font><font style="font-family:inherit;font-size:11pt;"> per share, respectively.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Restricted Stock Issuances</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">We have granted non-vested restricted stock awards (&#8220;restricted stock&#8221; or "RSAs") to management and non-employee directors pursuant to the Company's amended and restated Stock Incentive Plan. The restricted stock awards have varying vesting periods, but generally become fully vested between </font><font style="font-family:inherit;font-size:11pt;">one</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">four</font><font style="font-family:inherit;font-size:11pt;"> years after the grant date, depending on the specific award, performance targets met for performance-based awards granted to management, and vesting periods for time based awards. Management performance-based awards are granted at the target amount of shares that may be earned. We valued the restricted stock awards related to service and/or company performance targets based on grant date fair value and expense over the period when achievement of those conditions is deemed probable. For restricted stock awards related to market conditions, we utilize a Monte Carlo simulation model to estimate grant date fair value and expense over the requisite period. We recognize forfeitures as they occur. There were no modifications that affected our accounting for restricted stock awards in </font><font style="font-family:inherit;font-size:11pt;">the six months ended June 30, 2019</font><font style="font-family:inherit;font-size:11pt;"> or </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;">. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following table summarizes restricted stock transactions for </font><font style="font-family:inherit;font-size:11pt;">the six months ended June 30, 2019</font><font style="font-family:inherit;font-size:11pt;">:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:65%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RSAs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted-Average Grant Date Fair Value Per Award</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested as of December 31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">259,430</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74.26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,567</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71.38</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Vested</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,230</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85.09</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Forfeited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(500</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80.90</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested as of June 30, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">273,267</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.90</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The weighted average grant date fair value of awards granted was&#160;</font><font style="font-family:inherit;font-size:11pt;">$71.35</font><font style="font-family:inherit;font-size:11pt;"> and&#160;</font><font style="font-family:inherit;font-size:11pt;">$85.09</font><font style="font-family:inherit;font-size:11pt;">&#160;for </font><font style="font-family:inherit;font-size:11pt;">the three months ended June 30, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;">, respectively. The weighted average grant date fair value of awards granted was&#160;</font><font style="font-family:inherit;font-size:11pt;">$71.38</font><font style="font-family:inherit;font-size:11pt;"> and&#160;</font><font style="font-family:inherit;font-size:11pt;">$67.76</font><font style="font-family:inherit;font-size:11pt;">&#160;for </font><font style="font-family:inherit;font-size:11pt;">the six months ended June 30, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;">, respectively. Fair value of restricted stock vested was&#160;</font><font style="font-family:inherit;font-size:11pt;">$0.3</font><font style="font-family:inherit;font-size:11pt;"> million and&#160;</font><font style="font-family:inherit;font-size:11pt;">$0.3 million</font><font style="font-family:inherit;font-size:11pt;">&#160;for </font><font style="font-family:inherit;font-size:11pt;">the three months ended June 30, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;">, respectively. Fair value of restricted stock vested was&#160;</font><font style="font-family:inherit;font-size:11pt;">$0.3</font><font style="font-family:inherit;font-size:11pt;"> million and&#160;</font><font style="font-family:inherit;font-size:11pt;">$4.4 million</font><font style="font-family:inherit;font-size:11pt;">&#160;for </font><font style="font-family:inherit;font-size:11pt;">the six months ended June 30, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;">, respectively.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">As of </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;">, there was approximately&#160;</font><font style="font-family:inherit;font-size:11pt;">$2.6 million</font><font style="font-family:inherit;font-size:11pt;">&#160;of total unrecognized compensation cost related to restricted stock with market and time vesting conditions. The Company expects to recognize this expense over a weighted average period of&#160;</font><font style="font-family:inherit;font-size:11pt;">1.3</font><font style="font-family:inherit;font-size:11pt;">&#160;years. As of </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;">, we reviewed each of the underlying corporate performance targets and determined that approximately </font><font style="font-family:inherit;font-size:11pt;">176,000</font><font style="font-family:inherit;font-size:11pt;"> of shares of common stock were related to company performance targets in which we did not deem achievement probable. No compensation expense had been recorded at any period prior to June 30, 2019. </font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:4px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Restrictions on the transfer of Company stock</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The Company's Restated Certificate of Incorporation, as amended (the "Certificate of Incorporation"), places restrictions (the "Transfer Restrictions") on the transfer of the Company's stock that could adversely affect the Company's ability to utilize its domestic Federal Net Operating Loss Position. In particular, the Transfer Restrictions prevent the transfer of shares without the approval of the Company's Board of Directors if, as a consequence of such transfer, an individual, entity or groups of individuals or entities would become a 5-percent holder under Section 382 of the Internal Revenue Code of 1986, as amended, and the related Treasury regulations, and also prevents any existing&#160;5-percent holder from increasing his or her ownership position in the Company without the approval of the Company's Board of Directors. Any transfer of shares in violation of the Transfer Restrictions (a "Transfer Violation") shall be void&#160;ab initio&#160;under the Certificate of Incorporation, and the Company's Board of Directors has procedures under the Certificate of Incorporation to remedy a Transfer Violation including requiring the shares causing such Transfer Violation to be sold and any profit resulting from such sale to be transferred to a charitable entity chosen by the Company's Board of Directors in specified circumstances.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">EARNINGS PER SHARE</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Basic earnings per share ("EPS") is computed by dividing net income attributable to the Company by the weighted-average number of common shares outstanding during the period. The computation of diluted EPS is similar to the computation of basic EPS except that the numerator is increased to exclude charges that would not have been incurred, and the denominator is increased to include the number of additional common shares that would have been outstanding (using the if-converted and treasury stock methods), if securities containing potentially dilutive common shares such as stock options converting to common shares, and if such assumed conversion is dilutive. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;">The </font><font style="font-family:inherit;font-size:11pt;">following is a reconciliation of the weighted-average shares outstanding used in the calculation of basic and diluted EPS for the </font><font style="font-family:inherit;font-size:11pt;">three and six</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;"> (in thousands, except per share data):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Net (loss) income attributable to Heska Corporation</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(241</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,897</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">573</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4,052</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Basic weighted-average common shares outstanding</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,486</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,226</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,463</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,146</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Assumed exercise of dilutive stock options and restricted shares</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">624</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">493</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">635</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Diluted weighted-average common shares outstanding</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,486</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,850</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,956</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,781</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Basic (loss) earnings per share attributable to Heska Corporation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(0.03</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0.26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0.08</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0.57</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Diluted (loss) earnings per share attributable to Heska Corporation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(0.03</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0.24</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0.07</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0.52</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following stock options and restricted shares were excluded from the computation of diluted EPS because they would have been anti-dilutive (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;padding-left:12px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;padding-left:12px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Stock options and restricted shares</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">714</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">169</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">225</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">238</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">INVESTMENTS IN UNCONSOLIDATED AFFILIATES</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The carrying values of investments in unconsolidated affiliates, categorized by type of investment, is as follows (in thousands):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">June&#160;30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">December&#160;31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Equity method investment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4,693</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Non-marketable equity security investment</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,018</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,711</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8,018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Equity Method Investment</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">On September 24, 2018, we invested </font><font style="font-family:inherit;font-size:11pt;">$5.1 million</font><font style="font-family:inherit;font-size:11pt;">, including costs, in exchange for a </font><font style="font-family:inherit;font-size:11pt;">28.7%</font><font style="font-family:inherit;font-size:11pt;"> interest of a business as part of our product development strategy. The Company accounts for this investment using the equity method of accounting. Under the equity method, the carrying value of the investment is adjusted for the Company's proportionate share of the investee's reported earnings or losses with the corresponding share of earnings or losses reported as Equity in losses of unconsolidated affiliates, listed below Net income before equity in losses of unconsolidated affiliates within the Condensed Consolidated Statements of Income. Additionally, the Company will enter into a </font><font style="font-family:inherit;font-size:11pt;">15</font><font style="font-family:inherit;font-size:11pt;">-year Manufacturing Supply Agreement, which grants the Company global exclusivity to specified products. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Non-Marketable Equity Security Investment</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">On August 8, 2018, the Company invested </font><font style="font-family:inherit;font-size:11pt;">$3.0 million</font><font style="font-family:inherit;font-size:11pt;">, including costs, in MBio Diagnostics, Inc. ("MBio"), in exchange for preferred stock, representing a </font><font style="font-family:inherit;font-size:11pt;">6.9%</font><font style="font-family:inherit;font-size:11pt;"> interest in MBio. The Company&#8217;s investment in MBio is a non-marketable equity security, recorded using the measurement alternative of cost minus impairment, if any, plus or minus changes resulting from qualifying observable price changes. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">As part of the agreement, the Company entered into a Supply and License Agreement with MBio, which provides that MBio produce and commercialize products that will enhance the Company's diagnostic portfolio. As part of this agreement, the Company made an upfront payment to MBio of </font><font style="font-family:inherit;font-size:11pt;">$1.0 million</font><font style="font-family:inherit;font-size:11pt;"> related to a worldwide exclusive license agreement over a </font><font style="font-family:inherit;font-size:11pt;">20</font><font style="font-family:inherit;font-size:11pt;">-year period, recorded in both short and long-term other assets. In addition, the agreement provides for an additional contingent payment from Heska to MBio of </font><font style="font-family:inherit;font-size:11pt;">$10.0 million</font><font style="font-family:inherit;font-size:11pt;">, relating to the successful achievement of sales milestones. This potential future milestone payment has not yet been accrued as it is not deemed by the Company to be probable at this time.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Both parties in this arrangement are active participants and are exposed to significant risks and rewards dependent on the commercial success of the activities of the collaboration. The parties are actively working on developing and testing the product as well as funding the research and development. Heska classifies the amounts paid for MBio's research and development work within the CCA segment research and development operating expenses. Expense is recognized ratably when incurred and in accordance with the development plan.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The carrying values of investments in unconsolidated affiliates, categorized by type of investment, is as follows (in thousands):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">June&#160;30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">December&#160;31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Equity method investment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4,693</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Non-marketable equity security investment</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,018</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,711</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8,018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The weighted average assumptions used for the periods presented were as follows:</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.79423868312757%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Risk-free interest rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2.21%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1.09%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2.27%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1.06%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Expected lives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1.1 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1.2 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1.1 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1.2 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Expected volatility</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">39%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">44%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">39%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">44%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Expected dividend yield</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0%</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Amortization expense relating to other intangibles was as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;padding-left:12px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;padding-left:12px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Amortization expense</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">305</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">97</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">607</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">194</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">GOODWILL AND OTHER INTANGIBLES</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following summarizes the change in goodwill during </font><font style="font-family:inherit;font-size:11pt;">the six months ended June 30, 2019</font><font style="font-family:inherit;font-size:11pt;"> (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:82%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Carrying amount, December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">26,679</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Goodwill attributable to acquisitions (subject to change)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">503</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Foreign currency adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Carrying amount, June 30, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">27,190</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Other intangibles consisted of the following (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;padding-left:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;padding-left:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross Carrying Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated Amortization</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net Carrying Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross Carrying Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated Amortization</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net Carrying Amount</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Developed technology</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8,200</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(410</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,790</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8,200</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8,200</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Customer relationships and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,700</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(1,964</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,736</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,303</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(1,739</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,564</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">11,900</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(2,374</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">9,526</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">11,503</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(1,739</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">9,764</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Amortization expense relating to other intangibles was as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;padding-left:12px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;padding-left:12px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Amortization expense</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">305</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">97</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">607</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">194</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Estimated amortization expense related to intangibles for each of the five years from 2019 (remaining) through 2023 and thereafter is as follows (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:87%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Year Ending December 31,</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2019 (remaining)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">666</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,287</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,283</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,265</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">918</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4,107</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">9,526</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">INCOME TAXES</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Our total income tax (benefit) expense for our (loss) income before income taxes were as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;padding-left:12px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;padding-left:12px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(Loss) income before income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(587</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2,112</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(646</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,987</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total income tax (benefit) expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(426</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">215</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(1,436</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(65</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">There were cash payments of </font><font style="font-family:inherit;font-size:11pt;">$28 thousand</font><font style="font-family:inherit;font-size:11pt;"> and cash refunds, net of payments, of </font><font style="font-family:inherit;font-size:11pt;">$0.1 million</font><font style="font-family:inherit;font-size:11pt;">, respectively, for income taxes for the </font><font style="font-family:inherit;font-size:11pt;">three and six</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;">. There were </font><font style="font-family:inherit;font-size:11pt;">$12 thousand</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">$30 thousand</font><font style="font-family:inherit;font-size:11pt;"> in cash payments for income taxes, net of refunds, for the </font><font style="font-family:inherit;font-size:11pt;">three and six</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:11pt;">. The Company&#8217;s tax benefit increased to </font><font style="font-family:inherit;font-size:11pt;">$0.4 million</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">$1.4 million</font><font style="font-family:inherit;font-size:11pt;"> for the </font><font style="font-family:inherit;font-size:11pt;">three and six</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;">, respectively, compared to the tax expense of </font><font style="font-family:inherit;font-size:11pt;">$0.2 million</font><font style="font-family:inherit;font-size:11pt;"> for </font><font style="font-family:inherit;font-size:11pt;">the three months ended June 30, 2018</font><font style="font-family:inherit;font-size:11pt;"> and tax benefit of </font><font style="font-family:inherit;font-size:11pt;">$0.1 million</font><font style="font-family:inherit;font-size:11pt;"> for the </font><font style="font-family:inherit;font-size:11pt;">six</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2018</font><font style="font-family:inherit;font-size:11pt;">. The increase in tax benefits is due to lower financial income and stock-based compensation excess tax benefits recognized in our income statement. The Company recognized </font><font style="font-family:inherit;font-size:11pt;">$0.3 million</font><font style="font-family:inherit;font-size:11pt;"> in excess tax benefits related to employee share-based compensation for </font><font style="font-family:inherit;font-size:11pt;">the three months ended June 30, 2019</font><font style="font-family:inherit;font-size:11pt;"> compared to </font><font style="font-family:inherit;font-size:11pt;">$0.4 million</font><font style="font-family:inherit;font-size:11pt;"> recognized for </font><font style="font-family:inherit;font-size:11pt;">the three months ended June 30, 2018</font><font style="font-family:inherit;font-size:11pt;">. The Company recognized </font><font style="font-family:inherit;font-size:11pt;">$1.4 million</font><font style="font-family:inherit;font-size:11pt;"> in excess tax benefits related to employee share-based compensation for </font><font style="font-family:inherit;font-size:11pt;">the six months ended June 30, 2019</font><font style="font-family:inherit;font-size:11pt;"> compared to </font><font style="font-family:inherit;font-size:11pt;">$1.2 million</font><font style="font-family:inherit;font-size:11pt;"> recognized for </font><font style="font-family:inherit;font-size:11pt;">the six months ended June 30, 2018</font><font style="font-family:inherit;font-size:11pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">INTEREST AND OTHER EXPENSE, NET </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Interest and other expense, net, consisted of the following (in thousands):</font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Interest income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(133</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(63</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(225</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(119</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">147</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">77</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">224</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">142</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Other expense, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">78</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">65</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total interest and other expense, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">21</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">92</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">88</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Cash paid for interest for </font><font style="font-family:inherit;font-size:11pt;">the three months ended June 30, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;"> was </font><font style="font-family:inherit;font-size:11pt;">$71 thousand</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">$58 thousand</font><font style="font-family:inherit;font-size:11pt;">, respectively. Cash paid for interest for </font><font style="font-family:inherit;font-size:11pt;">the six months ended June 30, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;"> was </font><font style="font-family:inherit;font-size:11pt;">$127 thousand</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">$85 thousand</font><font style="font-family:inherit;font-size:11pt;">, respectively.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">INVENTORIES, NET</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Inventories, net, consisted of the following (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Raw materials</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">16,832</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">15,000</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Work in process</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,807</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,592</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">9,548</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8,085</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Allowance for excess or obsolete inventory</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(1,210</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(1,573</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total inventory, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">28,977</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">25,104</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Inventories are measured on a first-in, first-out basis and stated at lower of cost or net realizable value.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Supplemental cash flow information related to the Company's operating leases for the </font><font style="font-family:inherit;font-size:11pt;">six</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;"> was as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Cash paid for amounts included in the measurement of operating lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">889</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">ROU assets obtained in exchange for operating lease obligations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">341</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following table presents the weighted average remaining lease term and weighted average discount rate related to the Company's operating leases as of </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;">: </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Weighted average remaining lease term</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.2 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Weighted average discount rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.45</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">%</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following table presents the maturity of the Company's operating lease liabilities as of </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;"> (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Remainder of 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,052</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,605</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,429</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,321</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,766</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total operating lease payments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,173</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Less: imputed interest</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">669</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total operating lease liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">6,504</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">LEASES</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;background-color:#ffffff;font-style:italic;">Lessee Accounting </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;background-color:#ffffff;">The Company leases buildings, office equipment, and vehicles.</font><font style="font-family:inherit;font-size:11pt;"> </font><font style="font-family:inherit;font-size:11pt;">The Company&#8217;s finance leases were not material as of&#160;</font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;">&#160;and for the </font><font style="font-family:inherit;font-size:11pt;">three and six</font><font style="font-family:inherit;font-size:11pt;"> month period then ended. ROU assets arising from finance leases are included in Property and equipment, net in the accompanying Condensed Consolidated Balance Sheets. The current portion of the finance lease liabilities are included in Current portion of deferred revenue, and other and the non-current portion of the finance lease liabilities are included in Other liabilities in the accompanying Condensed Consolidated Balance Sheets. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">For the </font><font style="font-family:inherit;font-size:11pt;">three and six</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;">, operating lease expense was </font><font style="font-family:inherit;font-size:11pt;">$0.6 million</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">$1.1 million</font><font style="font-family:inherit;font-size:11pt;">, respectively, including immaterial variable lease costs. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Supplemental cash flow information related to the Company's operating leases for the </font><font style="font-family:inherit;font-size:11pt;">six</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;"> was as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Cash paid for amounts included in the measurement of operating lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">889</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">ROU assets obtained in exchange for operating lease obligations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">341</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following table presents the weighted average remaining lease term and weighted average discount rate related to the Company's operating leases as of </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;">: </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Weighted average remaining lease term</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.2 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Weighted average discount rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.45</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">%</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following table presents the maturity of the Company's operating lease liabilities as of </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;"> (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Remainder of 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,052</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,605</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,429</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,321</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,766</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total operating lease payments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,173</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Less: imputed interest</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">669</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total operating lease liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">6,504</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Lessor Accounting</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In our CCA segment, primarily related to our Point of Care laboratory products, the Company enters into sales-type leases as part of our subscription agreements. The following table presents the maturity of the Company's undiscounted lease receivables as of </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;"> (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Year Ending December 31,</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Remainder of 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,614</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,596</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,574</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,223</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2,431</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,974</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">16,412</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following table presents the maturity of the Company's undiscounted lease receivables as of </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;"> (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Year Ending December 31,</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Remainder of 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,614</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,596</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,574</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,223</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2,431</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,974</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">16,412</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Adoption of New Accounting Pronouncements</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Effective January 1, 2019, we adopted&#160;ASU 2018-07,&#160;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Compensation &#8211; Stock Compensation (Topic 718)</font><font style="font-family:inherit;font-size:11pt;">, </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Improvements to Non-employee Share-Based Payment Accounting</font><font style="font-family:inherit;font-size:11pt;">.&#160;This ASU is intended to simplify aspects of share-based compensation issued to non-employees by making the guidance consistent with accounting for employee share-based compensation. Guidance related to the stock compensation granted to employees is followed for non-employees, including the measurement date, valuation approach and performance conditions. The expense is recognized in the same period as though cash were paid for the good or service, ratably over the service period. The adoption of this ASU did not have an impact on our consolidated financial statements but did have a minimal impact on our related disclosures.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Effective January 1, 2019, we adopted ASU 2018-02, </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Income Statement-Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income</font><font style="font-family:inherit;font-size:11pt;">. The ASU permits companies to elect a reclassification of the disproportionate tax effects in accumulated other comprehensive income ("AOCI") caused by the Tax Cuts and Jobs Act of 2017 to retained earnings. As of </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;">, the Company does not have any disproportionate income tax effects in AOCI to reclassify. However, if the Company did have disproportionate income tax effects in AOCI in the future, it would reclassify them to retained earnings.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In February 2016, the FASB issued ASU 2016-02, </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Leases (</font><font style="font-family:inherit;font-size:11pt;">Topic 842</font><font style="font-family:inherit;font-size:11pt;font-style:italic;">)</font><font style="font-family:inherit;font-size:11pt;">, which supersedes ASC 840, </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Leases</font><font style="font-family:inherit;font-size:11pt;">. This update requires lessees to recognize a right-of-use (&#8220;ROU&#8221;) asset and a lease liability for all leases, including operating leases, with terms greater than 12 months on its balance sheet. The update also expands the required quantitative and qualitative disclosures by lessees and lessors about the amount, timing and uncertainty of cash flows arising from leases. The accounting for lessors does not fundamentally change except for changes to conform and align guidance to the lessee guidance as well as to the new revenue recognition guidance in ASU 2014-09, </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Revenue from Contracts with Customers (Topic 606)</font><font style="font-family:inherit;font-size:11pt;">. Subsequent to the issuance of Topic 842, the FASB clarified the guidance through several ASUs; hereinafter the collection of lease guidance is referred to as &#8220;ASC 842&#8221;.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The Company adopted ASC 842 on January 1, 2019, using the modified retrospective approach for all lease arrangements at the beginning of the period of adoption. Results for reporting periods beginning January 1, 2019 are presented under ASC 842, while prior period amounts were not adjusted and continue to be reported in accordance with the Company&#8217;s historic accounting under ASC 840, </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Leases</font><font style="font-family:inherit;font-size:11pt;">. For leases that commenced before the effective date of ASC 842, the Company elected the permitted practical expedients to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. The Company also elected to exclude leases with a term of 12 months or less from the recognized ROU assets and lease liabilities.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Adoption of the standard did not have a material net impact in our Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Income or Condensed Consolidated Statements of Cash Flows. The most significant impact was the recognition of ROU assets and lease liabilities for the operating leases, of which we are the lessee. As a result of the cumulative impact of adopting ASC 842, the Company recorded operating lease ROU assets of </font><font style="font-family:inherit;font-size:11pt;">$6.5 million</font><font style="font-family:inherit;font-size:11pt;"> and operating lease liabilities of </font><font style="font-family:inherit;font-size:11pt;">$6.9 million</font><font style="font-family:inherit;font-size:11pt;"> as of January 1, 2019, primarily related to building, vehicle, and office equipment leases, based on the present value of the future lease payments on the date of adoption. As a lessor, accounting for our subscription agreements will remain substantially unchanged. Refer to Note 6 for additional disclosures required by ASC 842. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The Company determines if an arrangement is a lease at inception based on whether control of an identified asset is transferred. For leases where the Company is the lessee, ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As most of the Company&#8217;s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as amortization expense and interest expense. The Company has lease agreements which require payments for lease and non-lease components and has elected to account for these as a single lease component for our building and office equipment leases, but as separate components for our vehicle leases. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Our revenue under subscription agreements relates to both operating-type lease (&#8220;OTL&#8221;) arrangements and sales-type lease (&#8220;STL&#8221;) arrangements. Determination of an OTL or STL is primarily determined as a result of the length of the contract as compared to the estimated useful life of the instrument, among other factors. A STL results in earlier recognition of instrument revenue. The cost of the customer-leased instruments is removed from inventory and recognized in the Consolidated Statements of Income. There is no residual value taken into consideration as it does not meet our capitalization requirements. Instrument lease revenue for OTL agreements is recognized on a straight-line basis over the life of the lease and included with the predominant non-lease components in consumable revenue. The costs of customer-leased instruments are recorded within property and equipment in the accompanying Consolidated Balance Sheets and depreciated over the instrument&#8217;s estimated useful life. The depreciation expense is reflected in cost of revenue in the accompanying Consolidated Statements of Income. The OTLs and STLs are not cancellable until after an initial term and include an option to renew. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">For lease arrangements with lease and non-lease components where the Company is the lessor, the Company allocates the total contract consideration to the lease and non-lease components on a relative standalone selling price basis using the Company&#8217;s best estimate of the standalone selling price of each distinct product or service in the contract. The primary method used to estimate standalone selling price is the price observed in standalone sales to customers of a prior period. Changes in these values can impact the amount of consideration allocated to each component of the contract. When prices in standalone sales are not available, we may use a cost-plus margin approach. Allocation of the transaction price is determined at the inception of the lease arrangement. The Company&#8217;s leases consist of leases with fixed and variable lease payments. For those leases with variable lease payments, the variable lease payment is typically based upon purchase of consumables used with the leased instruments and included in consumable revenue.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Accounting Pronouncements Not Yet Adopted</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In June 2016, the FASB issued ASU&#160;2016-13,</font><font style="font-family:inherit;font-size:11pt;font-style:italic;">&#160;Financial Instruments - Credit Losses (Topic 326)</font><font style="font-family:inherit;font-size:11pt;">, which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected. The income statement reflects the measurement of credit losses for newly recognized financial assets, as well as the increases or decreases of expected credit losses that have taken place during the period. The measurement of expected credit losses is based upon historical experience, current conditions and reasonable and supportable forecasts that affect the collectability of the reported amount. Subsequent to the issuance of ASU 2016-13, the FASB issued ASU 2018-19,</font><font style="font-family:inherit;font-size:11pt;font-style:italic;"> Codification Improvements to Topic 326, Financial Instruments - Credit Losses</font><font style="font-family:inherit;font-size:11pt;">, in November 2018</font><font style="font-family:inherit;font-size:11pt;font-style:italic;">.</font><font style="font-family:inherit;font-size:11pt;"> This ASU clarifies that receivables from operating leases are accounted for using the lease guidance and not as financial instruments. In April 2019, the FASB issued ASU&#160;2019-04,&#160;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Codification Improvements to Topic 326, Financial Instruments - Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments</font><font style="font-family:inherit;font-size:11pt;">, which further clarifies and improves guidance related to accounting for credit losses. In May 2019, the FASB issued ASU&#160;2019-05,&#160;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Financial Instruments - Credit Losses (Topic 326)</font><font style="font-family:inherit;font-size:11pt;">. This ASU provides relief to certain entities adopting ASU 2016-13. The amendment provides entities with an option to irrevocably elect the fair value option for certain financial assets. These amendments are</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:11pt;">effective for fiscal years beginning after December 15, 2019 and interim periods within those annual periods. We are currently evaluating the amended guidance and the impact on our consolidated financial statements and will adopt the provisions in the first quarter of 2020.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">LEASES</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;background-color:#ffffff;font-style:italic;">Lessee Accounting </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;background-color:#ffffff;">The Company leases buildings, office equipment, and vehicles.</font><font style="font-family:inherit;font-size:11pt;"> </font><font style="font-family:inherit;font-size:11pt;">The Company&#8217;s finance leases were not material as of&#160;</font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;">&#160;and for the </font><font style="font-family:inherit;font-size:11pt;">three and six</font><font style="font-family:inherit;font-size:11pt;"> month period then ended. ROU assets arising from finance leases are included in Property and equipment, net in the accompanying Condensed Consolidated Balance Sheets. The current portion of the finance lease liabilities are included in Current portion of deferred revenue, and other and the non-current portion of the finance lease liabilities are included in Other liabilities in the accompanying Condensed Consolidated Balance Sheets. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">For the </font><font style="font-family:inherit;font-size:11pt;">three and six</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;">, operating lease expense was </font><font style="font-family:inherit;font-size:11pt;">$0.6 million</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">$1.1 million</font><font style="font-family:inherit;font-size:11pt;">, respectively, including immaterial variable lease costs. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Supplemental cash flow information related to the Company's operating leases for the </font><font style="font-family:inherit;font-size:11pt;">six</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;"> was as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Cash paid for amounts included in the measurement of operating lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">889</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">ROU assets obtained in exchange for operating lease obligations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">341</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following table presents the weighted average remaining lease term and weighted average discount rate related to the Company's operating leases as of </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;">: </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Weighted average remaining lease term</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.2 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Weighted average discount rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.45</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">%</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following table presents the maturity of the Company's operating lease liabilities as of </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;"> (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Remainder of 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,052</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,605</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,429</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,321</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,766</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total operating lease payments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,173</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Less: imputed interest</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">669</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total operating lease liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">6,504</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Lessor Accounting</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In our CCA segment, primarily related to our Point of Care laboratory products, the Company enters into sales-type leases as part of our subscription agreements. The following table presents the maturity of the Company's undiscounted lease receivables as of </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;"> (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Year Ending December 31,</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Remainder of 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,614</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,596</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,574</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,223</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2,431</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,974</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">16,412</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">To maintain consistency and comparability, certain amounts in the financial statements have been reclassified to conform to current year presentation.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">PROPERTY AND EQUIPMENT, NET</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Property and equipment, net, consisted of the following (in thousands):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Land</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">377</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">377</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Building</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2,978</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2,978</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Machinery and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">31,013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">33,087</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Office furniture and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,700</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,687</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Computer hardware and software</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4,749</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4,704</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Leasehold and building improvements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">9,981</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">9,953</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Construction in progress</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,309</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,274</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">52,107</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">54,060</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Less accumulated depreciation </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(36,789</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(38,079</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total property and equipment, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">15,318</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">15,981</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Depreciation expense was </font><font style="font-family:inherit;font-size:11pt;">$0.9 million</font><font style="font-family:inherit;font-size:11pt;"> and $</font><font style="font-family:inherit;font-size:11pt;">1.0 million</font><font style="font-family:inherit;font-size:11pt;"> for </font><font style="font-family:inherit;font-size:11pt;">the three months ended June 30, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;">, respectively, and </font><font style="font-family:inherit;font-size:11pt;">$1.9 million</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">$2.1 million</font><font style="font-family:inherit;font-size:11pt;"> for </font><font style="font-family:inherit;font-size:11pt;">the six months ended June 30, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;">, respectively.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The Company has subscription agreements whereby its instruments in inventory may be placed at a customer's location on a rental basis. The cost of these instruments is transferred to machinery and equipment and depreciated, typically over a </font><font style="font-family:inherit;font-size:11pt;">5</font><font style="font-family:inherit;font-size:11pt;"> to </font><font style="font-family:inherit;font-size:11pt;">7</font><font style="font-family:inherit;font-size:11pt;"> year period depending on the circumstance under which the instrument is placed with the customer. Our cost of instruments under operating leases as of </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:11pt;">, was&#160;</font><font style="font-family:inherit;font-size:11pt;">$10.3 million</font><font style="font-family:inherit;font-size:11pt;">&#160;and&#160;</font><font style="font-family:inherit;font-size:11pt;">$10.8 million</font><font style="font-family:inherit;font-size:11pt;">, respectively, before accumulated depreciation of&#160;</font><font style="font-family:inherit;font-size:11pt;">$5.7 million</font><font style="font-family:inherit;font-size:11pt;">&#160;and&#160;</font><font style="font-family:inherit;font-size:11pt;">$6.1 million</font><font style="font-family:inherit;font-size:11pt;">, respectively.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Property and equipment, net, consisted of the following (in thousands):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Land</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">377</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">377</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Building</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2,978</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2,978</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Machinery and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">31,013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">33,087</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Office furniture and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,700</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,687</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Computer hardware and software</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4,749</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4,704</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Leasehold and building improvements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">9,981</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">9,953</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Construction in progress</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,309</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,274</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">52,107</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">54,060</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Less accumulated depreciation </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(36,789</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(38,079</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total property and equipment, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">15,318</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">15,981</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Summarized financial information concerning the Company's reportable segments is shown in the following tables (in thousands):</font></div><div style="line-height:120%;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Core Companion Animal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Vaccines and Pharmaceuticals</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;<br clear="none"/>&#160;<br clear="none"/>Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,716</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,430</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,146</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(254</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(312</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(566</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss before income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(275</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(312</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(587</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital expenditures</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">363</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">395</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">934</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">323</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,257</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended June 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Core Companion Animal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Vaccines and Pharmaceuticals</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;<br clear="none"/>&#160;<br clear="none"/>Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,644</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,662</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating (loss) income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,864</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(660</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,204</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Loss) income before income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,772</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(660</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,112</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital expenditures</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">397</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">436</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">838</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">300</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,138</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Six Months Ended June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Core Companion Animal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Vaccines and Pharmaceuticals</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;<br clear="none"/>&#160;<br clear="none"/>Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,432</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,225</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57,657</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(305</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(336</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(641</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss before income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(310</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(336</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(646</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital expenditures</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">553</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">629</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,881</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">641</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,522</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Six Months Ended June 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Core Companion Animal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Vaccines and Pharmaceuticals</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;<br clear="none"/>&#160;<br clear="none"/>Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53,463</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,964</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62,427</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating (loss) income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,787</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(712</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,075</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Loss) income before income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,699</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(712</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,987</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital expenditures</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">715</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">811</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,746</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">587</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,333</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">REVENUE</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">We separate our goods and services among:</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Point of Care laboratory products including instruments, consumables and services;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Point of Care imaging products including instruments, software and services;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Single use pharmaceuticals, vaccines and diagnostic tests primarily related to companion animals; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Other vaccines and pharmaceuticals ("OVP").</font></div></td></tr></table><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following table summarizes our Core Companion Animal ("CCA") revenue (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Point of Care laboratory revenue:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">16,120</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">15,053</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">32,081</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">28,693</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Consumables</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">13,208</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">11,524</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">25,524</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">22,344</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Sales-type leases</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">1,493</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">1,793</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">3,234</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">3,331</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Outright instrument sales</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">1,045</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">1,335</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">2,575</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">2,146</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">374</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">401</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">748</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">872</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Point of Care imaging revenue:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5,229</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4,462</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">10,639</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">10,434</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Outright instrument sales</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">4,405</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">3,566</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">8,951</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">8,705</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Service revenue</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">558</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">544</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">1,120</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">1,099</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Operating type leases and other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">266</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">352</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">568</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">630</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Other CCA revenue:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,367</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,129</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">6,712</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">14,336</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Other pharmaceuticals, vaccines and diagnostic tests</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">3,281</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">6,991</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">6,527</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">14,102</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;Research and development, license and royalty</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;revenue</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">86</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">138</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">185</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">234</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total CCA revenue</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">24,716</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">26,644</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">49,432</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">53,463</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Revenue from our OVP segment consists of revenue generated from contract manufacturing agreements and from other license, research and development revenue. The following table summarizes our OVP revenue (in thousands): </font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.79423868312757%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Contract manufacturing</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,327</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2,887</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,994</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8,678</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">License, research and development</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">103</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">131</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">231</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">286</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total OVP revenue</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,430</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8,225</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8,964</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Remaining Performance Obligations</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Remaining performance obligations represent the aggregate transaction price allocated to performance obligations with an original contract term greater than one year which are fully or partially unsatisfied at the end of the period. Remaining performance obligations include noncancelable purchase orders, the non-lease portion of minimum purchase commitments under long-term supply arrangements, extended warranty, service and other long-term contracts. Remaining performance obligations do not include revenue from contracts with customers with an original term of one year or less, revenue from long-term supply arrangements with no minimum purchase requirements, revenue expected from purchases made in excess of the minimum purchase requirements, or revenue from instruments leased to customers. While the remaining performance obligation disclosure is similar in concept to backlog, the definition of remaining performance obligations excludes leases and contracts that provide the customer with the right to cancel or terminate for convenience with no substantial penalty, even if historical experience indicates the likelihood of cancellation or termination is remote. Additionally, the Company has elected to exclude contracts with customers with an original term of one year or less from remaining performance obligations.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">As of&#160;</font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;">, the aggregate amount of the transaction price allocated to remaining minimum performance obligations was approximately&#160;</font><font style="font-family:inherit;font-size:11pt;">$89.5 million</font><font style="font-family:inherit;font-size:11pt;">. As of </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;">, the Company expects to recognize revenue as follows (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ending December 31,</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenue</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019 (remaining)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,289</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,138</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,315</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,244</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,848</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,641</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89,475</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Contract Balances</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets) and deferred revenue, and customer deposits and billings in excess of revenue recognized (contract liabilities) on the Condensed Consolidated Balance Sheets. In addition, the Company defers certain costs incurred to obtain contracts (contract costs).</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Contract Receivables</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Certain unbilled receivable balances related to long-term contracts for which we provide a free term to the customer where revenue has been recognized are recorded in other current and other non-current assets. We have no further performance obligations related to these receivable balances and the collection of these balances occurs over the term of the underlying contract. The balances as of </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;"> were </font><font style="font-family:inherit;font-size:11pt;">$1.0 million</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">$3.5 million</font><font style="font-family:inherit;font-size:11pt;"> for current and non-current assets, respectively, shown net of related unearned interest. The balances as of </font><font style="font-family:inherit;font-size:11pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:11pt;"> were </font><font style="font-family:inherit;font-size:11pt;">$0.9 million</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">$3.3 million</font><font style="font-family:inherit;font-size:11pt;"> for current and non-current assets, respectively, shown net of related unearned interest. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Contract Liabilities</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The Company receives cash payments from customers for licensing fees or other arrangements that extend for a specified term. These contract liabilities are classified as either current or long-term in the Condensed Consolidated Balance Sheets based on the timing of when the Company expects to recognize revenue. As of&#160;</font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;">&#160;and </font><font style="font-family:inherit;font-size:11pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:11pt;">, contract liabilities were&#160;</font><font style="font-family:inherit;font-size:11pt;">$8.9 million</font><font style="font-family:inherit;font-size:11pt;">&#160;and&#160;</font><font style="font-family:inherit;font-size:11pt;">$9.6 million</font><font style="font-family:inherit;font-size:11pt;">, respectively, and are included within "Current portion of deferred revenue, and other" and "Deferred revenue, net of current portion" in the accompanying Condensed Consolidated Balance Sheets. The&#160;decrease&#160;in the contract liability balance during the </font><font style="font-family:inherit;font-size:11pt;">six</font><font style="font-family:inherit;font-size:11pt;">-month period ended&#160;</font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;">&#160;is approximately </font><font style="font-family:inherit;font-size:11pt;">$1.5 million</font><font style="font-family:inherit;font-size:11pt;"> of revenue recognized during the period, offset by approximately </font><font style="font-family:inherit;font-size:11pt;">$0.7 million</font><font style="font-family:inherit;font-size:11pt;"> of additional deferred sales in </font><font style="font-family:inherit;font-size:11pt;">2019</font><font style="font-family:inherit;font-size:11pt;">. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Contract Costs</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The Company capitalizes certain direct incremental costs incurred to obtain customer contracts, typically sales-related commissions, where the recognition period for the related revenue is greater than one year. Contract costs are classified as current or non-current, and are included in "Other current assets" and "Other non-current assets" in the Condensed Consolidated Balance Sheets based on the timing of when the Company expects to recognize the expense. Contract costs are generally amortized into selling and marketing expense with a certain percentage recognized immediately based upon placement of the instrument with the remainder recognized on a straight-line basis (which is consistent with the transfer of control for the related goods or services) over the average term of the underlying contracts, approximately </font><font style="font-family:inherit;font-size:11pt;">6</font><font style="font-family:inherit;font-size:11pt;"> years. Management assesses these costs for impairment at least quarterly on a portfolio basis and as &#8220;triggering&#8221; events occur that indicate it is more-likely-than-not that an impairment exists. The balance of contract costs as of&#160;</font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;">&#160;and </font><font style="font-family:inherit;font-size:11pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:11pt;"> was </font><font style="font-family:inherit;font-size:11pt;">$2.6 million</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">$2.5 million</font><font style="font-family:inherit;font-size:11pt;">, respectively. Amortization expense for the </font><font style="font-family:inherit;font-size:11pt;">six</font><font style="font-family:inherit;font-size:11pt;">-month period ended&#160;</font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;"> was approximately </font><font style="font-family:inherit;font-size:11pt;">$0.5 million</font><font style="font-family:inherit;font-size:11pt;">, offset by approximately </font><font style="font-family:inherit;font-size:11pt;">$0.6 million</font><font style="font-family:inherit;font-size:11pt;"> of additional contract costs capitalized. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Contract liabilities are reported on the accompanying Condensed Consolidated Balance Sheets on a contract-by-contract basis whereas contract costs are calculated and reported on a portfolio basis.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">As of </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;">, the Company expects to recognize revenue as follows (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ending December 31,</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenue</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019 (remaining)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,289</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,138</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,315</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,244</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,848</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,641</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89,475</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Accrued liabilities consisted of the following (in thousands):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">June&#160;30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">December&#160;31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Accrued settlement (see Note 14)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">6,750</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Accrued payroll and employee benefits</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,118</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">759</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Accrued property taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">402</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">632</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2,235</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2,001</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total accrued liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,755</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">10,142</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Accumulated other comprehensive income (loss) consisted of the following (in thousands):</font></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Minimum Pension Liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Foreign Currency Translation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Accumulated Other Comprehensive Income</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balances at December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(419</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">696</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">277</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current period other comprehensive income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balances at June 30, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(419</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">717</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">298</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following stock options and restricted shares were excluded from the computation of diluted EPS because they would have been anti-dilutive (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;padding-left:12px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;padding-left:12px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Stock options and restricted shares</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">714</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">169</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">225</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">238</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Our total income tax (benefit) expense for our (loss) income before income taxes were as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;padding-left:12px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;padding-left:12px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(Loss) income before income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(587</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2,112</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(646</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,987</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total income tax (benefit) expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(426</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">215</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(1,436</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(65</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;">The </font><font style="font-family:inherit;font-size:11pt;">following is a reconciliation of the weighted-average shares outstanding used in the calculation of basic and diluted EPS for the </font><font style="font-family:inherit;font-size:11pt;">three and six</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;"> (in thousands, except per share data):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Net (loss) income attributable to Heska Corporation</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(241</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,897</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">573</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4,052</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Basic weighted-average common shares outstanding</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,486</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,226</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,463</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,146</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Assumed exercise of dilutive stock options and restricted shares</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">624</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">493</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">635</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Diluted weighted-average common shares outstanding</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,486</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,850</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,956</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,781</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Basic (loss) earnings per share attributable to Heska Corporation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(0.03</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0.26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0.08</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0.57</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Diluted (loss) earnings per share attributable to Heska Corporation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(0.03</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0.24</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0.07</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0.52</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Other intangibles consisted of the following (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;padding-left:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;padding-left:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross Carrying Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated Amortization</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net Carrying Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross Carrying Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated Amortization</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net Carrying Amount</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Developed technology</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8,200</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(410</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7,790</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8,200</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8,200</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Customer relationships and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,700</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(1,964</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,736</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,303</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(1,739</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,564</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">11,900</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(2,374</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">9,526</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">11,503</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(1,739</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">9,764</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following summarizes the change in goodwill during </font><font style="font-family:inherit;font-size:11pt;">the six months ended June 30, 2019</font><font style="font-family:inherit;font-size:11pt;"> (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:82%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Carrying amount, December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">26,679</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Goodwill attributable to acquisitions (subject to change)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">503</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Foreign currency adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Carrying amount, June 30, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">27,190</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Inventories, net, consisted of the following (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Raw materials</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">16,832</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">15,000</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Work in process</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,807</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,592</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">9,548</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8,085</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Allowance for excess or obsolete inventory</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(1,210</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(1,573</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Total inventory, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">28,977</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">25,104</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Asset information by reportable segment as of </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;"> is as follows (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Core Companion Animal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Vaccines and Pharmaceuticals</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments in unconsolidated affiliates</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,711</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,711</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">139,036</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,808</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162,844</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">103,455</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,797</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">123,252</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Asset information by reportable segment as of </font><font style="font-family:inherit;font-size:11pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:11pt;"> is as follows (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Core Companion Animal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Vaccines and Pharmaceuticals</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments in unconsolidated affiliates</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">133,586</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,866</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">156,452</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96,129</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,280</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">122,409</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following table summarizes information about stock options outstanding and exercisable at </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;">:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:25%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Options Outstanding</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Options Exercisable</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exercise Prices</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of<br clear="none"/>Options<br clear="none"/>Outstanding<br clear="none"/>at<br clear="none"/>June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Remaining</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contractual</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Life in Years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exercise</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of<br clear="none"/>Options<br clear="none"/>Exercisable<br clear="none"/>at<br clear="none"/>June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exercise</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Price</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$ 4.96 - $ 7.36</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93,352</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.65</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.998</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93,352</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.998</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$ 7.37 - $ 32.21</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79,273</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.79</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.897</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,941</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.828</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$ 32.22 - $ 62.50</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57,533</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.57</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39.797</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46,524</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39.724</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$ 62.51 - $ 69.77</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">130,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.68</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69.770</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,337</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69.770</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$ 69.78 - $ 108.25</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121,511</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">84.684</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,298</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80.960</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$ 4.96 - $ 108.25</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">481,669</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.67</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.920</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">305,452</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33.655</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">A summary of our stock option plans is as follows:</font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Six Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="padding-bottom:28px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#160;<br clear="none"/>&#160;<br clear="none"/>&#160;<br clear="none"/>Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Weighted Average Exercise Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="padding-bottom:28px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#160;<br clear="none"/>&#160;<br clear="none"/>&#160;<br clear="none"/>Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Weighted Average Exercise Price</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at beginning of period</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">620,553</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40.741</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">630,847</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.312</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted at market</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,200</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.193</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">153,700</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75.244</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(256</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">98.660</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18,978</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53.010</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expired</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(896</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65.414</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(149,828</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.776</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(144,120</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.740</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">481,669</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.920</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">620,553</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40.741</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercisable at end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">305,452</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33.655</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">386,176</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.214</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The following table summarizes restricted stock transactions for </font><font style="font-family:inherit;font-size:11pt;">the six months ended June 30, 2019</font><font style="font-family:inherit;font-size:11pt;">:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:65%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RSAs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted-Average Grant Date Fair Value Per Award</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested as of December 31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">259,430</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74.26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,567</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71.38</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Vested</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,230</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85.09</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Forfeited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(500</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80.90</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested as of June 30, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">273,267</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.90</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions for options granted in the </font><font style="font-family:inherit;font-size:11pt;">three and six</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">June 30,</font><font style="font-family:inherit;font-size:11pt;"> </font><font style="font-family:inherit;font-size:11pt;">2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;">.</font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;padding-left:24px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;padding-left:24px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Risk-free interest rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1.89%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2.76%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1.95%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2.64%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Expected lives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.7 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.9 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.7 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.9 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Expected volatility</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">40%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">40%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">40%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">40%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Expected dividend yield</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">0%</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Estimated amortization expense related to intangibles for each of the five years from 2019 (remaining) through 2023 and thereafter is as follows (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:87%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Year Ending December 31,</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2019 (remaining)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">666</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,287</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,283</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1,265</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">918</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4,107</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">9,526</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">SEGMENT REPORTING</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The Company is composed of </font><font style="font-family:inherit;font-size:11pt;">two</font><font style="font-family:inherit;font-size:11pt;"> reportable segments: CCA and OVP. The CCA segment includes Point of Care diagnostic laboratory instruments and consumables, and Point of Care digital imaging diagnostic instruments and software services as well as single use diagnostic and other tests, pharmaceuticals and vaccines, primarily for canine and feline use. These products are sold directly by the Company as well as through independent third-party distributors and through other distribution relationships. CCA segment products manufactured at the Des Moines, Iowa production facility included in the OVP segment's assets are transferred at cost and are not recorded as revenue for the OVP segment. The OVP segment includes private label vaccine and pharmaceutical production, primarily for cattle, but also for other animals including small mammals. All OVP products are sold by third parties under third-party labels.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Summarized financial information concerning the Company's reportable segments is shown in the following tables (in thousands):</font></div><div style="line-height:120%;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Core Companion Animal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Vaccines and Pharmaceuticals</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;<br clear="none"/>&#160;<br clear="none"/>Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,716</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,430</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,146</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(254</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(312</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(566</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss before income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(275</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(312</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(587</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital expenditures</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">363</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">395</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">934</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">323</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,257</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended June 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Core Companion Animal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Vaccines and Pharmaceuticals</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;<br clear="none"/>&#160;<br clear="none"/>Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,644</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,662</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating (loss) income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,864</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(660</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,204</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Loss) income before income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,772</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(660</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,112</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital expenditures</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">397</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">436</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">838</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">300</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,138</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Six Months Ended June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Core Companion Animal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Vaccines and Pharmaceuticals</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;<br clear="none"/>&#160;<br clear="none"/>Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,432</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,225</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57,657</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(305</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(336</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(641</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss before income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(310</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(336</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(646</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital expenditures</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">553</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">629</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,881</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">641</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,522</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Six Months Ended June 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Core Companion Animal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Vaccines and Pharmaceuticals</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;<br clear="none"/>&#160;<br clear="none"/>Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53,463</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,964</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62,427</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating (loss) income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,787</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(712</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,075</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Loss) income before income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,699</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(712</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,987</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital expenditures</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">715</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">811</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,746</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">587</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,333</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Asset information by reportable segment as of </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;"> is as follows (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Core Companion Animal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Vaccines and Pharmaceuticals</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments in unconsolidated affiliates</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,711</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,711</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">139,036</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,808</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162,844</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">103,455</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,797</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">123,252</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Asset information by reportable segment as of </font><font style="font-family:inherit;font-size:11pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:11pt;"> is as follows (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Core Companion Animal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Vaccines and Pharmaceuticals</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments in unconsolidated affiliates</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">133,586</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,866</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">156,452</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96,129</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,280</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">122,409</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Heska Corporation and its wholly-owned subsidiaries ("Heska", the "Company", "we" or "our") sell veterinary and animal health diagnostic and specialty products. Our offerings include Point of Care diagnostic laboratory instruments and supplies; digital imaging diagnostic products, software and services; vaccines; local and cloud-based data services; allergy testing and immunotherapy; and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. Our core focus is on supporting veterinarians in the canine and feline healthcare space.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Basis of Presentation and Consolidation</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In the opinion of management, the accompanying unaudited Condensed Consolidated Financial Statements contain all adjustments, consisting of normal, recurring adjustments, necessary to present fairly the financial position of the Company as of </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:11pt;">, the results of our operations and statements of stockholders' equity for the </font><font style="font-family:inherit;font-size:11pt;">three and six</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;">, and cash flows for the </font><font style="font-family:inherit;font-size:11pt;">six</font><font style="font-family:inherit;font-size:11pt;"> months ended </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;"> and </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;">.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The unaudited Condensed Consolidated Financial Statements included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") have been condensed or omitted pursuant to such rules and regulations. Our unaudited Condensed Consolidated Financial Statements include our accounts and the accounts of our wholly-owned subsidiaries since their respective dates of acquisitions. All intercompany accounts and transactions have been eliminated in consolidation. Where our ownership of a subsidiary is less than 100%, the non-controlling interest is reported on our Condensed Consolidated Balance Sheets. The non-controlling interest in our consolidated net income is reported as "Net loss attributable to redeemable non-controlling interest" on our Condensed Consolidated Statements of Income. These unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in our Annual Report on Form&#160;10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:11pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:11pt;"> and other financial information filed with the SEC.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Reclassification</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">To maintain consistency and comparability, certain amounts in the financial statements have been reclassified to conform to current year presentation.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Use of Estimates</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates are required when establishing the allowance for doubtful accounts and the net realizable value of inventory; determining future costs associated with warranties provided; determining the period over which our obligations are fulfilled under agreements to license product rights and/or technology rights; evaluating long-lived and intangible assets and investments for estimated useful lives and impairment; estimating the useful lives of instruments under leasing arrangements; determining the allocation of purchase price under purchase accounting; estimating the expense associated with the granting of stock; determining the need for, and the amount of a valuation allowance on deferred tax assets; and determining the value of the non-controlling interest in a business combination.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Critical Accounting Policies</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Our accounting policies are described in our audited Consolidated Financial Statements and Notes thereto contained in our Annual Report on Form 10-K for the year ended December&#160;31, </font><font style="font-family:inherit;font-size:11pt;">2018</font><font style="font-family:inherit;font-size:11pt;"> and other than the recently adopted accounting pronouncements described below, have not changed significantly since such filing.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Adoption of New Accounting Pronouncements</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Effective January 1, 2019, we adopted&#160;ASU 2018-07,&#160;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Compensation &#8211; Stock Compensation (Topic 718)</font><font style="font-family:inherit;font-size:11pt;">, </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Improvements to Non-employee Share-Based Payment Accounting</font><font style="font-family:inherit;font-size:11pt;">.&#160;This ASU is intended to simplify aspects of share-based compensation issued to non-employees by making the guidance consistent with accounting for employee share-based compensation. Guidance related to the stock compensation granted to employees is followed for non-employees, including the measurement date, valuation approach and performance conditions. The expense is recognized in the same period as though cash were paid for the good or service, ratably over the service period. The adoption of this ASU did not have an impact on our consolidated financial statements but did have a minimal impact on our related disclosures.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Effective January 1, 2019, we adopted ASU 2018-02, </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Income Statement-Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income</font><font style="font-family:inherit;font-size:11pt;">. The ASU permits companies to elect a reclassification of the disproportionate tax effects in accumulated other comprehensive income ("AOCI") caused by the Tax Cuts and Jobs Act of 2017 to retained earnings. As of </font><font style="font-family:inherit;font-size:11pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:11pt;">, the Company does not have any disproportionate income tax effects in AOCI to reclassify. However, if the Company did have disproportionate income tax effects in AOCI in the future, it would reclassify them to retained earnings.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In February 2016, the FASB issued ASU 2016-02, </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Leases (</font><font style="font-family:inherit;font-size:11pt;">Topic 842</font><font style="font-family:inherit;font-size:11pt;font-style:italic;">)</font><font style="font-family:inherit;font-size:11pt;">, which supersedes ASC 840, </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Leases</font><font style="font-family:inherit;font-size:11pt;">. This update requires lessees to recognize a right-of-use (&#8220;ROU&#8221;) asset and a lease liability for all leases, including operating leases, with terms greater than 12 months on its balance sheet. The update also expands the required quantitative and qualitative disclosures by lessees and lessors about the amount, timing and uncertainty of cash flows arising from leases. The accounting for lessors does not fundamentally change except for changes to conform and align guidance to the lessee guidance as well as to the new revenue recognition guidance in ASU 2014-09, </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Revenue from Contracts with Customers (Topic 606)</font><font style="font-family:inherit;font-size:11pt;">. Subsequent to the issuance of Topic 842, the FASB clarified the guidance through several ASUs; hereinafter the collection of lease guidance is referred to as &#8220;ASC 842&#8221;.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The Company adopted ASC 842 on January 1, 2019, using the modified retrospective approach for all lease arrangements at the beginning of the period of adoption. Results for reporting periods beginning January 1, 2019 are presented under ASC 842, while prior period amounts were not adjusted and continue to be reported in accordance with the Company&#8217;s historic accounting under ASC 840, </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Leases</font><font style="font-family:inherit;font-size:11pt;">. For leases that commenced before the effective date of ASC 842, the Company elected the permitted practical expedients to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. The Company also elected to exclude leases with a term of 12 months or less from the recognized ROU assets and lease liabilities.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Adoption of the standard did not have a material net impact in our Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Income or Condensed Consolidated Statements of Cash Flows. The most significant impact was the recognition of ROU assets and lease liabilities for the operating leases, of which we are the lessee. As a result of the cumulative impact of adopting ASC 842, the Company recorded operating lease ROU assets of </font><font style="font-family:inherit;font-size:11pt;">$6.5 million</font><font style="font-family:inherit;font-size:11pt;"> and operating lease liabilities of </font><font style="font-family:inherit;font-size:11pt;">$6.9 million</font><font style="font-family:inherit;font-size:11pt;"> as of January 1, 2019, primarily related to building, vehicle, and office equipment leases, based on the present value of the future lease payments on the date of adoption. As a lessor, accounting for our subscription agreements will remain substantially unchanged. Refer to Note 6 for additional disclosures required by ASC 842. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The Company determines if an arrangement is a lease at inception based on whether control of an identified asset is transferred. For leases where the Company is the lessee, ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As most of the Company&#8217;s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as amortization expense and interest expense. The Company has lease agreements which require payments for lease and non-lease components and has elected to account for these as a single lease component for our building and office equipment leases, but as separate components for our vehicle leases. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Our revenue under subscription agreements relates to both operating-type lease (&#8220;OTL&#8221;) arrangements and sales-type lease (&#8220;STL&#8221;) arrangements. Determination of an OTL or STL is primarily determined as a result of the length of the contract as compared to the estimated useful life of the instrument, among other factors. A STL results in earlier recognition of instrument revenue. The cost of the customer-leased instruments is removed from inventory and recognized in the Consolidated Statements of Income. There is no residual value taken into consideration as it does not meet our capitalization requirements. Instrument lease revenue for OTL agreements is recognized on a straight-line basis over the life of the lease and included with the predominant non-lease components in consumable revenue. The costs of customer-leased instruments are recorded within property and equipment in the accompanying Consolidated Balance Sheets and depreciated over the instrument&#8217;s estimated useful life. The depreciation expense is reflected in cost of revenue in the accompanying Consolidated Statements of Income. The OTLs and STLs are not cancellable until after an initial term and include an option to renew. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">For lease arrangements with lease and non-lease components where the Company is the lessor, the Company allocates the total contract consideration to the lease and non-lease components on a relative standalone selling price basis using the Company&#8217;s best estimate of the standalone selling price of each distinct product or service in the contract. The primary method used to estimate standalone selling price is the price observed in standalone sales to customers of a prior period. Changes in these values can impact the amount of consideration allocated to each component of the contract. When prices in standalone sales are not available, we may use a cost-plus margin approach. Allocation of the transaction price is determined at the inception of the lease arrangement. The Company&#8217;s leases consist of leases with fixed and variable lease payments. For those leases with variable lease payments, the variable lease payment is typically based upon purchase of consumables used with the leased instruments and included in consumable revenue.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Accounting Pronouncements Not Yet Adopted</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In June 2016, the FASB issued ASU&#160;2016-13,</font><font style="font-family:inherit;font-size:11pt;font-style:italic;">&#160;Financial Instruments - Credit Losses (Topic 326)</font><font style="font-family:inherit;font-size:11pt;">, which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected. The income statement reflects the measurement of credit losses for newly recognized financial assets, as well as the increases or decreases of expected credit losses that have taken place during the period. The measurement of expected credit losses is based upon historical experience, current conditions and reasonable and supportable forecasts that affect the collectability of the reported amount. Subsequent to the issuance of ASU 2016-13, the FASB issued ASU 2018-19,</font><font style="font-family:inherit;font-size:11pt;font-style:italic;"> Codification Improvements to Topic 326, Financial Instruments - Credit Losses</font><font style="font-family:inherit;font-size:11pt;">, in November 2018</font><font style="font-family:inherit;font-size:11pt;font-style:italic;">.</font><font style="font-family:inherit;font-size:11pt;"> This ASU clarifies that receivables from operating leases are accounted for using the lease guidance and not as financial instruments. In April 2019, the FASB issued ASU&#160;2019-04,&#160;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Codification Improvements to Topic 326, Financial Instruments - Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments</font><font style="font-family:inherit;font-size:11pt;">, which further clarifies and improves guidance related to accounting for credit losses. In May 2019, the FASB issued ASU&#160;2019-05,&#160;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;">Financial Instruments - Credit Losses (Topic 326)</font><font style="font-family:inherit;font-size:11pt;">. This ASU provides relief to certain entities adopting ASU 2016-13. The amendment provides entities with an option to irrevocably elect the fair value option for certain financial assets. These amendments are</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:11pt;">effective for fiscal years beginning after December 15, 2019 and interim periods within those annual periods. We are currently evaluating the amended guidance and the impact on our consolidated financial statements and will adopt the provisions in the first quarter of 2020.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates are required when establishing the allowance for doubtful accounts and the net realizable value of inventory; determining future costs associated with warranties provided; determining the period over which our obligations are fulfilled under agreements to license product rights and/or technology rights; evaluating long-lived and intangible assets and investments for estimated useful lives and impairment; estimating the useful lives of instruments under leasing arrangements; determining the allocation of purchase price under purchase accounting; estimating the expense associated with the granting of stock; determining the need for, and the amount of a valuation allowance on deferred tax assets; and determining the value of the non-controlling interest in a business combination.</font></div></div> EX-101.SCH 13 hska-20190630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2116100 - Disclosure - ACCRUED LIABILITIES link:presentationLink link:calculationLink link:definitionLink 2416402 - Disclosure - ACCRUED LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 2316301 - Disclosure - ACCRUED LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 2119100 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 2419402 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (Details) link:presentationLink link:calculationLink link:definitionLink 2319301 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - ACQUISITION AND RELATED PARTY ITEMS link:presentationLink link:calculationLink link:definitionLink 2404401 - Disclosure - ACQUISITION AND RELATED PARTY ITEMS (Details) link:presentationLink link:calculationLink link:definitionLink 2118100 - Disclosure - CAPITAL STOCK link:presentationLink link:calculationLink link:definitionLink 2418405 - Disclosure - CAPITAL STOCK CAPITAL STOCK - RESTRICTED STOCK (Details) link:presentationLink link:calculationLink link:definitionLink 2418404 - Disclosure - CAPITAL STOCK - EXERCISE PRICE (Details) link:presentationLink link:calculationLink link:definitionLink 2418403 - Disclosure - CAPITAL STOCK - NARRATIVE (Details) link:presentationLink link:calculationLink link:definitionLink 2418402 - Disclosure - CAPITAL STOCK - OPTION ACTIVITY (Details) link:presentationLink link:calculationLink link:definitionLink 2318301 - Disclosure - CAPITAL STOCK (Tables) link:presentationLink link:calculationLink link:definitionLink 2121100 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 2421401 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 1001501 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 2123100 - Disclosure - CREDIT FACILITY link:presentationLink link:calculationLink link:definitionLink 2423401 - Disclosure - CREDIT FACILITY (Details) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - EARNINGS PER SHARE link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - EARNINGS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 2309301 - Disclosure - EARNINGS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - GOODWILL AND OTHER INTANGIBLES link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - GOODWILL AND OTHER INTANGIBLES (Details) link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - GOODWILL AND OTHER INTANGIBLES (Details) link:presentationLink link:calculationLink link:definitionLink 2311301 - Disclosure - GOODWILL AND OTHER INTANGIBLES (Tables) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 2122100 - Disclosure - INTEREST AND OTHER EXPENSE, NET link:presentationLink link:calculationLink link:definitionLink 2422402 - Disclosure - INTEREST AND OTHER EXPENSE, NET (Details) link:presentationLink link:calculationLink link:definitionLink 2322301 - Disclosure - INTEREST AND OTHER EXPENSE, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - INVENTORIES, NET link:presentationLink link:calculationLink link:definitionLink 2414402 - Disclosure - INVENTORIES, NET (Details) link:presentationLink link:calculationLink link:definitionLink 2314301 - Disclosure - INVENTORIES, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - INVESTMENTS IN UNCONSOLIDATED AFFILIATES link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - INVESTMENTS IN UNCONSOLIDATED AFFILIATES (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - INVESTMENTS IN UNCONSOLIDATED AFFILIATES (Tables) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - LEASES link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - LEASES - LESEE ACCOUNTING (Details) link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - LEASES - LESEE ACCOUNTING (Details) link:presentationLink link:calculationLink link:definitionLink 2408403 - Disclosure - LEASES - LESSOR ACCOUNTING (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 2401402 - Disclosure - OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - PROPERTY AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 2412402 - Disclosure - PROPERTY AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 2312301 - Disclosure - PROPERTY AND EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - REVENUE link:presentationLink link:calculationLink link:definitionLink 2403402 - Disclosure - REVENUE (Details) link:presentationLink link:calculationLink link:definitionLink 2403403 - Disclosure - REVENUE - Performance Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - REVENUE (Tables) link:presentationLink link:calculationLink link:definitionLink 2124100 - Disclosure - SEGMENT REPORTING link:presentationLink link:calculationLink link:definitionLink 2424403 - Disclosure - SEGMENT REPORTING (Details) link:presentationLink link:calculationLink link:definitionLink 2424402 - Disclosure - SEGMENT REPORTING - NARRATIVE (Details) link:presentationLink link:calculationLink link:definitionLink 2324301 - Disclosure - SEGMENT REPORTING (Tables) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 14 hska-20190630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 15 hska-20190630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 16 hska-20190630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Revenue from Contract with Customer [Abstract] Revenue, Initial Application Period Cumulative Effect Transition [Table] Revenue, Initial Application Period Cumulative Effect Transition [Table] Product and Service [Axis] Product and Service [Axis] Product and Service [Domain] Product and Service [Domain] Core companion animal Core Companion Animal Health [Member] Core Companion Animal Health [Member] Point of Care laboratory revenue: Point Of Care Laboratory Revenue [Member] Point Of Care Laboratory Revenue [Member] Consumables Point Of Care Laboratory Revenue, Consumables [Member] Point Of Care Laboratory Revenue, Consumables [Member] Sales-type leases Point Of Care Laboratory Revenue, Sales-Type Leases [Member] Point Of Care Laboratory Revenue, Sales-Type Leases [Member] Outright instrument sales Point Of Care Laboratory Revenue, Outright Instrument Sales [Member] Point Of Care Laboratory Revenue, Outright Instrument Sales [Member] Other Point Of Care Laboratory Revenue, Other [Member] Point Of Care Laboratory Revenue, Other [Member] Point of Care imaging revenue: Point Of Care Imaging Revenue [Member] Point Of Care Imaging Revenue [Member] Outright instrument sales Point Of Care Imaging Revenue, Outright Instrument Sales [Member] Point Of Care Imaging Revenue, Outright Instrument Sales [Member] Service revenue Point Of Care Imaging Revenue, Service Revenue [Member] Point Of Care Imaging Revenue, Service Revenue [Member] Operating type leases and other Point Of Care Imaging Revenue, Operating Type Leases [Member] Point Of Care Imaging Revenue, Operating Type Leases [Member] Other CCA revenue: Other Revenue [Member] Other Revenue [Member] Other pharmaceuticals, vaccines and diagnostic tests Other Revenue, Other Pharmaceuticals, Vaccines And Diagnostic Tests [Member] Other Revenue, Other Pharmaceuticals, Vaccines And Diagnostic Tests [Member] Research and development, license and royalty revenue Other Revenue, Research And Development, License And Royalty Revenue [Member] Other Revenue, Research And Development, License And Royalty Revenue [Member] Other vaccines and pharmaceuticals Other Vaccines, Pharmaceuticals And Products [Member] Other Vaccines, Pharmaceuticals And Products [Member] Contract manufacturing Contract Manufacturing Contracts [Member] Contract Manufacturing Contracts [Member] License, research and development License, Research And Development [Member] License, Research And Development [Member] Revenue, Initial Application Period Cumulative Effect Transition [Line Items] Revenue, Initial Application Period Cumulative Effect Transition [Line Items] Total revenue, net Revenue from Contract with Customer, Including Assessed Tax Contract receivables, current Contract with Customer, Asset, Net, Current Contract receivables, noncurrent Contract with Customer, Asset, Net, Noncurrent Current portion of deferred revenue, and other Contract with Customer, Liability, Current Contract liabilities, revenue recognized Contract with Customer, Liability, Revenue Recognized Contract liabilities, increase due to additional deferred sales Contract with Customer, Liability, Increase Due To Additional Deferred Sales Contract with Customer, Liability, Increase Due To Additional Deferred Sales Average term of underlying contracts Contract with Customer, Timing of Satisfaction of Performance Obligation and Payment Capitalized contract costs Capitalized Contract Cost, Net Capitalized contract costs, amortization Capitalized Contract Cost, Amortization Capitalized contract costs during the period Capitalized Contract Costs During The Period Capitalized Contract Costs During The Period Leases [Abstract] Additional lease information Lease, Cost [Table Text Block] Schedule of maturity of operating leases Lessee, Operating Lease, Liability, Maturity [Table Text Block] Lessor, maturity of undiscounted lease receivables Lessor, Operating Lease, Payments to be Received, Maturity [Table Text Block] Other Income and Expenses [Abstract] Schedule of interest expense (income) and other income, net Interest Expense (Income) and Other Income, Net [Table Text Block] Interest Expense (Income) and Other Income, Net Equity Method Investments and Joint Ventures [Abstract] INVESTMENTS IN UNCONSOLIDATED AFFILIATES Equity Method Investments and Joint Ventures Disclosure [Text Block] Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Award Type [Axis] Award Type [Axis] Equity Award [Domain] Equity Award [Domain] Restricted Stock Restricted Stock [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Non-vested balance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Vested (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Non-vested balance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Non-vested balance (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Vested (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Forfeited (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Non-vested balance (in dollars per share) Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Net income after equity in losses from unconsolidated affiliates Net Income (Loss) Attributable Before Nonredeemable Noncontrolling Interest Income Net Income (Loss) Attributable Before Nonredeemable Noncontrolling Interest Income Other comprehensive (loss) income: Other Comprehensive Income (Loss), Net of Tax [Abstract] Foreign currency translation Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Comprehensive (loss) income Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Comprehensive loss attributable to redeemable non-controlling interest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Comprehensive (loss) income attributable to Heska Corporation Comprehensive Income (Loss), Net of Tax, Attributable to Parent Earnings Per Share [Abstract] Reconciliation of basic and diluted earnings per share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of antidilutive securities excluded from computation of earnings per share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Equity [Abstract] Schedule of accumulated other comprehensive income (loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Inventory Disclosure [Abstract] Schedule of inventory Schedule of Inventory, Current [Table Text Block] Schedule of weighted average valuation assumptions Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block] Schedule of stock options plans Share-based Compensation, Stock Options, Activity [Table Text Block] Schedule of shares authorized under stock options plans by exercise price Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block] Schedule of pricing models Fair Value Option, Disclosures [Table Text Block] EARNINGS PER SHARE Earnings Per Share [Text Block] Document And Entity Information Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Amendment Flag Amendment Flag Current Fiscal Year End Date Current Fiscal Year End Date Entity Current Reporting Status Entity Current Reporting Status Entity Filer Category Entity Filer Category Document Fiscal Period Focus Document Fiscal Period Focus Document Fiscal Year Focus Document Fiscal Year Focus Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Shell Company Entity Shell Company Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Raw materials Inventory, Raw Materials, Gross Work in process Inventory, Work in Process, Gross Finished goods Inventory, Finished Goods, Gross Allowance for excess or obsolete inventory Inventory Valuation Reserves Total inventory, net Inventory, Net Accounting Policies [Abstract] OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] Goodwill and Intangible Assets Disclosure [Abstract] GOODWILL AND OTHER INTANGIBLES Goodwill and Intangible Assets Disclosure [Text Block] Remaining performance obligation Revenue, Remaining Performance Obligation, Amount Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Expected timing of satisfaction Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Segment Reporting [Abstract] Number of reportable segments Number of Reportable Segments Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Total Accumulated Other Comprehensive Income AOCI Attributable to Parent [Member] Minimum Pension Liability Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Foreign Currency Translation Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] Beginning balance Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Current period other comprehensive income Other Comprehensive Income (Loss), Net of Tax Ending balance Property, Plant and Equipment [Abstract] Schedule of property and equipment Property, Plant and Equipment [Table Text Block] Income Tax Disclosure [Abstract] INCOME TAXES Income Tax Disclosure [Text Block] Business Combinations and Related Party Disclosures [Abstract] Business Combinations and Related Party Disclosures [Abstract] ACQUISITION AND RELATED PARTY ITEMS Business Combination Disclosure [Text Block] Goodwill [Roll Forward] Goodwill [Roll Forward] Carrying amount, December 31, 2018 Goodwill Goodwill attributable to acquisitions (subject to change) Goodwill, Acquired During Period Foreign currency adjustments Goodwill, Foreign Currency Translation Gain (Loss) Carrying amount, June 30, 2019 Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Developed technology Developed Technology Rights [Member] Customer relationships and other Customer Relationships And Other [Member] Customer Relationships And Other [Member] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets, Net [Abstract] Finite-Lived Intangible Assets, Net [Abstract] Gross carrying amount Finite-Lived Intangible Assets, Gross Accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Net carrying amount Finite-Lived Intangible Assets, Net Amortization expense Amortization of Intangible Assets Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] 2019 (remaining) Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year 2020 Finite-Lived Intangible Assets, Amortization Expense, Year Two 2021 Finite-Lived Intangible Assets, Amortization Expense, Year Three 2022 Finite-Lived Intangible Assets, Amortization Expense, Year Four 2023 Finite-Lived Intangible Assets, Amortization Expense, Year Five Thereafter Finite-Lived Intangible Assets, Amortization Expense, after Year Five Payables and Accruals [Abstract] ACCRUED LIABILITIES Accounts Payable and Accrued Liabilities Disclosure [Text Block] INTEREST AND OTHER EXPENSE, NET Interest and Other Income [Text Block] ACCUMULATED OTHER COMPREHENSIVE INCOME Comprehensive Income (Loss) Note [Text Block] Reconciliation of other significant reconciling items from segments to consolidated Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block] Schedule of revenue from external customers and long-lived assets, by geographical areas Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Optomed Optomed [Member] Optomed [Member] Investment, Name [Axis] Investment, Name [Axis] Investment, Name [Domain] Investment, Name [Domain] Cuattro, LLC Cuattro, LLC [Member] Cuattro, LLC [Member] Legal Entity [Axis] Legal Entity [Axis] Entity [Domain] Entity [Domain] Heska Imaging Heska Imaging [Member] Heska Imaging [Member] Counterparty Name [Axis] Counterparty Name [Axis] Counterparty Name [Domain] Counterparty Name [Domain] Related Party [Axis] Related Party [Axis] Related Party [Domain] Related Party [Domain] Affiliated Entity Affiliated Entity [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Percentage of voting interest acquired Business Acquisition, Percentage of Voting Interests Acquired Cash consideration transferred Payments to Acquire Businesses, Gross Debt assumed as consideration for business combination Business Combination, Consideration Transferred, Liabilities Incurred Minority interest Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners Committed purchase amount Business Combination, Contingent Consideration To Be Transferred Business Combination, Contingent Consideration To Be Transferred Equity transferred as consideration for asset acquisition (in shares) Asset Acquisition, Consideration Transferred, Equity Instruments Issued Or Issuable Asset Acquisition, Consideration Transferred, Equity Instruments Issued Or Issuable Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Equity transferred as consideration for asset acquisition, value Asset Acquisition, Consideration Transferred, Equity Issued, Value Asset Acquisition, Consideration Transferred, Equity Issued, Value Payments for asset acquisitions Payments For Asset Acquisitions Payments For Asset Acquisitions Related party - amount of transaction Related Party Transaction, Amounts of Transaction Due to related parties Due to Related Parties Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table] Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table] Exercise Price Range [Axis] Exercise Price Range [Axis] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain] $ 4.96 - $ 7.36 Exercise Price Range One [Member] Exercise Price Range One [Member] $ 7.37 - $ 32.21 Exercise Price Range Two [Member] Exercise Price Range Two [Member] $ 32.22 - $ 62.50 Exercise Price Range Three [Member] Exercise Price Range Three [Member] $ 62.51 - $ 69.77 Exercise Price Range Four [Member] Exercise Price Range Four [Member] $ 69.78 - $ 108.25 Exercise Price Range Five [Member] Exercise Price Range Five [Member] $ 4.96 - $ 108.25 Exercise Price Range Six [Member] Exercise Price Range Six Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] Number of Options Outstanding at June 30, 2019 Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options Weighted Average Remaining Contractual Life in Years Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term Weighted Average Exercise Price Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price Number of Options Exercisable at June 30, 2019 Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options Weighted Average Exercise Price Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price Exercise price range, lower (in dollars per share) Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit Exercise price range, upper (in dollars per share) Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit Debt Disclosure [Abstract] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Line of Credit Line of Credit [Member] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Revolving Credit Facility Revolving Credit Facility [Member] Variable Rate [Axis] Variable Rate [Axis] Variable Rate [Domain] Variable Rate [Domain] London Interbank Offered Rate (LIBOR) London Interbank Offered Rate (LIBOR) [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Additional maximum borrowing capacity increase Line Of Credit Facility, Contingent Increase In Maximum Borrowing Capacity Line Of Credit Facility, Contingent Increase In Maximum Borrowing Capacity Contingent maximum borrowing capacity Line of Credit Facility, Contingent Maximum Borrowing Capacity Line of Credit Facility, Contingent Maximum Borrowing Capacity Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Minimum annual interest charge Line of Credit Facility, Minimum Annual Interest Charge Line of Credit Facility, Minimum Annual Interest Charge Long-term line of credit Long-term Line of Credit Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] General Fluidics Corporation General Fluidics Corporation [Member] General Fluidics Corporation [Member] MBio Diagnostics, Inc. MBio Diagnostics, Inc. [Member] MBio Diagnostics, Inc. [Member] Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Equity method investment Equity Method Investments Non-marketable equity security investment Non-Marketable Equity Security Investment Non-Marketable Equity Security Investment Investments Investments Payments to acquire equity method investments Payments to Acquire Equity Method Investments Ownership percentage Equity Method Investment, Ownership Percentage Supply commitment term Supply Commitment, Term Supply Commitment, Term Payments to acquire non-marketable securities Payments To Acquire Non-Marketable Securities Payments To Acquire Non-Marketable Securities Non-Marketable equity security investment, ownership percentage Non-Marketable Equity Security Investment, Ownership Percentage Non-Marketable Equity Security Investment, Ownership Percentage Intangible asset acquired Non-Marketable Equity Security Investment, Intangible Assets Acquired Non-Marketable Equity Security Investment, Intangible Assets Acquired Intangible assets acquired, useful life Non-Marketable Equity Security Investment, Intangible Assets Acquired, Useful Life Non-Marketable Equity Security Investment, Intangible Assets Acquired, Useful Life Contingent consideration on milestones Non-Marketable Equity Security Investment, Consideration Transferred, Contingent Consideration Amount Non-Marketable Equity Security Investment, Consideration Transferred, Contingent Consideration Amount Operating lease expense Lease, Cost Cash paid for amounts included in the measurement of operating lease liabilities Operating Lease, Expense ROU assets obtained in exchange for operating lease obligations Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Weighted average discount rate Operating Lease, Weighted Average Discount Rate, Percent Operating Lease Liabilities, Payments Due [Abstract] Operating Lease Liabilities, Payments Due [Abstract] Remainder of 2019 Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year 2020 Lessee, Operating Lease, Liability, Payments, Due Year Two 2021 Lessee, Operating Lease, Liability, Payments, Due Year Three 2022 Lessee, Operating Lease, Liability, Payments, Due Year Four 2023 Lessee, Operating Lease, Liability, Payments, Due Year Five Total operating lease payments Lessee, Operating Lease, Liability, Payments, Due Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Total operating lease liabilities Operating Lease, Liability Schedule of accrued liabilities Schedule of Accrued Liabilities [Table Text Block] Interest income Interest Income, Deposits with Financial Institutions Interest expense Interest Expense Other, net Other Nonoperating Income (Expense) Total interest and other expense, net Nonoperating Income (Expense) Cash paid for interest Interest Paid, Including Capitalized Interest, Operating and Investing Activities Lessor, Operating Lease, Payments, Fiscal Year Maturity [Abstract] Lessor, Operating Lease, Payments, Fiscal Year Maturity [Abstract] Remainder of 2019 Lessor, Operating Lease, Payments to be Received, Remainder of Fiscal Year 2020 Lessor, Operating Lease, Payments to be Received, Two Years 2021 Lessor, Operating Lease, Payments to be Received, Three Years 2022 Lessor, Operating Lease, Payments to be Received, Four Years 2023 Lessor, Operating Lease, Payments to be Received, Five Years Thereafter Lessor, Operating Lease, Payments to be Received, Thereafter Lessor, Operating Lease, Payments to be Received Lessor, Operating Lease, Payments to be Received PROPERTY AND EQUIPMENT Property, Plant and Equipment Disclosure [Text Block] Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table] Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table] Consolidation Items [Axis] Consolidation Items [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Operating Segments Operating Segments [Member] Segments [Axis] Segments [Axis] Segments [Domain] Segments [Domain] Core Companion Animal Health Core Companion Animal Health Segment [Member] CCA segment Other Vaccines, Pharmaceuticals and Products Other Vaccines Pharmaceuticals and Products Segment [Member] OVP member Segment Reporting, Other Significant Reconciling Item [Line Items] Segment Reporting, Other Significant Reconciling Item [Line Items] Total revenue Revenues Operating (loss) income Operating Income (Loss) Income before income taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Capital expenditures Payments to Acquire Property, Plant, and Equipment Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Investments in unconsolidated affiliates Assets Assets Net Assets Net Assets INVENTORIES, NET Inventory Disclosure [Text Block] Increase in royalties payable Increase (Decrease) in Royalties Payable Warranty reserve Standard and Extended Product Warranty Accrual Litigation settlement, amount Litigation Settlement, Amount Awarded to Other Party Unconditional annual minimum inventory purchases Purchase Commitment, Remaining Minimum Amount Committed Employee Stock Option Employee Stock Option [Member] Employee Stock Employee Stock [Member] Risk-free interest rate (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Expected lives (in years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Expected volatility (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected dividend rate (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Outstanding at beginning of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Granted at market Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Expired Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Outstanding at end of period Exercisable at end of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Outstanding at beginning of period (in dollars per share) Granted at market (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Forfeited (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Expired (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Exercised (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Outstanding at ending of period (in dollars per share) Exercisable at end of period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price LEASES, LESSEE Lessee, Operating Leases [Text Block] LEASES, LESSOR Lessor, Operating Leases [Text Block] Net (loss) income attributable to Heska Corporation Net Income (Loss) Attributable to Parent Basic weighted-average common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Assumed exercise of dilutive stock options and restricted shares Weighted Average Number Diluted Shares Outstanding Adjustment Diluted weighted-average common shares outstanding Weighted Average Number of Shares Outstanding, Diluted Basic (loss) earnings per share attributable to Heska Corporation (in dollars per share) Earnings Per Share, Basic Diluted (loss) earnings per share attributable to Heska Corporation (in dollars per share) Earnings Per Share, Diluted Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Stock Options And Restricted Units Stock Options And Restricted Units [Member] Stock Options And Restricted Units [Member] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Stock options and restricted units excluded from computation of earnings per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Type [Domain] Land Land [Member] Building Building [Member] Machinery and equipment Machinery and Equipment [Member] Office furniture and equipment Office Furniture And Equipment [Member] Office Furniture And Equipment [Member] Computer hardware and software Computer Hardware And Software [Member] Computer Hardware And Software [Member] Leasehold and building improvements Leasehold and Building Improvements [Member] Leasehold and Building Improvements [Member] Construction in progress Construction in Progress [Member] Machinery and equipment Inventory Transferred To Machinery And Equipment [Member] Inventory Transferred To Machinery And Equipment [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Property and equipment, gross Property, Plant and Equipment, Gross Less accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Total property and equipment, net Property, Plant and Equipment, Net Depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant and Equipment, Period Increase (Decrease) Property plant and equipment, useful life Property, Plant and Equipment, Useful Life Operating leases, gross Property Subject to or Available for Operating Lease, Gross Operating leases, accumulated depreciation Property Subject to or Available for Operating Lease, Accumulated Depreciation Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Schedule of Timing of Revenue Expected to be Recognized Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block] Income Statement [Abstract] Statement [Table] Statement [Table] Statement [Line Items] Statement [Line Items] Revenue: Revenues [Abstract] Cost of revenue Cost of Revenue Gross profit Gross Profit Operating expenses: Operating Expenses [Abstract] Selling and marketing Selling and Marketing Expense Research and development Research and Development Expense General and administrative General and Administrative Expense Total operating expenses Operating Expenses Operating (loss) income Interest and other expense, net (Loss) income before income taxes and equity in losses of unconsolidated affiliates Income tax (benefit) expense: Income Tax Expense (Benefit), Intraperiod Tax Allocation [Abstract] Current income tax expense Current Income Tax Expense (Benefit) Deferred income tax (benefit) expense Deferred Income Tax Expense (Benefit) Total income tax (benefit) expense Income Tax Expense (Benefit) Net (loss) income before equity in losses of unconsolidated affiliates Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Equity in losses of unconsolidated affiliates Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest Net (loss) income after equity in losses of unconsolidated affiliates Net loss attributable to redeemable non-controlling interest Net Income (Loss) Attributable to Redeemable Noncontrolling Interest Net (loss) income attributable to Heska Corporation Earnings Per Share [Abstract] Weighted average outstanding shares used to compute basic (loss) earnings per share attributable to Heska Corporation (in shares) Weighted average outstanding shares used to compute diluted (loss) earnings per share attributable to Heska Corporation (in shares) Schedule of changes in goodwill Schedule of Goodwill [Table Text Block] Schedule of other intangible assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Schedule of amortization expense on intangible assets Finite-lived Intangible Assets Amortization Expense [Table Text Block] Schedule of estimated future amortization expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Carrying values of investments in unconsolidated entities Equity Method Investments [Table Text Block] CAPITAL STOCK Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Statement of Stockholders' Equity [Abstract] Traditional Common Stock Common Stock, Preferred Stock And Public Stock [Member] Common Stock, Preferred Stock And Public Stock [Member] Additional Paid-in Capital Additional Paid-in Capital [Member] Accumulated Other Comprehensive Income (Loss) Comprehensive Income [Member] Accumulated Deficit Retained Earnings [Member] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Beginning balance (in shares) Shares, Outstanding Adoption of accounting standards Cumulative Effect of New Accounting Principle in Period of Adoption Net income after equity in losses of unconsolidated affiliates Issuance of common stock, net of shares withheld for employee taxes Stock Issued During Period, Value, Employee Stock Purchase Plan Issuance of common stock, net of shares withheld for employee taxes (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Stock-based compensation Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Other comprehensive income (loss) Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax Ending balance (in shares) Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Net Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net income to cash (used in) provided by operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Non-cash impact of operating leases Operating Lease, Payments Deferred income tax benefit Stock-based compensation Share-based Compensation Equity in losses of unconsolidated affiliates Income (Loss) from Equity Method Investments Other losses Unrealized (gain) loss on foreign currency translation Unrealized gain loss on foreign currency transactions Changes in operating assets and liabilities (net of the effect of acquisitions): Increase (Decrease) in Operating Capital [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Inventories Increase (Decrease) in Inventories Due from related parties Increase (Decrease) in Due from Related Parties Lease receivable, current Increase (Decrease) in Leasing Receivables Other current assets Increase (Decrease) in Other Operating Assets Accounts payable Increase (Decrease) in Accounts Payable, Trade Due to related parties Increase (Decrease) in Due to Related Parties Accrued liabilities and other Increase (Decrease) in Accrued Liabilities Lease receivable, non-current Increase (Decrease) In Leasing Receivable, Noncurrent Increase (Decrease) In Leasing Receivable, Noncurrent Other non-current assets Increase (Decrease) in Other Noncurrent Assets Deferred revenue and other Increase (Decrease) in Contract with Customer, Liability Net cash (used in) provided by operating activities Net Cash Provided by (Used in) Operating Activities CASH FLOWS FROM INVESTING ACTIVITIES: Net Cash Provided by (Used in) Investing Activities [Abstract] Investment in subsidiary, net of cash acquired Payments to Acquire Investments Purchases of property and equipment Proceeds from disposition of property and equipment Proceeds from Sale of Property, Plant, and Equipment Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities CASH FLOWS FROM FINANCING ACTIVITIES: Net Cash Provided by (Used in) Financing Activities [Abstract] Borrowings on line of credit Proceeds from Lines of Credit Proceeds from issuance of common stock Proceeds from Issuance of Common Stock Repurchase of common stock Payments for Repurchase of Common Stock Distributions to non-controlling interest members Distribution Made to Limited Liability Company (LLC) Member, Cash Distributions Paid Repayments of other debt Proceeds from (Repayments of) Debt Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities NET EFFECT OF EXCHANGE RATE CHANGES ON CASH Effect of Exchange Rate on Cash and Cash Equivalents NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS Cash and Cash Equivalents, Period Increase (Decrease) CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD Cash and Cash Equivalents, at Carrying Value CASH AND CASH EQUIVALENTS, END OF PERIOD SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: Supplemental Cash Flow Information [Abstract] Non-cash transfers of equipment between inventory and property and equipment, net Property, Plant and Equipment, Transfers and Changes Schedule of components of income tax expense Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Statement of Financial Position [Abstract] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Traditional Common Stock Common Stock [Member] Public Common Stock Public Common Stock [Member] Public Common Stock [Member] Allowance for doubtful accounts Allowance for Doubtful Accounts Receivable Leases, allowance for doubtful accounts Loans and Leases Receivable, Allowance Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Preferred stock, shares authorized Preferred Stock, Shares Authorized Preferred stock, shares issued Preferred Stock, Shares Issued Preferred stock, shares outstanding Preferred Stock, Shares Outstanding Common stock, shares authorized Common Stock, Shares Authorized Common stock, shares issued Common Stock, Shares, Issued Common stock, shares outstanding Common Stock, Shares, Outstanding Fair value of stock options granted during period Stock Granted, Value, Share-based Compensation, Gross Weighted average grant date fair value Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Intrinsic value of options exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Proceeds from stock options exercised Proceeds from Stock Options Exercised Total unrecognized compensation expense related to outstanding stock options Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options Period for recognition of unrecognized compensation expense Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Intrinsic value of options outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Shares issued during period Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period Weighted average purchase price of shares purchased (in dollars per share) Award vesting period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Fair value of stock vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Performance shares, nonprobable performance targets (in shares) Share-Based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Performance Shares, Nonprobable Achievement Share-Based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Performance Shares, Nonprobable Achievement ASSETS Assets [Abstract] Current assets: Assets, Current [Abstract] Cash and cash equivalents Accounts receivable, net of allowance for doubtful accounts of $212 and $245, respectively Accounts Receivable, Net, Current Inventories, net Net investment in leases, current, net of allowance for doubtful accounts of $78 and $40, respectively Loans and Leases Receivable, Net of Deferred Income Prepaid expenses Prepaid Expense, Current Other current assets Other Assets, Current Total current assets Assets, Current Property and equipment, net Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Goodwill Intangible Assets, Net (Including Goodwill) Other intangible assets, net Other Intangible Assets, Net Deferred tax asset, net Deferred Tax Assets, Net Net investment in leases, non-current Loans And Leases Receivable, Net Of Deferred Income, Noncurrent Loans and Leases Receivable, Net of Deferred Income, Noncurrent Other non-current assets Other Assets, Noncurrent Total assets LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY Liabilities and Equity [Abstract] Liabilities Liabilities [Abstract] Current liabilities: Liabilities, Current [Abstract] Accounts payable Accounts Payable, Current Due to – related parties Due to Related Parties, Current Accrued liabilities Accrued Liabilities, Current Current operating lease liabilities Operating Lease, Liability, Current Current portion of deferred revenue, and other Deferred Revenue, Current Total current liabilities Liabilities, Current Deferred revenue, net of current portion Contract with Customer, Liability, Noncurrent Line of credit Line of Credit, Current Non-current operating lease liabilities Operating Lease, Liability, Noncurrent Other liabilities Other Liabilities, Noncurrent Total liabilities Liabilities Commitments and contingencies Commitments and Contingencies Redeemable non-controlling interest and mezzanine equity Redeemable Noncontrolling Interest, Equity, Carrying Amount Stockholders' equity: Stockholders' Equity Attributable to Parent [Abstract] Preferred stock, $.01 par value, 2,500,000 and 2,500,000 shares authorized, respectively, none issued or outstanding Preferred Stock, Value, Issued Common stock, $.01 par value, 10,250,000 and 10,250,000 shares authorized, respectively, none issued or outstanding Common Stock, Value, Issued Public common stock, $.01 par value, 10,250,000 and 10,250,000 shares authorized, 7,794,271 and 7,675,692 shares issued and outstanding, respectively Public Common Stock, Value, Issued Public Common Stock, Value, Issued Additional paid-in capital Additional Paid in Capital Accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated deficit Retained Earnings (Accumulated Deficit) Total stockholders' equity Stockholders' Equity Attributable to Parent Total liabilities, mezzanine equity and stockholders' equity Liabilities and Equity SEGMENT REPORTING Segment Reporting Disclosure [Text Block] CREDIT FACILITY Debt Disclosure [Text Block] REVENUE Revenue from Contract with Customer [Text Block] Schedule of Error Corrections and Prior Period Adjustment Restatement [Table] Schedule of Error Corrections and Prior Period Adjustment Restatement [Table] Adjustments for New Accounting Pronouncements [Axis] Adjustments for New Accounting Pronouncements [Axis] Type of Adoption [Domain] Type of Adoption [Domain] ASU 2016-02 Accounting Standards Update 2016-02 [Member] Error Corrections and Prior Period Adjustments Restatement [Line Items] Error Corrections and Prior Period Adjustments Restatement [Line Items] Total income tax (benefit) expense Cash paid for income taxes Income Taxes Paid Excess tax benefits related to employee share-based compensation Effective Income Tax Rate Reconciliation, Share-based Compensation, Excess Tax Benefit, Amount Basis of Presentation and Consolidation Basis of Accounting, Policy [Policy Text Block] Reclassification Reclassification, Policy [Policy Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Accrued settlement Estimated Litigation Liability, Current Accrued payroll and employee benefits Employee-related Liabilities, Current Accrued property taxes Accrual for Taxes Other than Income Taxes, Current Other Other Accrued Liabilities, Current Total accrued liabilities Percentage of total current liabilities Percentage Of Total Liabilities, Current Percentage Of Total Liabilities, Current EX-101.PRE 17 hska-20190630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 18 heskalogowhtbkgd08.jpg begin 644 heskalogowhtbkgd08.jpg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htm IDEA: XBRL DOCUMENT v3.19.2
Document and Entity Information - shares
 6 Months Ended
Jun. 30, 2019
Aug. 06, 2019
Document And Entity Information    
Entity Registrant Name Heska Corp  
Entity Central Index Key 0001038133  
Document Type 10-Q  
Document Period End Date Jun. 30, 2019  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Filer Category Accelerated Filer  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2019  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   7,796,571
XML 20 R2.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 9,992 $ 13,389
Accounts receivable, net of allowance for doubtful accounts of $212 and $245, respectively 12,775 16,454
Inventories, net 28,977 25,104
Net investment in leases, current, net of allowance for doubtful accounts of $78 and $40, respectively 3,379 2,989
Prepaid expenses 2,322 1,533
Other current assets 3,044 2,938
Total current assets 60,489 62,407
Property and equipment, net 15,318 15,981
Operating lease right-of-use assets 6,092  
Goodwill 27,190 26,679
Other intangible assets, net 9,526 9,764
Deferred tax asset, net 15,920 14,121
Net investment in leases, non-current 13,033 11,908
Investments in unconsolidated affiliates 7,711 8,018
Other non-current assets 7,565 7,574
Total assets 162,844 156,452
Current liabilities:    
Accounts payable 7,330 7,469
Due to – related parties 0 226
Accrued liabilities 3,755 10,142
Current operating lease liabilities 1,685  
Current portion of deferred revenue, and other 2,615 2,526
Total current liabilities 15,385 20,363
Deferred revenue, net of current portion 6,442 7,082
Line of credit 12,750 6,000
Non-current operating lease liabilities 4,819  
Other liabilities 196 598
Total liabilities 39,592 34,043
Commitments and contingencies
Redeemable non-controlling interest and mezzanine equity 330 0
Stockholders' equity:    
Preferred stock, $.01 par value, 2,500,000 and 2,500,000 shares authorized, respectively, none issued or outstanding 0 0
Common stock, $.01 par value, 10,250,000 and 10,250,000 shares authorized, respectively, none issued or outstanding 0 0
Public common stock, $.01 par value, 10,250,000 and 10,250,000 shares authorized, 7,794,271 and 7,675,692 shares issued and outstanding, respectively 78 77
Additional paid-in capital 256,952 257,034
Accumulated other comprehensive income 298 277
Accumulated deficit (134,406) (134,979)
Total stockholders' equity 122,922 122,409
Total liabilities, mezzanine equity and stockholders' equity $ 162,844 $ 156,452
XML 21 R3.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands
Jun. 30, 2019
Dec. 31, 2018
Allowance for doubtful accounts $ 212 $ 245
Leases, allowance for doubtful accounts $ 78 $ 40
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, shares authorized 2,500,000 2,500,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Traditional Common Stock    
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized 10,250,000 10,250,000
Common stock, shares issued 0 0
Common stock, shares outstanding 0 0
Public Common Stock    
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized 10,250,000 10,250,000
Common stock, shares issued 7,794,271 7,675,692
Common stock, shares outstanding 7,794,271 7,675,692
XML 22 R4.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Revenue:        
Total revenue, net $ 28,146 $ 29,662 $ 57,657 $ 62,427
Cost of revenue 15,734 16,597 32,702 36,055
Gross profit 12,412 13,065 24,955 26,372
Operating expenses:        
Selling and marketing 6,715 5,944 13,748 12,084
Research and development 2,239 559 3,605 1,229
General and administrative 4,024 4,358 8,243 8,984
Total operating expenses 12,978 10,861 25,596 22,297
Operating (loss) income (566) 2,204 (641) 4,075
Interest and other expense, net 21 92 5 88
(Loss) income before income taxes and equity in losses of unconsolidated affiliates (587) 2,112 (646) 3,987
Income tax (benefit) expense:        
Current income tax expense 28 12 72 29
Deferred income tax (benefit) expense (454) 203 (1,508) (94)
Total income tax (benefit) expense (426) 215 (1,436) (65)
Net (loss) income before equity in losses of unconsolidated affiliates (161) 1,897 790 4,052
Equity in losses of unconsolidated affiliates (127) 0 (308) 0
Net (loss) income after equity in losses of unconsolidated affiliates (288) 1,897 482 4,052
Net loss attributable to redeemable non-controlling interest (47) 0 (91) 0
Net (loss) income attributable to Heska Corporation $ (241) $ 1,897 $ 573 $ 4,052
Earnings Per Share [Abstract]        
Basic (loss) earnings per share attributable to Heska Corporation (in dollars per share) $ (0.03) $ 0.26 $ 0.08 $ 0.57
Diluted (loss) earnings per share attributable to Heska Corporation (in dollars per share) $ (0.03) $ 0.24 $ 0.07 $ 0.52
Weighted average outstanding shares used to compute basic (loss) earnings per share attributable to Heska Corporation (in shares) 7,486 7,226 7,463 7,146
Weighted average outstanding shares used to compute diluted (loss) earnings per share attributable to Heska Corporation (in shares) 7,486 7,850 7,956 7,781
Core companion animal        
Revenue:        
Total revenue, net $ 24,716 $ 26,644 $ 49,432 $ 53,463
Other vaccines and pharmaceuticals        
Revenue:        
Total revenue, net $ 3,430 $ 3,018 $ 8,225 $ 8,964
XML 23 R5.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]        
Net income after equity in losses from unconsolidated affiliates $ (288) $ 1,897 $ 482 $ 4,052
Other comprehensive (loss) income:        
Foreign currency translation 83 (112) 21 (31)
Comprehensive (loss) income (205) 1,785 503 4,021
Comprehensive loss attributable to redeemable non-controlling interest (47) 0 (91) 0
Comprehensive (loss) income attributable to Heska Corporation $ (158) $ 1,785 $ 594 $ 4,021
XML 24 R6.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Traditional Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2017 $ 100,440 $ 73 $ 243,598 $ 232 $ (143,463)
Beginning balance (in shares) at Dec. 31, 2017   7,303      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income after equity in losses of unconsolidated affiliates 4,052        
Ending balance at Jun. 30, 2018 109,922 $ 75 246,422 201 (136,776)
Ending balance (in shares) at Jun. 30, 2018   7,498      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Adoption of accounting standards 2,635       2,635
Beginning balance at Jan. 01, 2018 103,075 $ 73 243,598 232 (140,828)
Beginning balance (in shares) at Jan. 01, 2018   7,303      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income after equity in losses of unconsolidated affiliates 4,052       4,052
Issuance of common stock, net of shares withheld for employee taxes 458 $ 2 456    
Issuance of common stock, net of shares withheld for employee taxes (in shares)   195      
Stock-based compensation 2,368   2,368    
Other comprehensive income (loss) (31)     (31)  
Ending balance at Jun. 30, 2018 109,922 $ 75 246,422 201 (136,776)
Ending balance (in shares) at Jun. 30, 2018   7,498      
Beginning balance at Mar. 31, 2018 105,091 $ 74 243,377 313 (138,673)
Beginning balance (in shares) at Mar. 31, 2018   7,419      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income after equity in losses of unconsolidated affiliates 1,897       1,897
Issuance of common stock, net of shares withheld for employee taxes 1,742 $ 1 1,741    
Issuance of common stock, net of shares withheld for employee taxes (in shares)   79      
Stock-based compensation 1,304   1,304    
Other comprehensive income (loss) (112)     (112)  
Ending balance at Jun. 30, 2018 109,922 $ 75 246,422 201 (136,776)
Ending balance (in shares) at Jun. 30, 2018   7,498      
Beginning balance at Dec. 31, 2018 122,409 $ 77 257,034 277 (134,979)
Beginning balance (in shares) at Dec. 31, 2018   7,676      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income after equity in losses of unconsolidated affiliates 573       573
Issuance of common stock, net of shares withheld for employee taxes (2,461) $ 1 (2,462)    
Issuance of common stock, net of shares withheld for employee taxes (in shares)   118      
Stock-based compensation 2,380   2,380    
Other comprehensive income (loss) 21     21  
Ending balance at Jun. 30, 2019 122,922 $ 78 256,952 298 (134,406)
Ending balance (in shares) at Jun. 30, 2019   7,794      
Beginning balance at Mar. 31, 2019 121,277 $ 77 255,150 215 (134,165)
Beginning balance (in shares) at Mar. 31, 2019   7,747      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income after equity in losses of unconsolidated affiliates (241)       (241)
Issuance of common stock, net of shares withheld for employee taxes 608 $ 1 607    
Issuance of common stock, net of shares withheld for employee taxes (in shares)   47      
Stock-based compensation 1,195   1,195    
Other comprehensive income (loss) 83     83  
Ending balance at Jun. 30, 2019 $ 122,922 $ 78 $ 256,952 $ 298 $ (134,406)
Ending balance (in shares) at Jun. 30, 2019   7,794      
XML 25 R7.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income after equity in losses from unconsolidated affiliates $ 482 $ 4,052
Adjustments to reconcile net income to cash (used in) provided by operating activities:    
Depreciation and amortization 2,522 2,333
Non-cash impact of operating leases 750 0
Deferred income tax benefit (1,508) (94)
Stock-based compensation 2,380 2,368
Equity in losses of unconsolidated affiliates 308 0
Other losses 245 8
Changes in operating assets and liabilities (net of the effect of acquisitions):    
Accounts receivable 3,764 2,780
Inventories (2,978) 3,192
Due from related parties 0 1
Lease receivable, current (392) (524)
Other current assets (531) 250
Accounts payable (707) (2,510)
Due to related parties (226) (1,336)
Accrued liabilities and other (7,680) (1,332)
Lease receivable, non-current (1,090) (1,526)
Other non-current assets 28 (706)
Deferred revenue and other (723) (2,457)
Net cash (used in) provided by operating activities (5,356) 4,499
CASH FLOWS FROM INVESTING ACTIVITIES:    
Investment in subsidiary, net of cash acquired (622) 0
Purchases of property and equipment (629) (811)
Proceeds from disposition of property and equipment 0 4
Net cash used in investing activities (1,251) (807)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Borrowings on line of credit 6,750 0
Proceeds from issuance of common stock 1,018 1,613
Repurchase of common stock (3,480) (1,155)
Distributions to non-controlling interest members 0 (126)
Repayments of other debt (1,083) 0
Net cash provided by financing activities 3,205 332
NET EFFECT OF EXCHANGE RATE CHANGES ON CASH 5 (8)
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS (3,397) 4,016
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 13,389 9,659
CASH AND CASH EQUIVALENTS, END OF PERIOD 9,992 13,675
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Non-cash transfers of equipment between inventory and property and equipment, net $ 878 $ 528
XML 26 R8.htm IDEA: XBRL DOCUMENT v3.19.2
OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 6 Months Ended
Jun. 30, 2019
Accounting Policies [Abstract]  
OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Heska Corporation and its wholly-owned subsidiaries ("Heska", the "Company", "we" or "our") sell veterinary and animal health diagnostic and specialty products. Our offerings include Point of Care diagnostic laboratory instruments and supplies; digital imaging diagnostic products, software and services; vaccines; local and cloud-based data services; allergy testing and immunotherapy; and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. Our core focus is on supporting veterinarians in the canine and feline healthcare space.
Basis of Presentation and Consolidation
In the opinion of management, the accompanying unaudited Condensed Consolidated Financial Statements contain all adjustments, consisting of normal, recurring adjustments, necessary to present fairly the financial position of the Company as of June 30, 2019 and December 31, 2018, the results of our operations and statements of stockholders' equity for the three and six months ended June 30, 2019 and 2018, and cash flows for the six months ended June 30, 2019 and 2018.
The unaudited Condensed Consolidated Financial Statements included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") have been condensed or omitted pursuant to such rules and regulations. Our unaudited Condensed Consolidated Financial Statements include our accounts and the accounts of our wholly-owned subsidiaries since their respective dates of acquisitions. All intercompany accounts and transactions have been eliminated in consolidation. Where our ownership of a subsidiary is less than 100%, the non-controlling interest is reported on our Condensed Consolidated Balance Sheets. The non-controlling interest in our consolidated net income is reported as "Net loss attributable to redeemable non-controlling interest" on our Condensed Consolidated Statements of Income. These unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018 and other financial information filed with the SEC.
Reclassification
To maintain consistency and comparability, certain amounts in the financial statements have been reclassified to conform to current year presentation.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates are required when establishing the allowance for doubtful accounts and the net realizable value of inventory; determining future costs associated with warranties provided; determining the period over which our obligations are fulfilled under agreements to license product rights and/or technology rights; evaluating long-lived and intangible assets and investments for estimated useful lives and impairment; estimating the useful lives of instruments under leasing arrangements; determining the allocation of purchase price under purchase accounting; estimating the expense associated with the granting of stock; determining the need for, and the amount of a valuation allowance on deferred tax assets; and determining the value of the non-controlling interest in a business combination.
Critical Accounting Policies
Our accounting policies are described in our audited Consolidated Financial Statements and Notes thereto contained in our Annual Report on Form 10-K for the year ended December 31, 2018 and other than the recently adopted accounting pronouncements described below, have not changed significantly since such filing.
Adoption of New Accounting Pronouncements

Effective January 1, 2019, we adopted ASU 2018-07, Compensation – Stock Compensation (Topic 718), Improvements to Non-employee Share-Based Payment Accounting. This ASU is intended to simplify aspects of share-based compensation issued to non-employees by making the guidance consistent with accounting for employee share-based compensation. Guidance related to the stock compensation granted to employees is followed for non-employees, including the measurement date, valuation approach and performance conditions. The expense is recognized in the same period as though cash were paid for the good or service, ratably over the service period. The adoption of this ASU did not have an impact on our consolidated financial statements but did have a minimal impact on our related disclosures.

Effective January 1, 2019, we adopted ASU 2018-02, Income Statement-Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. The ASU permits companies to elect a reclassification of the disproportionate tax effects in accumulated other comprehensive income ("AOCI") caused by the Tax Cuts and Jobs Act of 2017 to retained earnings. As of June 30, 2019, the Company does not have any disproportionate income tax effects in AOCI to reclassify. However, if the Company did have disproportionate income tax effects in AOCI in the future, it would reclassify them to retained earnings.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which supersedes ASC 840, Leases. This update requires lessees to recognize a right-of-use (“ROU”) asset and a lease liability for all leases, including operating leases, with terms greater than 12 months on its balance sheet. The update also expands the required quantitative and qualitative disclosures by lessees and lessors about the amount, timing and uncertainty of cash flows arising from leases. The accounting for lessors does not fundamentally change except for changes to conform and align guidance to the lessee guidance as well as to the new revenue recognition guidance in ASU 2014-09, Revenue from Contracts with Customers (Topic 606). Subsequent to the issuance of Topic 842, the FASB clarified the guidance through several ASUs; hereinafter the collection of lease guidance is referred to as “ASC 842”.

The Company adopted ASC 842 on January 1, 2019, using the modified retrospective approach for all lease arrangements at the beginning of the period of adoption. Results for reporting periods beginning January 1, 2019 are presented under ASC 842, while prior period amounts were not adjusted and continue to be reported in accordance with the Company’s historic accounting under ASC 840, Leases. For leases that commenced before the effective date of ASC 842, the Company elected the permitted practical expedients to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. The Company also elected to exclude leases with a term of 12 months or less from the recognized ROU assets and lease liabilities.

Adoption of the standard did not have a material net impact in our Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Income or Condensed Consolidated Statements of Cash Flows. The most significant impact was the recognition of ROU assets and lease liabilities for the operating leases, of which we are the lessee. As a result of the cumulative impact of adopting ASC 842, the Company recorded operating lease ROU assets of $6.5 million and operating lease liabilities of $6.9 million as of January 1, 2019, primarily related to building, vehicle, and office equipment leases, based on the present value of the future lease payments on the date of adoption. As a lessor, accounting for our subscription agreements will remain substantially unchanged. Refer to Note 6 for additional disclosures required by ASC 842.
The Company determines if an arrangement is a lease at inception based on whether control of an identified asset is transferred. For leases where the Company is the lessee, ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as amortization expense and interest expense. The Company has lease agreements which require payments for lease and non-lease components and has elected to account for these as a single lease component for our building and office equipment leases, but as separate components for our vehicle leases.

Our revenue under subscription agreements relates to both operating-type lease (“OTL”) arrangements and sales-type lease (“STL”) arrangements. Determination of an OTL or STL is primarily determined as a result of the length of the contract as compared to the estimated useful life of the instrument, among other factors. A STL results in earlier recognition of instrument revenue. The cost of the customer-leased instruments is removed from inventory and recognized in the Consolidated Statements of Income. There is no residual value taken into consideration as it does not meet our capitalization requirements. Instrument lease revenue for OTL agreements is recognized on a straight-line basis over the life of the lease and included with the predominant non-lease components in consumable revenue. The costs of customer-leased instruments are recorded within property and equipment in the accompanying Consolidated Balance Sheets and depreciated over the instrument’s estimated useful life. The depreciation expense is reflected in cost of revenue in the accompanying Consolidated Statements of Income. The OTLs and STLs are not cancellable until after an initial term and include an option to renew.
For lease arrangements with lease and non-lease components where the Company is the lessor, the Company allocates the total contract consideration to the lease and non-lease components on a relative standalone selling price basis using the Company’s best estimate of the standalone selling price of each distinct product or service in the contract. The primary method used to estimate standalone selling price is the price observed in standalone sales to customers of a prior period. Changes in these values can impact the amount of consideration allocated to each component of the contract. When prices in standalone sales are not available, we may use a cost-plus margin approach. Allocation of the transaction price is determined at the inception of the lease arrangement. The Company’s leases consist of leases with fixed and variable lease payments. For those leases with variable lease payments, the variable lease payment is typically based upon purchase of consumables used with the leased instruments and included in consumable revenue.
Accounting Pronouncements Not Yet Adopted

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326), which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected. The income statement reflects the measurement of credit losses for newly recognized financial assets, as well as the increases or decreases of expected credit losses that have taken place during the period. The measurement of expected credit losses is based upon historical experience, current conditions and reasonable and supportable forecasts that affect the collectability of the reported amount. Subsequent to the issuance of ASU 2016-13, the FASB issued ASU 2018-19, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, in November 2018. This ASU clarifies that receivables from operating leases are accounted for using the lease guidance and not as financial instruments. In April 2019, the FASB issued ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments, which further clarifies and improves guidance related to accounting for credit losses. In May 2019, the FASB issued ASU 2019-05, Financial Instruments - Credit Losses (Topic 326). This ASU provides relief to certain entities adopting ASU 2016-13. The amendment provides entities with an option to irrevocably elect the fair value option for certain financial assets. These amendments are effective for fiscal years beginning after December 15, 2019 and interim periods within those annual periods. We are currently evaluating the amended guidance and the impact on our consolidated financial statements and will adopt the provisions in the first quarter of 2020.
XML 27 R9.htm IDEA: XBRL DOCUMENT v3.19.2
REVENUE
 6 Months Ended
Jun. 30, 2019
Revenue from Contract with Customer [Abstract]  
REVENUE
REVENUE

We separate our goods and services among:

•
Point of Care laboratory products including instruments, consumables and services;
•
Point of Care imaging products including instruments, software and services;
•
Single use pharmaceuticals, vaccines and diagnostic tests primarily related to companion animals; and
•
Other vaccines and pharmaceuticals ("OVP").
The following table summarizes our Core Companion Animal ("CCA") revenue (in thousands):
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Point of Care laboratory revenue:
$
16,120

 
$
15,053

 
$
32,081

 
$
28,693

    Consumables
13,208

 
11,524

 
25,524

 
22,344

    Sales-type leases
1,493

 
1,793

 
3,234

 
3,331

    Outright instrument sales
1,045

 
1,335

 
2,575

 
2,146

    Other
374

 
401

 
748

 
872

 
 
 
 
 
 
 
 
Point of Care imaging revenue:
5,229

 
4,462

 
10,639

 
10,434

    Outright instrument sales
4,405

 
3,566

 
8,951

 
8,705

    Service revenue
558

 
544

 
1,120

 
1,099

    Operating type leases and other
266

 
352

 
568

 
630

 
 
 
 
 
 
 
 
Other CCA revenue:
3,367

 
7,129

 
6,712

 
14,336

    Other pharmaceuticals, vaccines and diagnostic tests
3,281

 
6,991

 
6,527

 
14,102

    Research and development, license and royalty
    revenue
86

 
138

 
185

 
234

 
 
 
 
 
 
 
 
Total CCA revenue
$
24,716

 
$
26,644

 
$
49,432

 
$
53,463


Revenue from our OVP segment consists of revenue generated from contract manufacturing agreements and from other license, research and development revenue. The following table summarizes our OVP revenue (in thousands):
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Contract manufacturing
$
3,327

 
$
2,887

 
$
7,994

 
$
8,678

License, research and development
103

 
131

 
231

 
286

Total OVP revenue
$
3,430

 
$
3,018

 
$
8,225

 
$
8,964



Remaining Performance Obligations

Remaining performance obligations represent the aggregate transaction price allocated to performance obligations with an original contract term greater than one year which are fully or partially unsatisfied at the end of the period. Remaining performance obligations include noncancelable purchase orders, the non-lease portion of minimum purchase commitments under long-term supply arrangements, extended warranty, service and other long-term contracts. Remaining performance obligations do not include revenue from contracts with customers with an original term of one year or less, revenue from long-term supply arrangements with no minimum purchase requirements, revenue expected from purchases made in excess of the minimum purchase requirements, or revenue from instruments leased to customers. While the remaining performance obligation disclosure is similar in concept to backlog, the definition of remaining performance obligations excludes leases and contracts that provide the customer with the right to cancel or terminate for convenience with no substantial penalty, even if historical experience indicates the likelihood of cancellation or termination is remote. Additionally, the Company has elected to exclude contracts with customers with an original term of one year or less from remaining performance obligations.

As of June 30, 2019, the aggregate amount of the transaction price allocated to remaining minimum performance obligations was approximately $89.5 million. As of June 30, 2019, the Company expects to recognize revenue as follows (in thousands):
Year Ending December 31,
Revenue
2019 (remaining)
$
12,289

2020
22,138

2021
18,315

2022
15,244

2023
11,848

Thereafter
9,641

 
$
89,475



Contract Balances

The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets) and deferred revenue, and customer deposits and billings in excess of revenue recognized (contract liabilities) on the Condensed Consolidated Balance Sheets. In addition, the Company defers certain costs incurred to obtain contracts (contract costs).

Contract Receivables

Certain unbilled receivable balances related to long-term contracts for which we provide a free term to the customer where revenue has been recognized are recorded in other current and other non-current assets. We have no further performance obligations related to these receivable balances and the collection of these balances occurs over the term of the underlying contract. The balances as of June 30, 2019 were $1.0 million and $3.5 million for current and non-current assets, respectively, shown net of related unearned interest. The balances as of December 31, 2018 were $0.9 million and $3.3 million for current and non-current assets, respectively, shown net of related unearned interest.

Contract Liabilities

The Company receives cash payments from customers for licensing fees or other arrangements that extend for a specified term. These contract liabilities are classified as either current or long-term in the Condensed Consolidated Balance Sheets based on the timing of when the Company expects to recognize revenue. As of June 30, 2019 and December 31, 2018, contract liabilities were $8.9 million and $9.6 million, respectively, and are included within "Current portion of deferred revenue, and other" and "Deferred revenue, net of current portion" in the accompanying Condensed Consolidated Balance Sheets. The decrease in the contract liability balance during the six-month period ended June 30, 2019 is approximately $1.5 million of revenue recognized during the period, offset by approximately $0.7 million of additional deferred sales in 2019.

Contract Costs

The Company capitalizes certain direct incremental costs incurred to obtain customer contracts, typically sales-related commissions, where the recognition period for the related revenue is greater than one year. Contract costs are classified as current or non-current, and are included in "Other current assets" and "Other non-current assets" in the Condensed Consolidated Balance Sheets based on the timing of when the Company expects to recognize the expense. Contract costs are generally amortized into selling and marketing expense with a certain percentage recognized immediately based upon placement of the instrument with the remainder recognized on a straight-line basis (which is consistent with the transfer of control for the related goods or services) over the average term of the underlying contracts, approximately 6 years. Management assesses these costs for impairment at least quarterly on a portfolio basis and as “triggering” events occur that indicate it is more-likely-than-not that an impairment exists. The balance of contract costs as of June 30, 2019 and December 31, 2018 was $2.6 million and $2.5 million, respectively. Amortization expense for the six-month period ended June 30, 2019 was approximately $0.5 million, offset by approximately $0.6 million of additional contract costs capitalized.

Contract liabilities are reported on the accompanying Condensed Consolidated Balance Sheets on a contract-by-contract basis whereas contract costs are calculated and reported on a portfolio basis.
XML 28 R10.htm IDEA: XBRL DOCUMENT v3.19.2
ACQUISITION AND RELATED PARTY ITEMS
 6 Months Ended
Jun. 30, 2019
Business Combinations and Related Party Disclosures [Abstract]  
ACQUISITION AND RELATED PARTY ITEMS
ACQUISITIONS AND RELATED PARTY ITEMS
Optomed
On February 22, 2019, Heska acquired 70% of the equity of Optomed, a French-based endoscopy company, in exchange for approximately $0.2 million in cash and the assumption of approximately $0.4 million in debt. As part of the purchase, Heska entered into put options and call options on the remaining 30% minority interest. The written put options can be exercised based on the achievement of certain financial conditions over a specified period of time for a fixed amount. The options are not currently exercisable at the acquisition date or the reporting date. The estimated value of the non-controlling interest is inclusive of the probability weighted outcome of the options described herein. The Company is in process of finalizing its purchase price allocation. As part of the purchase agreement, Heska has committed to purchase from the minority interest holder, by the end of the fiscal year, real estate in the amount of approximately $1.0 million, which is currently under lease by Optomed.
Cuattro Veterinary Acquisitions
In February 2013, the Company acquired a majority interest in Cuattro Veterinary USA, LLC, which was owned by Kevin S. Wilson, among other members. The subsidiary was subsequently renamed Heska Imaging US, LLC ("US Imaging"). The remaining minority position in US Imaging was subject to purchase by Heska under a performance-based put option which was exercised in March 2017. In May 2017, we purchased the remaining minority interest position in US Imaging.

In May 2016, the Company closed a transaction to acquire Cuattro Veterinary, LLC ("International Imaging"), which was owned by Kevin S. Wilson, among other members. International Imaging is a provider to international markets of digital radiography technologies for veterinarians. As a leading provider of advanced veterinary diagnostic and specialty products, we made the acquisition in an effort to combine International Imaging's global reach with our domestic success in the imaging and laboratory markets in the United States.

In June 2017, the Company consolidated its assets and liabilities in the US Imaging and International Imaging companies into Heska Imaging, LLC ("Heska Imaging"). Cuattro, LLC ("Cuattro") is owned by Kevin S. Wilson, the CEO and President of the Company in addition to Mrs. Wilson and trusts for the benefit of Mr. and Mrs. Wilson's children and family. Steven M. Asakowicz and Rodney A. Lippincott, members of Cuattro Veterinary USA, LLC and Cuattro International prior to the acquisitions, each serve as Executive Vice President, Companion Animal Health Sales for the Company.
Purchase Agreement for Certain Assets
On December 21, 2018, the Company closed a transaction (the "Asset Acquisition") to acquire certain assets from Cuattro, all related to the CCA segment. Pursuant to the Asset Acquisition, dated November 26, 2018, the Company issued 54,763 shares of the Company's common stock, $0.01 par value per share (the "Common Stock"), to Cuattro on the closing date, at an aggregate value equal to approximately $5.4 million based on the adjusted closing price per share of the Common Stock as reported on the Nasdaq Stock Market on the Asset Acquisition agreement date. These shares were issued to Cuattro in a private placement in reliance upon an exemption from the registration requirements of the Securities Act pursuant to Section 4(a)(2) thereof and the safe harbor provided by Rule 506 of Regulation D promulgated thereunder. In addition to the Common Stock, the Company paid cash in the amount of $2.8 million to Cuattro as part of the transaction. The total purchase price was determined based on a valuation report from an independent third party. Part of the Asset Acquisition was an agreement to terminate the supply and license agreement that Heska had been operating under since the acquisition of Cuattro Veterinary USA, LLC.
The Company evaluated the acquisition of the purchased assets under ASC 805, Business Combinations and ASU 2017-01, Business Combinations (Topic 805) and concluded that as substantially all of the fair value of the gross assets acquired is concentrated in an identifiable group of similar assets, the transaction did not meet the requirements to be accounted for as a business combination and therefore was accounted for as an asset acquisition. Accordingly, the purchase price of the purchased assets was allocated entirely to an identifiable intangible asset. In addition to the software assets acquired, Cuattro is obligated, without further compensation, to assist the Company with the implementation of a third-party image hosting platform and necessary data migration.
Other Related Party Activities
Cuattro charged Heska Imaging $6.0 thousand and $2.3 million during the six months ended June 30, 2019 and 2018, respectively. The charge in 2019 relates to minor inventory purchases as the Company transitions the digital imaging software assets away from Cuattro. The charge in 2018 was primarily for digital imaging products, pursuant to an underlying supply contract which was terminated in December 2018.

The Company had no receivables from or payables to Cuattro as of June 30, 2019. Heska Imaging owed Cuattro $0.2 million as of December 31, 2018, which is reported in "Due to – related parties" on the Company's Condensed Consolidated Balance Sheets.
XML 29 R11.htm IDEA: XBRL DOCUMENT v3.19.2
INVESTMENTS IN UNCONSOLIDATED AFFILIATES
 6 Months Ended
Jun. 30, 2019
Equity Method Investments and Joint Ventures [Abstract]  
INVESTMENTS IN UNCONSOLIDATED AFFILIATES
INVESTMENTS IN UNCONSOLIDATED AFFILIATES
The carrying values of investments in unconsolidated affiliates, categorized by type of investment, is as follows (in thousands):
 
June 30, 2019
 
December 31, 2018
Equity method investment
$
4,693

 
$
5,000

Non-marketable equity security investment
3,018

 
3,018

 
$
7,711

 
$
8,018


Equity Method Investment
On September 24, 2018, we invested $5.1 million, including costs, in exchange for a 28.7% interest of a business as part of our product development strategy. The Company accounts for this investment using the equity method of accounting. Under the equity method, the carrying value of the investment is adjusted for the Company's proportionate share of the investee's reported earnings or losses with the corresponding share of earnings or losses reported as Equity in losses of unconsolidated affiliates, listed below Net income before equity in losses of unconsolidated affiliates within the Condensed Consolidated Statements of Income. Additionally, the Company will enter into a 15-year Manufacturing Supply Agreement, which grants the Company global exclusivity to specified products.
Non-Marketable Equity Security Investment

On August 8, 2018, the Company invested $3.0 million, including costs, in MBio Diagnostics, Inc. ("MBio"), in exchange for preferred stock, representing a 6.9% interest in MBio. The Company’s investment in MBio is a non-marketable equity security, recorded using the measurement alternative of cost minus impairment, if any, plus or minus changes resulting from qualifying observable price changes.

As part of the agreement, the Company entered into a Supply and License Agreement with MBio, which provides that MBio produce and commercialize products that will enhance the Company's diagnostic portfolio. As part of this agreement, the Company made an upfront payment to MBio of $1.0 million related to a worldwide exclusive license agreement over a 20-year period, recorded in both short and long-term other assets. In addition, the agreement provides for an additional contingent payment from Heska to MBio of $10.0 million, relating to the successful achievement of sales milestones. This potential future milestone payment has not yet been accrued as it is not deemed by the Company to be probable at this time.

Both parties in this arrangement are active participants and are exposed to significant risks and rewards dependent on the commercial success of the activities of the collaboration. The parties are actively working on developing and testing the product as well as funding the research and development. Heska classifies the amounts paid for MBio's research and development work within the CCA segment research and development operating expenses. Expense is recognized ratably when incurred and in accordance with the development plan.
XML 30 R12.htm IDEA: XBRL DOCUMENT v3.19.2
INCOME TAXES
 6 Months Ended
Jun. 30, 2019
Income Tax Disclosure [Abstract]  
INCOME TAXES
INCOME TAXES

Our total income tax (benefit) expense for our (loss) income before income taxes were as follows (in thousands):
 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
 
2019
 
2018
 
2019
 
2018
(Loss) income before income taxes
 
$
(587
)
 
$
2,112

 
$
(646
)
 
$
3,987

Total income tax (benefit) expense
 
(426
)
 
215

 
(1,436
)
 
(65
)

    
There were cash payments of $28 thousand and cash refunds, net of payments, of $0.1 million, respectively, for income taxes for the three and six months ended June 30, 2019. There were $12 thousand and $30 thousand in cash payments for income taxes, net of refunds, for the three and six months ended June 30, 2018. The Company’s tax benefit increased to $0.4 million and $1.4 million for the three and six months ended June 30, 2019, respectively, compared to the tax expense of $0.2 million for the three months ended June 30, 2018 and tax benefit of $0.1 million for the six months ended June 30, 2018. The increase in tax benefits is due to lower financial income and stock-based compensation excess tax benefits recognized in our income statement. The Company recognized $0.3 million in excess tax benefits related to employee share-based compensation for the three months ended June 30, 2019 compared to $0.4 million recognized for the three months ended June 30, 2018. The Company recognized $1.4 million in excess tax benefits related to employee share-based compensation for the six months ended June 30, 2019 compared to $1.2 million recognized for the six months ended June 30, 2018.
XML 31 R13.htm IDEA: XBRL DOCUMENT v3.19.2
LEASES
 6 Months Ended
Jun. 30, 2019
Leases [Abstract]  
LEASES, LESSEE
LEASES

Lessee Accounting

The Company leases buildings, office equipment, and vehicles. The Company’s finance leases were not material as of June 30, 2019 and for the three and six month period then ended. ROU assets arising from finance leases are included in Property and equipment, net in the accompanying Condensed Consolidated Balance Sheets. The current portion of the finance lease liabilities are included in Current portion of deferred revenue, and other and the non-current portion of the finance lease liabilities are included in Other liabilities in the accompanying Condensed Consolidated Balance Sheets.

For the three and six months ended June 30, 2019, operating lease expense was $0.6 million and $1.1 million, respectively, including immaterial variable lease costs.

Supplemental cash flow information related to the Company's operating leases for the six months ended June 30, 2019 was as follows (in thousands):

Cash paid for amounts included in the measurement of operating lease liabilities
$
889

ROU assets obtained in exchange for operating lease obligations
341


The following table presents the weighted average remaining lease term and weighted average discount rate related to the Company's operating leases as of June 30, 2019:

Weighted average remaining lease term
4.2 years

Weighted average discount rate
4.45
%

The following table presents the maturity of the Company's operating lease liabilities as of June 30, 2019 (in thousands):
Remainder of 2019
$
1,052

2020
1,605

2021
1,429

2022
1,321

2023
1,766

Total operating lease payments
7,173

Less: imputed interest
669

Total operating lease liabilities
$
6,504



Lessor Accounting
 
In our CCA segment, primarily related to our Point of Care laboratory products, the Company enters into sales-type leases as part of our subscription agreements. The following table presents the maturity of the Company's undiscounted lease receivables as of June 30, 2019 (in thousands):

Year Ending December 31,
 
Remainder of 2019
$
1,614

2020
3,596

2021
3,574

2022
3,223

2023
2,431

Thereafter
1,974

 
$
16,412
LEASES, LESSOR
LEASES

Lessee Accounting

The Company leases buildings, office equipment, and vehicles. The Company’s finance leases were not material as of June 30, 2019 and for the three and six month period then ended. ROU assets arising from finance leases are included in Property and equipment, net in the accompanying Condensed Consolidated Balance Sheets. The current portion of the finance lease liabilities are included in Current portion of deferred revenue, and other and the non-current portion of the finance lease liabilities are included in Other liabilities in the accompanying Condensed Consolidated Balance Sheets.

For the three and six months ended June 30, 2019, operating lease expense was $0.6 million and $1.1 million, respectively, including immaterial variable lease costs.

Supplemental cash flow information related to the Company's operating leases for the six months ended June 30, 2019 was as follows (in thousands):

Cash paid for amounts included in the measurement of operating lease liabilities
$
889

ROU assets obtained in exchange for operating lease obligations
341


The following table presents the weighted average remaining lease term and weighted average discount rate related to the Company's operating leases as of June 30, 2019:

Weighted average remaining lease term
4.2 years

Weighted average discount rate
4.45
%

The following table presents the maturity of the Company's operating lease liabilities as of June 30, 2019 (in thousands):
Remainder of 2019
$
1,052

2020
1,605

2021
1,429

2022
1,321

2023
1,766

Total operating lease payments
7,173

Less: imputed interest
669

Total operating lease liabilities
$
6,504



Lessor Accounting
 
In our CCA segment, primarily related to our Point of Care laboratory products, the Company enters into sales-type leases as part of our subscription agreements. The following table presents the maturity of the Company's undiscounted lease receivables as of June 30, 2019 (in thousands):

Year Ending December 31,
 
Remainder of 2019
$
1,614

2020
3,596

2021
3,574

2022
3,223

2023
2,431

Thereafter
1,974

 
$
16,412
XML 32 R14.htm IDEA: XBRL DOCUMENT v3.19.2
EARNINGS PER SHARE
 6 Months Ended
Jun. 30, 2019
Earnings Per Share [Abstract]  
EARNINGS PER SHARE
EARNINGS PER SHARE

Basic earnings per share ("EPS") is computed by dividing net income attributable to the Company by the weighted-average number of common shares outstanding during the period. The computation of diluted EPS is similar to the computation of basic EPS except that the numerator is increased to exclude charges that would not have been incurred, and the denominator is increased to include the number of additional common shares that would have been outstanding (using the if-converted and treasury stock methods), if securities containing potentially dilutive common shares such as stock options converting to common shares, and if such assumed conversion is dilutive.

The following is a reconciliation of the weighted-average shares outstanding used in the calculation of basic and diluted EPS for the three and six months ended June 30, 2019 and 2018 (in thousands, except per share data):
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Net (loss) income attributable to Heska Corporation
$
(241
)
 
$
1,897

 
$
573

 
$
4,052

 
 
 
 
 
 
 
 
Basic weighted-average common shares outstanding
7,486

 
7,226

 
7,463

 
7,146

Assumed exercise of dilutive stock options and restricted shares
—

 
624

 
493

 
635

Diluted weighted-average common shares outstanding
$
7,486

 
$
7,850

 
$
7,956

 
$
7,781

 
 
 
 
 
 
 
 
Basic (loss) earnings per share attributable to Heska Corporation
$
(0.03
)
 
$
0.26

 
$
0.08

 
$
0.57

Diluted (loss) earnings per share attributable to Heska Corporation
$
(0.03
)
 
$
0.24

 
$
0.07

 
$
0.52



The following stock options and restricted shares were excluded from the computation of diluted EPS because they would have been anti-dilutive (in thousands):
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Stock options and restricted shares
714

 
169

 
225

 
238
XML 33 R15.htm IDEA: XBRL DOCUMENT v3.19.2
GOODWILL AND OTHER INTANGIBLES
 6 Months Ended
Jun. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND OTHER INTANGIBLES
GOODWILL AND OTHER INTANGIBLES

The following summarizes the change in goodwill during the six months ended June 30, 2019 (in thousands):
Carrying amount, December 31, 2018
$
26,679

Goodwill attributable to acquisitions (subject to change)
503

Foreign currency adjustments
8

Carrying amount, June 30, 2019
$
27,190



Other intangibles consisted of the following (in thousands):
 
June 30, 2019
 
December 31, 2018
 
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
 
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
Developed technology
$
8,200

 
$
(410
)
 
$
7,790

 
$
8,200

 
$
—

 
$
8,200

Customer relationships and other
3,700

 
(1,964
)
 
1,736

 
3,303

 
(1,739
)
 
1,564

Total intangible assets
$
11,900

 
$
(2,374
)
 
$
9,526

 
$
11,503

 
$
(1,739
)
 
$
9,764


Amortization expense relating to other intangibles was as follows (in thousands):
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Amortization expense
$
305

 
$
97

 
$
607

 
$
194



Estimated amortization expense related to intangibles for each of the five years from 2019 (remaining) through 2023 and thereafter is as follows (in thousands):
Year Ending December 31,
 
2019 (remaining)
$
666

2020
1,287

2021
1,283

2022
1,265

2023
918

Thereafter
4,107

 
$
9,526
XML 34 R16.htm IDEA: XBRL DOCUMENT v3.19.2
PROPERTY AND EQUIPMENT
 6 Months Ended
Jun. 30, 2019
Property, Plant and Equipment [Abstract]  
PROPERTY AND EQUIPMENT
PROPERTY AND EQUIPMENT, NET
Property and equipment, net, consisted of the following (in thousands):
 
June 30, 2019
 
December 31, 2018
Land
$
377

 
$
377

Building
2,978

 
2,978

Machinery and equipment
31,013

 
33,087

Office furniture and equipment
1,700

 
1,687

Computer hardware and software
4,749

 
4,704

Leasehold and building improvements
9,981

 
9,953

Construction in progress
1,309

 
1,274

 
52,107

 
54,060

Less accumulated depreciation
(36,789
)
 
(38,079
)
Total property and equipment, net
$
15,318

 
$
15,981


Depreciation expense was $0.9 million and $1.0 million for the three months ended June 30, 2019 and 2018, respectively, and $1.9 million and $2.1 million for the six months ended June 30, 2019 and 2018, respectively.
The Company has subscription agreements whereby its instruments in inventory may be placed at a customer's location on a rental basis. The cost of these instruments is transferred to machinery and equipment and depreciated, typically over a 5 to 7 year period depending on the circumstance under which the instrument is placed with the customer. Our cost of instruments under operating leases as of June 30, 2019 and December 31, 2018, was $10.3 million and $10.8 million, respectively, before accumulated depreciation of $5.7 million and $6.1 million, respectively.
XML 35 R17.htm IDEA: XBRL DOCUMENT v3.19.2
INVENTORIES, NET
 6 Months Ended
Jun. 30, 2019
Inventory Disclosure [Abstract]  
INVENTORIES, NET
INVENTORIES, NET

Inventories, net, consisted of the following (in thousands):
 
June 30, 2019
 
December 31, 2018
Raw materials
$
16,832

 
$
15,000

Work in process
3,807

 
3,592

Finished goods
9,548

 
8,085

Allowance for excess or obsolete inventory
(1,210
)
 
(1,573
)
Total inventory, net
$
28,977

 
$
25,104



Inventories are measured on a first-in, first-out basis and stated at lower of cost or net realizable value.
XML 36 R18.htm IDEA: XBRL DOCUMENT v3.19.2
ACCRUED LIABILITIES
 6 Months Ended
Jun. 30, 2019
Payables and Accruals [Abstract]  
ACCRUED LIABILITIES
ACCRUED LIABILITIES
Accrued liabilities consisted of the following (in thousands):
 
June 30, 2019
 
December 31, 2018
Accrued settlement (see Note 14)
$
—

 
$
6,750

Accrued payroll and employee benefits
1,118

 
759

Accrued property taxes
402

 
632

Other
2,235

 
2,001

Total accrued liabilities
$
3,755

 
$
10,142


Other accrued liabilities consists of items that are individually less than 5% of total current liabilities.
XML 37 R19.htm IDEA: XBRL DOCUMENT v3.19.2
CAPITAL STOCK
 6 Months Ended
Jun. 30, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
CAPITAL STOCK
CAPITAL STOCK
Stock Option Plans
The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions for options granted in the three and six months ended June 30, 2019 and 2018.
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Risk-free interest rate
1.89%
 
2.76%
 
1.95%
 
2.64%
Expected lives
4.7 years
 
4.9 years
 
4.7 years
 
4.9 years
Expected volatility
40%
 
40%
 
40%
 
40%
Expected dividend yield
0%
 
0%
 
0%
 
0%

A summary of our stock option plans is as follows:
 
Six Months Ended June 30,
 
Year Ended December 31,
 
2019
 
2018
 
 
 
 
Options
 
Weighted Average Exercise Price
 
 
 
 
Options
 
Weighted Average Exercise Price
Outstanding at beginning of period
620,553

 
$
40.741

 
630,847

 
$
29.312

Granted at market
11,200

 
$
73.193

 
153,700

 
$
75.244

Forfeited
(256
)
 
$
98.660

 
(18,978
)
 
$
53.010

Expired
—

 
$
—

 
(896
)
 
$
65.414

Exercised
(149,828
)
 
$
16.776

 
(144,120
)
 
$
25.740

Outstanding at end of period
481,669

 
$
48.920

 
620,553

 
$
40.741

Exercisable at end of period
305,452

 
$
33.655

 
386,176

 
$
21.214


The total estimated fair value of stock options granted during the six months ended June 30, 2019 and 2018 was computed to be approximately $0.3 million and $3.5 million, respectively. The amounts are amortized ratably over the vesting periods of the options. The weighted average estimated fair value of options granted during the six months ended June 30, 2019 and 2018 was computed to be approximately $26.67 and $26.74, respectively. The total intrinsic value of options exercised during the six months ended June 30, 2019 and 2018 was $11.6 million and $3.1 million, respectively. The cash proceeds from options exercised during the six months ended June 30, 2019 and 2018 was $0.5 million and $1.3 million, respectively.
The following table summarizes information about stock options outstanding and exercisable at June 30, 2019:
 
 
Options Outstanding
 
Options Exercisable
Exercise Prices
 
Number of
Options
Outstanding
at
June 30, 2019
 
Weighted
Average
Remaining
Contractual
Life in Years
 
Weighted
Average
Exercise
Price
 
Number of
Options
Exercisable
at
June 30, 2019
 
Weighted
Average
Exercise
Price
$ 4.96 - $ 7.36
 
93,352

 
3.65
 
$
6.998

 
93,352

 
$
6.998

$ 7.37 - $ 32.21
 
79,273

 
4.79
 
$
15.897

 
78,941

 
$
15.828

$ 32.22 - $ 62.50
 
57,533

 
6.57
 
$
39.797

 
46,524

 
$
39.724

$ 62.51 - $ 69.77
 
130,000

 
8.68
 
$
69.770

 
43,337

 
$
69.770

$ 69.78 - $ 108.25
 
121,511

 
8.10
 
$
84.684

 
43,298

 
$
80.960

$ 4.96 - $ 108.25
 
481,669

 
6.67
 
$
48.920

 
305,452

 
$
33.655


As of June 30, 2019, there was approximately $4.3 million in total unrecognized compensation cost related to outstanding stock options. That cost is expected to be recognized over a weighted average period of 1.36 years, with all cost to be recognized by the end of February 2023, assuming all options vest according to the vesting schedules in place at June 30, 2019. As of June 30, 2019, the aggregate intrinsic value of outstanding options was approximately $18.3 million and the aggregate intrinsic value of exercisable options was approximately $15.9 million.
The Company issues new shares upon share option exercise, which may be netted or withheld to meet strike price or related tax obligations.
Employee Stock Purchase Plan (the "ESPP")

For the three months ended June 30, 2019 and 2018, we issued 2,786 and 2,327 shares under the ESPP, respectively. For the six months ended June 30, 2019 and 2018, we issued 5,369 and 5,454 shares under the ESPP, respectively.
For the three and six months ended June 30, 2019 and 2018, we estimated the fair values of stock purchase rights granted under the ESPP using the Black-Scholes pricing model. The weighted average assumptions used for the periods presented were as follows:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Risk-free interest rate
2.21%
 
1.09%
 
2.27%
 
1.06%
Expected lives
1.1 years
 
1.2 years
 
1.1 years
 
1.2 years
Expected volatility
39%
 
44%
 
39%
 
44%
Expected dividend yield
0%
 
0%
 
0%
 
0%

For the three months ended June 30, 2019 and 2018, the weighted-average fair value of the purchase rights granted was $18.69 and $17.98 per share, respectively. For the six months ended June 30, 2019 and 2018, the weighted-average fair value of the purchase rights granted was $18.82 and $15.86 per share, respectively.
Restricted Stock Issuances
We have granted non-vested restricted stock awards (“restricted stock” or "RSAs") to management and non-employee directors pursuant to the Company's amended and restated Stock Incentive Plan. The restricted stock awards have varying vesting periods, but generally become fully vested between one and four years after the grant date, depending on the specific award, performance targets met for performance-based awards granted to management, and vesting periods for time based awards. Management performance-based awards are granted at the target amount of shares that may be earned. We valued the restricted stock awards related to service and/or company performance targets based on grant date fair value and expense over the period when achievement of those conditions is deemed probable. For restricted stock awards related to market conditions, we utilize a Monte Carlo simulation model to estimate grant date fair value and expense over the requisite period. We recognize forfeitures as they occur. There were no modifications that affected our accounting for restricted stock awards in the six months ended June 30, 2019 or 2018.
The following table summarizes restricted stock transactions for the six months ended June 30, 2019:
 
RSAs
 
Weighted-Average Grant Date Fair Value Per Award
Non-vested as of December 31, 2018
259,430

 
$
74.26

     Granted
18,567

 
71.38

     Vested
(4,230
)
 
85.09

     Forfeited
(500
)
 
80.90

Non-vested as of June 30, 2019
273,267

 
$
73.90



The weighted average grant date fair value of awards granted was $71.35 and $85.09 for the three months ended June 30, 2019 and 2018, respectively. The weighted average grant date fair value of awards granted was $71.38 and $67.76 for the six months ended June 30, 2019 and 2018, respectively. Fair value of restricted stock vested was $0.3 million and $0.3 million for the three months ended June 30, 2019 and 2018, respectively. Fair value of restricted stock vested was $0.3 million and $4.4 million for the six months ended June 30, 2019 and 2018, respectively.

As of June 30, 2019, there was approximately $2.6 million of total unrecognized compensation cost related to restricted stock with market and time vesting conditions. The Company expects to recognize this expense over a weighted average period of 1.3 years. As of June 30, 2019, we reviewed each of the underlying corporate performance targets and determined that approximately 176,000 of shares of common stock were related to company performance targets in which we did not deem achievement probable. No compensation expense had been recorded at any period prior to June 30, 2019.
Restrictions on the transfer of Company stock

The Company's Restated Certificate of Incorporation, as amended (the "Certificate of Incorporation"), places restrictions (the "Transfer Restrictions") on the transfer of the Company's stock that could adversely affect the Company's ability to utilize its domestic Federal Net Operating Loss Position. In particular, the Transfer Restrictions prevent the transfer of shares without the approval of the Company's Board of Directors if, as a consequence of such transfer, an individual, entity or groups of individuals or entities would become a 5-percent holder under Section 382 of the Internal Revenue Code of 1986, as amended, and the related Treasury regulations, and also prevents any existing 5-percent holder from increasing his or her ownership position in the Company without the approval of the Company's Board of Directors. Any transfer of shares in violation of the Transfer Restrictions (a "Transfer Violation") shall be void ab initio under the Certificate of Incorporation, and the Company's Board of Directors has procedures under the Certificate of Incorporation to remedy a Transfer Violation including requiring the shares causing such Transfer Violation to be sold and any profit resulting from such sale to be transferred to a charitable entity chosen by the Company's Board of Directors in specified circumstances.
XML 38 R20.htm IDEA: XBRL DOCUMENT v3.19.2
ACCUMULATED OTHER COMPREHENSIVE INCOME
 6 Months Ended
Jun. 30, 2019
Equity [Abstract]  
ACCUMULATED OTHER COMPREHENSIVE INCOME
ACCUMULATED OTHER COMPREHENSIVE INCOME
Accumulated other comprehensive income (loss) consisted of the following (in thousands):
 
Minimum Pension Liability
 
Foreign Currency Translation
 
Total Accumulated Other Comprehensive Income
Balances at December 31, 2018
$
(419
)
 
$
696

 
$
277

Current period other comprehensive income
—

 
21

 
21

Balances at June 30, 2019
$
(419
)
 
$
717

 
$
298
XML 39 R21.htm IDEA: XBRL DOCUMENT v3.19.2
COMMITMENTS AND CONTINGENCIES
 6 Months Ended
Jun. 30, 2019
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES
Royalty Agreements
The Company holds certain rights to market and manufacture products developed or created under certain research, development, and licensing agreements with various entities. In connection with such agreements, the Company has agreed to pay the entities royalties on net product sales. In each of the three months ended June 30, 2019 and 2018, royalties of $0.1 million became payable under these agreements. In each of the six months ended June 30, 2019 and 2018, royalties of $0.2 million became payable under these agreements.
Warranties

The Company's current terms and conditions of sale include a limited warranty that its products and services will conform to published specifications at the time of shipment and a more extensive warranty related to certain products. The Company also sells a renewal warranty for certain of its products. The typical remedy for breach of warranty is to correct or replace any defective product, and if not possible or practical, the Company will accept the return of the defective product and refund the amount paid. Historically, the Company has incurred minimal warranty costs. The Company's warranty reserve was $0.2 million at both June 30, 2019 and December 31, 2018.

Litigation
From time to time, the Company may be involved in litigation relating to claims arising out of its operations. The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred, and the amount can be reasonably estimated.

On October 10, 2018, we reached an agreement in principle to settle the complaint that was filed against the Company by Shaun Fauley on March 12, 2015 in the U.S. District Court Northern District of Illinois (the "Court") alleging our transmittal of unauthorized faxes in violation of the federal Telephone Consumer Protection Act of 1991, as amended by the Junk Fax Prevention Act of 2005, as a class action (the "Fauley Complaint"). The settlement, which received the Court's approval on February 28, 2019 and was not subsequently appealed by a class member, required us to make available a total of $6.8 million to pay class members, as well as to pay attorneys' fees and expenses to legal counsel to the class. The Company recorded the loss provision in the third quarter of 2018 in connection with the settlement agreement and does not have insurance coverage for the Fauley Complaint. The payment in respect of the settlement was made in full on April 3, 2019, and all activity related to the Fauley Complaint has ceased.
As of June 30, 2019, the Company was not a party to any other legal proceedings that were expected, individually or in the aggregate, to have a material adverse effect on its business, financial condition, or operating results.

Off-Balance Sheet Commitments

Unconditional Purchase Obligations
The Company has contractual obligations with suppliers for unconditional annual minimum inventory purchases in the amounts of $16.7 million as of June 30, 2019.
XML 40 R22.htm IDEA: XBRL DOCUMENT v3.19.2
INTEREST AND OTHER EXPENSE, NET
 6 Months Ended
Jun. 30, 2019
Other Income and Expenses [Abstract]  
INTEREST AND OTHER EXPENSE, NET
INTEREST AND OTHER EXPENSE, NET
Interest and other expense, net, consisted of the following (in thousands):
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Interest income
$
(133
)
 
$
(63
)
 
$
(225
)
 
$
(119
)
Interest expense
147

 
77

 
224

 
142

Other expense, net
7

 
78

 
6

 
65

Total interest and other expense, net
$
21

 
$
92

 
$
5

 
$
88


Cash paid for interest for the three months ended June 30, 2019 and 2018 was $71 thousand and $58 thousand, respectively. Cash paid for interest for the six months ended June 30, 2019 and 2018 was $127 thousand and $85 thousand, respectively.
XML 41 R23.htm IDEA: XBRL DOCUMENT v3.19.2
CREDIT FACILITY
 6 Months Ended
Jun. 30, 2019
Debt Disclosure [Abstract]  
CREDIT FACILITY
CREDIT FACILITY

On July 27, 2017, and subsequently amended in May 2018, December 2018 and July 2019, we entered into a Credit Agreement (the "Credit Agreement") with JPMorgan Chase Bank, N.A. ("Chase") which provides for a revolving credit facility up to $30.0 million (the "Credit Facility"). The Credit Facility provides us with the ability to borrow up to $30.0 million although the amount of the Credit Facility may be increased by an additional $20.0 million up to a total of $50.0 million subject to receipt of additional lender commitments and other conditions. Any interest on borrowings due is to be charged at either the (i) rate of interest per annum publicly announced from time to time by Chase as its prime rate in effect at its principal offices in New York City, subject to a floor, minus 1.65%, or (ii) the interest rate per annum equal to (a) LIBOR for the interest period in effect multiplied by (b) Chase's Statutory Reserve Rate (as defined in the Credit Agreement), plus 1.10% and payable monthly. There is an annual minimum interest charge of $60 thousand under the Credit Agreement. Chase holds first right of priority over all other liens, if any were to exist. Borrowings under the Credit Facility are subject to certain financial and non-financial covenants and are available for various corporate purposes, including general working capital, capital investments, and certain permitted acquisitions. Failure to comply with any of the covenants, representations or warranties could result in our being in default on the loan and could cause all outstanding amounts payable to Chase to become immediately due and payable or impact our ability to borrow under the agreement. The Credit Agreement also permits us to issue letters of credit, although there are currently none outstanding. The maturity date of the Credit Facility is July 27, 2020. The foregoing discussion of the Credit Facility is a summary only and is qualified in its entirety by reference to the full text of the Credit Agreement, a copy of which has been filed as an exhibit to the Company's Current Report on Form 8-K filed with the SEC on August 2, 2017, incorporated herein by reference. Additionally, the following amendments are included in summary only and are qualified in their entirety by reference to the full text of the First Facility Amendment, a copy of which has been filed as an exhibit to the Company's Quarterly Report on Form 10-Q filed with the SEC on August 8, 2018, the Second Facility Amendment, a copy of which has been filed as an exhibit to the Company's Annual Report on Form 10-K filed with the SEC on March 7, 2019 and the Third Facility Amendment, a copy of which has been filed as an exhibit to this Quarterly Report on Form 10-Q filed with the SEC on August 7, 2019, each of which are incorporated herein by reference.

At June 30, 2019, we had a $12.8 million line of credit outstanding under the Credit Facility and we were in compliance with all financial covenants.
XML 42 R24.htm IDEA: XBRL DOCUMENT v3.19.2
SEGMENT REPORTING
 6 Months Ended
Jun. 30, 2019
Segment Reporting [Abstract]  
SEGMENT REPORTING
SEGMENT REPORTING
The Company is composed of two reportable segments: CCA and OVP. The CCA segment includes Point of Care diagnostic laboratory instruments and consumables, and Point of Care digital imaging diagnostic instruments and software services as well as single use diagnostic and other tests, pharmaceuticals and vaccines, primarily for canine and feline use. These products are sold directly by the Company as well as through independent third-party distributors and through other distribution relationships. CCA segment products manufactured at the Des Moines, Iowa production facility included in the OVP segment's assets are transferred at cost and are not recorded as revenue for the OVP segment. The OVP segment includes private label vaccine and pharmaceutical production, primarily for cattle, but also for other animals including small mammals. All OVP products are sold by third parties under third-party labels.

Summarized financial information concerning the Company's reportable segments is shown in the following tables (in thousands):
Three Months Ended June 30, 2019
 
Core Companion Animal
 
Other Vaccines and Pharmaceuticals
 
 
 
Total
Total revenue
 
$
24,716

 
$
3,430

 
$
28,146

Operating loss
 
(254
)
 
(312
)
 
(566
)
Loss before income taxes
 
(275
)
 
(312
)
 
(587
)
Capital expenditures
 
32

 
363

 
395

Depreciation and amortization
 
934

 
323

 
1,257

Three Months Ended June 30, 2018
 
Core Companion Animal
 
Other Vaccines and Pharmaceuticals
 
 
 
Total
Total revenue
 
$
26,644

 
$
3,018

 
$
29,662

Operating (loss) income
 
2,864

 
(660
)
 
2,204

(Loss) income before income taxes
 
2,772

 
(660
)
 
2,112

Capital expenditures
 
39

 
397

 
436

Depreciation and amortization
 
838

 
300

 
1,138



Six Months Ended June 30, 2019
 
Core Companion Animal
 
Other Vaccines and Pharmaceuticals
 
 
 
Total
Total revenue
 
$
49,432

 
$
8,225

 
$
57,657

Operating loss
 
(305
)
 
(336
)
 
(641
)
Loss before income taxes
 
(310
)
 
(336
)
 
(646
)
Capital expenditures
 
76

 
553

 
629

Depreciation and amortization
 
1,881

 
641

 
2,522



Six Months Ended June 30, 2018
 
Core Companion Animal
 
Other Vaccines and Pharmaceuticals
 
 
 
Total
Total revenue
 
$
53,463

 
$
8,964

 
$
62,427

Operating (loss) income
 
4,787

 
(712
)
 
4,075

(Loss) income before income taxes
 
4,699

 
(712
)
 
3,987

Capital expenditures
 
96

 
715

 
811

Depreciation and amortization
 
1,746

 
587

 
2,333



Asset information by reportable segment as of June 30, 2019 is as follows (in thousands):
As of June 30, 2019
 
Core Companion Animal
 
Other Vaccines and Pharmaceuticals
 
Total
Investments in unconsolidated affiliates
 
$
7,711

 
$
—

 
$
7,711

Total assets
 
139,036

 
23,808

 
162,844

Net assets
 
103,455

 
19,797

 
123,252


Asset information by reportable segment as of December 31, 2018 is as follows (in thousands):
As of December 31, 2018
 
Core Companion Animal
 
Other Vaccines and Pharmaceuticals
 
Total
Investments in unconsolidated affiliates
 
$
8,018

 
$
—

 
$
8,018

Total assets
 
133,586

 
22,866

 
156,452

Net assets
 
96,129

 
26,280

 
122,409
XML 43 R25.htm IDEA: XBRL DOCUMENT v3.19.2
OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 6 Months Ended
Jun. 30, 2019
Accounting Policies [Abstract]  
Basis of Presentation and Consolidation
In the opinion of management, the accompanying unaudited Condensed Consolidated Financial Statements contain all adjustments, consisting of normal, recurring adjustments, necessary to present fairly the financial position of the Company as of June 30, 2019 and December 31, 2018, the results of our operations and statements of stockholders' equity for the three and six months ended June 30, 2019 and 2018, and cash flows for the six months ended June 30, 2019 and 2018.
The unaudited Condensed Consolidated Financial Statements included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") have been condensed or omitted pursuant to such rules and regulations. Our unaudited Condensed Consolidated Financial Statements include our accounts and the accounts of our wholly-owned subsidiaries since their respective dates of acquisitions. All intercompany accounts and transactions have been eliminated in consolidation. Where our ownership of a subsidiary is less than 100%, the non-controlling interest is reported on our Condensed Consolidated Balance Sheets. The non-controlling interest in our consolidated net income is reported as "Net loss attributable to redeemable non-controlling interest" on our Condensed Consolidated Statements of Income. These unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018 and other financial information filed with the SEC.
Reclassification
To maintain consistency and comparability, certain amounts in the financial statements have been reclassified to conform to current year presentation.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates are required when establishing the allowance for doubtful accounts and the net realizable value of inventory; determining future costs associated with warranties provided; determining the period over which our obligations are fulfilled under agreements to license product rights and/or technology rights; evaluating long-lived and intangible assets and investments for estimated useful lives and impairment; estimating the useful lives of instruments under leasing arrangements; determining the allocation of purchase price under purchase accounting; estimating the expense associated with the granting of stock; determining the need for, and the amount of a valuation allowance on deferred tax assets; and determining the value of the non-controlling interest in a business combination.
Recent Accounting Pronouncements
Adoption of New Accounting Pronouncements

Effective January 1, 2019, we adopted ASU 2018-07, Compensation – Stock Compensation (Topic 718), Improvements to Non-employee Share-Based Payment Accounting. This ASU is intended to simplify aspects of share-based compensation issued to non-employees by making the guidance consistent with accounting for employee share-based compensation. Guidance related to the stock compensation granted to employees is followed for non-employees, including the measurement date, valuation approach and performance conditions. The expense is recognized in the same period as though cash were paid for the good or service, ratably over the service period. The adoption of this ASU did not have an impact on our consolidated financial statements but did have a minimal impact on our related disclosures.

Effective January 1, 2019, we adopted ASU 2018-02, Income Statement-Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. The ASU permits companies to elect a reclassification of the disproportionate tax effects in accumulated other comprehensive income ("AOCI") caused by the Tax Cuts and Jobs Act of 2017 to retained earnings. As of June 30, 2019, the Company does not have any disproportionate income tax effects in AOCI to reclassify. However, if the Company did have disproportionate income tax effects in AOCI in the future, it would reclassify them to retained earnings.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which supersedes ASC 840, Leases. This update requires lessees to recognize a right-of-use (“ROU”) asset and a lease liability for all leases, including operating leases, with terms greater than 12 months on its balance sheet. The update also expands the required quantitative and qualitative disclosures by lessees and lessors about the amount, timing and uncertainty of cash flows arising from leases. The accounting for lessors does not fundamentally change except for changes to conform and align guidance to the lessee guidance as well as to the new revenue recognition guidance in ASU 2014-09, Revenue from Contracts with Customers (Topic 606). Subsequent to the issuance of Topic 842, the FASB clarified the guidance through several ASUs; hereinafter the collection of lease guidance is referred to as “ASC 842”.

The Company adopted ASC 842 on January 1, 2019, using the modified retrospective approach for all lease arrangements at the beginning of the period of adoption. Results for reporting periods beginning January 1, 2019 are presented under ASC 842, while prior period amounts were not adjusted and continue to be reported in accordance with the Company’s historic accounting under ASC 840, Leases. For leases that commenced before the effective date of ASC 842, the Company elected the permitted practical expedients to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. The Company also elected to exclude leases with a term of 12 months or less from the recognized ROU assets and lease liabilities.

Adoption of the standard did not have a material net impact in our Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Income or Condensed Consolidated Statements of Cash Flows. The most significant impact was the recognition of ROU assets and lease liabilities for the operating leases, of which we are the lessee. As a result of the cumulative impact of adopting ASC 842, the Company recorded operating lease ROU assets of $6.5 million and operating lease liabilities of $6.9 million as of January 1, 2019, primarily related to building, vehicle, and office equipment leases, based on the present value of the future lease payments on the date of adoption. As a lessor, accounting for our subscription agreements will remain substantially unchanged. Refer to Note 6 for additional disclosures required by ASC 842.
The Company determines if an arrangement is a lease at inception based on whether control of an identified asset is transferred. For leases where the Company is the lessee, ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as amortization expense and interest expense. The Company has lease agreements which require payments for lease and non-lease components and has elected to account for these as a single lease component for our building and office equipment leases, but as separate components for our vehicle leases.

Our revenue under subscription agreements relates to both operating-type lease (“OTL”) arrangements and sales-type lease (“STL”) arrangements. Determination of an OTL or STL is primarily determined as a result of the length of the contract as compared to the estimated useful life of the instrument, among other factors. A STL results in earlier recognition of instrument revenue. The cost of the customer-leased instruments is removed from inventory and recognized in the Consolidated Statements of Income. There is no residual value taken into consideration as it does not meet our capitalization requirements. Instrument lease revenue for OTL agreements is recognized on a straight-line basis over the life of the lease and included with the predominant non-lease components in consumable revenue. The costs of customer-leased instruments are recorded within property and equipment in the accompanying Consolidated Balance Sheets and depreciated over the instrument’s estimated useful life. The depreciation expense is reflected in cost of revenue in the accompanying Consolidated Statements of Income. The OTLs and STLs are not cancellable until after an initial term and include an option to renew.
For lease arrangements with lease and non-lease components where the Company is the lessor, the Company allocates the total contract consideration to the lease and non-lease components on a relative standalone selling price basis using the Company’s best estimate of the standalone selling price of each distinct product or service in the contract. The primary method used to estimate standalone selling price is the price observed in standalone sales to customers of a prior period. Changes in these values can impact the amount of consideration allocated to each component of the contract. When prices in standalone sales are not available, we may use a cost-plus margin approach. Allocation of the transaction price is determined at the inception of the lease arrangement. The Company’s leases consist of leases with fixed and variable lease payments. For those leases with variable lease payments, the variable lease payment is typically based upon purchase of consumables used with the leased instruments and included in consumable revenue.
Accounting Pronouncements Not Yet Adopted

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326), which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected. The income statement reflects the measurement of credit losses for newly recognized financial assets, as well as the increases or decreases of expected credit losses that have taken place during the period. The measurement of expected credit losses is based upon historical experience, current conditions and reasonable and supportable forecasts that affect the collectability of the reported amount. Subsequent to the issuance of ASU 2016-13, the FASB issued ASU 2018-19, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, in November 2018. This ASU clarifies that receivables from operating leases are accounted for using the lease guidance and not as financial instruments. In April 2019, the FASB issued ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments, which further clarifies and improves guidance related to accounting for credit losses. In May 2019, the FASB issued ASU 2019-05, Financial Instruments - Credit Losses (Topic 326). This ASU provides relief to certain entities adopting ASU 2016-13. The amendment provides entities with an option to irrevocably elect the fair value option for certain financial assets. These amendments are effective for fiscal years beginning after December 15, 2019 and interim periods within those annual periods. We are currently evaluating the amended guidance and the impact on our consolidated financial statements and will adopt the provisions in the first quarter of 2020.
XML 44 R26.htm IDEA: XBRL DOCUMENT v3.19.2
REVENUE (Tables)
 6 Months Ended
Jun. 30, 2019
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
The following table summarizes our Core Companion Animal ("CCA") revenue (in thousands):
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Point of Care laboratory revenue:
$
16,120

 
$
15,053

 
$
32,081

 
$
28,693

    Consumables
13,208

 
11,524

 
25,524

 
22,344

    Sales-type leases
1,493

 
1,793

 
3,234

 
3,331

    Outright instrument sales
1,045

 
1,335

 
2,575

 
2,146

    Other
374

 
401

 
748

 
872

 
 
 
 
 
 
 
 
Point of Care imaging revenue:
5,229

 
4,462

 
10,639

 
10,434

    Outright instrument sales
4,405

 
3,566

 
8,951

 
8,705

    Service revenue
558

 
544

 
1,120

 
1,099

    Operating type leases and other
266

 
352

 
568

 
630

 
 
 
 
 
 
 
 
Other CCA revenue:
3,367

 
7,129

 
6,712

 
14,336

    Other pharmaceuticals, vaccines and diagnostic tests
3,281

 
6,991

 
6,527

 
14,102

    Research and development, license and royalty
    revenue
86

 
138

 
185

 
234

 
 
 
 
 
 
 
 
Total CCA revenue
$
24,716

 
$
26,644

 
$
49,432

 
$
53,463


Revenue from our OVP segment consists of revenue generated from contract manufacturing agreements and from other license, research and development revenue. The following table summarizes our OVP revenue (in thousands):
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Contract manufacturing
$
3,327

 
$
2,887

 
$
7,994

 
$
8,678

License, research and development
103

 
131

 
231

 
286

Total OVP revenue
$
3,430

 
$
3,018

 
$
8,225

 
$
8,964
Schedule of Timing of Revenue Expected to be Recognized
As of June 30, 2019, the Company expects to recognize revenue as follows (in thousands):
Year Ending December 31,
Revenue
2019 (remaining)
$
12,289

2020
22,138

2021
18,315

2022
15,244

2023
11,848

Thereafter
9,641

 
$
89,475
XML 45 R27.htm IDEA: XBRL DOCUMENT v3.19.2
INVESTMENTS IN UNCONSOLIDATED AFFILIATES (Tables)
 6 Months Ended
Jun. 30, 2019
Equity Method Investments and Joint Ventures [Abstract]  
Carrying values of investments in unconsolidated entities
The carrying values of investments in unconsolidated affiliates, categorized by type of investment, is as follows (in thousands):
 
June 30, 2019
 
December 31, 2018
Equity method investment
$
4,693

 
$
5,000

Non-marketable equity security investment
3,018

 
3,018

 
$
7,711

 
$
8,018
XML 46 R28.htm IDEA: XBRL DOCUMENT v3.19.2
INCOME TAXES (Tables)
 6 Months Ended
Jun. 30, 2019
Income Tax Disclosure [Abstract]  
Schedule of components of income tax expense
Our total income tax (benefit) expense for our (loss) income before income taxes were as follows (in thousands):
 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
 
2019
 
2018
 
2019
 
2018
(Loss) income before income taxes
 
$
(587
)
 
$
2,112

 
$
(646
)
 
$
3,987

Total income tax (benefit) expense
 
(426
)
 
215

 
(1,436
)
 
(65
)
XML 47 R29.htm IDEA: XBRL DOCUMENT v3.19.2
LEASES (Tables)
 6 Months Ended
Jun. 30, 2019
Leases [Abstract]  
Additional lease information
Supplemental cash flow information related to the Company's operating leases for the six months ended June 30, 2019 was as follows (in thousands):

Cash paid for amounts included in the measurement of operating lease liabilities
$
889

ROU assets obtained in exchange for operating lease obligations
341


The following table presents the weighted average remaining lease term and weighted average discount rate related to the Company's operating leases as of June 30, 2019:

Weighted average remaining lease term
4.2 years

Weighted average discount rate
4.45
%
Schedule of maturity of operating leases
The following table presents the maturity of the Company's operating lease liabilities as of June 30, 2019 (in thousands):
Remainder of 2019
$
1,052

2020
1,605

2021
1,429

2022
1,321

2023
1,766

Total operating lease payments
7,173

Less: imputed interest
669

Total operating lease liabilities
$
6,504
Lessor, maturity of undiscounted lease receivables
The following table presents the maturity of the Company's undiscounted lease receivables as of June 30, 2019 (in thousands):

Year Ending December 31,
 
Remainder of 2019
$
1,614

2020
3,596

2021
3,574

2022
3,223

2023
2,431

Thereafter
1,974

 
$
16,412
XML 48 R30.htm IDEA: XBRL DOCUMENT v3.19.2
EARNINGS PER SHARE (Tables)
 6 Months Ended
Jun. 30, 2019
Earnings Per Share [Abstract]  
Reconciliation of basic and diluted earnings per share
The following is a reconciliation of the weighted-average shares outstanding used in the calculation of basic and diluted EPS for the three and six months ended June 30, 2019 and 2018 (in thousands, except per share data):
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Net (loss) income attributable to Heska Corporation
$
(241
)
 
$
1,897

 
$
573

 
$
4,052

 
 
 
 
 
 
 
 
Basic weighted-average common shares outstanding
7,486

 
7,226

 
7,463

 
7,146

Assumed exercise of dilutive stock options and restricted shares
—

 
624

 
493

 
635

Diluted weighted-average common shares outstanding
$
7,486

 
$
7,850

 
$
7,956

 
$
7,781

 
 
 
 
 
 
 
 
Basic (loss) earnings per share attributable to Heska Corporation
$
(0.03
)
 
$
0.26

 
$
0.08

 
$
0.57

Diluted (loss) earnings per share attributable to Heska Corporation
$
(0.03
)
 
$
0.24

 
$
0.07

 
$
0.52
Schedule of antidilutive securities excluded from computation of earnings per share
The following stock options and restricted shares were excluded from the computation of diluted EPS because they would have been anti-dilutive (in thousands):
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Stock options and restricted shares
714

 
169

 
225

 
238
XML 49 R31.htm IDEA: XBRL DOCUMENT v3.19.2
GOODWILL AND OTHER INTANGIBLES (Tables)
 6 Months Ended
Jun. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of changes in goodwill
The following summarizes the change in goodwill during the six months ended June 30, 2019 (in thousands):
Carrying amount, December 31, 2018
$
26,679

Goodwill attributable to acquisitions (subject to change)
503

Foreign currency adjustments
8

Carrying amount, June 30, 2019
$
27,190
Schedule of other intangible assets
Other intangibles consisted of the following (in thousands):
 
June 30, 2019
 
December 31, 2018
 
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
 
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
Developed technology
$
8,200

 
$
(410
)
 
$
7,790

 
$
8,200

 
$
—

 
$
8,200

Customer relationships and other
3,700

 
(1,964
)
 
1,736

 
3,303

 
(1,739
)
 
1,564

Total intangible assets
$
11,900

 
$
(2,374
)
 
$
9,526

 
$
11,503

 
$
(1,739
)
 
$
9,764
Schedule of amortization expense on intangible assets
Amortization expense relating to other intangibles was as follows (in thousands):
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Amortization expense
$
305

 
$
97

 
$
607

 
$
194
Schedule of estimated future amortization expense
Estimated amortization expense related to intangibles for each of the five years from 2019 (remaining) through 2023 and thereafter is as follows (in thousands):
Year Ending December 31,
 
2019 (remaining)
$
666

2020
1,287

2021
1,283

2022
1,265

2023
918

Thereafter
4,107

 
$
9,526
XML 50 R32.htm IDEA: XBRL DOCUMENT v3.19.2
PROPERTY AND EQUIPMENT (Tables)
 6 Months Ended
Jun. 30, 2019
Property, Plant and Equipment [Abstract]  
Schedule of property and equipment
Property and equipment, net, consisted of the following (in thousands):
 
June 30, 2019
 
December 31, 2018
Land
$
377

 
$
377

Building
2,978

 
2,978

Machinery and equipment
31,013

 
33,087

Office furniture and equipment
1,700

 
1,687

Computer hardware and software
4,749

 
4,704

Leasehold and building improvements
9,981

 
9,953

Construction in progress
1,309

 
1,274

 
52,107

 
54,060

Less accumulated depreciation
(36,789
)
 
(38,079
)
Total property and equipment, net
$
15,318

 
$
15,981
XML 51 R33.htm IDEA: XBRL DOCUMENT v3.19.2
INVENTORIES, NET (Tables)
 6 Months Ended
Jun. 30, 2019
Inventory Disclosure [Abstract]  
Schedule of inventory
Inventories, net, consisted of the following (in thousands):
 
June 30, 2019
 
December 31, 2018
Raw materials
$
16,832

 
$
15,000

Work in process
3,807

 
3,592

Finished goods
9,548

 
8,085

Allowance for excess or obsolete inventory
(1,210
)
 
(1,573
)
Total inventory, net
$
28,977

 
$
25,104
XML 52 R34.htm IDEA: XBRL DOCUMENT v3.19.2
ACCRUED LIABILITIES (Tables)
 6 Months Ended
Jun. 30, 2019
Payables and Accruals [Abstract]  
Schedule of accrued liabilities
Accrued liabilities consisted of the following (in thousands):
 
June 30, 2019
 
December 31, 2018
Accrued settlement (see Note 14)
$
—

 
$
6,750

Accrued payroll and employee benefits
1,118

 
759

Accrued property taxes
402

 
632

Other
2,235

 
2,001

Total accrued liabilities
$
3,755

 
$
10,142
XML 53 R35.htm IDEA: XBRL DOCUMENT v3.19.2
CAPITAL STOCK (Tables)
 6 Months Ended
Jun. 30, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of weighted average valuation assumptions
The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions for options granted in the three and six months ended June 30, 2019 and 2018.
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Risk-free interest rate
1.89%
 
2.76%
 
1.95%
 
2.64%
Expected lives
4.7 years
 
4.9 years
 
4.7 years
 
4.9 years
Expected volatility
40%
 
40%
 
40%
 
40%
Expected dividend yield
0%
 
0%
 
0%
 
0%
Schedule of stock options plans
A summary of our stock option plans is as follows:
 
Six Months Ended June 30,
 
Year Ended December 31,
 
2019
 
2018
 
 
 
 
Options
 
Weighted Average Exercise Price
 
 
 
 
Options
 
Weighted Average Exercise Price
Outstanding at beginning of period
620,553

 
$
40.741

 
630,847

 
$
29.312

Granted at market
11,200

 
$
73.193

 
153,700

 
$
75.244

Forfeited
(256
)
 
$
98.660

 
(18,978
)
 
$
53.010

Expired
—

 
$
—

 
(896
)
 
$
65.414

Exercised
(149,828
)
 
$
16.776

 
(144,120
)
 
$
25.740

Outstanding at end of period
481,669

 
$
48.920

 
620,553

 
$
40.741

Exercisable at end of period
305,452

 
$
33.655

 
386,176

 
$
21.214

The following table summarizes restricted stock transactions for the six months ended June 30, 2019:
 
RSAs
 
Weighted-Average Grant Date Fair Value Per Award
Non-vested as of December 31, 2018
259,430

 
$
74.26

     Granted
18,567

 
71.38

     Vested
(4,230
)
 
85.09

     Forfeited
(500
)
 
80.90

Non-vested as of June 30, 2019
273,267

 
$
73.90
Schedule of shares authorized under stock options plans by exercise price
The following table summarizes information about stock options outstanding and exercisable at June 30, 2019:
 
 
Options Outstanding
 
Options Exercisable
Exercise Prices
 
Number of
Options
Outstanding
at
June 30, 2019
 
Weighted
Average
Remaining
Contractual
Life in Years
 
Weighted
Average
Exercise
Price
 
Number of
Options
Exercisable
at
June 30, 2019
 
Weighted
Average
Exercise
Price
$ 4.96 - $ 7.36
 
93,352

 
3.65
 
$
6.998

 
93,352

 
$
6.998

$ 7.37 - $ 32.21
 
79,273

 
4.79
 
$
15.897

 
78,941

 
$
15.828

$ 32.22 - $ 62.50
 
57,533

 
6.57
 
$
39.797

 
46,524

 
$
39.724

$ 62.51 - $ 69.77
 
130,000

 
8.68
 
$
69.770

 
43,337

 
$
69.770

$ 69.78 - $ 108.25
 
121,511

 
8.10
 
$
84.684

 
43,298

 
$
80.960

$ 4.96 - $ 108.25
 
481,669

 
6.67
 
$
48.920

 
305,452

 
$
33.655
Schedule of pricing models
The weighted average assumptions used for the periods presented were as follows:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Risk-free interest rate
2.21%
 
1.09%
 
2.27%
 
1.06%
Expected lives
1.1 years
 
1.2 years
 
1.1 years
 
1.2 years
Expected volatility
39%
 
44%
 
39%
 
44%
Expected dividend yield
0%
 
0%
 
0%
 
0%
XML 54 R36.htm IDEA: XBRL DOCUMENT v3.19.2
ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)
 6 Months Ended
Jun. 30, 2019
Equity [Abstract]  
Schedule of accumulated other comprehensive income (loss)
Accumulated other comprehensive income (loss) consisted of the following (in thousands):
 
Minimum Pension Liability
 
Foreign Currency Translation
 
Total Accumulated Other Comprehensive Income
Balances at December 31, 2018
$
(419
)
 
$
696

 
$
277

Current period other comprehensive income
—

 
21

 
21

Balances at June 30, 2019
$
(419
)
 
$
717

 
$
298
XML 55 R37.htm IDEA: XBRL DOCUMENT v3.19.2
INTEREST AND OTHER EXPENSE, NET (Tables)
 6 Months Ended
Jun. 30, 2019
Other Income and Expenses [Abstract]  
Schedule of interest expense (income) and other income, net
Interest and other expense, net, consisted of the following (in thousands):
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Interest income
$
(133
)
 
$
(63
)
 
$
(225
)
 
$
(119
)
Interest expense
147

 
77

 
224

 
142

Other expense, net
7

 
78

 
6

 
65

Total interest and other expense, net
$
21

 
$
92

 
$
5

 
$
88
XML 56 R38.htm IDEA: XBRL DOCUMENT v3.19.2
SEGMENT REPORTING (Tables)
 6 Months Ended
Jun. 30, 2019
Segment Reporting [Abstract]  
Reconciliation of other significant reconciling items from segments to consolidated
Summarized financial information concerning the Company's reportable segments is shown in the following tables (in thousands):
Three Months Ended June 30, 2019
 
Core Companion Animal
 
Other Vaccines and Pharmaceuticals
 
 
 
Total
Total revenue
 
$
24,716

 
$
3,430

 
$
28,146

Operating loss
 
(254
)
 
(312
)
 
(566
)
Loss before income taxes
 
(275
)
 
(312
)
 
(587
)
Capital expenditures
 
32

 
363

 
395

Depreciation and amortization
 
934

 
323

 
1,257

Three Months Ended June 30, 2018
 
Core Companion Animal
 
Other Vaccines and Pharmaceuticals
 
 
 
Total
Total revenue
 
$
26,644

 
$
3,018

 
$
29,662

Operating (loss) income
 
2,864

 
(660
)
 
2,204

(Loss) income before income taxes
 
2,772

 
(660
)
 
2,112

Capital expenditures
 
39

 
397

 
436

Depreciation and amortization
 
838

 
300

 
1,138



Six Months Ended June 30, 2019
 
Core Companion Animal
 
Other Vaccines and Pharmaceuticals
 
 
 
Total
Total revenue
 
$
49,432

 
$
8,225

 
$
57,657

Operating loss
 
(305
)
 
(336
)
 
(641
)
Loss before income taxes
 
(310
)
 
(336
)
 
(646
)
Capital expenditures
 
76

 
553

 
629

Depreciation and amortization
 
1,881

 
641

 
2,522



Six Months Ended June 30, 2018
 
Core Companion Animal
 
Other Vaccines and Pharmaceuticals
 
 
 
Total
Total revenue
 
$
53,463

 
$
8,964

 
$
62,427

Operating (loss) income
 
4,787

 
(712
)
 
4,075

(Loss) income before income taxes
 
4,699

 
(712
)
 
3,987

Capital expenditures
 
96

 
715

 
811

Depreciation and amortization
 
1,746

 
587

 
2,333
Schedule of revenue from external customers and long-lived assets, by geographical areas
Asset information by reportable segment as of June 30, 2019 is as follows (in thousands):
As of June 30, 2019
 
Core Companion Animal
 
Other Vaccines and Pharmaceuticals
 
Total
Investments in unconsolidated affiliates
 
$
7,711

 
$
—

 
$
7,711

Total assets
 
139,036

 
23,808

 
162,844

Net assets
 
103,455

 
19,797

 
123,252


Asset information by reportable segment as of December 31, 2018 is as follows (in thousands):
As of December 31, 2018
 
Core Companion Animal
 
Other Vaccines and Pharmaceuticals
 
Total
Investments in unconsolidated affiliates
 
$
8,018

 
$
—

 
$
8,018

Total assets
 
133,586

 
22,866

 
156,452

Net assets
 
96,129

 
26,280

 
122,409
XML 57 R39.htm IDEA: XBRL DOCUMENT v3.19.2
OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
$ in Thousands
Jun. 30, 2019
Jan. 01, 2019
Error Corrections and Prior Period Adjustments Restatement [Line Items]    
Operating lease right-of-use assets $ 6,092  
Total operating lease liabilities $ 6,504  
ASU 2016-02    
Error Corrections and Prior Period Adjustments Restatement [Line Items]    
Operating lease right-of-use assets   $ 6,500
Total operating lease liabilities   $ 6,900
XML 58 R40.htm IDEA: XBRL DOCUMENT v3.19.2
REVENUE (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Total revenue, net $ 28,146 $ 29,662 $ 57,657 $ 62,427  
Contract receivables, current 1,000   1,000   $ 900
Contract receivables, noncurrent 3,500   3,500   3,300
Current portion of deferred revenue, and other 8,900   8,900   9,600
Contract liabilities, revenue recognized     1,500    
Contract liabilities, increase due to additional deferred sales     $ 700    
Average term of underlying contracts     P6Y0M0D    
Capitalized contract costs 2,600   $ 2,600   $ 2,500
Capitalized contract costs, amortization     500    
Capitalized contract costs during the period     600    
Core companion animal          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Total revenue, net 24,716 26,644 49,432 53,463  
Point of Care laboratory revenue:          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Total revenue, net 16,120 15,053 32,081 28,693  
Consumables          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Total revenue, net 13,208 11,524 25,524 22,344  
Sales-type leases          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Total revenue, net 1,493 1,793 3,234 3,331  
Outright instrument sales          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Total revenue, net 1,045 1,335 2,575 2,146  
Other          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Total revenue, net 374 401 748 872  
Point of Care imaging revenue:          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Total revenue, net 5,229 4,462 10,639 10,434  
Outright instrument sales          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Total revenue, net 4,405 3,566 8,951 8,705  
Service revenue          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Total revenue, net 558 544 1,120 1,099  
Operating type leases and other          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Total revenue, net 266 352 568 630  
Other CCA revenue:          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Total revenue, net 3,367 7,129 6,712 14,336  
Other pharmaceuticals, vaccines and diagnostic tests          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Total revenue, net 3,281 6,991 6,527 14,102  
Research and development, license and royalty revenue          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Total revenue, net 86 138 185 234  
Other vaccines and pharmaceuticals          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Total revenue, net 3,430 3,018 8,225 8,964  
Contract manufacturing          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Total revenue, net 3,327 2,887 7,994 8,678  
License, research and development          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Total revenue, net $ 103 $ 131 $ 231 $ 286  
XML 59 R41.htm IDEA: XBRL DOCUMENT v3.19.2
REVENUE - Performance Obligations (Details)
$ in Thousands
Jun. 30, 2019
USD ($)
Revenue from Contract with Customer [Abstract]  
Remaining performance obligation $ 89,475
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2019-07-01  
Revenue from Contract with Customer [Abstract]  
Remaining performance obligation $ 12,289
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Expected timing of satisfaction 6 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-01-01  
Revenue from Contract with Customer [Abstract]  
Remaining performance obligation $ 22,138
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Expected timing of satisfaction 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-01-01  
Revenue from Contract with Customer [Abstract]  
Remaining performance obligation $ 18,315
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Expected timing of satisfaction 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01  
Revenue from Contract with Customer [Abstract]  
Remaining performance obligation $ 15,244
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Expected timing of satisfaction 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01  
Revenue from Contract with Customer [Abstract]  
Remaining performance obligation $ 11,848
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Expected timing of satisfaction 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01  
Revenue from Contract with Customer [Abstract]  
Remaining performance obligation $ 9,641
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Expected timing of satisfaction
XML 60 R42.htm IDEA: XBRL DOCUMENT v3.19.2
ACQUISITION AND RELATED PARTY ITEMS (Details) - USD ($)
 6 Months Ended
Feb. 22, 2019
Dec. 21, 2018
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
Business Acquisition [Line Items]          
Common stock, par value (in dollars per share)   $ 0.01      
Cuattro, LLC | Heska Imaging | Affiliated Entity          
Business Acquisition [Line Items]          
Related party - amount of transaction     $ 6,000 $ 2,300,000  
Heska Imaging | Affiliated Entity          
Business Acquisition [Line Items]          
Due to related parties     $ 0   $ 200,000
Optomed          
Business Acquisition [Line Items]          
Minority interest 30.00%        
Cuattro, LLC          
Business Acquisition [Line Items]          
Equity transferred as consideration for asset acquisition (in shares)   54,763      
Equity transferred as consideration for asset acquisition, value   $ 5,400,000      
Payments for asset acquisitions   $ 2,800,000      
Optomed          
Business Acquisition [Line Items]          
Percentage of voting interest acquired 70.00%        
Cash consideration transferred $ 200,000        
Debt assumed as consideration for business combination 400,000        
Committed purchase amount $ 1,000,000        
XML 61 R43.htm IDEA: XBRL DOCUMENT v3.19.2
INVESTMENTS IN UNCONSOLIDATED AFFILIATES (Details) - USD ($)
$ in Thousands
Sep. 24, 2018
Aug. 08, 2018
Jun. 30, 2019
Dec. 31, 2018
Schedule of Equity Method Investments [Line Items]        
Equity method investment     $ 4,693 $ 5,000
Non-marketable equity security investment     3,018 3,018
Investments     $ 7,711 $ 8,018
General Fluidics Corporation        
Schedule of Equity Method Investments [Line Items]        
Supply commitment term 15 years      
General Fluidics Corporation        
Schedule of Equity Method Investments [Line Items]        
Payments to acquire equity method investments $ 5,100      
Ownership percentage 28.70%      
MBio Diagnostics, Inc.        
Schedule of Equity Method Investments [Line Items]        
Payments to acquire non-marketable securities   $ 3,000    
Non-Marketable equity security investment, ownership percentage   6.90%    
Intangible asset acquired   $ 1,000    
Intangible assets acquired, useful life   20 years    
Contingent consideration on milestones   $ 10,000    
XML 62 R44.htm IDEA: XBRL DOCUMENT v3.19.2
INCOME TAXES (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Income Tax Disclosure [Abstract]        
Income before income taxes $ (587) $ 2,112 $ (646) $ 3,987
Total income tax (benefit) expense (426) 215 (1,436) (65)
Cash paid for income taxes 28 12 100 30
Excess tax benefits related to employee share-based compensation $ 300 $ 400 $ 1,400 $ 1,200
XML 63 R45.htm IDEA: XBRL DOCUMENT v3.19.2
LEASES - LESEE ACCOUNTING (Details)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2019
USD ($)
Jun. 30, 2019
USD ($)
Leases [Abstract]    
Operating lease expense $ 600 $ 1,100
Cash paid for amounts included in the measurement of operating lease liabilities   889
ROU assets obtained in exchange for operating lease obligations   $ 341
Weighted average remaining lease term 4 years 2 months 12 days 4 years 2 months 12 days
Weighted average discount rate 4.45% 4.45%
Operating Lease Liabilities, Payments Due [Abstract]    
Remainder of 2019 $ 1,052 $ 1,052
2020 1,605 1,605
2021 1,429 1,429
2022 1,321 1,321
2023 1,766 1,766
Total operating lease payments 7,173 7,173
Less: imputed interest 669 669
Total operating lease liabilities $ 6,504 $ 6,504
XML 64 R46.htm IDEA: XBRL DOCUMENT v3.19.2
LEASES - LESSOR ACCOUNTING (Details)
$ in Thousands
Jun. 30, 2019
USD ($)
Lessor, Operating Lease, Payments, Fiscal Year Maturity [Abstract]  
Remainder of 2019 $ 1,614
2020 3,596
2021 3,574
2022 3,223
2023 2,431
Thereafter 1,974
Lessor, Operating Lease, Payments to be Received $ 16,412
XML 65 R47.htm IDEA: XBRL DOCUMENT v3.19.2
EARNINGS PER SHARE (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2018
Earnings Per Share [Abstract]          
Net (loss) income attributable to Heska Corporation $ (241) $ 1,897 $ 573 $ 4,052 $ 4,052
Basic weighted-average common shares outstanding (in shares) 7,486 7,226 7,463   7,146
Assumed exercise of dilutive stock options and restricted shares 0 624 493   635
Diluted weighted-average common shares outstanding 7,486 7,850 7,956   7,781
Basic (loss) earnings per share attributable to Heska Corporation (in dollars per share) $ (0.03) $ 0.26 $ 0.08   $ 0.57
Diluted (loss) earnings per share attributable to Heska Corporation (in dollars per share) $ (0.03) $ 0.24 $ 0.07   $ 0.52
Stock Options And Restricted Units          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Stock options and restricted units excluded from computation of earnings per share 714 169 225   238
XML 66 R48.htm IDEA: XBRL DOCUMENT v3.19.2
GOODWILL AND OTHER INTANGIBLES (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
Goodwill [Roll Forward]          
Carrying amount, December 31, 2018     $ 26,679    
Goodwill attributable to acquisitions (subject to change)     503    
Foreign currency adjustments     8    
Carrying amount, June 30, 2019 $ 27,190   27,190    
Finite-Lived Intangible Assets, Net [Abstract]          
Gross carrying amount 11,900   11,900   $ 11,503
Accumulated amortization (2,374)   (2,374)   (1,739)
Net carrying amount 9,526   9,526   9,764
Amortization expense 305 $ 97 607 $ 194  
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]          
2019 (remaining) 666   666    
2020 1,287   1,287    
2021 1,283   1,283    
2022 1,265   1,265    
2023 918   918    
Thereafter 4,107   4,107    
Net carrying amount 9,526   9,526   9,764
Developed technology          
Finite-Lived Intangible Assets, Net [Abstract]          
Gross carrying amount 8,200   8,200   8,200
Accumulated amortization (410)   (410)   0
Net carrying amount 7,790   7,790   8,200
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]          
Net carrying amount 7,790   7,790   8,200
Customer relationships and other          
Finite-Lived Intangible Assets, Net [Abstract]          
Gross carrying amount 3,700   3,700   3,303
Accumulated amortization (1,964)   (1,964)   (1,739)
Net carrying amount 1,736   1,736   1,564
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]          
Net carrying amount $ 1,736   $ 1,736   $ 1,564
XML 67 R49.htm IDEA: XBRL DOCUMENT v3.19.2
PROPERTY AND EQUIPMENT (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
Property, Plant and Equipment [Line Items]          
Property and equipment, gross $ 52,107   $ 52,107   $ 54,060
Less accumulated depreciation (36,789)   (36,789)   (38,079)
Total property and equipment, net 15,318   15,318   15,981
Depreciation and amortization 900 $ 1,000 1,900 $ 2,100  
Operating leases, gross 10,300   10,300   10,800
Operating leases, accumulated depreciation 5,700   5,700   6,100
Land          
Property, Plant and Equipment [Line Items]          
Property and equipment, gross 377   377   377
Building          
Property, Plant and Equipment [Line Items]          
Property and equipment, gross 2,978   2,978   2,978
Machinery and equipment          
Property, Plant and Equipment [Line Items]          
Property and equipment, gross 31,013   31,013   33,087
Office furniture and equipment          
Property, Plant and Equipment [Line Items]          
Property and equipment, gross 1,700   1,700   1,687
Computer hardware and software          
Property, Plant and Equipment [Line Items]          
Property and equipment, gross 4,749   4,749   4,704
Leasehold and building improvements          
Property, Plant and Equipment [Line Items]          
Property and equipment, gross 9,981   9,981   9,953
Construction in progress          
Property, Plant and Equipment [Line Items]          
Property and equipment, gross $ 1,309   $ 1,309   $ 1,274
Machinery and equipment | Minimum          
Property, Plant and Equipment [Line Items]          
Property plant and equipment, useful life     5 years    
Machinery and equipment | Maximum          
Property, Plant and Equipment [Line Items]          
Property plant and equipment, useful life     7 years    
XML 68 R50.htm IDEA: XBRL DOCUMENT v3.19.2
INVENTORIES, NET (Details) - USD ($)
$ in Thousands
Jun. 30, 2019
Dec. 31, 2018
Inventory Disclosure [Abstract]    
Raw materials $ 16,832 $ 15,000
Work in process 3,807 3,592
Finished goods 9,548 8,085
Allowance for excess or obsolete inventory (1,210) (1,573)
Total inventory, net $ 28,977 $ 25,104
XML 69 R51.htm IDEA: XBRL DOCUMENT v3.19.2
ACCRUED LIABILITIES (Details) - USD ($)
$ in Thousands
Jun. 30, 2019
Dec. 31, 2018
Payables and Accruals [Abstract]    
Accrued settlement $ 0 $ 6,750
Accrued payroll and employee benefits 1,118 759
Accrued property taxes 402 632
Other 2,235 2,001
Total accrued liabilities $ 3,755 $ 10,142
Percentage of total current liabilities 5.00%  
XML 70 R52.htm IDEA: XBRL DOCUMENT v3.19.2
CAPITAL STOCK - OPTION ACTIVITY (Details) - $ / shares
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
Employee Stock Option          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Risk-free interest rate (as a percent) 1.89% 2.76% 1.95% 2.64%  
Expected lives (in years) 4 years 8 months 6 days 4 years 10 months 24 days 4 years 8 months 6 days 4 years 10 months 24 days  
Expected volatility (as a percent) 40.00% 40.00% 40.00% 40.00%  
Expected dividend rate (as a percent) 0.00% 0.00% 0.00% 0.00%  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]          
Outstanding at beginning of period     620,553 630,847 630,847
Granted at market     11,200   153,700
Forfeited     (256)   (18,978)
Expired     0   (896)
Exercised     (149,828)   (144,120)
Outstanding at end of period 481,669   481,669   620,553
Exercisable at end of period 305,452   305,452   386,176
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]          
Outstanding at beginning of period (in dollars per share)     $ 40.741 $ 29.312 $ 29.312
Granted at market (in dollars per share)     73.193   75.244
Forfeited (in dollars per share)     98.660   53.010
Expired (in dollars per share)     0.000   65.414
Exercised (in dollars per share)     16.776   25.740
Outstanding at ending of period (in dollars per share) $ 48.920   48.920   40.741
Exercisable at end of period (in dollars per share) $ 33.655   $ 33.655   $ 21.214
Employee Stock          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Risk-free interest rate (as a percent) 2.21% 1.09% 2.27% 1.06%  
Expected lives (in years) 1 year 1 month 6 days 1 year 2 months 18 days 1 year 1 month 6 days 1 year 2 months 18 days  
Expected volatility (as a percent) 39.00% 44.00% 39.00% 44.00%  
Expected dividend rate (as a percent) 0.00% 0.00% 0.00% 0.00%  
XML 71 R53.htm IDEA: XBRL DOCUMENT v3.19.2
CAPITAL STOCK - NARRATIVE (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Fair value of stock options granted during period     $ 0.3 $ 3.5
Weighted average grant date fair value     $ 26.67 $ 26.74
Intrinsic value of options exercised     $ 11.6 $ 3.1
Proceeds from stock options exercised     $ 0.5 $ 1.3
Weighted average purchase price of shares purchased (in dollars per share) $ 18.69 $ 17.98 $ 18.82 $ 15.86
Employee Stock Option        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Intrinsic value of options exercised     $ 15.9  
Total unrecognized compensation expense related to outstanding stock options $ 4.3   $ 4.3  
Period for recognition of unrecognized compensation expense     1 year 4 months 9 days  
Intrinsic value of options outstanding $ 18.3   $ 18.3  
Employee Stock        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Shares issued during period 2,786 2,327 5,369 5,454
Restricted Stock        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total unrecognized compensation expense related to outstanding stock options $ 2.6   $ 2.6  
Period for recognition of unrecognized compensation expense     1 year 4 months  
Weighted average purchase price of shares purchased (in dollars per share) $ 71.35 $ 85.09 $ 71.38 $ 67.76
Fair value of stock vested   $ 0.3 $ 0.3 $ 4.4
Performance shares, nonprobable performance targets (in shares) 176,000   176,000  
Restricted Stock | Minimum        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Award vesting period     1 year  
Restricted Stock | Maximum        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Award vesting period     4 years  
XML 72 R54.htm IDEA: XBRL DOCUMENT v3.19.2
CAPITAL STOCK - EXERCISE PRICE (Details)
 6 Months Ended
Jun. 30, 2019
$ / shares
shares
$ 4.96 - $ 7.36  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Number of Options Outstanding at June 30, 2019 | shares 93,352
Weighted Average Remaining Contractual Life in Years 3 years 7 months 25 days
Weighted Average Exercise Price $ 6.998
Number of Options Exercisable at June 30, 2019 | shares 93,352
Weighted Average Exercise Price $ 6.998
Exercise price range, lower (in dollars per share) 4.96
Exercise price range, upper (in dollars per share) $ 7.36
$ 7.37 - $ 32.21  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Number of Options Outstanding at June 30, 2019 | shares 79,273
Weighted Average Remaining Contractual Life in Years 4 years 9 months 14 days
Weighted Average Exercise Price $ 15.897
Number of Options Exercisable at June 30, 2019 | shares 78,941
Weighted Average Exercise Price $ 15.828
Exercise price range, lower (in dollars per share) 7.37
Exercise price range, upper (in dollars per share) $ 32.21
$ 32.22 - $ 62.50  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Number of Options Outstanding at June 30, 2019 | shares 57,533
Weighted Average Remaining Contractual Life in Years 6 years 6 months 25 days
Weighted Average Exercise Price $ 39.797
Number of Options Exercisable at June 30, 2019 | shares 46,524
Weighted Average Exercise Price $ 39.724
Exercise price range, lower (in dollars per share) 32.22
Exercise price range, upper (in dollars per share) $ 62.50
$ 62.51 - $ 69.77  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Number of Options Outstanding at June 30, 2019 | shares 130,000
Weighted Average Remaining Contractual Life in Years 8 years 8 months 4 days
Weighted Average Exercise Price $ 69.770
Number of Options Exercisable at June 30, 2019 | shares 43,337
Weighted Average Exercise Price $ 69.770
Exercise price range, lower (in dollars per share) 62.51
Exercise price range, upper (in dollars per share) $ 69.77
$ 69.78 - $ 108.25  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Number of Options Outstanding at June 30, 2019 | shares 121,511
Weighted Average Remaining Contractual Life in Years 8 years 1 month 6 days
Weighted Average Exercise Price $ 84.684
Number of Options Exercisable at June 30, 2019 | shares 43,298
Weighted Average Exercise Price $ 80.960
Exercise price range, lower (in dollars per share) 69.78
Exercise price range, upper (in dollars per share) $ 108.25
$ 4.96 - $ 108.25  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Number of Options Outstanding at June 30, 2019 | shares 481,669
Weighted Average Remaining Contractual Life in Years 6 years 8 months 1 day
Weighted Average Exercise Price $ 48.920
Number of Options Exercisable at June 30, 2019 | shares 305,452
Weighted Average Exercise Price $ 33.655
Exercise price range, lower (in dollars per share) 4.96
Exercise price range, upper (in dollars per share) $ 108.25
XML 73 R55.htm IDEA: XBRL DOCUMENT v3.19.2
CAPITAL STOCK CAPITAL STOCK - RESTRICTED STOCK (Details) - $ / shares
shares in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Granted (in dollars per share) $ 18.69 $ 17.98 $ 18.82 $ 15.86
Restricted Stock        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Non-vested balance (in shares)     259,430  
Granted (in shares)     18,567  
Vested (in shares)     (4,230)  
Forfeited (in shares)     (500)  
Non-vested balance (in shares) 273,267   273,267  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Non-vested balance (in dollars per share)     $ 74.26  
Granted (in dollars per share) $ 71.35 $ 85.09 71.38 $ 67.76
Vested (in dollars per share)     85.09  
Forfeited (in dollars per share)     80.90  
Non-vested balance (in dollars per share) $ 73.90   $ 73.90  
XML 74 R56.htm IDEA: XBRL DOCUMENT v3.19.2
ACCUMULATED OTHER COMPREHENSIVE INCOME (Details)
$ in Thousands
 6 Months Ended
Jun. 30, 2019
USD ($)
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]  
Beginning balance $ 122,409
Ending balance 122,922
Total Accumulated Other Comprehensive Income  
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]  
Beginning balance 277
Current period other comprehensive income 21
Ending balance 298
Minimum Pension Liability  
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]  
Beginning balance (419)
Current period other comprehensive income 0
Ending balance (419)
Foreign Currency Translation  
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]  
Beginning balance 696
Current period other comprehensive income 21
Ending balance $ 717
XML 75 R57.htm IDEA: XBRL DOCUMENT v3.19.2
COMMITMENTS AND CONTINGENCIES (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Feb. 28, 2019
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
Commitments and Contingencies Disclosure [Abstract]            
Increase in royalties payable   $ 0.1 $ 0.1 $ 0.2 $ 0.2  
Warranty reserve   0.2   0.2   $ 0.2
Litigation settlement, amount $ 6.8          
Unconditional annual minimum inventory purchases   $ 16.7   $ 16.7    
XML 76 R58.htm IDEA: XBRL DOCUMENT v3.19.2
INTEREST AND OTHER EXPENSE, NET (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Other Income and Expenses [Abstract]        
Interest income $ (133) $ (63) $ (225) $ (119)
Interest expense 147 77 224 142
Other, net 7 78 6 65
Total interest and other expense, net 21 92 5 88
Cash paid for interest $ 71 $ 58 $ 127 $ 85
XML 77 R59.htm IDEA: XBRL DOCUMENT v3.19.2
CREDIT FACILITY (Details) - Line of Credit - Revolving Credit Facility - USD ($)
Jul. 27, 2017
Jun. 30, 2019
Debt Instrument [Line Items]    
Maximum borrowing capacity $ 30,000,000.0  
Additional maximum borrowing capacity increase 20,000,000.0  
Contingent maximum borrowing capacity $ 50,000,000.0  
Basis spread on variable rate 1.10%  
Minimum annual interest charge $ 60,000  
Long-term line of credit   $ 12,800,000
London Interbank Offered Rate (LIBOR)    
Debt Instrument [Line Items]    
Basis spread on variable rate 1.65%  
XML 78 R60.htm IDEA: XBRL DOCUMENT v3.19.2
SEGMENT REPORTING - NARRATIVE (Details)
 6 Months Ended
Jun. 30, 2019
segment
Segment Reporting [Abstract]  
Number of reportable segments 2
XML 79 R61.htm IDEA: XBRL DOCUMENT v3.19.2
SEGMENT REPORTING (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
Segment Reporting, Other Significant Reconciling Item [Line Items]          
Total revenue $ 28,146 $ 29,662 $ 57,657 $ 62,427  
Operating (loss) income (566) 2,204 (641) 4,075  
Income before income taxes (587) 2,112 (646) 3,987  
Capital expenditures 395 436 629 811  
Depreciation and amortization 1,257 1,138 2,522 2,333  
Investments in unconsolidated affiliates 7,711   7,711   $ 8,018
Assets 162,844   162,844   156,452
Net Assets 123,252   123,252   122,409
Operating Segments | Core Companion Animal Health          
Segment Reporting, Other Significant Reconciling Item [Line Items]          
Total revenue 24,716 26,644 49,432 53,463  
Operating (loss) income (254) 2,864 (305) 4,787  
Income before income taxes (275) 2,772 (310) 4,699  
Capital expenditures 32 39 76 96  
Depreciation and amortization 934 838 1,881 1,746  
Investments in unconsolidated affiliates 7,711   7,711   8,018
Assets 139,036   139,036   133,586
Net Assets 103,455   103,455   96,129
Operating Segments | Other Vaccines, Pharmaceuticals and Products          
Segment Reporting, Other Significant Reconciling Item [Line Items]          
Total revenue 3,430 3,018 8,225 8,964  
Operating (loss) income (312) (660) (336) (712)  
Income before income taxes (312) (660) (336) (712)  
Capital expenditures 363 397 553 715  
Depreciation and amortization 323 $ 300 641 $ 587  
Investments in unconsolidated affiliates 0   0   0
Assets 23,808   23,808   22,866
Net Assets $ 19,797   $ 19,797   $ 26,280
EXCEL 80 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 81 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 82 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 83 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.2 html 227 380 1 false 65 0 false 5 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://Heska.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://Heska.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 1001501 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://Heska.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME Sheet http://Heska.com/role/CondensedConsolidatedStatementsOfIncome CONDENSED CONSOLIDATED STATEMENTS OF INCOME Statements 4 false false R5.htm 1003000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Sheet http://Heska.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Statements 5 false false R6.htm 1004000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Sheet http://Heska.com/role/CondensedConsolidatedStatementsOfStockholdersEquity CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Statements 6 false false R7.htm 1005000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://Heska.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 2101100 - Disclosure - OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://Heska.com/role/OperationsAndSummaryOfSignificantAccountingPolicies OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 2103100 - Disclosure - REVENUE Sheet http://Heska.com/role/Revenue REVENUE Notes 9 false false R10.htm 2104100 - Disclosure - ACQUISITION AND RELATED PARTY ITEMS Sheet http://Heska.com/role/AcquisitionAndRelatedPartyItems ACQUISITION AND RELATED PARTY ITEMS Notes 10 false false R11.htm 2105100 - Disclosure - INVESTMENTS IN UNCONSOLIDATED AFFILIATES Sheet http://Heska.com/role/InvestmentsInUnconsolidatedAffiliates INVESTMENTS IN UNCONSOLIDATED AFFILIATES Notes 11 false false R12.htm 2107100 - Disclosure - INCOME TAXES Sheet http://Heska.com/role/IncomeTaxes INCOME TAXES Notes 12 false false R13.htm 2108100 - Disclosure - LEASES Sheet http://Heska.com/role/Leases LEASES Notes 13 false false R14.htm 2109100 - Disclosure - EARNINGS PER SHARE Sheet http://Heska.com/role/EarningsPerShare EARNINGS PER SHARE Notes 14 false false R15.htm 2111100 - Disclosure - GOODWILL AND OTHER INTANGIBLES Sheet http://Heska.com/role/GoodwillAndOtherIntangibles GOODWILL AND OTHER INTANGIBLES Notes 15 false false R16.htm 2112100 - Disclosure - PROPERTY AND EQUIPMENT Sheet http://Heska.com/role/PropertyAndEquipment PROPERTY AND EQUIPMENT Notes 16 false false R17.htm 2114100 - Disclosure - INVENTORIES, NET Sheet http://Heska.com/role/InventoriesNet INVENTORIES, NET Notes 17 false false R18.htm 2116100 - Disclosure - ACCRUED LIABILITIES Sheet http://Heska.com/role/AccruedLiabilities ACCRUED LIABILITIES Notes 18 false false R19.htm 2118100 - Disclosure - CAPITAL STOCK Sheet http://Heska.com/role/CapitalStock CAPITAL STOCK Notes 19 false false R20.htm 2119100 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME Sheet http://Heska.com/role/AccumulatedOtherComprehensiveIncome ACCUMULATED OTHER COMPREHENSIVE INCOME Notes 20 false false R21.htm 2121100 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://Heska.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 21 false false R22.htm 2122100 - Disclosure - INTEREST AND OTHER EXPENSE, NET Sheet http://Heska.com/role/InterestAndOtherExpenseNet INTEREST AND OTHER EXPENSE, NET Notes 22 false false R23.htm 2123100 - Disclosure - CREDIT FACILITY Sheet http://Heska.com/role/CreditFacility CREDIT FACILITY Notes 23 false false R24.htm 2124100 - Disclosure - SEGMENT REPORTING Sheet http://Heska.com/role/SegmentReporting SEGMENT REPORTING Notes 24 false false R25.htm 2201201 - Disclosure - OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://Heska.com/role/OperationsAndSummaryOfSignificantAccountingPoliciesPolicies OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 25 false false R26.htm 2303301 - Disclosure - REVENUE (Tables) Sheet http://Heska.com/role/RevenueTables REVENUE (Tables) Tables http://Heska.com/role/Revenue 26 false false R27.htm 2305301 - Disclosure - INVESTMENTS IN UNCONSOLIDATED AFFILIATES (Tables) Sheet http://Heska.com/role/InvestmentsInUnconsolidatedAffiliatesTables INVESTMENTS IN UNCONSOLIDATED AFFILIATES (Tables) Tables http://Heska.com/role/InvestmentsInUnconsolidatedAffiliates 27 false false R28.htm 2307301 - Disclosure - INCOME TAXES (Tables) Sheet http://Heska.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://Heska.com/role/IncomeTaxes 28 false false R29.htm 2308301 - Disclosure - LEASES (Tables) Sheet http://Heska.com/role/LeasesTables LEASES (Tables) Tables http://Heska.com/role/Leases 29 false false R30.htm 2309301 - Disclosure - EARNINGS PER SHARE (Tables) Sheet http://Heska.com/role/EarningsPerShareTables EARNINGS PER SHARE (Tables) Tables http://Heska.com/role/EarningsPerShare 30 false false R31.htm 2311301 - Disclosure - GOODWILL AND OTHER INTANGIBLES (Tables) Sheet http://Heska.com/role/GoodwillAndOtherIntangiblesTables GOODWILL AND OTHER INTANGIBLES (Tables) Tables http://Heska.com/role/GoodwillAndOtherIntangibles 31 false false R32.htm 2312301 - Disclosure - PROPERTY AND EQUIPMENT (Tables) Sheet http://Heska.com/role/PropertyAndEquipmentTables PROPERTY AND EQUIPMENT (Tables) Tables http://Heska.com/role/PropertyAndEquipment 32 false false R33.htm 2314301 - Disclosure - INVENTORIES, NET (Tables) Sheet http://Heska.com/role/InventoriesNetTables INVENTORIES, NET (Tables) Tables http://Heska.com/role/InventoriesNet 33 false false R34.htm 2316301 - Disclosure - ACCRUED LIABILITIES (Tables) Sheet http://Heska.com/role/AccruedLiabilitiesTables ACCRUED LIABILITIES (Tables) Tables http://Heska.com/role/AccruedLiabilities 34 false false R35.htm 2318301 - Disclosure - CAPITAL STOCK (Tables) Sheet http://Heska.com/role/CapitalStockTables CAPITAL STOCK (Tables) Tables http://Heska.com/role/CapitalStock 35 false false R36.htm 2319301 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables) Sheet http://Heska.com/role/AccumulatedOtherComprehensiveIncomeTables ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables) Tables http://Heska.com/role/AccumulatedOtherComprehensiveIncome 36 false false R37.htm 2322301 - Disclosure - INTEREST AND OTHER EXPENSE, NET (Tables) Sheet http://Heska.com/role/InterestAndOtherExpenseNetTables INTEREST AND OTHER EXPENSE, NET (Tables) Tables http://Heska.com/role/InterestAndOtherExpenseNet 37 false false R38.htm 2324301 - Disclosure - SEGMENT REPORTING (Tables) Sheet http://Heska.com/role/SegmentReportingTables SEGMENT REPORTING (Tables) Tables http://Heska.com/role/SegmentReporting 38 false false R39.htm 2401402 - Disclosure - OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://Heska.com/role/OperationsAndSummaryOfSignificantAccountingPoliciesDetails OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://Heska.com/role/OperationsAndSummaryOfSignificantAccountingPoliciesPolicies 39 false false R40.htm 2403402 - Disclosure - REVENUE (Details) Sheet http://Heska.com/role/RevenueDetails REVENUE (Details) Details http://Heska.com/role/RevenueTables 40 false false R41.htm 2403403 - Disclosure - REVENUE - Performance Obligations (Details) Sheet http://Heska.com/role/RevenuePerformanceObligationsDetails REVENUE - Performance Obligations (Details) Details 41 false false R42.htm 2404401 - Disclosure - ACQUISITION AND RELATED PARTY ITEMS (Details) Sheet http://Heska.com/role/AcquisitionAndRelatedPartyItemsDetails ACQUISITION AND RELATED PARTY ITEMS (Details) Details http://Heska.com/role/AcquisitionAndRelatedPartyItems 42 false false R43.htm 2405402 - Disclosure - INVESTMENTS IN UNCONSOLIDATED AFFILIATES (Details) Sheet http://Heska.com/role/InvestmentsInUnconsolidatedAffiliatesDetails INVESTMENTS IN UNCONSOLIDATED AFFILIATES (Details) Details http://Heska.com/role/InvestmentsInUnconsolidatedAffiliatesTables 43 false false R44.htm 2407402 - Disclosure - INCOME TAXES (Details) Sheet http://Heska.com/role/IncomeTaxesDetails INCOME TAXES (Details) Details http://Heska.com/role/IncomeTaxesTables 44 false false R45.htm 2408402 - Disclosure - LEASES - LESEE ACCOUNTING (Details) Sheet http://Heska.com/role/LeasesLeseeAccountingDetails LEASES - LESEE ACCOUNTING (Details) Details 45 false false R46.htm 2408403 - Disclosure - LEASES - LESSOR ACCOUNTING (Details) Sheet http://Heska.com/role/LeasesLessorAccountingDetails LEASES - LESSOR ACCOUNTING (Details) Details 46 false false R47.htm 2409402 - Disclosure - EARNINGS PER SHARE (Details) Sheet http://Heska.com/role/EarningsPerShareDetails EARNINGS PER SHARE (Details) Details http://Heska.com/role/EarningsPerShareTables 47 false false R48.htm 2411402 - Disclosure - GOODWILL AND OTHER INTANGIBLES (Details) Sheet http://Heska.com/role/GoodwillAndOtherIntangiblesDetails GOODWILL AND OTHER INTANGIBLES (Details) Details http://Heska.com/role/GoodwillAndOtherIntangiblesTables 48 false false R49.htm 2412402 - Disclosure - PROPERTY AND EQUIPMENT (Details) Sheet http://Heska.com/role/PropertyAndEquipmentDetails PROPERTY AND EQUIPMENT (Details) Details http://Heska.com/role/PropertyAndEquipmentTables 49 false false R50.htm 2414402 - Disclosure - INVENTORIES, NET (Details) Sheet http://Heska.com/role/InventoriesNetDetails INVENTORIES, NET (Details) Details http://Heska.com/role/InventoriesNetTables 50 false false R51.htm 2416402 - Disclosure - ACCRUED LIABILITIES (Details) Sheet http://Heska.com/role/AccruedLiabilitiesDetails ACCRUED LIABILITIES (Details) Details http://Heska.com/role/AccruedLiabilitiesTables 51 false false R52.htm 2418402 - Disclosure - CAPITAL STOCK - OPTION ACTIVITY (Details) Sheet http://Heska.com/role/CapitalStockOptionActivityDetails CAPITAL STOCK - OPTION ACTIVITY (Details) Details 52 false false R53.htm 2418403 - Disclosure - CAPITAL STOCK - NARRATIVE (Details) Sheet http://Heska.com/role/CapitalStockNarrativeDetails CAPITAL STOCK - NARRATIVE (Details) Details 53 false false R54.htm 2418404 - Disclosure - CAPITAL STOCK - EXERCISE PRICE (Details) Sheet http://Heska.com/role/CapitalStockExercisePriceDetails CAPITAL STOCK - EXERCISE PRICE (Details) Details 54 false false R55.htm 2418405 - Disclosure - CAPITAL STOCK CAPITAL STOCK - RESTRICTED STOCK (Details) Sheet http://Heska.com/role/CapitalStockCapitalStockRestrictedStockDetails CAPITAL STOCK CAPITAL STOCK - RESTRICTED STOCK (Details) Details 55 false false R56.htm 2419402 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (Details) Sheet http://Heska.com/role/AccumulatedOtherComprehensiveIncomeDetails ACCUMULATED OTHER COMPREHENSIVE INCOME (Details) Details http://Heska.com/role/AccumulatedOtherComprehensiveIncomeTables 56 false false R57.htm 2421401 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://Heska.com/role/CommitmentsAndContingenciesDetails COMMITMENTS AND CONTINGENCIES (Details) Details http://Heska.com/role/CommitmentsAndContingencies 57 false false R58.htm 2422402 - Disclosure - INTEREST AND OTHER EXPENSE, NET (Details) Sheet http://Heska.com/role/InterestAndOtherExpenseNetDetails INTEREST AND OTHER EXPENSE, NET (Details) Details http://Heska.com/role/InterestAndOtherExpenseNetTables 58 false false R59.htm 2423401 - Disclosure - CREDIT FACILITY (Details) Sheet http://Heska.com/role/CreditFacilityDetails CREDIT FACILITY (Details) Details http://Heska.com/role/CreditFacility 59 false false R60.htm 2424402 - Disclosure - SEGMENT REPORTING - NARRATIVE (Details) Sheet http://Heska.com/role/SegmentReportingNarrativeDetails SEGMENT REPORTING - NARRATIVE (Details) Details 60 false false R61.htm 2424403 - Disclosure - SEGMENT REPORTING (Details) Sheet http://Heska.com/role/SegmentReportingDetails SEGMENT REPORTING (Details) Details http://Heska.com/role/SegmentReportingTables 61 false false All Reports Book All Reports hska-20190630.xml hska-20190630.xsd hska-20190630_cal.xml hska-20190630_def.xml hska-20190630_lab.xml hska-20190630_pre.xml http://fasb.org/srt/2018-01-31 http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/us-gaap/2018-01-31 true true ZIP 85 0001038133-19-000050-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001038133-19-000050-xbrl.zip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

*(^&H])KG+]OU[(46@83HG0AQG0CP"?\BC44EO+J&JYD(S1"LCNX[>$Y M%Z@WB"N'13HNUY'GK2Z,H!K/'!K<]: ,ZAT9&G."-12\O73M3W,K==DW7:8J\-7L8266^: "P_8 ML8?G0,CA,E(.2>$ MV 1NONZ4Q@"_5@LPD!4O?E\ UWG-RC$-JZVM-QQ',!UX**44-M4*$;A2)O$ M +;*)6-30-UR2Q2QPAD_5_P$8VMDS=5NOIH?MQF >X2A;+(Y@XX"E):%G>YT M&:GAEE%2<8()6;D07P/$CC">QH4YAJD).I BC"E(D=5M D'U:^-K)804.+$ M"7;0.W1.1"0<$M'BP)*19)4H&P0['*H5V%<[QAZ(?*WF' 7I!NX7C<+;= :# M3=[=@@@O!<45_TK7:_6^T0>@CRK=&UP404H\(. MMH3BT5&&[O6$XJZZ;[EHT&1[PW@:>X([BYS3A"L=:>".2U64%!4>]'Q=A=?# MZXG3[0@I#%B=U!+DL05#.2JB8]D 5)-J'?A*1\@#D:_5,>*&.HE4-)R;5&29 MH?PTB3 KJ)%5MU^P!@-^;QA/9$]0( PS N0;,CBD2Z]YQT+LL <7L[HG*#J\ M8CW=#H 8.XVM=9+ZZ"71CMN8=P!$)&CO:\K9T]UD<)Z\MFNX0'@5D )#P#MB MP:]@P;GB3A!3/E;.?M5*2F M%,U@-C0"69M^B9&Q*&CBO9">J'!?AHY/,97K_/2NJ1<31^+?L6]&Y/?;X&W,_B$0&3-Y049N1'@#7J-;%!&2(F+5,Y44:LJ2,\U$8JRE%HKP?@YVJGMYBH1ID22TP&X#]4#9^R\M>*O6< MT0J\:V]EB@&YLLH2)]A7:JHQA=MV2 T\S<"7=^NV#['28*3GB@;FG528.5*V MG%($9%#+&48]!+O N+9+F:,D()8RY5(:8*IB6Y:B-S75_2Y6;Q%L"^G'_M7U M]/WE[Y-YM>@MJP=H8J6E/K4!0,12J4T!+1%@:M=<']$-%DX=++L!?332* I! MTOTWE1J 4^DI!,BZ^';&+?YQ>_RX>=L M?(,;<%LH%@4Z/ J'@E-,<;#.RC(03&@5]9M?/K _R*^8^ WAKX%A"?YD/55; MH>UTQ2BM YCFB&M-#%,"W-:B((E!$M%J-!NA%6.]%9A]P&Z3$@P;9 6BZ4ZE MLP$4<2QN6!NB>:@I*$[Y7F#G9>]WNP_GHC1(&^LBUTBD[B;E99 8 JL8?D13 M50/J(@#;@M=:2$@#$16206O8AEX06Q028L3@FE; %*W<_MT8O#;#H+6")0E" M2RD""HQ&4+)EA5]&J'!5 LK54@&U,.P 9/N]7\6=B!X[$[W1A*;SRSF0.J5T M5($4=0RY#LCD98ZS:[#]^U^S!W<%%!!(D.&<_MV[S^/.< )0Y=YH+_^W0>[, M/>BL_.+-Y\[WK4]&4IDBZR/V@7H,2@BF%.PL(F MW@2.!?5QEF;L]KQT*:6K]<&&Q6HO%3Q MS7 :'(^N*",&MA./U981CTB8#^F'?(/.+Y6/)M-Q-NV/Y['7A=T +_Y]V+D9 MC:?]_\EZ?P77(D^H&_=3VT4_&R>/-1OW1["%+D$.K-)ZBYM3%H.5R[ 4B#,7 M3'2"ZI1?'\#5$=WCI_B63+[]AA^Y#?C/ Q%6XQ M=3UASRM77;F-+F\0 .*Z@S*$EZ3EKF-!?TZ:?WHVP.CU*8, MI_:DA*6ZM!X7UZB5 (>X$IP^KUG+FJUQ!\!I(I0&RB@GRKH4Y2DOQEDP?RMY M1ENX Z^3TH^^.TPD#@5.L/A_[+UI592]\.Z<-K M#LFX,4%Q1G0,Q 9PJ"K#*B94G@C&-FR W7.ZJ P^:(?3U$7&_HRYE'NX; M'9<"''+*-+$6BTB]]C34 S$=_-YH:=8;L@L;SW'?T]ZZ=88A;&W:8ZC3+@9P MGZM4&:-P =*<@+!>^'_WT[;7]D4T45ZR@"56DAF72+C>)FI,8 ?T0;0(85)CK2:<.$*DJAP' QS0G!U#\XK-!]_@X\A<@LTP M+NIZQV+R;^--\WWJ&72ORDETM4U1?RP_9=+/X_G+C1^&8TSB'='2 CVH$HEQXQ'(TV6/*Z!H50['ASS,GZ:J:[PN%6V&W= M!W:7_OFH!>A](9@C7FJM@ZD95EGK;AN(<=LY[G_>7<*1^6!#JH!@BB"+912H MG@GF04(VBI<(N1W@=SWTNW$2J-/OR1:>@K6<$'5SW;!=[F )1 NLE;JG,=)" MI>QN-7U<<,QI4[ZSM4KCNQ^MW0N=1AT\XL[HU.N#M09_UFM5[7T2J=.6-J!+ M]8\$W%9KYDT$-S0H*D$S(L*TX*+*[Z5\GVG.5UEK87X26-\F7%SD5 7'F %M MS^%Z2E4A*"M FC>WD*[M:WRJ"YT&9RI'''-,,\$M>&P^=;>E%@OPZ#%HS@9G MZB,0>R?:S2(4DSZD@DS,A= FA4H3J -%$I/8 +7$FZWPQX/UKG$$P7O%='"> MX:"]="I6K%3H,S;1#<:!RY]\Y$E+HF? U=%MF&S5\_$G#; M[=%/$5P/GD((1J5J6;"\Z]95C38,05];//,DL+YU-C1UUN/ 93"<>A>Q0U7' MC26*-7N%!'EJ@^N4NCHC)MA:(5+LR@IOB-.YJY/$8-*NR(8@?VJ=>;H=H)P$ MSA7EG"-A ]5"EH,6TLP@99N3*3AOA3/'U=Z"'!EZUQV_'>>+]_[6'KZ"%'OQ7^5$5JG?-4*$NC]M&C*D+$"-"6 M//S17T\FL[TA'K 2QLM(/8Z,1)"A2M4\8.3*WHSZV#L.7![COH>]%<;$8&(( M>)-@<6E#B"6TWE$82%@9\M+J8=_.II/400A2>$_P:F*D-8IZ+TR:N)?2+//M M0"Z@_4^\=)8''?M60 ?$# (7@E+#"=':DIJ8:93@"=_LJ=MZS/S=>Q_MUORK(8C*D&:;68.((KSN!4X;^IHIDKV. M=M/M]ZI!12VZ,3$-_%9A0V-'F3EC,*5V75QMY]R-%E4?0F<3RZ3K(@K:UZ6&J/ M&#"&+!S76ZU4$ SY6*],";8Y31D+O [8'4=ZX/EW."I2@YYU4J0 G_&@NGSM MJ)CH\8:A!@"1=LZ_LN=O_^4[J4E.^""TNI."\ ^W6,>/(LX: RD M$3EG/DU8TS51@,%S6^O.;>>X_WEWE>XY#J+626\D6 RIBX96=J1QBFX8W821 MVLZ%=SWVAV[*KK879[>*V8@B2=NZ603GRG.<" 41"D8$;M1&L:TWV'&RUBZT MB_*E"=IIY*33A#C!1-I]DBY$M#'HKCQZW]LDX?/V)KG9D_!',;[L3]8MT"U( M6>/X-.%@^OV5IA(+7AA&" MP7Z@,=RL87O@\5-HX;^ZXS$@Z7N> = =[+945NHMP ZUV'K.4ZD) M*%3'J_092'C3M%0:]18;SW"?4ZZ;*LNG],BK"-S*X:S!4LT9-]4I00V93;,= M]C_E57]ZKPF[S( A3[%46K.0IH!01^I%3P@WZQ8;NY 6W[W'B6[5UCQHDC"( MHV"IS9V$/*Z>@ND42'/M>#Y36@=SG09K'9K*/:Z400 M&AWWX"/*F&9A@4..J@EF2H.QV, B9T@TSGC+:1YX[GF,=.MG[??Y\O J#'U] M,YL6XW_OCGO?P&V%]WX874W3C[MR0R)X"JYG-#(%*-(&RZK$20%Q-ROZTL*^ M8X9$GH;S933H@<]N9_U!MU\/$QP6.MU=7_S/*SA]1 ^^7E<3';Q@G<@ 2B)2C@N=,38#5M)J3QVLG_3O?P"WO;X^S[LPI, A31#M0$%BAZ-_6^+O)FH0:$1:["BDEI.P6N;8T^P1F4,!U_B M$<_]F)I=!10CF%\4\8B%1D8B58'"6/#]FIJ=Z6.&Q ,UNW2>J1@T$CC53EG@ M[UJS6]!RC="*UJIA)Q\3..ZOV5,1 4ASZ5+3C_$@W-T<$E(UH]-8-GV^(X'$ MGII=&ZFB-DQQD0(A =1Y+=N-LLVI"H^HV>][\WMI=N=,!.]5"IRC/()A7&MV M<&-%DP(H.E;1L(=FUSQP!-HA$.TU6+:1S;$OHVG:,X^GV>][Z?MH=F6P$RD# M33DQX/:E-76U58=U:%:HI4A+VW#8NS.86ZP%*#/.N'?!IAQ$%1@GC'+;W%?% M[RR^UWIN]SOSK6.V'4]; "EF3H!]9+GB=1Z5<<&;:\HY;::D'G;F/+WJJAA/ MX$7WI3O\?(]=9EA()#A3"!0&I\IS\ +J' KBJC'\DY,[7F+#X=J[U.X%UL)% MF291$&.B -^%U'U1:J.%T-/Y>'WI<]#Z.;A4J2VW#+"W952:ZM,J0(^#* M4HQ(K;&W+_[Z3O[]#O!:W/N 8.H/GPI,,D41O,=12R*U%S%4VT !3&DA)(") M/QQ,'V:?_KNXG'XC*/QZOSHE6F(-V/@BURYN5]2@\:T\"&M M,,(,_B.MJ,.%TC+/&BTTHM$1V<*1#P^"VS(F-((K02C7V@=LB":2@PY*T3+N M7&P.Z^#;S.^\58K MXB'WNPVAAC"PAXT&E6"<"L%((&U0="& "TU$8UX.1AM2HP^Y7]5$GDI-^KE5 M=3[;O9)'*];32#&B0<44"U3IU]%6]-809LZFPIT&P^QYP M^7:[MC!7HW2ZX_%W>+5\T)XE892DIK.(P;$4E,:NKBU' OB/34V-I0(13T;D/@YFJW5F^89<^[+I#W\L3?_,;)VZNE MU[9VV/6*_O_[M?C<'83A%+YL*;@UZT[A0+_^ZBK=7/85S-+9;M(WKO;Q_WL! M_WU]W?T\]_3GRGS+,2?V^_)?YA:!N;KJ#_KI]?)(N^8 @%A(X^8(<1R["%16 M5<-RC!@1#1.8K N(/:#8&O#U"0-_>7.&D-$%YZS25$?MT[(X7 ,?^68H6K0# M^4G1!:D'-I@OOA:#4;;"[CL-1D(2,2E_0/2!:P- M0#U4P0*!G&M&O@FACW;NVY?G1C@J-PQQ&X3U$LZ?X6T0C4$T$H]4K.WXV^/< MTVZ:AQZZXZ3%)VN3TB_7JT-W;H@10!W!:.&DT9I0)V2]?L-OVFSQ"E.FY3K0 M=YWIH3>X=5F,ICZ+;6D#\F A^5@':S1G8;I&D^X]?#R\$LQ;339#CX7^\^8X2%P2G$JV5R0(4G-MJJJ)N[U(_: M#'@+0=;NM/8 @O(,.4, VXSQ"*B:T)R(;)&[1M>&Y%^ M,D#*O;G5U^V:;JJ)!4T5"! /1M%37?7$LV#\AD2TQ TSX@2!4HY;76U:KGN9 M$TGUNY^'HPF\_A&\L)W)ZP!NN\&!6>R\2[TYI/(" S"F;RX\U/H9T-5F#JS8 M$UY\/_H.DNO[':D020G:T"-"0)1Q(UT] S48YWRSGFUMP]II07!+U[Q9=,WO MFDP0@R7! W L!U,.N#;49<6,F.;24KK>3G4R\'HWZ@^G;Z]<=UQ4[NT="8IB M"B(=/ L!ZI $Q7CE900=9;-0C+%3-:VV0F@>V$P)DQSV"6W ,\V"M#!S49T 1U9T0 M:692$5L&T$C?JK&ZA*X?NU^ M2F--1^-:(Z;:H%F._>XB+^(-N+UI*:9UAAHO9:S&;@89J&TJ1\S),P38KH&( M2!I*N+O150]Q/U' 7&/5A; EMP&@76=,Z+)#:;WBA=CP(^ ]AE2-W9 MK-#>"$.TU*S*.TEVY(P0?',U3.# L.98AKY'4G$6):>"1$)L&4 KC0[12;JAU0.Q42:K%<%[* M!KJ@P"95DEM$L#4AJP/P4YBUS;Q$HSKMY&%V+Q]/NY"FM^8%)Y8X(6A4"6Z! M$Z%U4WPIV:CT.'7 [17.4]Y928P!RR.Q*4-*V@PO!]Y/W-!*@_11IA#W@M<# MXGE6!V5QC,88A)Q"S+IDNAJ'%44*-]4CH<<9 'T8P';)?!3!E9:46_"#O'=! MZPPEJRT%_=BL:5#B:,,&!X[G<4:YY$2##8&(0(P$X;-Z%&!/8-XT(.2)6JSM MQ_,T217#)(!=88G5'$0]SKP8O=-1-H>!8G:B'E-[\3PAC:88.\HI:$E.03&6 M,%-@X8MF#)32(ZRCV5&EZE.[/9CE6(,;XRW7M)[BSB/WS;8:HHZ1,/3!:_,D M9LYP2Y'5QE-)'1A/\Y(J;QHV)O#:\84][PBF^\7S&#&,I=Y<*R+\3Y'(43TF M#YSD9J"*27RBE/20>!ZPF$J=BYZ*("/BS$E7$Q(X+LT)F.CXE/V=@+1'/$\[ M))6G('.8M$09&5V=.$E38IK3 *@X4>8Z6#C/.R[!_24@=83A+,V?KK/"X+0T M-S]3HHY55SU5-(]9HHT C]@1Y7V05M03YX,'W=^H"CK"0/O= ?C@8)Y+0_FH M2HOF@Q*&]PWF>6ZMQSZ"@<4%-YYK'J(%>U\H8WA=(*LL0PU50(ZPPNR!,+N7?T>,UMY[ MR@RSAFG)P BKB8T)UX ;8T<8RWL8X/:*Y0G'O"2I7MAR$%G:,%,+>VDP:M3- M(*(F+IH2EBM&T2%!2:GKQ3O%;(X$$/THW^L"E>9*# M&T$8&16A^E[#E<:9Z5:5EZ8"AH([WEQ*9M4#9$ M\.U P#02G4PS>GR9ECN!Z"&A/*F(0]P)F]H6 J..BI*0'/(>AV;L_#C3 ZV6 MY@6;JC@E14Q0RE1:D"-R+892()6:8Y"$Q"=*.0<+Y1$O<>0.@4\"C@C6 AF3 M01@5Y88W2ZSY<:8:GK PCR F00%*H:3S@:@T4C@7Y@G%X=]FI88Z2@OIL0KS M$!$QN<*">^,<=\##/,M[IRQ&H:$1%2$G"J_[QO*8-0)+KI PU :73(?,D][Z MJ.*FO8ZB,M=*DF;:&>T)2>IRZ7# 5@F>^N=:+BZ.,&3QZ81YQ MRF/F(@?+0D3AO90\PXT09TEL.,=*\Q.U+%HJS%/&8V4EP6F<.M/AO>*YH7.>-<>RZ(MS8B1")#63U2 MRG5H-N1(=OJ"OJU&6TQ16A)-- +_T 5@OZPCG0U!V>8^8\+EZ=M>#RW,PXD- M$57 ECH@FL919)@QQ^*&S"H]3./-?/[PNV)\-0+3.^WJ_C3H?[[C/.\54\E: MQ0VF1@9*N. 6_BT#E)X$AYHF>!IXONE.MQ^JG5LLS5R]PR/2Y,?+*0"Q?PUO M>7OU 5Z=I*A=/ZTT[XZGOCM=W2C2[F,O>J/TG/^7SOX*R5=I4_*VB$XTW@AI MJ29 4]@Z%5V-A1A,T\PG1&TT\\]8V(X%@@ %MV%!**PD]]IB;JS!TCA4Y;(] MV'-F0]_ EC%99RS<@@6\ PLA[5T,EC@3M538 V>0.2\8UBQ4!$O[+)'VQ0+9 M@07P8%A@BIH@(O$1!5 &-2\ L)MS.,!2WZCKSEBX!0MT!Q;RPB>M,$XC#6U" M@9UPQX'%US/JX6;*,_ MUC(2;KLJ?* _ZN%GA:>%%;4H#\(QQ, 5MCX@@R,!_[C$3(PF8OKBK^_$FSWQ M< >PGE%U9U-K40EAN272(XL")EY@QDPUDRX&%B0!5.&_GU'UA/;8DAW,7)H> MY#2WX/5K+'WI$X*9Q:SC9U0]M=&VR _%X*WR(G+E0]JU1K2N4148TF=4/;5E MMPCK,JHLB583%8T .R*MH:UT5;1(G%'UU.;?(BCF!=C:RN& A"78IP&.-:HH MC^A%YX])_Y=A?_"O+Z;C6?&B\^<-4-Z\:_36?15$$X(\0U0KK7E**976ON#P M8VC&'[;MJYCLQF(KZ?%]60%]O,4[(?B\]*Z\?G? ;33O(?< MSB:I(F!2O^\.-6'56W=.'^4I]>V#BH*3*!%GNH(-#4HTDB);-S <(VQNJZ;H M+JHI[@8I1&4$"PMY1X.V4KGH5 4I3C=T5F^;77YW0-TZMQ%9XYB1J6Y8)S-= M2L.H"4Y3+ AN](=LG=NXUW%.@Z8]QH%:&XDU$:0-0FGL4H(-PD#MOEDXNVT2 MX3'"IE6:%B$PBJ6@J<18!HJ,#!E23!@N30-2VR9XW1%0.V87*- 'C*=R'.:C M(IQ07'J=0N(TG/S.LPOV.LYIT'3PSKK(-&?>(>HBPE5_DQ!!;FC/W-J-?XRP M:96F5PW&_F7>,=]8,OQKO_NI/^A/O^_/!I@IQC#SREF-HW","=#W2 M>_^S+E_Y0Y'7U)IA[TUW_(\BO?G>VS[P?6: MW;S]+ \X\6TXH!I3:CV(1,D43[811GD1I%+@F-'FE%V"U*&/O,,BP")2'8U$ M$H%?3R-%H@INIDXYW%P,+]=2E@,N[[O?TDOG6'??R?_Y63*9E^*09REG3/N_3 ^>;B]]T_TC;SM=43'YFJJ!: M"]9,IN-^BL1\F(XN_U&KC47!BP8II 41$5//TYP34Z;4N-'20+%>P+VH7)]D@ M^0C*\NU-WJ,-&O.JZ$^3$BV_=RN@[P7(;8,')(D2;+V(2(A46")%90@8A:18 MMODFZ5X3T)SH+HQ\$) \*B9F<-O_*I*A4_3,5[!E/A?_!@_/H=78[8,Q.9AM M54@/1=+R;G0N/>$B[X:TGAF$>34*B!OIN5OSH !2^=Y@=:(+_9AXNA/ '@>% M^7LGC\I)2IG N0&&2K.(HG72N I+J?38;^ DK/C:H+7'@LA38.$>O-2T^:/7X,#]*UK@W4MH4<#H8;SR@$0N% M69"1L"H1[V7@46X5*C9RHZH7':0966I;O@ MXE;NXA=*G)'R,*2TR5U6:AD9X89:G9)4$J=N-.T8USJ@]26_"T0*>2'/B+PW M(INAE&6D4.2H99P&8W.U!%>\%GF,H?6=&DO0]$"EMV3@.:^+^-AE\!RD7O MMUD";K.,3?TG:]7W=4P0APT@BP3+K+6=82FRP+,X)%C%@% M 9@15CB O:ICK0;PL%68L0OR*(;XW6%U_+AK@;E6<,>L(]IR$&^," ;8L[;& MG8_KFP.7<$0HD?!Q-NX.#!_9>\>5R9B94C-1S1*G5/H!:JMC&RZ/$?=NN3[7_N]8MA[#]]Z3UT4KF\&H^]%L04]KW^+R_P4 M30A46_"2'#A(&'S5LF!)(&G]2GYVF/V3%W]M@YON"H*3@W=)5KN@[F1:QN92 MQ:!* Q:Y82(.1HK":JN!,J&4Y%DS\\%!O698+@*ZWP6*9 M6O#24)$TWMD@'J0G<67AR!G>K5%YT)('XU/3@#1!@10'E9IDN:(N4O;L->C? M1@-X3.K4.9QE3E;\7.&H(U(QSP,&6V7,V3-)GA?,'9@D*]"X02!OHW8 M5T"O#"(.$T;!>PW*:K!=*H&.H[)L,^@/3>W'!_H'R_65 @*$B"H%R M57>6ZMICZOU&+?HCTGM+PGV%WM,&*H,4$\8;HQ&F:6T)B/:\51!M=$9_.'IO MPUI?*>&(B,AHI'311RF]@U\J^ZOR'45G'<8"IU4/F"CGN<_RG0>GTCCKG:T4EPNA M- )31@.T)2<1 OHW6V4J)JY8^#0J(+%6.,Z0, MJVUW^&$+X$DK%?VG _@'2_9ED(<@,=CM+ 2-O,,@V&..K3/'E-%ALR4#M'X& M^0-I/1!LC1?>,X*<\!*'M!U.,\>IBI9M]E,1$8=RFHX0\&U8[5I,;:C1'?1.OR#/*'T3KE+. H%$B78 5& M-!*?Y3KF,6"W,<$!M*[;Z)MZ5,"_K3V"8GS9GZ05@O?OS+A'2@-[[\ S0A9K MA9 VCL1J"HU#*4^]H3"6*H%;L16W7?V1X;J['/P><$W+T)Q2&HQ"#S\#^?*J MNM5:ACW=!%?$&6^CQ>R1X;I6+U;]I7@W[E_>JW'B3M!>61WF'$Y=+5P%HR0( M:\:JXF[KG5O?$+RHKR/X@N V#,']8'(4:&B)Z%=J[+$ /:D5UX81PX6RNA(E MUC&YOLIZ@09*+P1O0VX_.1J*R4KE*^B*<7\XZ5_>>8'4JW:LLU+O_HL#U8]8_C4JOH M2%">"0Y&LR>U20&[:YY M?H#J&32WUF*=JJO8@>X#!?6T.2;P'4*6P$G07 MXX&;P(@V,IC:AQ#$;^K3Q9B<(DQ;'\KF%-A:V'MMD'384J-CY05[HX7>[@6+ M"]FB$_P44T\>9W(0I\PB*9T $.LTTHDB7<^4C!9OG=$ !9MQ(.?'L!O9]/) MM#OL]8>?;W,G6HPOK#8E&QZ%27O(02XXP[2)\UF0.FQPY51KC:^[ ' @*&\+ M6N!PFQ8T^E"IXC8J5VQ*+H:[O61R8VV;7@ M:(A69B0>%*[YU."LN7^+ \D286Q(>UW8&F7I4A3!HTAF#.QTI]5@Y(SWH89]L2@;+^A M$Q,,=&A28" R#+X5LG4$D:=)/AM'E[4R9OCI0=DR52*NK:1140R\[0*1-&U; M3%2IL0\KDV7G5$E;D9V$AY4B#X@#00K(Y!R;5%A M&^Q6CX[:/V=HJ=(X)+^W%&5;P @99\,Y%*L#8]3IO5JH3QE3J;7C!X"KO M5?EPS'AIA)./@6,TM>!Y$*^P$0$DO>("UY'@".;)UH'D_(+MEK\/ M>W#P!4C>#;H+,S _\WTZYJ^C;\6X_*E_W9_N1,$#OMQ^;W[]8C=R\V^Q_[78 M6882 U=>I%D1U!.AC)%EI%Y@HG38.IM?Z(O=6?UV0/I#HFXT&^^.$9!(M%+4 M("322G2P[2K4T;2G=2OJR 7?V>%S1MU]4?=VN)/I= 3KPNBTOAA83("9(>9, M)XW?RG3L8G<%V!EQ]T7N/LVVHDYX#/+ MM8F*F$@PQL'B&G-,T*UZ3E[0G1FO(T=[74*%%9OK=G;H_,R 3> UW' M'9&2$$.99['R%\!D"<9LRO]2LGN]:^M0_:$1>0>3TS+-E-<4Z8B8=C$&7+$B M0L;P3>6_C-*#L>$9D?4(\+I7< M'1L>[V*T!H49N/3"^("<8((941611Q^4V52"@PGF^-"8;(+UA\;D':Q6;G1P M#C-'@],:M)_P534Z"%WG-DUXP'?:*'?&Y..:K3X(0"05C")P)ZV43E8%AM&F MM71/9+:>\;BGVHD\#UI**T,=HL."J4UF MJR;R&>'Q]YN;8PV2W\5<=9)$8#@P6E%4UCJJ5!TE1Q9MCY)CI"[(SID^[<#T MA\3=73+YPB(7E,88,Y"A)DA%ZGPPB7A[)E]?R$/%5L^HNXM%JA!E2#,A)$$@ M-CT3=4 < V.AK>6<\H(>*B%\1MR=3%"BG S6,9&DI0?[$X6:Y; T6WOPS^+R M"(Q.S07!BBH?C5)I-A6J!B@ USGI^&V53X=RZL^XNXN929$SF!I*P<+D(HW- MPZK&7,!BJ[Q,51B'"JSMPMRGW5UTG];K4V];)?&Q&%_C-KN$%^E9H6.T..*@ MN7%"V.!0O:7':LQ>_/4=_CMY R;&&B@/1JS?/"MW4$>698, !13SGP M%JHW[UBB-8"3_1VC-X0]=WC>L[MU(;!16FZA"; ^]]P0@DFY3H=*+4S4/PQA M/J@8?Y'V)2EA'\#@=-Y[>+;E+H_<]E@9A=4/0ICW[V!?L#A&U%M!0S121X^ M'$6]^4;IX#)AXC?B#,>[T*5%Q!!*J")"2L&(\'6=5\#<693I4CU_:#Y47*J( MHO'48:NC=)%J(T8IL)_MO:H?#1Q*8WQS:7N\V$#%ZB$&*PA!%PUF,]*3T7Z<:-\84EUA M=A

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�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end